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ABSTRACT 
The main aims and objectives of this study was to determine if plant essential oils 
(PEOs) and polyphenol-rich fruit extracts (PRFEs) could reduce the viability of 
Giardia duodenalis trophozoites, Trypanosoma cruzi epimastigotes and 
Cryptospordium parvum oocysts in vitro. All PEOs tested reduced epimastigote and 
trophozoite viability at a concentration of 0.02% v/v, with titrations of the PEOs 
showing a concentration dependant decrease in viability. The minimum inhibitory 
concentrations (MICs) of PEOs demonstrated that myrtle and elemi oil were the most 
active PEOs (trophozoites = 0.005% v/v; epimastigotes = 0.00125% v/v) with the 
terpenes, α-pinene and limonene, constituents of these oils, being responsible for 
their action. Incubation of palmarosa oil and its terpene, geraniol, with C. parvum 
oocysts caused the almost complete excystation of oocysts (in the presence of 
increased temperature and time), with geranium oil and its terpene, citronellol, being 
nearly as effective. PRFEs reduce trophozoite viability, with 4 members of the 
Rosaceae Family causing complete reduction at 167 μg ml-1, possibly through their 
ellagitannin content. Cloudberry extract was found to have an MIC comparable to the 
drug metronidazole (67 μg ml-1). The historical use of blueberries for the treatment of 
diarrhoeal diseases was demonstrated by the ability of blueberry PRFE, pressed juice 
and drink to kill trophozoites. Protein expression was both inhibited and upregulated 
in several proteins in whole cell lysates of PEO treated trophozoites, indicating a 
supplemental intracellular mode of action. Both PEOs and PRFEs cause 
morphological changes to epimastigotes and trophozoites through flagellar truncation 
and internalisation, swelling and rounding of the cell body, cytoplasmic condensation 
and the formation of large membrane protrusions. These indicate an action on the 
membrane itself with possible changes in osmoregulation. Both PEOs and PRFEs 
can be considered to be candidates for novel drug discovery for the treatments of 
cryptosporidiosis, giardiasis and American trypanosomiasis. 
 
 
 
 
 
Key words: Giardia duodenalis; Trypanosoma cruzi; Cryptosporidium parvum; 
plant essential oils; monoterpenes; terpenic compounds; fruits; polyphenol-rich fruit 
extracts. 
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Introduction 
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Plants and their extracts have been used for many centuries as treatments for various 
ailments from headaches to parasite infections (Jones 1996), yet it has only been in 
the last 20 – 30 years or so that scientists have seriously begun to look closely at 
these plants and discover if these traditional remedies truly work and if so, how they 
work. 
 
Less than 10% of approximately 250,000 of the world’s flowering plant species have 
been tested and examined scientifically for their medicinal properties (Editorial 
1994). This means that there is a vast, untapped reservoir of potential new drugs 
available to study. Furthermore, several parasites, such as Giardia duodenalis 
(Upcroft, Upcroft and Boreham 1990; Upcroft & Upcroft 2001), Plasmodium 
falciparum (Le Bras & Durand 2003; Sibley & Hunt 2003; Wilairatana et al. 2002), 
Trypanosoma cruzi (Camandaroba et al. 2003; Filardi & Brener 1982; Sgambatti de 
Andrade et al. 1996) and Leishmania donovani (Sundar 2001; Sundar et al. 2001) are 
becoming more resistant to conventional drugs, or in the case of Cryptosporidium 
spp.  lack effective chemotherapeutics (Mead 2002; Smith & Corcoran 2004) and 
new therapies, therefore require to be found. 
 
1:1 Historical use of plants 
Most of the knowledge about the therapeutic use of plants has been through folklore 
and has been handed down by word of mouth. Other ways in which modern scientists 
can obtain such information is by examining ancient texts, such as the ancient Greek 
Dioscorides’ Materia Medica or the medieval Macer Floridus’ De Viribus Herbarum 
or Chinese herbalism. It was through this later route that a new pharmaceutical 
product was developed from the compound artemesinin, which when used in 
combination with modern synthetic chloroquine-derived compounds was found to be 
effective in the treatment of P. falciparum malaria (Simpson 2002). Artemesinin 
comes from the herb plant Artemesia annua (Figure 1.1) where use has been 
recorded since 341BC as a Chinese herbal remedy for malaria (Li & Wu 1998; 
O'Neill et al. 2001). Since the isolation of the antimalarial principle in 1970s (Li & 
Wu 1998) it has taken almost 30 years for it to become part of the World Health 
Organisation’s Essential Medicines list, especially in cases where the parasite has 
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become resistant to both chloroquine and sulphoxine-pyramethamine (Simpson 
2002). 
 
 
Figure 1.1 Sweet Wormwood (Artemesia annua) and its active constituent 
artemisinin. 
Illustration: Köhler's Medizinal-Pflanzen in naturgetreuen Abbildungen mit kurz 
erläuterndem Texte: Atlas zur Pharmacopoea germanica (Köhler's Medicinal Plants) 
1887. published in four volumes. Franz Eugen Köhler and ed. Gustav Pabst. 
Photograph: J-P Anthony (copyright© Scottish Parasite Diagnostic Laboratory 
[SPDL], Glasgow and Queen Margaret University [QMU], Edinburgh) photographed 
at the Botanic Gardens, Glasgow, 2004. 
 
Sometimes the simple aqueous infusion/decoction of the plant material can be used 
to great effect. The term decoction refers to the process where plant material (usually 
the roots or bark) is added to water and then boiled, allowed to cool and then given to 
drink, whereas an infusion is usually made when the leaves and flowering tops 
(either dried or fresh) are added to boiled water and allowed to infuse like a tea. In 
the case of malaria, a recent study using a local remedy of N’Dribala 
(Cochlospermum planchonii) roots in a decoction was shown to be effective, 
resulting in 52% of the patients reaching parasitological cure (c.f. 57% in 
chloroquine treated patients) in the treatment of uncomplicated P. falciparum 
infection in humans and was comparable to treatment with Chloroquine, but with no 
significant side effects (Benoit-Vical et al. 2003). 
 
Many of the studies being undertaken currently involve investigating the use of 
aqueous infusions or various alcoholic extracts. However, it is likely that purified 
plant essential oils may be a particularly good way of preventing and treating 
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diseases caused by parasites. Properties such as low density (around 0.94 g ml-1) and 
ready diffusion across cell membranes (due to membrane lipid solubility) may 
enhance the targeting of active constituents within the oil to intracellular parasites 
(Boyom et al. 2003). The oils and their constituents have been well characterised by 
high performance liquid chromatography (HPLC) and the suppliers of these oils have 
good quality control in regard to consistent composition and purity, due to the 
requirements of the food and aromatherapy industries. As the oils lack contaminants 
and because they are ‘clean’, then it is easy to separate the compounds within the oils 
on HPLC or gas liquid chromatography (GLC). A major advantage of using oils, 
especially those which are commercially sourced, is that it is possible to get the same 
batch from suppliers over long periods of time. It is now possible to make synthetic 
oils, with many of the constituents being characterised and synthesised in the 
laboratory. 
 
Although the greatest amount of research concerning the effects of plants on parasite 
infections has been carried using aqueous or alcoholic extractions some, work has 
been undertaken using plant oils. 
 
1:2 Antiparasitic effects of plant essential oils (PEOs) 
Generalised parasiticidal actions 
Of the plant essential oils available and currently used only one has been investigated 
for actions against multiple prokaryotic or eukaryotic organisms. Garlic oil has a 
multitude of effects including antibacterial, antifungal, antiviral and antiparasitic 
(Ankri & Mirelman 1999). As a parasiticidal compound, it affects the growth of over 
12 different parasites by cysteine proteinase inhibition and parasite proliferation by 
the inhibition of phosphatidyl choline (PC) synthesis. The allicin constituent of garlic 
(Figure 1.2) inhibits the growth of Entamoeba histolytica at concentrations of 30 µg 
ml-1 in vitro (Ankri & Mirelman 1999; Mirelman, Monheit and Varon 1987) with 
lower concentrations able to inhibit the virulence of trophozoites by 90% as 
measured by the ability to destroy baby hamster kidney (BHK) cell monolayers in 
vitro (Ankri et al. 1997). This and other garlic oil constituents inhibit the growth of 
other protozoan parasites including: G. lamblia (syn. intestinalis and duodenalis), 
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Leptomonas colosoma, Crithidia fasculata (Ankri & Mirelman 1999; Lun et al. 
1994), Cryptosporidium baileyi (Sreter, Szell and Varga 1999), Tetratrichomonas 
gallinarum, Histomonas meleagridis (Zenner et al. 2003), G. intestinalis (Harris et 
al. 2000), P. berghei (Perez, De la Rosa and Apitz 1994), T. brucei brucei, T. b. 
rhodesiense, T. b. gambiense, T. evansi, T. congolense, T. equiperdum (Lun et al. 
1994) and T. cruzi (Urbina et al. 1993). 
 
 
Figure 1.2 Garlic (Allium sativum) and its main constituent allicin with its 
condensation product ajoene.  
Illustration: Medical botany, William Woodville. Published by James Phillips, 
London, 1793, Vol. 3. Photograph: J-P Anthony (copyright© SPDL and QMU) 
photographed at the Botanic Gardens, Glasgow, 2004. 
 
The mode of action of allicin and its condensation product, ajoene, have both been 
investigated. Reported mechanisms of action include interaction with important 
thiol-containing enzymes (Ankri & Mirelman 1999). The specific enzymes vary from 
organism to organism but in the case of E. histolytica, allicin inhibits cysteine 
proteinases, alcohol dehydrogenases (Ankri et al. 1997) and thioredoxin reductases 
(Ankri & Mirelman 1999). Ajoene can inhibit T. cruzi proliferation by possible 
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inhibition of PC biosynthesis (Urbina et al. 1993). Allicin was also found to be toxic 
to mammalian cells but at a concentration of greater than 100 µg ml-1 (c.f. 5 µg ml-1 
for E. histolytica) (Ankri et al. 1997). This difference may be explained by 
mammalian cells having a much higher level of glutathione than microbial cells 
allowing the cell to reactivate enzymes inhibited by allicin (Rabinkov et al. 1998). 
The modes of action of these constituents of garlic oil have only been investigated in 
E. histolytica and T. cruzi, but they may act in similar ways in other parasites. 
 
Of the oils shown in Table 1.1, oregano and basil have been shown to be effective 
against more than 2 parasites. In human trials, the emulsified oil of oregano was 
given orally to volunteers for 6 weeks which resulted in the clearance of E. 
hartmanni, Endolimax nana and Blastocystis hominis (Force, Sparks and Ronzio 
2000). When given in the feed of broiler chickens infected with Eimeria tenella, oil 
of oregano exerted an anticoccidial effect although this was lower than that of the 
favoured drug, Lasalocid®. 
 
Treatment of head lice (Pediculus humanus capitis) with oregano oil as a 1% 
solution diluted in water produced 100% mortality in adults, when followed by a 
rinse mixture of the oil (0.1%), malt vinegar (49.5%) and water (49.5%) 17 h later 
and a 99.3% mortality for eggs (Veal 1996). The adult mortality rate was found to be 
the same for thyme oil (100%) but with a much lower activity against eggs (50.8% 
mortality). Essential oil isolated from thyme has also been found to inhibit the 
growth in vitro of T. b. brucei at a level comparable to the drug Suramin®. The 50% 
Effective Dose (ED50, that quantity of oil required to produce a specified effect in 
50% of the animal population) was 0.4 µg ml-1 for thyme oil and 0.5 µg ml-1 for 
Suramin® (Mikus et al. 2000). When thyme oil was tested in vitro with G. lamblia 
cysts, it’s effect following a 60 min exposure, was comparable to the drug 
metronidazole (lethal effect = thyme oil 91.1%; metronidazole 89.4%) (Sahebani, 
Farsangi and Movahed 2004). 
 
Basil oil inhibits the growth of T. cruzi epimastigotes in vitro with a 50% Inhibitory 
Concentration (IC50, that quantity of oil required to inhibit 50% in the growth or 
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viability of a population) determined to be 102 μg ml-1 and lysis of trypomastigotes 
at an IC50 of 467.5 μg ml-1. Following treatment with basil, epimastigotes examined 
under scanning electron microscopy (SEM) showed no apparent changes to the 
plasma membrane but morphological changes to the cell body was exhibited with 
basil treated cells being rounded when compared to untreated controls (Santoro et al. 
2007b). This would indicate that basil does not exert an effect via direct interaction 
with components of the plasma membrane but with the intracellular organelles. This 
oil and its major constituent, eugenol, were also found to inhibit H. contortus ova 
from hatching in vitro (Pessoa et al. 2002). When given orally to mice infected with 
P. berghei, basil oil suppressed parasitaemia by up to 77.8 % at 500 mg/kg/day, 
although this was far lower than that obtained with chloroquine given at a dose of 10 
mg/kg/day (100 % suppression; Tchoumbougnang et al. 2005). 
 
In vivo experiments in chickens have shown that both cinnamon and lemon oil have 
anti-flagellate activity against T. gallinarum and H. meleagridis (Zenner et al. 2003) 
(Table 1.1 and 1.3). The effective minimal lethal concentration of cinnamon oil used 
on both parasite species was determined to be 0.25 µl ml-1 and 0.5 µl ml-1 
respectively, with that of lemon oil being 0.125 µl ml-1 and 1 µl ml-1 respectively 
(Zenner et al. 2003). In addition to this anti-flagellate activity, cinnamon also has 
insecticidal actions with 10 mg g-1 of the essential oil impregnated filter paper, fed to 
termites (Coptotermes formosanus), killing them all within 7 days (Chang & Cheng 
2002). The active constituent of the oil, cinnamaldehyde, was more effective at lower 
concentrations (1 mg g-1) than the oil (Chang & Cheng 2002). Cinnamon oil when 
used as a treatment for P. humanus capitis in the manner described for oregano and 
thyme, also caused louse mortality but was not as effective (adults: 86%, eggs: 
25.7%) although 100% mortality rates were achieved when ethanol was used as a 
solvent in the pre-rinse mixture. The concentration of ethanol used did not to 
contribute to the lethality of cinnamon oil and that the phenolic compounds within 
the oil may be responsible for the lousicidal actions exhibited, possibly through 
neurotoxicity (Veal 1996). 
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Lemon balm, also known as balmint, has been tested in vitro against T. brucei and L. 
major both of which have conventional treatments available but are currently 
expensive or have strong side effects. The essential oil was found to inhibit the 
growth of T. brucei (ED50 3.9 µg ml-1; Suramin ED50 0.5 µg ml-1) and L. major (ED50 
7 µg ml-1; amphotericin B ED50 0.3 µg ml-1) (Mikus et al. 2000). When tea tree oil 
(TTO) was used in these experiments the results for T. brucei inhibition indicated 
that this oil might be an alternative to Suramin® for the treatment of trypanosomiasis 
(ED50 0.5 µg ml-1 for both compounds). One of the major constituents of TTO is 
terpinen-4-ol which has a greater inhibitory action on the blood stream forms of T. 
brucei (ED50 0.02 µg ml-1) and was over a 1000 fold more toxic to the parasite than 
the human cell line HL-60 (Mikus et al. 2000). It was proposed that a deeper 
investigation of these compounds trypanocidal activity should be undertaken to 
determine their effectiveness as a new drug therapy. 
 
Antitrypanosomal activity of PEOs 
Again garlic appears to be the most active compound, with the constituent allicin 
being of particular importance (Table 1.1). The chemically stable transformation 
product of allicin is diallyl trisulphide (DAT) and is effective in inhibiting the growth 
of the many species of the bloodstream form of trypanosomes, especially those 
responsible for African trypanosomiasis (Lun et al. 1994). These include T. brucei 
brucei, T. b. rhodesiense, T. b. gambiense, T. evansi, T. congolense and T. 
equiperdum with DAT inhibiting growth at concentrations comparable to the 
commercial drug Suramin® (trypanosome IC50 = 0.8 - 5.5 µg ml-1 (4.5 – 31 µM); 
Suramin® IC50 = 10 µM; Lun et al. 1994). This compound has been reported to have 
been used in China for the treatment of many diseases, such as bacterial and fungal 
infections, with only mild side effects (Lun et al. 1994). A condensation product of 
allicin is effective against both the epimastigote amastigote forms of T. cruzi to an 
even greater degree. Ajoene immediately inhibits the proliferation of epimastigotes at 
a concentration of 80 µM, reducing their proliferation by 50% with 40 µM and 
causing cell lysis within 24 h with 100 µM (Urbina et al. 1993). Concentrations as 
low as 40 µM were enough to completely eliminate T. cruzi amastigotes from Vero 
cells in vitro within 96 h. The inhibition of epimastigote growth was accompanied by 
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changes in phospholipid composition of the parasite cell membrane, causing the 
previously most abundant phospholipids (PC) to become the least abundant and their 
immediate precursor (phosphatidylethanolamine) becoming the most abundant. This 
suggests that ajoene exerts its effects by inhibiting the final stage of PC biosynthesis 
and alters the phospholipid composition of the cell. This was observed ultra 
structurally with a concentration dependent alteration in intracellular membranous 
structures (Urbina et al. 1993). Garlic with its trypanocidal actions may yet be used 
as an alternative treatment for trypanosomiasis, especially African trypanosomiasis, 
considering that the drugs currently in use for the later stages of this disease are 
extremely toxic (Sibley & Hunt 2003). 
 
The essential oils of lemon balm, peppermint, thyme, TTO and the African plant 
Strychnos spinosa have also been tested in vitro for activity against T. brucei with 
varying degrees of success (Table 1.1). Of these oils, TTO has the most trypanocidal 
activity followed by thyme, peppermint and finally lemon balm (Mikus et al. 2000). 
All the oils tested showed a much greater toxicity for the parasite than for the 
mammalian cell suggesting that these oils could be a source of novel drugs which 
could be directed specifically against the parasite. This was also shown in the same 
series of experiments when the terpene compounds of these oils were also tested. In 
this case only terpinen-4-ol from TTO had a relatively high trypanocidal activity 
with a selectivity of 1000, which is within the range of commercially available drugs 
such as Suramin® (Mikus et al. 2000). 
 
The leaves of Strychnos spinosa are used in African traditional medicine for the 
treatment of African trypanosomiasis. An essential oil and its constituents have been 
tested against the bloodstream form of T. brucei in vitro and also against the murine 
J774 macrophage (Hoet et al. 2006). The oil itself, whilst effective against the 
parasite (IC50 = 13.5 µg ml-1) was sadly found not to be selective for the parasite 
alone (selectivity index (SI) = 4.4). However, constituents of the oil (E-nerolidol and 
linalool) were found not only to have a more potent effect on the parasite but also a 
more selective one (IC50 = 1.7 and 2.5 µg ml-1; SI = 35.7 and > 40 respectively). 
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These 2 terpenes show promise as novel drug candidates and require further in vitro 
and in vivo testing. 
 
Thyme essential oil and its major constituent thymol have also been more recently 
investigated for effects on both the insect and bloodstream forms of T. cruzi (Table 
1.1). Both were found to inhibit the growth of epimastigotes after 24 h incubation in 
vitro (Thyme oil IC50 = 77 µg ml-1; Thymol IC50 = 62 µg ml-1) and also had higher 
trypanocidal effects with trypomastigotes over the same incubation period (Thyme 
oil IC50 = 38 µg ml-1; Thymol IC50 = 53 µg ml-1). Although morphological analysis 
of the parasites SEM showed little alteration at the plasma membrane, transmission 
electron microscopy (TEM) showed cytoplasmic swelling with occasional 
morphological alteration in both the plasma and flagellar membrane (Santoro et al. 
2007a). In addition the oils of basil, clove, lemon grass, oregano and yarrow have 
also been tested against T. cruzi epimastigotes and trypomastigotes and exhibit a 
range of IC50 from 77 – 145.5 µg ml-1 for epimastigotes and 15.5 – 467.5 µg ml-1 for 
trypomastigotes (Santoro et al. 2007a, 2007b and 2007c). 
 
Anticoccidial and antiflagellate activity of PEOs 
Again garlic has been shown to have important parasiticidal actions (Table 1.1), with 
activity against the coccidian parasite C. baileyi (Sreter, Szell and Varga 1999), the 
poultry flagellates T. gallinarum and H. meleagridis (Zenner et al. 2003) and the 
human pathogenic flagellate G. intestinalis (Harris et al. 2000; Lun et al. 1994) being 
observed.  When tested in chickens, an extract of garlic was found to be only 
partially effective with a 24.4% reduction in Cryptosporidium oocyst output. The 2 
commercially available derivatives of the anticoccidial drug triazinone fared no 
better. It was concluded that none of the drugs could be recommended for 
chemoprophylaxis or therapy of cryptosporidiosis in chickens (Sreter, Szell and 
Varga 1999). Garlic’s antiflagellate activity, however, is far more encouraging. In G. 
intestinalis, both whole garlic extract and its constituents have definite antigiardial 
effects, causing a loss of flagellar movement and motility, loss of osmoregularity, 
disc fragmentation and flagellar internalisation (Harris et al. 2000) and growth 
inhibition (Lun et al. 1994). Although T. gallinarum and H. meleagridis are both 
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killed by garlic (Zenner et al. 2003) the mechanism of action has yet to be 
determined. The same effect is also observed with both the oils of Cinnamon and 
Lemon (Zenner et al. 2003). When oil of oregano was given in their feed to chickens 
experimentally infected with the coccidian parasite Eimeria tenella excretion of 
oocysts was reduced and an increase in survival was observed (Giannenas et al. 
2003). Although these effects were less than lasalocid, it may be that this oil can be a 
source of novel anticoccidial drugs. 
 
1:3 Toxicity of PEOs 
As with any chemotherapeutic compound, there can be side effects or toxicity, 
usually at concentrations greater than therapeutic doses. Generally plant oils are well 
tolerated in humans and animals (Tisserand & Balacs 1995), although there can be 
differences in this tolerance between species. However, although most oils are well 
tolerated with only mild side effects, some are not recommended for internal or 
external use such as the oil from the bark of cinnamon and lemon oil for external use 
as it is known to be phototoxic (Tisserand & Balacs 1995). A summary of toxic oils 
can be seen in Table 1.2. 
 
Cytotoxicity 
Many of the oils that affect parasites also exhibit either in vivo or in vitro toxicity to 
varying degrees. This toxicity can be mild or the selectivity of the oil is such that the 
parasite is affected to a greater degree than the host. For example the active 
constituents of garlic have wide ranging antiparasitic effects (Ankri et al. 1997; 
Ankri & Mirelman 1999; Harris et al. 2000; Lun et al. 1994; Mirelman, Monheit and 
Varon 1987; Perez, De la Rosa and Apitz 1994; Urbina et al. 1993; Zenner et al. 
2003), can be both cytotoxic and genotoxic in vitro (Musk, Clapham and Johnson 
1997) and are lethal if given intragastrically to rats causing pulmonary oedema 
(Joseph, Rao and Sundaresh 1989). However, if the oil of garlic is given orally to rats 
at the same concentrations, it is not toxic (Joseph, Rao and Sundaresh 1989). 
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Table 1.1 Plant oils with known action against parasites. 
 
? = Name unknown  
 
FAMILY BOTANICAL NAME 
VULGAR 
NAME 
PARASITE(S)  
AFFECTED 
Alliaceae Allium sativum Garlic G.  duodenalis (syn. intestinalis 
and lamblia), L. major, L. 
colosoma, C. fasculata, 
Cryptosporidium spp., T. 
gallinarum, H. meleagridis, P. 
berghei, T. brucei brucei, T. b. 
rhodesiense, T. b. gambiense, T. 
evansi, T. congolense, T. 
equiperdum, T. cruzi, E. 
histolytica 
Annonaceae Hexalobus 
crispiflorus 
Pachypodanthium 
confine 
Xylopia aethiopica 
 
Xylopia phloidora 
? 
 
Bohingo 
 
African Guinea 
Pepper 
Bolando 
P. falciparum 
 
P. falciparum 
 
P. falciparum 
 
P. falciparum 
Asteraceae Achillea millefolium Yarrow T. cruzi 
Chenopodiaceae Chenopodium 
ambrosioides 
Epazote / Jesuit’s 
Tea 
L. amazonensis 
Cochlospermaceae Cochlospermum 
planchonii 
False Cotton / 
N’Dribala 
P. falciparum 
Euphorbiaceae Antidesma 
laciniatum 
Croton cajucara 
? 
 
Sacaca 
P. falciparum 
 
L. amazonensis 
Lamiaceae Melissa officinalis 
Ocimum 
gratissimum 
Ocimum sanctum 
Oreganum vulgare 
 
 
 
Tetradenia riparia 
Thymus vulgaris 
Lemon Balm 
Wild / African 
Basil 
Sacred 
Balm/Basil 
Oregano 
 
 
Nutmeg Bush 
Thyme 
T. brucei, L. major  
P. berghei, H. contortus, T. cruzi 
C. elegans 
E. hartmanni, E. nana, B. 
hominis, P. humanus capitis,  E. 
tenella, T. cruzi 
 
 
P. falciparum 
P. humanus capitis,  T. cruzi, G.  
duodenalis 
Lauraceae Cinnamomum 
zeylanicum 
Cinnamon T. gallinarum and H. meleagridis 
Loganiaceae Strychnos spinosa Spiny Monkey 
Orange 
T. brucei 
Myristiceae Virola surinamensis Light Virola P. falciparum 
Myrtaceae Melaleuca 
alternifolia 
Syzygium 
aromaticum 
Tea Tree 
 
Clove 
T. brucei 
 
T. cruzi 
Poaceae Cymbopogon 
citratus 
Lemon Grass P. berghei, T. cruzi 
Ranunculaceae Nigella sativa Black 
Seed/Cumin 
Schistosoma mansoni 
Rutaceae Citrus limon Lemon T. gallinarum and H. meleagridis 
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Table 1.2 Plant oils that demonstrate cytotoxic activity. 
FAMILY BOTANICAL 
NAME 
VULGAR 
NAME 
REF. 
Alliaceae Allium sativum Garlic (Joseph, Rao and Sundaresh 
1989; Musk, Clapham and 
Johnson 1997) 
Annonaceae Pachypodanthium 
confine 
Bohingo (Boyom et al. 2003) 
 Xylopia 
aethiopica 
African Guinea 
Pepper 
(Boyom et al. 2003; Gonzalez-
Coloma et al. 2002; Nakanishi 
et al. 2003; Zeng et al. 2003) 
Cochlospermaceae Cochlospermum 
planchonii 
False Cotton/ 
N’Dribala 
(Benoit-Vical et al. 1999; 
Benoit-Vical et al. 2003; 
Vonthron-Senecheau et al. 
2003) 
Euphorbiaceae Antidesma 
laciniatum 
? (Boyom et al. 2003) 
 Croton cajucara Sacaca (Anazetti et al. 2003; Freire et 
al. 2003; Rodriguez & Haun 
1999; Agner et al. 2001 and 
1999) 
Lamiaceae Melissa 
officinalis 
Lemon Balm (Ballard et al. 2002; Mikus et 
al. 2000) 
 Menthe piperita Peppermint (Gaworski et al. 1994; Lazutka 
et al. 2001; Nair 2001; 
Spindler & Madsen 1992; Vo, 
Chan and King 2003) 
 Thymus vulgaris Thyme (Haroun, Mahmoud and Adam 
2002; Wang et al. 1999) 
Myriceae Eucalyptus 
globulus 
Eucalyptus (Darben, Cominos and Lee 
1998; De Vincenzi et al. 2002; 
Gouin & Patel 1996; Patel & 
Wiggins 1980; Schnitzler, 
Schon and Reichling 2001) 
Myristicaceae Myristica 
fragrans 
Nutmeg (Banerjee et al. 1994; 
Hallstrom & Thuvander 1997; 
Janssens et al. 1990; Pecevski 
et al. 1981; Sangalli & Chiang 
2000) 
Myrtaceae Eugenia 
caryophyleta 
Clove (Abdo et al. 2001; Simpson 
1998) 
 Melaleuca 
alternifolia 
Tea Tree (Del Beccaro 1995; Jacobs & 
Hornfeldt 1994; Schnitzler, 
Schon and Reichling 2001; 
Soderberg, Johansson and Gref 
1996) 
Ranunculaceae Nigella sativa Black Seed/ 
Cumin 
(Mansour et al. 2001; Worthen, 
Ghosheh and Crooks 1998; 
Zaoui et al. 2002; Ali & 
Blunden 2003) 
Zingiberaceae Curcuma longa Turmeric (Chan, Chi-Tang and Hsing 
1995; Deshpande et al. 1998; 
Kandarkar et al. 1998) 
 
? = Name unknown. 
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Similar findings occurred when testing the N’Dribala plant. A decoction of roots 
given to human volunteers with uncomplicated P. falciparum infections caused no 
significant side effects (Benoit-Vical et al. 2003) but, in vitro, the essential oil was 
cytotoxic to K562 cells (a human erythroblastic cell line) IC50 = 860 – 950 µg ml-1 
(Benoit-Vical et al. 2003). This was, however, far lower than the reported IC50 value 
of the oil against the parasite (22 – 35 µg ml-1) (Benoit-Vical et al. 2003).   
 
Eucalyptus oil, sometimes known as camphor oil and its major constituent eucalyptol 
has been given “Generally Recognised as Safe” status by the Flavour and Extract 
Manufacturer’s Association (FEMA) and is approved by the FDA for food additive 
use (De Vincenzi et al. 2002). However, the oil is also widely regarded as being 
extremely toxic if ingested, causing central nervous system (CNS) depression 
(fatigue, loss of consciousness, headaches, decreased alertness) and tonic-clonic 
seizures rapidly following its ingestion (Gouin & Patel 1996; Patel & Wiggins 1980). 
Toxicological data for humans show a minimum lethal dose of 50 mg kg-1 which is 
500 times greater than the proposed total daily intake limit of 0.1 mg kg-1 eucalyptol 
(De Vincenzi et al. 2002). This oil may also be useful as an antiviral being 3 times 
more toxic to herpes simplex virus (HSV) types 1 and 2 than to RC-37 cells (African 
green monkey kidney cells) (Schnitzler, Schon and Reichling 2001). 
 
Of the plant essential oils commonly used, TTO is probably the best known. It has 
been tested extensively by scientists for its antibacterial and antifungal effects with 
work now being carried out on its potential as an antiparasitic and antiviral agent. 
This oil is considered to be non-poisonous and as such is freely available ‘over the 
counter’ in chemists as an herbal remedy (Soderberg, Johansson and Gref 1996). 
TTO has not been shown to be cytotoxic in vitro to human epithelial and fibroblast 
cells (Soderberg, Johansson and Gref 1996). Only at concentrations greater than 100 
µg ml-1 did cell viability rapidly decline, which was thought to be due to its lipophilic 
character, with the oil interacting with cellular membranes, disrupting normal 
membrane activity (Soderberg, Johansson and Gref 1996). Its use internally however, 
should be avoided as the ingestion of less than 5 ml by children under the age of 24 
months has caused severe poisoning with ataxia and a drowsiness with difficulty to 
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arouse, until the stomach was cleared of oil (Del Beccaro 1995; Jacobs & Hornfeldt 
1994). 
 
During the course of investigating antiplasmodial actions of various Cameroonian 
essential oils (Pachypodanthium confine, Antidesma laciniatum, Xylopia aethiopica, 
X. phloiodora and Hexalobus crispiflorus) in vitro all were found to be effective 
against P. falciparum, however, 2 plants were found to have high IC50 values 
indicating their toxicity to erythrocytes (Boyom et al. 2003). These oils were from P. 
confine and A. laciniatum. An essential oil that showed similar properties was 
African Guinea Pepper (X. aethiopica) and the major constituent of this oil, 
acetogenin, which is common to the Annonaceae family of plants, has been tested for 
its anti-tumour activities. The acetogenins and their analogues have shown 
remarkable selective cytotoxicity against human tumour cells (Nakanishi et al. 2003; 
Zeng et al. 2003). Some of the acetogenins have actions that have been characterised 
to be mitochondrial complex I inhibitors having cytotoxic effects on a panel of 
tumour cell lines, including the multidrug resistant cell SW480, selective cytotoxicity 
to insect Sf9 cells (Fall armyworm [Spodoptera frugiperda] pupal ovarian cells) and 
also antitrypanosomal action (Gonzalez-Coloma et al. 2002). Other acetogenins have 
had their cytotoxicity to human cancer cell lines evaluated as being DNA 
topoisomerase I poisons (Lopez-Lazaro et al. 2001). 
 
The diterpene compounds from Croton cajucara (Sacaca) such as dehydrocrotonin 
and its analogues exhibit potent antineoplastic properties in that they induce terminal 
differentiation in the target cancerous cell and, hopefully, trigger apoptosis. In one 
test system, dimethylamide-crotonin and its parent compound dehydrocrotonin 
inhibited the growth of leukaemic HL60 cells in vitro without causing serious 
damage to human peripheral blood mononuclear cells (Anazetti et al. 2003). In 
further tests using the same cells, the cytotoxic reaction was explained to be due to 
adduct formation with DNA and proteins and/or oxidative stress induction (Freire et 
al. 2003). 
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Lemon balm has been examined for both its antiparasitic effects and its cytotoxic 
effects on HL60 cells. When tested it was found to have a 3.6 – 6.5 fold greater 
selectivity for T. brucei and L. major than to HL60 as evaluated using the Alamar 
blue assay (Mikus et al. 2000). The oil was also shown to be without any significant 
side effects when used to treat agitation in severe dementia (Ballard et al. 2002). 
 
Thyme, commonly used in the kitchen, when given to rats in their diet, was found to 
have no toxic effects even when 10% of their diet constituted of thyme leaves 
(Haroun, Mahmoud and Adam 2002). However, the acetophenone glycosides 
isolated from a butanol soluble fraction of thyme extracts have shown weak 
cytotoxicity to human leukaemic cells in vitro, the mode of action being through 
DNA synthesis inhibition (Haroun, Mahmoud and Adam 2002; Wang et al. 1999). 
Not all essential oils appear to have such adverse effects. Some will be protective 
such the oil of black seed / black cumin (Nigella sativa) and its constituents. This oil 
has been shown to be hepatoprotective where liver injury was induced in mice by 
carbon tetrachloride poisoning (Mansour et al. 2001). High LD50 values (the dose 
which kills 50% of the animals tested) in rats and mice given the oil acutely and 
chronically suggest a low toxicity of the oil, although chronic administration can 
significantly increase haematocrit and haemoglobin levels in the rat as well as 
lowering its leukocyte and platelet count (Zaoui et al. 2002). In general, this oil has 
hepatoprotective effects and can help protect against the chromosomal aberrations 
induced as a result of Schistosoma mansoni infection (Aboul-Ela 2002) and may be 
protective in this disease by modulating the immune response and reducing 
inflammation (Mahmoud, El-Abhar and Saleh 2002). Some possible protective 
effects of nutmeg oil are its ability to affect enzymes associated with activation and 
detoxication of chemical carcinogens and mutagens.  When gavaged in mice over 14 
days, oil of nutmeg increased levels of cytochrome P450 significantly and aryl 
hydrocarbon hydroxylase activity was significantly reduced. Enzyme activities that 
were also elevated by this oil include glutathione S-transferase and acid-soluble 
sulphydryl (Banerjee et al. 1994). 
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Dermatological reactions 
Many plant oils are used safely in aromatherapy where they are often in contact with 
the skin, although few oils have actually been tested thoroughly for dermatological 
reactions, with dermatitis or other allergic reactions usually reported in the worst 
instances. As some oils may have possible antiparasitical effect on the skin (the 
destruction of T. cruzi epimastigotes around the bite wound of the Reduviid bug) the 
potential for adverse reactions need to be investigated. 
 
Eucalyptus oil has been used safely on the skin, however, excessive topical 
application of the oil can lead to a loss of consciousness, ataxia and muscle weakness 
which can be reversed by removal of the oil (Darben, Cominos and Lee 1998). In an 
experiment to treat human facial demodocidosis, eucalyptus oil was used topically in 
concentrations of 25 – 100% with no side-effects reported suggesting that the topical 
application of the oil needs to be widespread for its toxic effects to be shown (Morsy, 
Morsy and Sanand 2002). 
 
TTO has been shown to reduce inflammation induced by histamine in human skin 
when applied topically, with no adverse reactions (Koh et al. 2002) and also reduces 
the histamine induced oedema in murine ears through the suppression of further 
histamine release (Brand et al. 2002). Conversely, contact dermatitis is not an 
uncommon occurrence with TTO topical administration with 4 out of 105 human 
patients experiencing moderate to severe dermatitis in TTO treatment of Tinea pedis 
(Satchell et al. 2002). However, there were no reported adverse reaction when TTO 
was used to treat head lice (Veal 1996) indicating that the majority of people will not 
experience allergic reactions to this oil and only a small, but significant minority 
being afflicted (Tisserand & Balacs 1995). 
 
The use of lemon oil topically should be avoided (Tisserand & Balacs 1995). This 
product contains furocoumarin derivatives that are known to induce photoxicity. Of 
these, bergapten is the most toxic, followed by oxypeucedanin, which causes photo 
pigmentation on coloured guinea pig skin without preceding visible erythema 
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(Naganuma et al. 1985). Due to the phototoxic nature of lemon oil, no more than a 
2% solution can be applied externally to the skin (Tisserand & Balacs 1995). 
 
1:4 Parasites investigated 
Three parasites covering 2 different phyla were used in this study to investigate the 
antiparasitical actions of 12 plant essential oils (Appendix 1) and 11 soft fruit 
extracts (Appendix 2). The parasites investigated represent 3 organisms from the 
World Health Organisations (WHO) neglected diseases initiative which was 
organised to provide improvements to the health and quality of life for people 
affected by diseases with expensive and/or lengthy treatment regimens. As these 
diseases predominantly afflict the very poor, there is no adequate incentive for 
research and development by pharmaceutical companies (WHO 2003; Savioli, 
Thompson and Smith 2006). The parasites investigated are shown in Table 1.3 and 
further described in the text. 
 
Table 1.3 Parasites used in experiments. 
PHYLUM FAMILY NAME DISEASE 
Sarcomastigophora  Trypanosomatidae Trypanosoma cruzi American 
trypanosomiasis 
Sarcomastigophora  Hexamitidae Giardia duodenalis Giardiasis 
Apicomplexa Cryptosporidiidae  Cryptosporidium 
parvum 
Cryptosporidiosis 
 
 
1:5 Giardia duodenalis 
The flagellated protozoan parasite G. duodenalis was first observed by Antony van 
Leeuwenhoek in 1681 by investigation of his diarrhoeic stools. G. duodenalis (syn. 
G. lamblia and G. intestinalis) is a simple binucleated, unicellular organism having a 
world wide distribution (Ortega & Adam 1997). It is estimated that 280 million 
humans are infected every year and is the most common intestinal infection in the 
developed world (Lane & Lloyd 2002; Olson, Ceri and Morck 2000).  In developing 
countries in Asia, Africa and Latin America, an estimated 200 million people have 
symptomatic giardiasis with 500,000 new cases reported each year (Lane & Lloyd 
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2002). With industrialised nations, such as the United States of America (USA or 
US), between 2 – 5% of stool samples submitted for examination can be infected 
with this organism. In less industrialised countries this Figure can reach 20 – 30% 
(Marshall et al. 1997; Ortega & Adam 1997). 
 
Giardia has 2 major stages in its life cycle, a replicative trophozoite stage and an 
infective cyst stage. Infection begins with the ingestion of environmentally resistant 
and infective cysts. After passage through the acidic environment of the stomach and 
into the proximal small intestine, excystation occurs, releasing 2 trophozoites. The 
free swimming trophozoites reproduce by binary fission and infect the upper part of 
the small intestine, particularly the duodenum of their vertebrate hosts, by attachment 
to the surface of the intestinal wall.  Passage of trophozoites to the large colon causes 
the initiation of encystment in the presence of biliary secretions and slight alkalinity.  
The environmentally robust cysts are shed in the faeces and are able to infect other 
hosts upon ingestion.  
 
Trophozoite morphology 
The trophozoite of G. duodenalis (Figure 1.3 A, B and C) has a pyriform 
morphology which measures 12 – 15 µm in length, 5 – 9 µm wide, with a rounded 
anterior end and a pointed posterior end that terminates in 2 flagella (Adam 2001). It 
is binucleated and bilaterally symmetrical with the 2 oval nuclei located in the 
anterior end of the parasite (Figure 1.3 A). This provides the parasite, when viewed 
dorsally under light microscopy, with the appearance of a ‘face’. The parasite is 
dorsoventrally flattened with a convex dorsal surface. Ventrally, the trophozoite 
surface has a concave, bilobed adhesive disc (ventral disc) which when applied to the 
host’s intestinal cell wall, working in conjunction with the ventral flagella, is 
responsible for this organisms’ ability to further strongly adhere to the host cell 
surface (Figure 1.3 B & C). This pair of flagella, along with three further pairs of 
flagella – the anterior, posterior and caudal flagella – arise from kinetosomes located 
between the anterior portions of the 2 oval nuclei, which are themselves found in the 
anterior end of the parasite (Figure 1.3 A). The flagellate swims rapidly, swaying 
from side to side like a falling leaf, a motion also known as ‘skipping’. 
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Figure 1.3 Trophozoites of Giardia duodenalis. 
Live trophozoites were isolated in vitro from axenic cultures and viewed under 
brightfield microscopy (x1000 mag) in ventral view (C) and dorsal view (A) and 
ventrally under scanning electron microscopy (B). The parasites show classical 
pyriform morphology and the flagella can be clearly seen in all panels (fl) with the 
dual nuclei visible in dorsal view (Panel A; nu). The ventral disc is also visible in 
panel C (sd) and in panel B with the ventral flagella easily visible. SEM image 
courtesy of the Centres for Disease Control and Prevention (CDC) and Dr. J. Carr. 
Brightfield microscopy images by J-P Anthony (copyright© SPDL). 
  
 
Cyst morphology 
The cyst is produced in the lower bowel and cysts occur in large numbers in the 
stool. They are oval, measuring approximately 5 by 7 to 10 µm in diameter. 
Encystation occurs after the trophozoite has undergone nuclear division but before 
cytokinesis, thus providing the cyst with a single trophozoite containing 4 nuclei 
(Figure 1.4) and capable of rapidly completing cytoplasmic division upon 
excystation, producing 2 trophozoites faster than with a normal replication cycle. 
 
A web-like filamentous layer comprises the outer cyst wall with each filament being 
7 – 20 nm in diameter (Erlandsen et al. 1990; Erlandsen, Bemrick and Pawley 1989) 
and comprising of four major proteins, 29, 75, 88 and 102 kDa in size (Erlandsen et 
al. 1990) 2 of them being known as cyst wall proteins (CWP) 1 and 2. Underlying 
this filamentous outer cyst wall is a double membranous layer, the inner membrane 
layer being separated from the outer membrane by a thin layer of cytoplasm and 
these membranes separated from the trophozoite plasma membrane by a peritrophic 
space. It is currently thought that this peritrophic space originates from the 
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elongation and joining of large cytoplasmic vacuoles from within the trophozoite 
forming a single clear vacuole that surrounds the cytoplasm of the parasite, pressing 
against the inner surface of the plasma membrane, ultimately forming the outermost 
cyst membrane. This process is repeated to form both an inner membrane layer and 
eventually a new plasma membrane (Chavez-Munguia, Cedillo-Rivera and Martinez-
Palomo 2004). 
 
 
Figure 1.4 Cysts of G. duodenalis. 
Iodine stained cysts of Giardia duodenalis from faecal smears viewed under 
brightfield microscopy.  Cyst formations begin in the jejunum after exposure to 
biliary secretions and are passed as environmentally robust infective cysts in the 
faeces. Images courtesy of the CDC. 
 
Protein degradation and transport 
Giardia is a diplomonad (of the Order Diplomonadida) and like all members of this 
order share certain characteristics including 2 karyomastigonts, each having four 
pairs of flagella, 2 nuclei and lack both mitochondria and a recognizable Golgi 
apparatus (Adam 2001; Marti et al. 2003). A compartment with functional and 
structural characteristics of the endoplasmic reticulum (ER) has been identified and 
characterized as an endomembraneous network, which extends throughout the cell 
body. Other morphologically recognizable membrane compartments are the 
peripheral vesicles (PVs, approximately 150 – 200 nm in size), which are thought to 
perform both lysosomal and endosomal activities (Adam 2001).  
 
These PVs are located beneath the plasma membrane of the cell body except at the 
flagella or where it covers the cytoskeletal structures of the ventral disc. By the 
uptake of acridine orange, these vesicles were shown to be acidic and by their ability 
to concentrate exogenous lucifer yellow also demonstrated their endocytic nature 
(Lanfredi-Rangel et al. 1998; Feely, Gardner and Hardin 1991). 
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Characteristic of most eukaryotes is the ability to degrade and recycle proteins from 
within the cell or those which are either endocytosed or phagocytosed. Higher 
eukaryotes have early endosomes responsible for the internalisation of proteins and 
their subsequent return to the cell membrane or transport to late endosomes. This is 
followed by their transport to and degradation by lysosomes. Although Giardia is a 
eukaryote, it appears not to have this early / late division of endosomes. This was 
demonstrated in experiments by Lanfredi-Rangel et al. (1998) which showed that 
when incubated with horseradish peroxidase, the PVs of Giardia were labelled 
rapidly after a few min and that this labelling persisted even after several h.  
 
In the same experiments by Lanfredi-Rangel et al. (1998) also suggested a lysosomal 
function to the PVs because of the localisation of acid phosphatase within most of 
the vesicles and also in the cisternae of the ER. Glucose-6-phosphatase localisation 
(a marker of ER) showed the formation of an electron-dense reaction product within 
the ER but also within a few of the PVs. This suggested that the PVs show continuity 
with the ER. Earlier experiments (Lindmark 1988; Feely & Dyer 1987) demonstrated 
the PVs’ lysosomal functions through various hydrolase, proteinase and RNAse 
activities. These experiments suggest that the early/late endosomal and lysosomal 
system, which act discretely in higher eukaryotes, can be found as a single unit in 
Giardia’s peripheral vesicular network and act in concert with the ER. 
 
Although structures consistent with the ER had been described in Giardia by EM, it 
wasn’t until experiments by Gupta et al. (1994) showed the presence of the BiP gene, 
a hsp70 (heat shock protein) homologue found in the lumen of the ER in higher 
eukaryotes, which is responsible for the folding and translocation of proteins across 
the ER membrane, using molecular techniques and later Soltys, Falah and Gupta 
(1996) demonstrated that BiP antibodies localised to ER-like structures that the 
presence of an ER was confirmed.  
 
The presence of three protein-disulphide isomerase genes (gPDI-1, 2 and 3) and their 
expression provided further evidence of an ER within Giardia as these enzymes are 
known to be within the lumen of the ER (Knodler et al. 1999). A major function of 
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the ER is the formation and folding of disulphide bonds for membrane and secreted 
proteins. When correct disulphide bond formation is inhibited in the ER by 
dithiothreitol (DTT; a reductant which interferes with the redox environment of the 
ER), protein modification and transport can be prevented. In higher eukaryotes, this 
causes a reduction in protein glycosylation. Giardia, however, has very few secreted 
glycosylated proteins (Adam 1991). Nevertheless, DTT can inhibit the formation of 
disulphide bonds in cyst wall proteins, inhibiting the differentiation of Giardia 
trophozoites into cysts suggesting a role for gPDIs in this process (Knodler et al. 
1999). 
 
Encystation 
The encystation process generally begins in the jejunum after exposure to biliary 
secretions. By mimicking these conditions, it has been possible to perform 
encystation of G. duodenalis in vitro (Gillin et al. 1987; Gillin, Reiner and Boucher 
1988; Schupp et al. 1988). A slightly alkaline pH (7.8) was required to generate cysts 
resistant to hypotonic conditions as found in faeces (Gillin et al. 1987). Other 
important factors were the presence of bile salts and saturated fatty acids (Gillin et al. 
1987; Gillin, Reiner and Boucher 1988). 
 
Once encystation is initiated, the process can be completed within 26 h and involves 
2 phases, an early phase (completed within 10 h) and a late phase (completed within 
16 h). During the early phase, intracellular synthesis and transport of the cyst wall 
proteins occur. At this time, a Golgi-like stack of membranes arise and are associated 
with the development of cyst wall antigens and their transport via large (up to 1 µm), 
osmophillic, secretory vesicles known as encystation-specific vesicles (ESVs) 
(Reiner, McCaffery and Gillin 1990). There is increasing evidence that ESVs may be 
the cisternae of an unique Golgi equivalent in Giardia (Adam 2001; Hehl & Marti 
2004; Luján et al. 1995; Marti et al. 2003). As these ESVs appear during encystation 
it is possible that they are newly generated at this time and are not constitutively 
expressed. Experiments by Marti et al. (2003) however, found a lack of regulated 
expression of Golgi apparatus associated proteins suggesting that, at the molecular 
level at least, the secretory system of Giardia is not stage-regulated. Further to this, 
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antibodies generated against proteins of the endomembrane system showed that cyst 
wall proteins were exported through the re-organisation membrane compartments 
that were biochemically similar to ESVs (Marti et al. 2003). These results 
demonstrate ESVs are part of a Golgi cisternae-like system which is constitutively 
expressed rather than being generated de novo. 
 
Excystation 
Within the mammalian host, excystation occurs rapidly after passage through the 
acidic environment of the stomach and after entry into and exposure to elements of 
the proximal small intestine (Adam 2001). Excystation was first induced in vitro 
using acidic solutions (optimum pH 1.3 – 2.7; Bingham & Meyer 1979) which 
suggest an importance of passage through the acidic environment of the stomach for 
excystation. This may not always be the case, with G. muris excystation having 
occurred in vitro at pH 7.5 in vitro (Feely, Gardner and Hardin 1991) and may 
explain cases of giardiasis in patients with reduced gastric acidity. Subsequently a pH 
of 4 has been assessed as the optimum pH and that the use of pancreatic proteases 
such as trypsin or chymotrypsin being required for in vitro excystation and suggest 
the role for pancreatic secretions for excystation in vivo (Boucher & Gillin 1990). 
 
Life cycle 
Humans are indicated as reservoirs of this protozoan, although other mammals 
including dogs, cats, farm animals and beavers have been shown to harbour Giardia 
(Ortega & Adam 1997; McGlade et al. 2003; Hunter & Thompson 2005). 
Transmission in humans may occur via direct faecal-oral contact or from faecally 
contaminated water and food (Smith et al. 2007). The zoonotic transmission of 
Giardia is still unclear but has been described in northeast India from dogs (Traub et 
al. 2004) and direct contact with farm animals and pets have also been associated 
with giardia infection (Warburton, Jones and Bruce 1994; Hunter & Thompson 
2005). 
 
The infection cycle begins with the consumption of infective cysts, usually from the 
faecal-oral route by contaminated food or water (Figure 1.5). After the safe passage 
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of the cysts through the stomach excystation occurs, releasing 2 trophozoites into the 
lumen of the proximal small intestine. The trophozoites divide by binary fission, 
beginning with the nuclear division, followed by the locomotor apparatus, the ventral 
disc and finally the cytoplasm. In this way, large numbers of trophozoites are rapidly 
generated within the lumen of the small intestine. Whilst trophozoites may be found 
in the profuse watery stools of symptomatic infection (reviewed by Dawson 2005), 
only the cysts are capable of surviving out with the host. Cyst formation occurs with 
the passage of trophozoites, in conjunction with intestinal contents, to the colon. 
Exposure of trophozoites to the slightly alkaline environment (pH 7.8) of the colon 
and to biliary secretions such as bile salts and saturated fatty acid causes the 
induction of encystment. These cysts are shed in the faeces and are resilient to the 
environment, remaining viable in lake water for up to 56 days, in tap water for up to 
14 days (de Regnier et al. 1989) and 2 – 3 months at temperatures below 10°C 
(WHO 2004). 
 
Clinical Manifestations in Man 
Giardiasis has an incubation period of anywhere between 5 and 25 days with 
approximately 60% of infected individuals being asymptomatic (Ortega & Adam 
1997). In the remaining 40% of individuals, symptoms usually commence 1 – 2 
weeks after infection and will normally last 2 – 6 weeks with the diarrhoea 
improving after approximately 1 week. In this acute phase, symptoms include: 
nausea, anorexia, malaise, possible discomfort in the upper intestine and possibly a 
low grade fever and chills. Following from these symptoms are the sudden onset of 
explosive, watery, foul smelling diarrhoea and associated with abdominal distension 
and an increase in foul flatulence. Cramping of the upper to mid-epigastria may 
occur accompanied with foul belching. This acute stage may last only for a few days 
in immunocompetent hosts and the infection will commonly resolve spontaneously. 
However, the acute stage has been known to last months leading to malabsorption, 
steatorrhoea (fatty stools), debility and weight loss. Some patients may become 
asymptomatic cyst passers for a period and will display no other clinical 
manifestations. 
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Following on from the acute stage is the development of a chronic or subacute stage 
of infection. Typically the patient exhibits recurrent and brief episodes of loose stools 
(which may be frothy, yellowish and float on the toilet water) accompanied by foul 
flatus and increased abdominal distension. Not uncommon is a condition called the 
‘purple burps’ where belching is accompanied with a rotten egg taste.  Anorexia and 
nausea are common as well as fatigue, headaches and myalgias possibly occurring. 
These symptoms are alleviated following effective drug treatment. 
 
Treatment 
In the majority of cases, a short treatment regimen of tinidazole (Fasigyn®) (2 g once 
in adults) or metronidazole (Flagyl®) (250 mg three times daily 7 days for adults) are 
80% to 95% effective, respectively (Petri 2005). However, side effects are common 
with these drugs and are described as nausea, headaches, diarrhoea, abdominal 
cramps, a strong metallic taste, dizziness, dark discoloured urine and a disulphiram-
like reaction when taken with alcohol (nausea and vomiting) (Harris, Plummer and 
Lloyd 2001; Ortega & Adam 1997). 
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Figure 1.5 Life-cycle of G. duodenalis. 
Cysts are resistant forms and are responsible for transmission of giardiasis.  Both 
cysts and trophozoites can be found in faeces (diagnostic stages) .  The cysts are 
hardy and can survive several months in cold water.  Infection occurs following the 
ingestion of cysts in contaminated water, food, or by the faecal-oral route (hands or 
fomites) .  In the small intestine, excystation releases trophozoites (each cyst 
produces 2 trophozoites) .  Trophozoites multiply by longitudinal binary fission 
remaining in the lumen of the proximal small bowel where they can be free or 
attached to the mucosa by a ventral sucking disk .  Encystation occurs as the 
parasites transit toward the colon.  The cyst is the stage found most commonly in 
non-diarrhoeal faeces .  Because the cysts are infectious when passed in the stool or 
shortly afterward, person-to-person transmission is possible.  While animals such as 
cattle, beavers and dogs are infected with Giardia, their importance as a reservoir 
and zoonotic source of transmission is unclear. Source: Figure adapted from the 
Public Health Image Library – National Institutes of Health and the CDC. 
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1:6 Cryptosporidium parvum 
Cryptosporidium parvum is an enteric protozoan parasite first identified in 1976 
(Nime et al. 1976; Meisel et al. 1976) as causing gastrointestinal disease in humans, 
characterised by self limiting diarrhoea in immunocompetent hosts and chronic, 
severe diarrhoea and potentially fatal consequences in immunocompromised hosts 
(Hunter & Nichols 2002; Farthing 2000). Since the discovery of human 
cryptosporidiosis many human outbreaks have occurred in immunocompetent 
humans. In the period 1983 – 2003 there has been an estimated 504,019 individuals 
infected with Cryptosporidium oocysts in 165 documented waterborne outbreaks, 
worldwide (Karanis, Kourenti and Smith 2007; Smith & Rose 1998). The largest 
waterborne outbreak to date has been the 1993 outbreak in Milwaukee, Wis. USA 
where over 400,000 people were estimated to be infected (MacKenzie et al. 1994a 
and 1994b), although due to the reporting methods employed to ascertain infection in 
that particular outbreak (telephone enquiries and self-reporting of diarrhoeal 
symptoms) this figure could have been over estimated (Hunter & Syed 2001).  
 
Of the 19 known valid species and 40 genotypes of Cryptosporidium, 8 species (C. 
hominis, C. parvum, C. meleagridis, C. felis, C. canis, C. suis, C. andersoni and C. 
muris) and 5 genotypes of Cryptosporidium (chipmunk, cervine [2 of 3 genotypes], 
monkey, and skunk) can infect humans. Of the 8 species, C. hominis and C. parvum 
are responsible for the majority of human disease (Table 1.4; Smith 2008; Feltus et 
al. 2006; Leoni et al. 2006; Nichols, Campbell and Smith 2006; Caccio et al. 2005; 
Ryan et al. 2004; Xiao et al. 2004). C. parvum has been the species most studied 
with respect to infectivity in vivo and viability in vitro. C. parvum, which can be 
cultured in vitro, has also been the species used mostly for drug discovery 
investigations and as such was used in experiments for this thesis and shall be 
discussed in this introduction. The parasite has a complex life cycle that involves 
both a sexual and asexual reproductive cycle which can be completed within a single 
host beginning with the ingestion of an infective oocyst and the eventual passing of 
further oocysts in the faeces of the infected host. The oocyst is environmentally 
robust and chlorine insensitive, which coupled with its small size make it possible for 
it to survive water treatment. 
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Cryptosporidium is an apicomplexan parasite of the Order Eucoccidiorida and forms 
oocysts containing 4 sporozoites which are not contained within a sporocyst. The 
sporozoites when excysted, infect the epithelia of the intestinal tract (enterocytes) of 
various mammals (Smith, Nichols and Grimason 2005).  In vitro and in vivo 
investigations into C. parvum excystation have highlighted some of the host- and 
parasite-derived triggers required to initiate infection, although the process of 
excystation is still poorly understood.  
 
Morphology of the oocyst 
When viewed under Nomarski differential interference contrast (DIC) microscopy 
oocysts of C. parvum appear spherical or slightly ovoid, smooth, thick walled and 
refractile measuring 4.5 – 5.5 µm in diameter. Each oocyst contains 4 elongated and 
curved naked sporozoites, although all 4 sporozoites may not be visible at the same 
time (Figure 1.6).  
 
 
Figure 1.6 Oocysts of C. parvum. 
Oocysts of C. parvum viewed under Nomarski DIC (x1250 total magnification) 
showing three out of four sporozoites (Sp) in a typical ‘finger’ arrangement and the 
thick, protective oocyst wall (OW). Nomarski DIC image taken by J-P Anthony 
(copyright© SPDL). 
 
The sizes of Cryptosporidium oocysts are varied and one cannot always rely on 
oocyst size alone as a means of identification of species, as can be seen in Table 1.4. 
A more reliable form of identification between species is through genetic 
characterisation as determined by polymerase chain reaction, restriction fragment 
length polymorphism and DNA sequencing analyses at 2 18S rRNA loci (Nichols, 
Campbell and Smith 2003; Nichols, Campbell and Smith 2006; Xiao et al. 2000a; 
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Xiao et al. 1999), the Cryptosporidium oocyst wall protein (COWP) locus (Homan et 
al. 1999; Xiao et al. 2000b), thrombospondin-related adhesive protein 1 (TRAP-C1; 
(Spano et al. 1998)) and β-tubulin (Caccio et al. 1999; Rochelle et al. 1999; 
Sulaiman, Xiao and Lal 1999; Widmer et al. 1998). 
 
 Table 1.4 Characteristics of recognized Cryptosporidium species. 
Species of 
Cryptosporidium 
Major Host Oocyst 
Dimensions 
(μm) 
Site of Infection Reference 
C. andersoni Cattle 5.5 x 7.4 Abomasum (Lindsay et al. 2000) 
C. baileyi Poultry 4.6 x 6.2 Bursa of Fabricus, 
cloaca and trachea 
(Current, Upton and 
Haynes 1986) 
C. bovis Cattle 4.7-5.3 x 4.2-4.8 Small intestine (Barker & Carbonell 
1974) 
C. canis Dogs 4.95 x 4.71 Small intestine (Fayer et al. 2001) 
C. fayeri  Red kangaroo 
(Macropus 
rufus) 
4.5-5.1 × 3.8-5.0 Intestine (Ryan, Power and 
Xiao 2008) 
C. felis Cats 4.5 x 5.0 Small intestine (Asahi et al. 1991; 
Iseki 1979) 
C. galli Finches, 
Chickens 
8.25 x 6.3 Proventriculus (Ryan et al. 2003; 
Pavlasek 2001 & 
1999) 
C. hominis Humans 4.5 x 5.5 Small intestine (Morgan-Ryan et al. 
2002) 
C. macropodum  Grey kangaroo 
(Macropus 
giganteus) 
Not known Not known (Power & Ryan 
2008) 
C. meleagridis Turkeys 4.5-4.0 x 4.6-5.2 Small intestine (Slavin 1955) 
C. molnari Fish  4.7 x 4.5 Small intestine and 
stomach 
(Fayer 2008; 
Alvarez-Pellitero & 
Sitjà-Bobadilla 
2002) 
C. muris Rodents 5.6 x 7.4 Stomach (Tyzzer 1907) 
C. parvum Man and other 
mammals 
4.5 x 5.5 Small intestine (Tyzzer 1912) 
C. ryanae 
(previously 
Cryptosporidium 
deer-like 
genotype) 
Cattle (Bos 
taurus) 
2.94-4.41  x 
2.94-3.68 
Not known (Fayer, Santin and 
Trout 2008; Santin 
et al. 2004) 
C. scophthalmi Fish (Turbot) 3.7-5.0  x 3.0-
4.7 
Intestine, very 
seldom in the 
stomach 
(Alvarez-Pellitero et 
al. 2004) 
C. serpentis Snakes, Reptiles 5.6-6.6 x 4.8-5.6 Stomach, gastric 
glands 
(Levine 1980) 
C. suis Pigs 4.9-4.4 x 4.0-4.3 Small and large 
intestine 
(Ryan et al. 2004) 
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Table 1.4 – Continued 
Species of 
Cryptosporidium 
Major Host Oocyst 
Dimensions 
(μm) 
Site of Infection Reference 
C. varanii 
 (previously C. 
saurophilum 
Lizards 4.2-5.2 x 4.4-5.6 
 
Stomach and small 
intestine. 
 
(Pavlasek & Ryan 
2008; Koudela & 
Modry 1998) 
C. wrairi Guinea pigs 4.9-5.0 x 4.8-5.6 Small intestine (Vetterling & Jervis 
1971; Vetterling, 
Takeuchi and 
Madden 1971) 
 
At least 8 species (C. hominis, C. parvum, C. meleagridis, C. felis, C. canis, C. suis, 
C. andersoni and C. muris) and 5 genotypes Cryptosporidium (chipmunk, cervine [2 
of 3 genotypes], monkey, and skunk) can infect humans, but it is C. parvum and C. 
hominis which are responsible for the majority of human instances of 
cryptosporidiosis (Feltus et al. 2006; Leoni et al. 2006; Nichols, Campbell and Smith 
2006; Caccio et al. 2005; Ryan et al. 2004; Xiao et al. 2004). Table adapted from 
Smith (2008) and Smith et al. (2007).  
 
 
Oocyst wall structure 
The oocysts of Cryptosporidium are extremely resistant to environmental pressures 
(Nichols, Paton and Smith 2004; Robertson, Campbell and Smith 1992) and 
disinfectants (Angus et al. 1982; Blewett 1989; Campbell et al. 1982; Korich et al. 
1990; Li et al. 2004; Pavlasek 1984; Peeters et al. 1989). The oocyst wall is the 
interface between the host, the oocyst and the environment and is composed of 3 
main layers: outer, central and inner layers and measured to be 40 – 50 nm thick 
(Harris & Petry 1999; Nanduri et al. 1999). Coating the oocyst wall is a 
carbohydrate-rich glycocalyx, 20 – 30 nm thick and is antigenic (Nanduri et al. 
1999). 
 
The outer layer of the oocyst wall is composed of acidic glycoproteins and lipids 
between 5 and 10 nm thick which is variably electron dense (Harris & Petry 1999; 
Robertson, Campbell and Smith 1993a). A 5 nm lipid-rich central layer separates the 
outer and inner layers of the oocyst wall. Finally there is an inner layer which is 30 
nm thick and composed of 2 further layers: a 10 nm electron dense outer-inner layer 
and a 20 nm less electron dense inner-inner layer. With the 10 nm thick outer-inner 
layer a typical fibrillar array can be seen in negatively stained sections as disordered 
filamentous material (Smith & Ronald 2002). A protease sensitive, 20 nm thick, 
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cross-linked filamentous glycoprotein layer comprises the inner-inner layer (Bonnin, 
Dubremetz and Camerlynck 1991) and along with the central lipid layer, provides 
much of the structural rigidity and elasticity of the oocyst wall (Harris & Petry 1999). 
The inner layer of C. parvum oocysts also contains a unique feature of a linear suture 
which spans one third to one half of the circumference of the oocyst wall which 
allows the exit of sporozoites during the excystation process. 
 
Oocyst sources for experimentation  
Oocysts are most commonly purchased commercially for use in experimental 
research. These will come from various infected animals and in the case of C. 
parvum, cattle. In vitro studies have been successful in culturing C. parvum in 
enterocytes and have been invaluable in the investigation of Cryptosporidium’s life 
cycle (Current & Haynes 1984; Current & Reese 1986). Recently, there have been 
some controversial advances in the field of in vitro culture where it has been claimed 
that the life cycle of C. parvum has been successfully completed without the 
requirement of the enterocyte (Hijjawi et al. 2004, 2002 and 2001). Replication of 
this experiment by others, however, has proven difficult (Girouard et al. 2006). 
 
Life cycle 
Asexual reproduction 
Infection begins through the ingestion of infective, sporulated oocysts. In the case of 
C. parvum a remarkably low infectious dose can initiate infection (dose required to 
cause infection in 50% of test subjects; ID50 = 9 – 1042 oocysts; (Okhuysen et al. 
1999)). Four naked, motile sporozoites are released through the suture of the oocyst 
in response to temperature (37oC), pH fluctuations, bile salts, reducing agents, 
proteases and time (Fayer & Leek 1984; Kato et al. 2001; Robertson, Campbell and 
Smith 1993b; Smith, Nichols and Grimason 2005). Exposure to acid (pH ~2) 
followed by incubation in bile salts, reducing agents and proteases, mimicking transit 
through the acidic stomach to the alkaline small intestine, enhances excystation in 
vitro, but the fact that oocysts can excyst in vivo and cause disease in extraintestinal 
locations indicates that some of these host-derived triggers are not essential (Smith, 
Nichols and Grimason 2005).  
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Upon excystation, sporozoites attach to the luminal surface of enterocytes and 
rapidly invade these cells with the complete process of location, attachment, invasion 
and internalisation occurring within 25 min of excystation with C. parvum 
sporozoites (Langer & Riggs 1999). 
 
The sporozoite, upon locating the surface of the enterocyte, will orientate itself so 
that its anterior pole is towards the surface, with ligand-receptor interactions 
mediating attachment (Smith, Nichols and Grimason 2005). As the sporozoite 
penetrates the cell, the apical membrane of the enterocyte extends and protrudes over 
the apical end of the parasite. Complete engulfment of the parasite follows, with the 
sporozoite contained within a parasitophorous vacuole comprising of sporozoite 
plasma membrane and enterocyte apical membrane (Chen et al. 1998). This vacuole 
whilst intracellular, is separated from the cell cytoplasm by an electron-dense 
structure of host cellular elements such as actin (Chen et al. 2002; Clark 1999; Elliot 
et al. 2001; Tzipori & Griffiths 1998). 
 
The sporozoites differentiate into round trophozoites which, after nuclear division, 
results in the development of multinucleated schizonts sometimes known as meronts 
(schizogony). There are 2 types of schizonts; type I and type II. The type I schizont is 
involved in the asexual reproduction of C. parvum and is distinguishable from type II 
schizonts by containing between 6 and 8 nuclei which develop into 6 – 8 type I 
merozoites which are small in size (1 x 1.2 µm) and generally round to oval in shape 
(Current & Reese 1986; Hijjawi et al. 2004, 2002 and 2001). A type II schizont will 
contain 4 merozoites which can vary in morphology between being spindle shaped 
with pointed ends (3.5 x 2 µm) and round or oval (1.6 x 1.5 µm) (Current & Reese 
1986; Hijjawi et al. 2004, 2002 and 2001). Release of the actively motile merozoites 
from type I schizonts can infect neighbouring cells and undergo a replicative cycle 
similar to that already described for trophozoites, thus providing further type I 
merozoite progeny and a means of re-infection, or they can develop into type II 
schizonts. 
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Sexual reproduction 
A mature type II schizont contains 4 type II merozoites which can initiate the sexual 
multiplication cycle (gametogony). Each individual merozoite produces either 
microgamonts or macrogamonts. The microgamont is large (5.6 x 5 µm) and 
spherical in shape and nuclear division in the microgamont produces numerous 
microgametes (Current & Reese 1986; Hijjawi et al. 2004, 2002 and 2001). The 
motile microgametes (oval shaped with a large nucleus filling most of the cytoplasm; 
2.2 x 1.6 µm) are released from the parasitophorous vacuole and each can fertilise a 
macrogamont (5 x 4 µm, containing a peripheral nucleus) (Current & Reese 1986; 
Hijjawi et al. 2004, 2002 and 2001). The product of fertilisation (zygote) develops 
into an oocyst. Sporozoite generation occurs in the zygote in a process of sporogony 
and most zygotes (approximately 80%) will become fully sporulated oocysts 
(containing 4 sporozoites each) to be released in the intestinal lumen and from there 
pass into the faeces (Current & Garcia 1991; Current& Reese 1986). These are 
infectious to other susceptible hosts when excreted. However, autoinfection of the 
host can also occur with approximately 20% of the zygotes failing to form a thick 
oocyst wall (Current & Garcia 1991; Current & Reese 1986). The sporozoites in 
these sporulated oocysts are contained within a “single unit membrane” which, upon 
release from the host cell, ruptures releasing the sporozoites into the intestinal lumen 
(Current & Garcia 1991; Current & Reese 1986). These released sporozoites are able 
to reinfect the host enterocytes and begin the process of schizogony, gametogony and 
sporogony again (Current & Garcia 1991; Current 1988; Current & Reese 1986; 
Fayer 2007; Smith, Nichols and Grimason 2005).  
 
Large numbers of oocysts can be generated in the host and approximately 1010 
oocysts can be excreted by an infected symptomatic host (Karanis, Kourenti and 
Smith 2007). The complete life-cycle can be seen in Figure 1.7. 
 
Clinical Manifestations in Humans 
The most frequently recognized clinical picture of cryptosporidiosis involves an 
enteric infection with chronic, watery and often debilitating diarrhoea in more than 
90% of immunocompetent patients (Hunter & Nichols 2002; Farthing 2000; 
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MacKenzie et al. 1994b). However, asymptomatic infection also occurs (Farthing 
2000). A non-specific low-grade fever, malaise, anorexia, abdominal discomfort and 
nausea may accompany the diarrhoea, but no clinical or characteristic laboratory 
feature other than identification of the organism or oocyst in a clinical specimen can 
distinguish the cause of the illness. In an immunocompetent host, cryptosporidiosis is 
usually acute and self-limiting with the symptoms lasting 1 - 2 weeks. These 
symptoms, if chronic, can lead to weight loss, dehydration and malnutrition (Juranek 
1995; MacKenzie et al. 1994b). The severity of the illness varies but appears to be 
directly related to the patient's immunocompromised state. Immunocompetent 
persons usually experience a short-term diarrhoeal illness when symptomatic, 
whereas a prolonged cholera-like illness may be seen in severely immunosuppressed 
persons, such as those with autoimmune deficiency syndrome (AIDS). Improvements 
to human immunodeficiency virus (HIV) treatment such as the highly active 
antiretroviral therapy (HAART), which suppresses HIV replication and increases 
circulating CD4 T lymphocyte cells (Ho et al. 1995; Wei et al. 1995), has led to a 
reduction of cryptosporidiosis among HIV-positive patients (reviewed by Smith & 
Corcoran 2004; Chen et al. 2002; Schmidt et al. 2001). Whilst C. parvum infection is 
normally confined to the gastrointestinal tract, cryptosporidiosis has been identified 
in the biliary tract (causing thickening of the gallbladder wall), the respiratory 
system, middle ear, pancreas and stomach, principally in AIDS patients (Casemore, 
Gardner and O'Mahony 2007; Clark 1999; Farthing 2000). 
 
Treatment 
Despite the fact that more than 200 drugs have been tested for their anti-
cryptosporidial effects (Mead 2002) in vitro (e.g. growth inhibition in CaCo2 and 
HCT-8 cells; (Theodos et al. 1998)) and in vivo (infectivity studies in mice and pigs; 
(Tzipori 1998)) effective, specific drug treatment for cryptosporidiosis remains a 
goal. This is not to say, however, there is no effective drug therapy for 
Cryptosporidium infection. Nitazoxanide has been demonstrated to have efficacy for 
cryptosporidiosis with immunocompetent patients, inhibits C. parvum growth in vitro 
and has been licenced for paediatric use in the USA (Rossignol 2006; Bailey & 
Erramousepe 2004; Smith & Corcoran 2004; Amadi et al. 2002; Theodos et al. 
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1998). This drug has demonstrated clinical (resolution of diarrhoea) and 
parasitological (absence of Cryptosporidium in stools) response rates of 80% and 
70%, respectively with immunocompetent patients (Bailey & Erramousepe 2004). 
Lower response rates were seen with immunocompromised patients. In June 2004, 
nitazoxanide was also licenced by the US Food and Drug Administration (FDA) for 
use in all persons ≥ 1 year of age.  
 
As chronic cryptosporidiosis is more likely to occur in those patients with lower CD4 
T cell counts (Elliot et al. 1997; Hashmey et al. 1997; Navin et al. 1999; Pozio et al. 
1997) and that HAART allows the recovery of CD4 T cells (Ho et al. 1995; Wei et 
al. 1995) it has been shown that this therapy can reduce the incidence of 
cryptosporidiosis in HIV-postive patients (reviewed by Smith & Corcoran 2004). 
Investigations by Hommer et al. (2003) have demonstrated that the protease 
inhibitors used in HAART reduce enterocyte invasion by Cryptosporidium 
sporozoites and also reduce the development of sporozoites in vitro. The 
combination of nitazoxanide and HAART has been suggested as a possible treatment 
for cryptosporidiosis in immunocompromised patients (Smith & Corcoran 2004). As 
cryptosporidiosis is, in most cases, a self-limiting illness in immunocompetent 
individuals, general, supportive care is the only treatment that is required. Oral or 
intravenous rehydration and replacement of electrolytes may be necessary for those 
with particularly voluminous, watery diarrhoea (Flanigan & Soave 1993).  
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Figure 1.7 Life-cycle of C. parvum. 
Sporulated oocysts, containing 4 sporozoites, are excreted by the infected host 
through faeces and possibly other routes such as respiratory secretions .  
Transmission of Cryptosporidium parvum occurs mainly through contact with 
contaminated water (e.g., drinking or recreational water).  Occasionally food sources 
may serve as vehicles for transmission. Zoonotic and anthroponotic transmission of 
C. parvum occur through exposure to infected animals or exposure to water 
contaminated by faeces of infected animals .  Following ingestion (and possibly 
inhalation) by a suitable host , excystation occurs.  The sporozoites are released 
and parasitize epithelial cells ( , ) of the gastrointestinal tract or other tissues such 
as the respiratory tract.  In these cells, the parasites undergo asexual multiplication 
(schizogony or merogony) ( , , ) and then sexual multiplication (gametogony) 
producing microgamonts (male) and macrogamonts (female) .  Upon 
fertilization of the macrogamonts by the microgametes ( ), oocysts ( , ) develop 
that sporulate in the infected host.  Two different types of oocysts are produced, the 
thick-walled, which is commonly excreted from the host  and the thin-walled 
oocyst , which is primarily involved in autoinfection.  Oocysts are infective upon 
excretion, thus permitting direct and immediate faecal-oral transmission. Source: 
Public Health Image Library – CDC and Alexander J. da Silva/Melanie Moser 2002. 
Cryptosporidium stages were reproduced from Juranek DD. Cryptosporidiosis. In: 
Strickland, G.T., editor. 2000. Hunter’s Tropical Medicine and Emerging Infectious 
Diseases, 8th ed. Philadelphia: WB Saunders.  Originally adapted from the life cycle 
that appears in Current, W.L. and Garcia. L.S. 1991. Cryptosporidiosis. Clinical and 
Microbiological Reviews. vol. 4, pp. 325-58. 
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1:7 Trypanosoma cruzi 
This flagellated protozoan parasite, described by Carlos Chagas in 1909 (Chagas 
1909) from dissected cone-nosed bugs (Reduviid bugs), was not associated with 
disease (American trypanosomiasis) until several years later. The disease caused by 
this parasite is also known by the name of its discoverer and Chagas’ disease is of 
major medical importance throughout Latin America with 16 – 18 million people 
infected, up to 120 million at risk of infection (25% of the population of Latin 
America) 25 – 30% of those infected chronically suffering irreversible damage to the 
heart and digestive tract leading to approximately 50,000 fatalities every year (WHO 
2002). Infection by this parasite presents acute and chronic symptomology. During 
the acute phase of infection a patent parasitaemia lasting 2 – 3 months occurs which 
is usually asymptomatic, but can present with manifestations that include fever, 
anorexia, lymphadenopathy, mild hepatosplenomegaly and myocarditis.  Due to the 
infection often being asymptomatic at his stage, the disease is often not diagnosed. 
 
After this acute phase there is a chronic phase of infection which has an 
indeterminate period of infection lasting from several years to persisting indefinitely 
with varied symptoms ranging from cardiomyopathy, peripheral nervous system 
damage or dysfunction of the digestive tract. If untreated, the disease can be fatal, 
usually due to heart attacks brought on by cardiomyopathy. At present there is no 
known cure for chronic Chagas’ disease, only for the alleviation of the clinical 
manifestations. Chronically infected human hosts living in endemic regions form an 
important parasite reservoir with the life cycle alternating between vertebrate and 
insect hosts. The replicative epimastigote and infective metacyclic trypomastigotes 
are found in the blood-sucking arthropod vectors (the Reduviid bugs) with the 
intracellular and replicative amastigotes and bloodstream trypomastigotes in the 
mammalian host. 
 
Trypanosoma cruzi is a flagellate of the order Kinetoplastida, Family 
Trypanosomatidae, characterized by the presence of one flagellum and a single 
mitochondrion in which is situated the kinetoplast, a specialized DNA-containing 
organelle.  During its life-cycle, the parasite developes into different forms which are 
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identified by the relative position of the kinetoplast in relation to the cell nucleus and 
emergence of the flagellum from the cell body.  
 
Morphology in the Mammalian Host 
Trypomastigote 
The trypomastigote stages of the parasite can be found in the circulating blood and 2 
morphological types of bloodstream trypomastigotes have been observed. One is 
slender, with an elongated nucleus, a subterminal kinetoplast and a short free 
flagellum. The other is broad, with an oval nucleus, an almost terminal kinetoplast 
and with a long free flagellum. It has been postulated that the slender forms are 
responsible for infection in the vertebrate host, with the broad forms infecting the 
invertebrate.  
 
In most cases a slender form is found, being 16 – 20 µm long with a pointed 
posterior end (Figure 1.8 A). It contains a large mitochondrion which extends 
throughout the length of the cell with a kinetoplast within it that is located sub 
terminally at the posterior end of the parasite which can often cause the cell body to 
‘bulge’ around it and positioned to the basis of the flagellum. The kinetoplast is rod-
like in shape and contains ~30% of the parasites total DNA and is known as 
kinetoplast DNA (k-DNA). The nucleus is elongated, located anteriorly to the 
kinetoplast and is almost central within the cell body. A single flagellum is attached 
to the basal body and emerges from a specialised invagination, the flagellar pocket. 
This pocket surrounds the kinetosome from which the flagellum arises and is found 
closely associated with the kinetoplast. The flagellum runs along the surface of the 
cell body and continues past as a ‘free whip’ anterior to the cell and is able to propel 
the organism in an undulating fashion. An undulating membrane is formed with the 
association of the flagellar membrane which is closely apposed to the cell body 
surface and the beating action of the flagellum. As the flagellum beats the close 
association of the flagellar membrane to the cell surface pulls this area of the pellicle 
into a fold and this fold in conjunction with the flagella constitute the undulating 
membrane. The flagellum is important not only for movement but also for the 
attachment of the parasite to the surface of mammalian host cells and to the intestinal 
 40
perimicrovillar membranes in the invertebrate host. Attachment of the 
trypomastigote leads to the invasion of the cell by the parasite and the eventual 
differentiation of the trypomastigote into the replicative intracellular amastigote 
form. It is the ability of this parasite to invade a wide range of nucleated cells in the 
mammalian host, allowing it to infiltrate and replicate in privileged sites that makes 
treatment of Chagas’ disease difficult. 
 
 
 
Figure 1.8 Life-cycle stages of T. cruzi. 
Various life cycle stages of T. cruzi showing geimsa stained trypomastigotes in a 
blood smear (A) showing the centrally located nucleus (nu) anterior to the 
kinetoplast (k) which is located at the posterior end and the single long flagellum is 
also visible (fl). Amastigotes in a pseudocyst (pc) are visible in a geimsa stained 
section of monkey heart (B – left hand side) with a single HeLa cell filled with 
amastigotes (am) (B –right hand side).  The insect forms are shown in panel C and 
can be cultured axenically in vitro. The short flagellum is visible on the left hand 
image (Nomarski DIC, x1250 mag.) and in Geimsa stained epimastigotes the basket 
shaped kinetoplast (k) is located anteriorally to the round and central nucleus (nu). 
Images are courtesy of the CDC (Geimsa stained epimastigotes) and Dr. Mae Melvin 
(trypomastigotes); Dr. L.L. Moore Jnr. (amastigotes in monkey cardiac muscle); Dr. 
A.J. Sulzer (amastigotes in HeLa cell); J-P Anthony (copyright© SPDL; 
epimastigotes under Nomarski DIC). 
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 Amastigote 
These replicative stages of the parasite develop rapidly after invasion of the 
trypomastigote. Invasion occurs initially through the formation of a membrane bound 
vacuole which will subsequently be disrupted releasing the parasite into the 
cytoplasm. The vacuole is acidified by the fusion of lysosomes and the parasite 
secretes a porin-like molecule, Tc-Tox, which facilitates parasite exit from the 
vacuole into the cytoplasm of the host cell (Andrews 1993). It is after this transition 
that the parasite differentiates into the amastigote stage with the proliferation of 
amastigotes causing the formation of a pseudocyst (Andrews 1993). The parasite 
shortens in length and becomes spheroid between 3 – 5 µm in diameter (De Souza 
2002; Tyler & Engman 2001). At this time the flagellum is internalised, projecting 
only slightly beyond the flagellar pocket (Figure 1.8 B). The kinetoplast also changes 
morphology from a rounded, basket-like shape with a more open and less organised 
k-DNA seen in the trypomastigote, to a rod-like structure with tightly packed k-
DNA, which remains basally to the flagellum. A rounded nucleus can also be 
observed which, as in trypomastigotes, is found in a central position in the cell body, 
anterior to the kinetoplast. When ingested along with trypomastigotes in a Reduviid 
bug blood meal, they can transform in the insect mid gut to form epimastigotes. The 
cell body begins to swell and the flagellum lengthens and begins to beat. At this 
point they are known as sphaeromastigotes and as the cell density increases, the cell 
body lengthens further as does the flagellum to become the epimastigote form of the 
life cycle (Tyler & Engman 2001). 
 
Morphology in the Insect Host 
Epimastigote 
These replicative forms are generally found within the mid gut of the Reduviidae 
host and can be easily maintained in axenic cultures making them the most accessible 
of the life cycle for study. Upon ingestion of a blood meal, a pleomorphic population 
of trypomastigotes and amastigotes are ingested (Andrews et al. 1987; Ley et al. 
1988) and transformation of the trypomastigotes and amastigotes occurs in the mid 
gut into a short, replicative form in the gut or into long, slender, non-replicative 
forms which travel to the hind gut and rectum (de Souza 2002). They are spindle 
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shaped and are 20 – 40 µm in length with a basket shaped kinetoplast located 
anteriorally to the round and central nucleus. Its flagella emerge from the cell body 
as in the trypomastigote but beginning almost halfway down the length of its body 
and so has a much shorter undulating membrane (Figure 1.8 C). Whilst in the mid 
gut of the invertebrate host, the epimastigotes divide by binary fission and are closely 
associated with the microvilli of the intestine, attaching to the intestinal cells through 
the flagella by means that have still to be determined (Kollien & Schaub 2000). 
During the process of replication, various stages of the life cycle can often be 
observed; with intermediate amastigote-like (sphaeromastigote) and trypomastigote-
like cells appearing. Division and replication occurs in the mid gut but many 
parasites can be found attached to the waxy cuticle lining of the insects’ rectum. 
Whilst here the parasite is non-replicative and transforms into a metacyclic 
trypomastigote. 
 
Metacyclic Trypomastigote 
Attachment of epimastigotes to the cuticle of the rectum is a requirement for 
metacyclogenesis. This attachment is via non-specific hydrophobic interaction of the 
flagella and the waxy cuticle (Kollien & Schaub 2000). In experiments where 
interference with epimastigote attachment to culture vessels in vitro can prevent this 
transformation (Bonaldo et al. 1988) and enhancing the conditions required for 
attachment (hydrophobic, wax-coated culture vessels) can increase metacyclogenesis 
(Kleffmann, Schmidt and Schaub 1998).  
 
The metacyclic trypomastigote is identical to the trypomastigote in morphology. 
Upon their generation in the Reduviid host they detach from the rectal gland and are 
expelled in the faeces and urine during a blood meal to enter the vertebrate host 
through mucosal membranes or the contamination of the feeding wound by infested 
faeces/urine. This latter method of infection usually occurs when the ‘itchy’ bite 
wound is scratched by the host and the infested faeces are accidentally rubbed into 
the wound due to their close proximity to the wound. 
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Life Cycle 
The sylvatic cycle starts when the haematophagous invertebrate host feeds on the 
vertebrate host by sucking blood and ingesting the trypomastigote and amastigote 
forms of the parasite (Figure 1.9). There are approximately 110 species of triatomine 
bugs identified from the Reduviidae family that are potential vectors of T. cruzi 
(Garcia & Azambuja 1991). Of these, only 5 are of epidemiological importance: 
Triatoma infestans, T. brasiliensis, T. dimidiate, Rhodnius prolixus and 
Panstrongylus megistus (WHO 2002). Upon ingestion, the bloodstream 
trypomastigotes transform into epimastigotes and these, plus the ingested 
amastigotes, divide by binary fission in the intestine of the Reduviid bug and in the 
rectum, a certain proportion of the epimastigotes transform into metacyclic 
trypomastigotes which are eliminated with the faeces and are able to infect the 
vertebrate host (domestic cycle) (Garcia & Azambuja 1991; Kollien & Schaub 
2000).   
Contrary to what is known about African trypanosomes, the trypomastigote form of 
T. cruzi does not divide in the bloodstream and when introduced into the mammalian 
host, the metacyclic trypomastigote must invade a cell to complete its life cycle.  
Unlike other intracellular parasites, T. cruzi invasion of the vertebrate host cell does 
not appear to involve an actin-mediated, phagocytosis-like process. Invasion appears 
to be initiated by parasite signalling causing the recruitment of host cell lysosomes 
(through Ca2+ regulated lysosome exocytosis) and their fusion at the host cell plasma 
membrane opposed to the site of parasite attachment allowing a gradual entry of the 
parasite through a host membrane derived lysosomal vacuole (Andrews 1995; 
Burleigh & Woolsey 2002; Ley et al. 1990; Rodriguez et al. 1996; Tan & Andrews 
2002; Tardieux et al. 1992). This lysosomal-parasitophorous vacuole with its 
inherent acidic environment is essential for the subsequent differentiation of the 
trypomastigote into the replicative amastigote form and also to trigger the activation 
of a parasite derived pore-forming protein (TcTox) required for the eventual 
disruption of the vacuole (Andrews et al. 1990; Burleigh & Woolsey 2002; 
Tomlinson et al. 1995; Tyler & Engman 2001). 
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Transition of the trypomastigote to the amastigote in the cell begins in the 
parasitophorous vacuole with the transformation into a sphaeromastigote presenting a 
rounded shape with a long flagellum. However, after some hours, this flagellum has 
shortened, reaching a length of about 1 µm (de Souza 2002). During the 
trypomastigote-sphaeromastigote transformation there is an intermediary phase 
which is designated as epimastigote, although this form is somewhat different from 
the epimastigote observed in axenic cultures and the Reduviid mid gut. The 
sphaeromastigote form remains unchanged, increasing in size for a time of 20 – 35 h 
before initiating a process of binary division that is repeated every 12 – 14 h for 
around 9 cycles of division. When the cell is saturated with parasites, amastigotes 
begin their differentiation into trypomastigotes, a process that takes several h. 
Changes occur in the general organisation of the parasite at this point with a 
lengthening of the flagellum from 1 – 20 µm and the kinetoplast changing from its 
tighter, more spindle-like shape to a rounded shape with a loose basket arrangement 
of the k-DNA. The population of intracellular parasites does not differentiate 
completely synchronously and, therefore, at any given time all transitional stages 
between sphaeromastigotes, amastigotes, epimastigotes and trypomastigotes can be 
found in one cell. The intense movements of trypomastigotes at the end of this 
intracellular cycle disrupt the cell, releasing free parasites that can invade other cells. 
Cyst-like pockets of parasites (pseudocysts) can occur in various tissues such as 
cardiac muscle or brain tissue. If the arthropod vector takes a blood meal from the 
mammalian host at this time point of the life cycle it becomes infected with parasites. 
The vector will eventually require feed again, which will lead to the infection of the 
mammalian, thus propagating the infection. 
 
Clinical Manifestations in Humans 
Infection by T. cruzi in humans can cause a 2 stage disease: an acute stage occurring 
soon after infection lasting up to 3 months and a chronic stage that may not become 
symptomatic for 10 years after infection and can last the lifetime of the host.  
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Acute phase 
An intense and localised inflammatory response occurs at the site of inoculation 
forming a small red nodule/lesion (chagoma). Where the infection has occurred 
through the conjunctiva of the eye, the inflammatory response causes oedema of the 
conjunctiva and eyelid and a swelling of the preauricular lymph node. These ocular 
symptoms collectively constitute the classical sign of acute infection known as 
Romaña’s sign. 
 
The acute phase is usually asymptomatic, but can present with manifestations that 
include fever, anorexia, lymphadenopathy, mild hepatosplenomegaly and 
myocarditis.  Most acute cases resolve over a period of 2 to 3 months into an 
asymptomatic chronic stage.  
 
During the acute phase there is an intense parasitaemia due to the cycle of 
intracellular infection and pseudocyst formation with the re-current rupture of cells 
by escaping trypomastigotes leading to further acute, local inflammatory responses 
accompanied by the further degeneration and necrosis of cells in the vicinity, 
particularly ganglion cells. Pseudocysts can be found in almost any tissue type and 
organ with the heart muscle usually invaded with some denervation occurring in this 
site (Marcelino de Souza et al. 2001; Rodrigues et al. 2002; WHO 2002). 
 
Chronic stage 
The chronic phase begins when the intense parasitaemia declines and the general 
symptoms of the acute infection disappear along with any other clinical symptoms of 
acute myocarditis. It is thought that equilibrium between the patients’ immune 
responses and the parasite is reached with this status quo often remaining for the 
lifetime of the individual. Parasites can often be found circulating in the peripheral 
blood for many years after initial infection as well as IgG antibodies against T. cruzi. 
This latent period of infection (indeterminate form) affects around 50 – 70% of all 
infected individuals and lasts for the lifetime of the host. During this stage they are 
potential reservoirs of infection in endemic areas through Reduviid bugs and blood 
donation. 
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The symptomatic chronic stage may not occur for years or even decades after initial 
infection and affects 30 – 50% of infected individuals. These patients are often aged 
20 – 50 years old (an economically productive group). Its manifestations include 
cardiomyopathy (the most serious manifestation), pathologies of the digestive tract 
such as megaesophagus and megacolon and weight loss.  Chronic Chagas disease 
and its complications can be fatal with most deaths occurring due to heart failure. 
 
Treatment 
If the symptoms are recognised in the acute phase, effective chemotherapy is 
available in the form of nitroimidazole or nitrofuran derivatives such as benznidazole 
or nifurtimox. However, resistance to these drugs are being reported (Buckner et al. 
1998). Both drugs require a high degree of patient compliance in order for optimum 
results. Nifurtimox is given at a dose of 5 mg/kg/day orally slowly increased to 15 
mg/kg/day (divided over 3 doses) for 2 to 4 months during the acute cycle of 
infection. However, this drug is now no longer being produced and, whilst there are 
still stocks available, the cost to the patient can be prohibitive ($48 US per treatment 
regimen, the equivalent of one month’s pay for a Bolivian miner; (Weir 2006). 
Benznidazole is generally given at 5 – 10 mg/kg/day orally in 2 daily doses for 1 – 2 
months. Side effects are most common in adults for both drugs with a range of 
symptoms common to both, varying from neurotoxicity, anorexia, nausea and 
leukopoenia with nifurtimox exhibiting these most frequently and benznidazole 
showing a greater degree of skin manifestations such as rashes, occurring in as much 
as 30% of patients (Castro, de Mecca and Bartel 2006). This drug is no longer 
produced by the original manufacturer (Roche) and is now produced by the Brazilian 
government who were given the commercial rights and equipment to manufacture 
this drug. Problems with the supply of the primary constituent of this drug have lead 
to delays in its distribution, often up to 4 months (Weir 2006). 
 
One of the favoured drugs currently being used is benznidazole. Its use in acute 
infections is as an antiparasitical but its use in chronic infection is regarded as 
controversial. It is now being used in children as a treatment for chronic infection 
due to the discovery that chronic symptoms are not due to autoimmune disease but 
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inflammatory reactions induced by the continual release of parasites at local lesions. 
When administered to serologically positive school children (7 – 12 years old) 
chronically infected, benznidazole converted 60% of the children to sero-negativity 
with no further development of heart damage (Sgambatti de Andrade et al. 1996; 
Sosa Estani et al. 1998). In murine studies of chronic infection, Benznidazole 
administration can also lead to a reduction in cardiomyopathy (Bustamante et al. 
2007) and further clinical studies in adults also found reduced cardiomyopathy and 
increased sero-negativity with drug treatment (Viotti et al. 2006). 
 
However, in chronic infection the most frequently used treatment is the management 
of the clinical manifestations of the disease such as pace makers being fitted for heart 
arrhythmias and chronic heart failure, transplantation and surgery for megacolon. 
 
Increasing drug resistance and reduced drug availability is leading to advances in the 
search for alternative chemotherapies for this infection. One component is the search 
for plant metabolites and plant extracts as a source of new antiparasitical drugs. 
Naphthylisoquinoline alkaloids from tropical plants have wide ranging parasiticidal 
activities affecting Plasmodium (Bringmann et al. 2003a; Francois et al. 1997), 
Leishmania (Bringmann et al. 2000; Bringmann et al. 2003b) and Trypanosoma spp. 
(Bringmann et al. 2008). Unfortunately the plants from which the alkaloids are 
derived are difficult to cultivate and are rare. However efforts are being made to 
synthesise these compounds and promising results have been achieved with the 
synthesised compounds being as effective as their natural counterparts (Bringmann et 
al. 2008). Other alkaloids are also effective, with the canthinones exhibiting 
effectiveness in the acute stage of infection in mice and short-term chronic stage, 
allowing 80 – 100% survival compared to control groups, at a dosage and 
effectiveness comparable to that of Benznidazole (50 mg/kg/day) (Ferreira et al. 
2007). 
 
Triterpenic compounds also have antitrypanosomal effects on trypomastigotes 
isolated from infected mice (Rosas et al. 2007) and another class of terpenes isolated 
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from plants, the sesquiterpenes affect the growth of epimastigotes in vitro (Brengio et 
al. 2000) as do sesquiterpene lactones (Jimenez-Ortiz et al. 2005). 
 
 
Figure 1.9 Life-cycle of T. cruzi. 
The life cycle is initiated when an infected triatomine insect vector (Reduviidae) 
takes a blood meal and releases metacyclic trypomastigotes in its faeces or urine near 
the site of the bite wound.  Scratching and rubbing the irritated bite wound allows 
entry of these trypomastigotes to the host through the wound itself or through intact 
mucosal membranes, such as the conjunctiva .  
 
Inside the host, the trypomastigotes invade cells, where they differentiate into 
intracellular amastigotes within a parasitophorous vacuole . The amastigotes 
multiply by binary fission  and differentiate into trypomastigotes and then are 
released into the circulation as bloodstream trypomastigotes . Trypomastigotes 
infect cells from a variety of tissues and transform into intracellular amastigotes in 
new infection sites. Clinical manifestations can result from this infective cycle. The 
bloodstream trypomastigotes do not replicate (different from the African 
trypanosomes). Replication resumes only when the parasites enter another cell or are 
ingested by another vector.  The “kissing” or “assassin” bug becomes infected by 
feeding on human or animal blood that contains circulating parasites . The ingested 
trypomastigotes transform into epimastigotes in the vector’s midgut . The parasites 
multiply and differentiate in the midgut and differentiate into infective metacyclic 
trypomastigotes in the hindgut . Trypanosoma cruzi can also be transmitted through 
blood transfusions, organ transplantation, transplacentally and in laboratory 
accidents. Source: Figure from the CDC. 
 49
1:8 Research Hypothesis 
Little scientific work has been carried out on plant essential oils (PEOs) and their 
potential use as a source of novel antiparasitical drugs. Whilst there is much evidence 
for plant extracts (as obtained through alcoholic extractions of plant material) having 
antimicrobial, antifungal and antiviral action, with a brief search in PubMed showing 
over 3000 articles (accessed 25th June 2007) a similar enquiry for plant extracts with 
coccidian, Giardia and Trypanosoma parasites found only 214 articles with only 8 of 
them concerned with PEOs and all within the past 10 – 15 years. This search is 
broken down in the following way: 
 
• 16 articles for plants with action against coccidian parasites and 33 against 
Giardia. Of these papers, 5 were concerned with PEOs that had anticoccidial 
and anti-flagellate effects. These 5 papers covered 7 PEOs and a total of 9 
parasites with 2 of the PEOs being found to have anti-giardial activity. There 
was nothing found for plant oils against Cryptosporidium.  
 
• 165 articles for plants tested for antitrypanosomal action. Of these, only 3 
articles concerned the antitrypanosomal effect of PEOs for a total of 5 PEOs 
and 2 species of Trypanosoma. 
 
From this it can be readily seen that there is a dearth of relevant investigative data 
concerning PEOs and their possible anti-parasitical actions. The few PEOs that have 
been investigated have shown great promise in their antiparasitical properties with 
their active constituent being isolated and often found to have greater effect than the 
whole oil and also more effective than the drug of choice. However, with less than 
10% of approximately 250,000 of the world’s flowering plant species having been 
tested and examined scientifically for their medicinal properties (Editorial 1994), the 
few PEOs already reported is just the tip of the iceberg.  
 
As Giardia and Cryptosporidium have a worldwide distribution and infect millions 
of people each year (an estimated 280 million for Giardia alone) and Trypanosoma 
cruzi is responsible for around 50,000 deaths and 16 – 18 million infections per 
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annum in South America, but with little effective chemotherapy available, there is a 
real need for new treatments that are cheap, readily available and easy to produce. 
Plants and their extracts may, in endemic areas, be the only accessible form of 
treatment and so the traditional uses of certain plants must be preserved and 
scientifically examined for potentially new drugs.  
 
Much of our current knowledge of the use of plants has come through traditional 
remedies. In the United Kingdom an historical use of the Bilberry (syn. 
Whortleberry, Blueberry, Blaeberry and Whinberry) is shown in the following 
passage: 
 
“…sell us whortle berries, or the vaccinia nigra of Virgil,… …the astringency 
lies all in the black skin and not in the pulse. Our soldiers eat them for the 
bloody flux, while encamped at Fort-Angus (Fort Augustus – Ed.)…our men 
were getting flux from loch [Ness] water…” – Anon. Physician, 3rd 
September 1746. (Anon. 1825) 
 
The true causes of such fluxes (diarrhoea) are poorly understood, but could be due to 
various enteropathogens including Giardia and Cryptosporidium.  
 
Other evidence for the treatment of fluxes using bilberries comes from the study of 
archaeological material at microscopic level. An archaeobotanical / archaeomedical 
project investigating the contents of a sealed hospital drain dating from the early 14th 
century AD (Soutra) in Scotland, UK discovered Giardia cyst remains in human 
faecal material in the presence of bilberries. Also identified were Ascaris and 
Trichuris ova in the presence of common tormentil (Potentilla erecta) and wild 
strawberry (Fragaria vesca) (Personal Communications, Dr. Brian Moffat, Director 
of the Soutra Hospital Archaeoethnopharmacological Research Project [SHARP], 
Edinburgh, 2006). The Augustinian canons at that hospital and other sites used these 
plants as remedies for helminthic infections and bilberries, in particular, for 
diarrhoea. 
 
Due to such evidence being previously discovered at Soutra, investigations which 
would identify other enteric protozoan parasites were initiated with the hope of being 
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able to identify them molecularly as well as microscopically and, if possible, to 
identify plant material which may have been used to treat the parasite infection. 
 
Such evidence suggests that there is a potential not only for PEOs having 
antiparasitical actions but also the fruits of some plants might also be a source of new 
drugs. Also with the current trend for ‘functional foods’, that is to say foods which 
have more than just a nutritional value and have other ‘health benefits’ such as 
influence over the immune system or reduction of cholesterol, the consumption of 
fruits when diagnosed with a parasitic illness may be an effective (and tasty) 
alternative to conventional chemotherapy with reduced occurrences of side effects, 
increased patient compliance and a potential source of novel drugs. The research 
hypothesis for this project is that plant products have the potential to inhibit 
protozoan parasite of medicinal importance. 
 
The rather specific number of PEOs and polyphenol-rich fruit extracts (PRFEs) 
studied reflects merely the availability of the material at the commencement of study 
due to their costs and availability. PEOs were gifted by the essential oil manufacturer 
(F.D. Copeland and Sons) and the PRFEs gifted by the Scottish Crop Research 
Institute.  
 
1:9 Project Aim and specific objectives 
This project intends to investigate 12 different PEOs and 11 different PRFEs for 
activity against the protozoan parasites G. duodenalis, C. parvum and T. cruzi. The 
aim of the project is to determine potentially active compounds from the composition 
of the effective PEOs and their mechanism of action through microscopic and 
biochemical means. The specific objectives of this project are: 
• To assess the current scientific literature for the antiparasitical effects of 
PEOs and to identify areas of further study. 
• To determine the minimum concentration of PEOs required to inhibit the 
growth of G. duodenalis trophozoites and T. cruzi epimastigotes and to 
influence the excystation of C. parvum oocysts. 
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• To determine the minimum concentration of PRFEs required to inhibit the 
growth of G. duodenalis trophozoites and T. cruzi epimastigotes and to 
influence the excystation of C. parvum oocysts. 
• To determine which factors such as temperature, time, pH, bile modify or 
alter the activity of the above products. 
• To determine the mode of action of the above products by investigating their 
effects on motility, morphology and biochemistry on the parasites mentioned. 
• To compare the inhibitory properties of the PEOs and PRFEs with drugs 
currently used for the treatment of infections caused by the above parasites. 
• To determine the validity of the historical / traditional use of bilberries for the 
treatment diarrhoea by investigating the in vitro inhibitory properties of 
extracts of this fruit upon G. duodenalis trophozoites and C. parvum oocysts. 
• To determine the presence of plant material in conjunction with protozoan 
parasites in archaeological samples and to assess their use as medicinal herbal 
remedies from the Viking to the medieval period of British history. 
• To identify protozoan parasites within archaeological samples from Viking 
latrines and medieval hospital drains using microscopic (fluorescent and 
bright field) and genetic methods. 
 
 
 
 53
CHAPTER 2 
 
Giardia duodenalis 
 
The inhibitory effect of various PEOs and their constituents on Giardia 
duodenalis trophozoite viability in vitro. 
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2:1 ABSTRACT 
The effects of a range of plant essential oils (PEOs) on G. duodenalis trophozoite 
viability in vitro were investigated in this study. All PEOs tested demonstrated 
antigiardial activity at a concentration of 0.02% (200 μg ml-1) and in a dose 
dependent manner, with oils of myrrh, myrtle and elemi having the greatest 
inhibitory effect with a minimum inhibitory concentration (MIC) of 0.005% (50 μg 
ml-1) respectively which was more effective than metronidazole (MIC = 67 μg ml-1). 
Metronidazole had a greater effect on trophozoite viability at lower concentrations 
than any of the oils tested where the 90% and 50% inhibitory concentrations (IC90 
and IC50) were 21.8 μg ml-1 and 5.6 μg ml-1, respectively. All the PEOs tested failed 
to reach these levels and had a wide range of activity (IC90 = 0.003 – 0.013 % [30 – 
130 μg ml-1], IC50 = 0.0009 – 0.007 % [9 – 70 μg ml-1]). All the PEOs, with the 
exception of myrrh were able to reduce trophozoite viability to 0% within 60 min of 
incubation at 0.005% (50 μg ml-1). Both myrtle and elemi inhibited the expression of 
a 37 kDa protein in whole cell lysates which was also observed in trophozoites killed 
using either metronidazole or by flash freezing in liquid nitrogen. Heat killed 
trophozoites failed to abolish this protein. Myrtle oil also inhibited a ~70 kDa protein 
and elemi upregulated a 100 kDa protein in a concentration dependent manner. The 
major constituents of myrtle (α-pinene and eucalyptol) and elemi (limonene), when 
used at concentrations equivalent to that found in 0.02% of whole oil, were able to 
kill all trophozoites, but not at lower concentrations. Also, these compounds did not 
have an effect on the reported actions on protein expression, suggesting that the 
compounds present in the greatest proportions are not necessarily responsible for the 
reported activity. To conclude, PEOs can kill G. duodenalis trophozoites and modify 
the morphology of G. duodenalis. Terpenic compounds present in these oils may be 
responsible for this activity. The rapid action of PEOs has shown a potential for 
novel drug design which could reduce the duration of treatment. Furthermore, myrtle 
and elemi oils can interfere with the protein profile of G. duodenalis trophozoites as 
well as reduce their viability. 
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2:2 INTRODUCTION 
The protozoan parasite, Giardia duodenalis (syn. G. lamblia, G. intestinalis) has a 
worldwide distribution and is a common cause of diarrhoea. Whilst there is effective 
drug treatment available for G. duodenalis, anecdotal evidence of resistance has been 
shown (Wright et al. 2003). Oral metronidazole is the drug of choice, but side effects 
such as nausea, headaches and an unpalatable strong metallic taste reduce patient 
compliance.  
 
G. duodenalis has been recognised as an anaerobe although recent evidence suggests 
that this organism does require very small amounts of oxygen to survive (Bénéré et 
al. 2007). This can usually be provided by their axenic culture in tubes which are 
filled to 90 – 95% of their capacity. Traditionally 2 major choices for susceptibility 
assays have been available: tube assays and microtitre plate assays. Microtitre plates 
are problematic due to the variability of the anaerobic environment and the need to 
remove the plates from the anaerobic or low-oxygen environment to monitor the 
progress of the assay. Tube assays are cumbersome and time-consuming, especially 
when trying to screen many novel drugs, with few if any replicates possible (Upcroft 
& Upcroft 2001). The use of adhesive sealant tape to cover the wells of the microtitre 
plate has alleviated the problems of low-oxygen environments whereby filling the 
wells of the plate to almost their maximum capacity and sealing in a small air bubble 
creates a micro-environment suitable for trophozoite survival (Bénéré, 2007).  
 
Population densities of Giardia can have an impact on their culture and on 
susceptibility assays. Using few trophozoites, it becomes difficult to determine 
viability using chemical assays such as tetrazolium salt reduction and by enumeration 
with microscopy and Trypan blue inclusion / exclusion. The same problems arise 
when the population density is too great. When performing susceptibility assays it is 
necessary to use a population density such that an accurate measurement can be 
taken of trophozoite viability whether it is a concentration required to inhibit the 
viability of 50% of trophozoites or their complete inhibition.  A seeding density 
previously used by Upcroft & Upcroft (2001) of 4 x 104 trophozoites per well of a 96 
well microtitre plate was found to be sufficient for a visual assessment of viability 
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after 72 h. In [3H] thymidine assays initial inoculates of 103 per well have been 
successfully used from 24 h to 96 h of incubation (Perez et al. 2001). Biochemical 
reduction of tetrazolium salts has been found to be accurate when using 5 x 104 
trophozoites per well for 72 h incubation (Bénéré 2007). As can be seen, there is a 
range of trophozoite concentrations that can be used, dependant on the assay used to 
assess viability. 
 
The solubility of drugs can be problematic when trying to assess their effectiveness 
in vitro and they are usually used in conjunction with diluents. In the case of the 
plant essential oils to be used herein, solubility is of major importance as is the 
potential effects of the diluent used to solubilise the oils. Common diluents used with 
in vitro experiments are ethanol and dimethyl sulphoxide (DMSO). Both can have 
adverse effects on the viability on Giardia trophozoites when used at high 
concentrations (70% for ethanol; Freitas et al. 2006 and 0.05% for DMSO; 
Campanati, Gadelha and Monteiro-Leal (2001) although DMSO is used as a 
cryopreservative at concentrations of up to 10%; Phillips, Boreham and Shepard 
(1984). As the maximum concentration of diluent to be used in vitro will be 0.06%, 
the effects of each diluent must be assessed at this concentration and above. 
 
The nitroimidazole, metronidazole, is the drug of choice for giardiasis (Upcroft & 
Upcroft 1993), but with variability of its in vitro effects being reported (2.5 µM 
[Bénéré 2007] – 6.3 µM [Upcroft & Upcroft 2001]). The reduction of metronidazole 
resistance in resistant strains has also been reported when these strains are cultured in 
the absence of the drug for long periods of time (Upcroft & Upcroft 2001). 
Therefore, it is important to be able to verify a working concentration of drug that 
can kill 100% of trophozoites (minimum inhibitory concentration; MIC) within the 
time frame of the experiment. To this end, a titration of metronidazole was carried 
out to calculate the MIC of the drug. 
 
Recent advances in the understanding of the biochemistry and molecular biology of 
protozoa have permitted the study of molecules that directly participate in the 
parasites’ life cycle or in pathogenicity (North, Mottram and Coombs 1990). For 
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example, the understanding of antigenic variance can allow inferences to be made on 
the survival strategies used by the parasite (Müller & Gottstein 1998) and 
vaccination against the parasite (Olson, Ceri and Morck 2000). Antibiotic resistance 
can be characterised and the mechanisms by which the parasite can achieve 
resistance can be investigated (Müller et al. 2007; Upcroft & Upcroft 2001; Upcroft 
et al. 1996).  
 
Plant oils and extracts made from them have a wide range of effects on cell biology 
whether it is on the membrane, interfering with surface proteins, or within the cell, 
inhibiting proteins.  
 
The method used for primary protein analysis is sodium dodecyl-polyacrylamide gel 
electrophoresis (SDS-PAGE). One-dimensional SDS-PAGE or 2-dimensional gel 
electrophoresis (2DE) are commonly used techniques for resolving protein solutions 
for further analysis. This technique separates proteins according to molecular weight 
and electrophoretic mobility and can be used to discover differences in protein 
quantities / profiles between various samples. 
 
As antibiotic resistance has been noted in Giardia new drugs are being sought to 
combat the infection (Upcroft & Upcroft 2001). The antimicrobial properties of plant 
products have been recognised for numerous years and recently there has been 
renewed interest with plants and plant products being used as traditional remedies for 
various ailments in numerous countries, with little or no side effects (Jones 1996; 
Heinrich 2000 & 2003). Plants can have inhibitory properties against a range of 
microbes such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli 
and Candida albicans with researchers investigating the historical and folk lore uses 
of plants in different parts of the world such as South America (Rosado-Vallado et 
al. 2000; Yasunaka et al. 2005), India (Samy, Ignacimuthu and Sen 1998; Samy & 
Ignacimuthu 2000), Africa (Kudi et al. 1999) and the Middle East (Essawi & Srour 
2000). Even the antiviral properties of plants are being investigated (Cowan 1999; 
Jassim & Naji 2003). The antimicrobial properties of herbs and spices have been 
recognised for thousands of years and recently there has been renewed interest in 
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such products, especially plant oils (Smith-Palmer, Stewart and Fyfe 1998; Kumar & 
Berwal 1998).  
 
An ethanol extract of clove oil was found to inhibit prostaglandin E2 (PGE2) 
production in activated murine macrophages (Kim et al. 2003) and 1,8-cineol from 
eucalyptus oil inhibited cytokine production (Juergens et al. 2003). It is thought that 
the cytopathic effects of TTO is due to its lipophilic character, with the oil interacting 
with the cellular membrane and disrupting normal membrane activity (Soderberg, 
Johansson and Gref 1996). Antibody led responses can also be affected by oils with 
rosmarinic acid from lemon balm inhibiting the classical complement pathway by 
blocking both C5 convertase (Peake et al. 1991) and C3 convertase (Englberger et al. 
1988). The inhibition of PGE2 production in activated murine macrophages by 
eugenol, prepared from an ethanol extract from cloves, is due to the inhibition of 
COX-2 mRNA expression (Kim et al. 2003). In rats, the fixed oil of basil was found 
to inhibit both cyclooxygenase and lipooxygenase pathways of arachidonic acid 
metabolism (Singh 1999). The mode of action of allicin and its condensation 
product, ajoene, have both been investigated and it has been reported that the 
mechanism of action is through interaction with important thiol-containing enzymes 
(Ankri & Mirelman 1999). Ajoene can inhibit T. cruzi proliferation by possibly 
inhibiting phosphatidylcholine biosynthesis (Urbina et al. 1993). 
 
Much of the work concerning plants has dealt with alcoholic extracts, but some 
investigations have been carried out using the concentrates produced by steam 
distillation of plant material. This is the essential oil which has common uses as 
fragrance in perfumes and as flavourings in food. These are refined extracts of plants, 
concentrating the many constituents into a lipophilic, low density formulation which 
may enhance the adsorption of active constituents from within the oil and enhance 
the targeting of active constituents within the oil to intracellular parasites (Boyom et 
al. 2003). Investigations have shown that plant oils can have antimicrobial/antifungal 
activity (Fyfe, Armstrong and Stewart 1997; Smith-Palmer, Stewart and Fyfe 1998, 
2002; Hammer, Carson and Riley 1999; Burt 2004; Hammer, Carson and Riley 
2003; Terzi et al. 2007; Kalemba & Kunicka 2003), antiviral effects (Cowan 1999; 
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Jassim & Naji 2003) and more recently, antiparasitic properties (reviewed by 
Anthony, Fyfe and Smith 2005). 
 
Garlic extract inhibits G. duodenalis trophozoite growth in vitro, primarily due to the 
transformation product (diallyl trisulphide) of its major constituent (allicin) (Lun et 
al. 1994). Treatment of humans with garlic extract can reduce clinical signs and 
symptoms more rapidly than metronidazole, the drug of choice (Soffar & Mokhtar 
1991). Whole garlic extract co-cultured with trophozoites causes internalisation of 
flagella and ventral disc fragmentation (Harris et al. 2000; Anthony, Fyfe and Smith 
2005). Thyme oil can also be as effective as metronidazole in killing G. duodenalis 
cysts (Sahebani, Farsangi and Movahed 2004). More recently, lavender oil from 
Lavandula angustifolia and L. intermedia were found to inhibit the growth of G. 
duodenalis trophozoites in vitro at concentrations of < 1% (Moon, Wilkinson and 
Cavanagh 2006). 
 
There is limited information available for the antigiardial properties of plants. A brief 
search on PubMed shows 35 journal articles for plants with antigiardial properties, 
most concerning the crude extract of the plant or alcoholic extracts (PubMed search 
dated 26th Sept. 2007). Of these articles, only 2 investigated the antigiardial 
properties of plant essential oils (thyme and lavender oil). This leaves our 
understanding of PEOs as a potential source of novel antigiardial drugs as scanty, at 
best. As PEOs are a concentrate of various constituents, the identification of active 
compounds from either the crude extracts or the more refined extractions can assist 
in targeting future novel drug searches. A range of compounds are already known to 
inhibit the growth or kill G. duodenalis trophozoites both in vitro and in vivo, 
including the flavones (Khan et al. 2000), flavenoids (Barbosa, Calzada and Campos 
2006 & 2007; Calzada, Cervantes-Martínez and Yépez-Mulia 2005; Calzada et al. 
2003; Calzada, Meckes and Cedillo-Rivera 1999), flavenol glycosides (Calzada & 
Alanís 2007; Calzada 2005), alkaloids (Moo-Puc et al. 2007), terpenoids (mono, tri 
and sesqui) (Mena-Rejón et al. 2007; Said Fernández et al. 2005), gallic acids 
(Alanís et al. 2003) and proanthocyanidins (Calzada et al. 2001; 1999). 
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In this series of experiments the effect of incubating 12 different PEOs over a 24 h 
period with intact G. duodenalis trophozoites to determine whether they influenced 
G. duodenalis trophozoite viability in vitro was investigated. The minimum 
inhibitory concentrations for these PEOs were also determined and their active 
constituents discovered. Further, an analysis into the possible mechanism of action of 
the effective oils and constituents were performed using 1-D SDS-PAGE 
fractionation. 
 
 
 61
2:3 MATERIALS AND METHODS 
2.3.1 Parasite culture 
Source and maintenance of G. duodenalis trophozoites 
Trophozoites of the BVM strain of G. duodenalis (donated by Dr. T. Paget, The 
Universities of Kent and Greenwich at Medway, UK) were maintained axenically in 
sealed flat sided 110 mm x 16 mm culture tubes (Nunc, Denmark) angled 5° from the 
horizontal, at 37ºC, in a modified TYI-S-33 medium (Appendix 4) supplemented 
with 10% (v/v) heat-inactivated foetal bovine serum (Gibco-BRL, Paisley, UK) and 
filled to maximum capacity. Sub-culturing was performed routinely at 72 – 96 h 
intervals by harvesting from the culture tubes through chilling on ice water (to 
facilitate trophozoite detachment) for 20 min and then pipetting 1 ml of the 
suspended trophozoites into ~9 ml of fresh TYI-S-33 medium.  
 
G. duodenalis enumeration for experiments 
Trophozoite enumeration was performed using an improved Neubauer 
haemocytometer and trophozoite viability determined by Trypan blue inclusion / 
exclusion where dead cells (stained cells) were determined microscopically. A lack 
of motility and changes to the morphology served as corroborating parameters of cell 
death (TBMM). Briefly, trophozoites were harvested from the culture tubes 
following chilling on ice water for 20 min and then centrifuging the culture tubes 
(500 x g for 5 min). The supernatant was aspirated to waste and the pellet 
resuspended in 1 ml TYI-S-33 medium. A 20 µl aliquot of this suspension was added 
to 80 µl of TYI-S-33 medium in a 1.5 ml microcentrifuge tube to dilute the numbers 
of trophozoites for easier counting. A 20 µl aliquot of this suspension was then added 
to 20 µl 0.4% Trypan blue solution (Gibco, UK) and mixed thoroughly. After 
mixing, 10 µl aliquots were dispensed into both chambers of an improved Neubauer 
haemocytometer, allowed to settle (30 – 60 sec) then enumerated. Trophozoite 
enumeration was determined under bright field microscopy with trophozoites being 
counted within the grids of the haemocytometer chamber. The average number of 
live trophozoites from each chamber counted in five large grids was used to 
enumerate the sample and calculated as follows: 
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Average number of trophozoites x dilution factor x 5 x 104 = Trophozoites ml-1 
Viable trophozoites were determined by Trypan blue exclusion, motility and flagellar 
movement. Trophozoites were determined to be dead following the inclusion of 
Trypan blue and/or a lack of motility. 
 
G. duodenalis titration for in vitro experiments 
Initial experiments used flat sided 110 mm x 16 mm culture tubes containing 1 x 106 
trophozoites ml-1, however, it was soon discovered that the parasites could be 
cultured for the duration of an experiment in 96 well microtitre plates. This allowed 
for a more rapid screening of PEOs. A concentration of trophozoites that would 
provide an even monolayer of trophozoites in microtitre plate wells was determined. 
Trophozoites at concentrations ranging from 3.3 x 104 – 3.3 x 105 trophozoites ml-1 
were assessed over 24 h at 37°C using 150 µl well-1 and 150 µl of modified TYI-S-
33 medium. A concentration of 2.7 x 105 trophozoites ml-1 (equivalent of 4.5 x104 
well-1) was found to give an even monolayer over 24 h and was used for experiments 
in 96 well microtitre plates (data not shown). 
 
Parasite lysate preparation 
Parasite concentrations of 2.7 x 105 ml-1 to 5 x 107 ml-1 were prepared in 1 ml 
volumes of complete TYI-33-S medium initially and then treated to three cycles of 
centrifugation (500 x g, 5 min) and washing in 1 ml volumes of electrode running 
buffer (TGS). The supernatant was aspirated to waste and the pellet resuspended in 
100 µl of TGS and treated to 15 cycles of freeze / thawing in liquid nitrogen (1 min) 
and 56°C (1 min). This lysate was then centrifuged (12,500 x g, 1 min) and the 
resultant supernatant removed to a fresh 1.5 ml microcentrifuge tube and kept at -
80°C until used in electrophoresis.  
 
2:3.2 Experimental treatments of parasites 
Ethanol and dimethyl sulphoxide titrations 
To determine which diluent could be safely used in the experiments a titration was 
carried out using 2 potential diluents (Ethanol [EtOH] and dimethyl sulphoxide 
[DMSO]) from a starting concentration of 75% diluent / 25% distilled water. A final 
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concentration equivalent to 0.02% v/v in the microtitre well was achieved by diluting 
10.67 µl of diluent (75% v/v stock EtOH or DMSO) in 1 ml of modified TYI-S-33 
medium and vortexing for 20 sec. 150 µl of this solution was then immediately 
added to 150 µl of 2.7 x 105 trophozoites ml-1. Doubling dilutions of the solution 
were performed to give a range of concentrations equivalent to those used in PEO 
titrations (0, 0.0067, 0.0167, 0.033, 0.067% EtOH or DMSO v/v). Incubation 
occurred in sealed 96 well microtitre plates at 37°C for 24 h following which parasite 
viability was assessed by TBMM. The diluent which failed to have any significant 
detrimental impact on trophozoite viability was used as the diluent of choice for PEO 
experiments. 
 
 Incubation of G. duodenalis trophozoites with metronidazole 
A concentration of 2.7 x 105 trophozoites ml-1 was tested against the reference drug 
metronidazole at the following concentrations: 0, 1.7, 2.5, 3.35, 6.7, 16.7, 33.5, 50.2, 
67, 83.7 and 167 µg ml-1 diluted in TYI-S-33 medium with 150 µl of each 
concentrate being added to 150 µl of trophozoites. Incubation occurred in sealed 96 
well microtitre plates at 37°C for 24 h. Following titration (Figure 2.2), 
metronidazole at a concentration of 67 µg ml-1 (20 µg per 300 µl well) was 
determined to be the minimum concentration that killed 100% of trophozoites in 
vitro. This concentration was used in all positive controls.  
 
PEOs preparation 
All PEOs were diluted in absolute ethanol to provide 25% v/v stock solutions (25% 
PEO, 75% absolute ethanol), which were used in these experiments. The full list of 
PEOs investigated is given in Appendix 1. A final concentration of 0.02% in the 
microtitre well was achieved by diluting 10.67 µl of PEO (25% v/v stock) in 1 ml of 
modified TYI-S-33 medium and vortexing for 20 sec with 150 µl of this being 
immediately added to 150 µl of 2.7 x 105 trophozoites ml-1. Thus, the maximum 
concentration of ethanol in the well was 0.067%, which has no effect on the viability 
of trophozoites during the incubation period used. 
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 Incubation of G. duodenalis trophozoites with PEOs 
After 72 h of culture, trophozoites were harvested by chilling culture vessels in iced 
water for 20 min. Experiments were performed in sterile, 96 well microtitre plates 
covered with plate sealer film and lids (Costar, Corning). Final concentrations of 
0.02% of PEOs were initially used. Where 100% killing of trophozoites was 
observed, the PEOs responsible were further titrated at concentrations of 0.01, 0.005, 
0.0025 and 0.00125% using doubling dilutions to determine their MIC. The 
microtitre plates were sealed and incubated for 24 h at 37ºC and after 2 h of 
incubation the parasites were examined microscopically in their wells for adherence 
and, also again at 24 h, prior to the determination of viability with Trypan blue.  
 
The positive control consisted of 4 x 104 trophozoites in 300 µl TYI-S-33 containing 
67 µg ml-1 of metronidazole which had been previously assessed as the MIC for this 
drug with this concentration of trophozoites, isolate and method. The negative 
controls consisted of 4 x 104 trophozoites in 300 µl TYI-S-33 in the absence of PEOs 
or metronidazole. All samples were prepared in triplicate. 
 
 Incubation of G. duodenalis trophozoites with PEO constituents 
Following on from the PEO titration experiments, three PEOs exhibited the greatest 
antigiardial properties as assessed by MIC. Oils of myrrh, myrtle and elemi were 
more closely examined for their composition using Gas Chromatography coupled 
with Mass Spectroscopy (GC-MS). This procedure was carried out by F.D. Copeland 
& Sons with the composition of the PEOs given in Appendix 3. Constituents which 
made the greater part of the PEO were assessed at their equivalent concentration 
within the PEO such that a constituent which constitutes 75% of the make up a PEO 
would be used at a concentration equal to 75% of the final concentration of the whole 
PEO, i.e. 75% of 0.2% = 0.15%. Where there were multiple constituents found in 
similar concentration within a PEO they would be used at their equivalent 
concentrations individually and in combination to determine the individual active 
constituent and if any effects observed were additive in action or were cumulative. In 
the case of myrtle oil the major constituents were found to be the monoterpenes α-
pinene and eucalyptol (syn. 1,8-cineole) comprising 51.72% and 22.35% of the 
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whole oil respectively. Elemi oil composition was found to consist of the terpene 
limonene (syn. (+)-p-Mentha-1,8-diene; (+)-Carvene; (R)-4-Isopropenyl-1-methyl-1-
cyclohexene) (51.54%), α-phellandrene (16.23%) and elemol (10.90%). Myrrh oil 
composition was found to consist of furanic sesquiterpenes furanodiene (31.97%) 
and curezene (26.69%). At the time of writing only α-pinene, eucalyptol and 
limonene were readily available from chemical companies and these were used in 
experiments and prepared in the same manner as their whole oils. 
 
Incubation of G. duodenalis trophozoites with PEOs and PEO constituents 
over a 2 h time course 
During the 2 h observation period for trophozoite adherence it was noted that there 
was evidence of antiparasitical action occurring already. A short time course 
experiment was employed to determine how quickly the PEOs exhibited antigiardial 
effects. G. duodenalis trophozoites were incubated in sealed microtitre plates for 30, 
60 and 120 min in the presence or absence of PEOs and the constituents’ α-pinene, 
eucalyptol and limonene at their MIC (Table 2.1). 
 
Table 2.1 Minimal inhibitory concentration of PEOs used in experiments. 
MIC (%) PEO 
0.02 Amyris 
0.02 Buchu 
0.02 Lavender 
0.02 Patchouli 
0.02 Sweet Fennel 
0.01 Geranium 
0.01 Marjoram 
0.01 Palmarosa 
0.01 Thyme 
0.005 Elemi 
0.005 Myrrh 
0.005 Myrtle 
0.002586 α-Pinene 
0.002577 Limonene 
0.00112 Eucalyptol 
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2:3.3 Parasite culture analysis 
G. duodenalis cell count assay 
Trophozoite enumeration was performed using an improved Neubauer 
haemocytometer and trophozoite viability determined by TBMM. Briefly, 
trophozoites were harvested from wells by chilling the plate on ice water for 20 min 
and the contents of triplicate wells were combined into 1.5 ml microcentrifuge tubes 
and then centrifuged (10 sec, bench top centrifuge 5410, 1.5 ml microcentrifuge tube 
GmbH, Germany). The supernatant was aspirated to waste and the pellet resuspended 
in 100 µl TYI-S-33 and 100 µl 0.4% w/v Trypan blue solution (Gibco, UK) and 
mixed thoroughly. After mixing, 10 µl were dispensed into both chambers of an 
improved Neubauer haemocytometer, allowed to settle (30 – 60 sec) then assessed. 
Trophozoite viability was determined under bright field microscopy using the 
following formula: (L ÷ (L+D)) x 100 where L is the number of live trophozoites 
(unstained, motile and altered morphology from pyriform) and D the number of dead 
trophozoites (stained with Trypan blue, non-motile,) at a total magnification of x400. 
In all cases the trophozoites were enumerated in batches where 4 sets of triplicate 
wells were harvested at any one time and Trypan blue exposure was always < 5 min 
for each sample with the remaining samples kept on ice until enumerated. 
 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) analysis 
Initial experiments were prepared to determine the appropriate numbers of parasites 
required for electrophoretic analysis. Concentrations of trophozoites used in these 
experiments ranged from 2.7 x 105 ml-1 to 5 x 107 ml-1 for each well of a 96 well 
microtitre plate in quintuplicate.  From these results, a concentration of 5 x 107 ml-1 
trophozoites would be required in experiments involving PEOs and their 
constituents. A Bio-Rad Protean 3 mini-prep system (Bio-Rad, USA) was employed 
with a 12% acrylamide separating gel and 4% acrylamide stacking gel prepared 
according to the manufacturer’s instructions (Appendix 5).  
 
10 µl aliquots of lysate prepared from 5 x 107 ml-1 trophozoites were added to 30 µl 
of sample buffer and heated to 100°C in a water bath for 5 min. To the first well of a 
10 well SDS-PAGE gel were added 10 µl of molecular weight marker (Precision 
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Plus Protein standard; unstained; 10 – 250 kDa, Bio-Rad) and to each of the 
following wells were added 30 µl of the boiled lysate / sample buffer mix. This 
would give a maximum concentration of 3.75 x 106 parasites lane-1. The optimal 
voltage and running time combination was determined to be at 180V and 55 min or 
200V and 40 min for the best separation of proteins with 180V and 55 min being 
found to have the best resolution (data not shown). On completion of electrophoresis 
the gel was removed and stained with colloidal blue G (Sigma-Aldrich), a Coomassie 
blue based protein analysis stain, according to the manufacturer’s instructions 
(Appendix 5). The gel was visualised and digitally photographed using a white light 
source that is incorporated in the gel image analyser Gel Doc 2000 system (Bio-Rad, 
UK) and analysed with Quantity One® software (Bio-Rad).  
 
Precision Plus Protein standards (Bio-Rad) are precise recombinant prestained and 
unstained protein standards for electrophoresis and Western blotting. They are 
designed as high accuracy protein reference bands for determining molecular weights 
of unknown proteins. The molecular weight marker can resolve 10 bands 
corresponding to precise weight recombinant protein standards, but with the 
concentration of gel being used this was reduced to 9 bands. Markers were 
electrophoresed at 180V for 55 min on a 12 % separating acrylamide gel with 
Colloidal blue G staining. The 10 kDa marker is not represented on the gel as the 
time required for sample electrophoretic separation consistently ran the marker off 
the gel. Other molecular weight markers were used in the beginning of the 
experiments and were: Kaleidoscope polypeptide standards 3.7 – 34.9 kDa (Bio-Rad) 
and High and Low Range Polypeptide SDS-PAGE standards 14.3 – 200kDa (Bio-
Rad). 
 
PEOs and their constituents’ effects on G. duodenalis cell biology 
A concentration of 5 x 107 trophozoites ml-1 (equivalent to 3.75 x 106 trophozoites 
lane-1) was found to provide the best protein resolution and was therefore used in the 
following experiments. The parasites were prepared as previously described for PEO 
screening and titrations in 96 well microtitre plates with oils of myrtle, elemi oils and 
their constituents (α-pinene, eucalyptol and limonene respectively) effects on protein 
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expression assessed after 24 h incubation (37°C) with viability determination using 
Trypan blue inclusion/exclusion. Controls included heat killed (56°C, 10 min), freeze 
killed (liquid nitrogen, 2 min) and metronidazole treated trophozoites. All samples 
were prepared in quintuplicate and the experiments performed in duplicate. Lysates 
for each sample were prepared as previously described. The prepared lysate was then 
either used immediately or frozen at -80°C for SDS-PAGE analysis.  
 
 Statistical analysis 
In this series of experiments Giardia trophozoites from each microtitre well from 2 
experiments, were counted giving a total of either 6 or 10 enumerations (where 
stated) for each PEO concentration tested. The means and standard deviations of 
these counts were used in formulating graphs and tables. A Student’s 2-tailed, 
unpaired, t-test was used to determine significance with a P value of less than or 
equal to 0.05 being regarded as significant. The construction of dose–response curves 
and calculation of IC50 and IC90 values and statistical analysis was performed using 
XLfit 4® software and Microsoft Excel® software. 
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2:4 RESULTS 
Ethanol and DMSO titrations  
Incubation of G. duodenalis trophozoites in the presence of serial dilutions of DMSO 
at concentrations to be found with the diluted PEOs, significantly reduced their 
viability over a 24 h period (Table 2.2). Ethanol treatment, however, did not affect 
trophozoites viability (Table 2.2). Viable (motile and sessile) trophozoites excluded 
Trypan blue. Motile trophozoites exhibited forward movement during which they 
rotated around their longitudinal axis displaying both a tumbling movement 
resembling that of a falling leaf and an up and down movement known as ‘skipping’. 
Sessile (viable) trophozoites excluded Trypan blue and retained their typical 
pyriform shape and internal morphology (Figure 2.1, panels 1 - 3). Dead trophozoites 
included Trypan blue and often their typical pyriform shape became either slightly 
misshapen or rounded and swollen (Figure 2.1, panels 4 - 9).  
 
DMSO when used at concentrations equivalent to that found in a 0.02% dilution of 
PEO significantly reduced the viability of trophozoites in a dose dependent manner 
(Table 2.2, P < 0.05). Ethanol, however, was not found to have any significant effect 
on trophozoite viability or morphology and was used as the diluent for PEOs in 
experiments (Table 2.2, P > 0.05).  
 
Incubation of G. duodenalis trophozoites with metronidazole 
Incubation of G. duodenalis trophozoites in the presence of serial dilutions of the 
reference drug, metronidazole, significantly reduced their viability over a 24 h 
period. A standard dose response curve was observed and the minimum 
concentration of metronidazole required to kill 100% of trophozoite in vitro was 
determined to be 67 µg ml-1 (Figure 2.2). This concentration of reference drug was 
then used a standard by which PEOs, soft fruit extracts and their constituents could 
be compared for all experiments using Giardia trophozoites. 
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Table 2.2 In vitro viability of G. duodenalis trophozoites using varied 
concentrations of ethanol and DMSO.  
 
 Viability of Trophozoites (%) 
Concentration (% v/v) Ethanol DMSO 
0 4.49 ± 2.0 4.49 ± 2.0 
0.0067 6.38  ± 2.5 19.35 ± 16.6 
0.0167 5.23 ± 2.6 25.09 ± 21.3 
0.033 4.20 ± 2.3 39.64 ± 31.0 
0.067 8.62 ± 5.6 60.72 ± 36.5 
 
Trophozoites were incubated for 24 h in the presence of either ethanol or DMSO (0, 
0.067, 0.033, 0.0167 and 0.0067%) and their viability assessed.  
 
 
Incubation of G. duodenalis trophozoites with PEOs 
Screening of PEOs  
Incubation of G. duodenalis trophozoites in the presence of PEOs at a final 
concentration of 0.02% v/v or metronidazole at 67 µg ml-1 were equally effective at 
reducing trophozoite viability by 100% as assessed by TBMM (Appendix 6). 
 
Dead trophozoites all had similar morphology, retaining a pyriform shape or were 
rounded and swollen or had evidence of blebbing. In metronidazole treated G. 
duodenalis trophozoites, the nuclei were enlarged and darkly stained, cytoplasmic 
staining also appeared ‘grainy’ possibly due to vacuole formation with the 
trophozoite which retained its pyriform morphology. Blebbing was also evident 
(Figure 2.3 A). Representative examples of trophozoite morphology caused by PEOs 
are shown in panels B – E. All panels show a ‘grainy’ cytoplasm with nuclei being 
slightly enlarged and darkly stained. Treatment of trophozoites with patchouli oil 
affected their morphology, causing the swelling and rounding up of trophozoites 
(Figure 2.3 B). Myrrh treated trophozoites retained their pyriform shape and also 
showed evidence of blebbing (Figure 2.3 C), as did those treated with elemi (Figure 
2.3 E). The greatest change to trophozoite morphology was caused by myrtle (Figure 
2.3 D) with all trophozoites becoming swollen, rounded, blebbed and with large 
vacuole formation occurring in the cytoplasm. 
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Figure 2.1 In vitro viability of G. duodenalis trophozoites as assessed by TBMM.  
Trophozoites were incubated for 24 h in the presence or absence of ethanol or 
DMSO (0, 0.067, 0.033, 0.0167 and 0.0067%) and viable trophozoites were viewed 
under bright field microscopy (x1250 total magnification). Viable G. duodenalis 
trophozoites are shown in division (panel 1); in ventral view, showing typical 
pyriform appearance and ventral sucking disc (sd) (panel 2); in dorsal view, 
exhibiting flagella (fl) and the 2 characteristic nuclei (nu) (panel 3). Dead 
trophozoites included Trypan blue, often retaining their pyriform shape. Some were 
slightly misshapen (panels 4 -7) or swollen (panels 8 and 9). In some trophozoites, 
blebbing (bl) was evident (panels 4 and 7) and flagella appeared truncated (tr) (panel 
7). DMSO treatment caused changes in trophozoite morphology and panels 4 – 9 
show typical examples of these changes. Photographs were taken (copyright© SPDL) 
using a ColorView Soft Imaging System MTV-3 camera and analySIS® software. 
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Figure 2.2 In vitro viability of G. duodenalis trophozoites using varied 
concentrations of metronidazole.  
Trophozoites were incubated for 24 h in the presence of different concentrations of 
the reference drug, metronidazole (0 – 167 µg ml-1) and their viability assessed by 
TBMM.  
 
Titration of PEOs 
As all PEOs were found to be equally effective at killing the trophozoites at 0.02%, 
titrations were performed to determine the MIC of PEOs required to kill 100% of 
trophozoites in vitro. Initial titrations were carried out from 0.02% to 0.005% in 
doubling dilutions where it was discovered that only a few PEOs retained a 100% 
killing level at the lowest concentration of 0.005% (Figure 2.4). These PEOs were 
myrrh, myrtle and elemi. Oils of marjoram, palmarosa, thyme and geranium all had 
an MIC of 0.01% with sweet fennel, lavender, amyris, patchouli and buchu oil 
having an MIC of 0.02% (Figure 2.4 and Table 2.3).  
 
As myrrh, myrtle and elemi still elicited a 100% killing effect on G. duodenalis 
trophozoites, a further titration of doubling dilutions was performed with these PEOs 
to determine their MIC. Plant oil activity was found to be dose dependant with all 
three oils failing to completely reduce trophozoite viability at concentrations lower 
than 0.005% (Figure 2.5). From this it was deduced that the MIC for myrrh, myrtle 
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and elemi was 0.005% although > 80% of trophozoites were non-viable with 
0.0025% myrrh which then dropped to < 40% with 0.00125% myrrh. The change 
from trophozoites being viable to non-viable was more marked with oils of myrtle 
and elemi where at 0.0025% both oils caused ~30% trophozoite death, a 70% 
increase in viability from 0.005% (Figure 2.5).  
 
The MIC for myrrh, myrtle and elemi oils (0.005%) compares favourably with that 
of metronidazole (67 μg ml-1) when one converts the percentage concentration values 
for PEOs into μg ml-1. If 1 μg ml-1 is equal to 1 part per million then 1 ppm is equal 
to 1/1,000,000 which is equal to 0.0001%. Since the MIC for the 3 most effective 
oils was 0.005% this is equal to 50 μg ml-1. This is actually lower than that calculated 
for metronidazole and would indicate that these oils at a concentration of 0.005% (or 
50 μg ml-1) are more effective than metronidazole. However, metronidazole has a 
greater effect on trophozoite viability at lower concentrations than any of the oils 
tested where the 90% and 50% inhibitory concentrations (IC90 and IC50) were 
calculated to be 21.8 μg ml-1 and 5.6 μg ml-1 respectively (Table 2.3). All the PEOs 
tested failed to reach these levels and, collectively, had a wide variety of activity 
(IC90 = 0.003 – 0.013 % [30 – 130 μg ml-1], IC50 = 0.0009 – 0.007 % [9 – 70 μg ml-
1], Table 2.3). The most effective oil at the IC90 and IC50 level was not myrrh, myrtle 
or elemi but actually palmarosa oil (IC90 = 0.003 % [30 μg ml-1], IC50 = 0.0009 % [9 
μg ml-1], Table 2.3). This would indicate that palmarosa has a very narrow range of 
activity when compared to myrrh, myrtle or elemi on an individual basis. 
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Figure 2.3 In vitro viability of G. duodenalis trophozoites incubated with PEOs 
for light microscopy.  
Trophozoites were incubated for 24 h in the presence or absence of a final 
concentration of 0.02% PEO or 67 µg ml-1 of metronidazole and their viability 
assessed by TBMM. Panel A shows the effects of metronidazole on G. duodenalis 
trophozoites. The nuclei are enlarged (arrows) and darkly stained, cytoplasmic 
staining also appears ‘grainy’ possibly due to vacuole formation with the trophozoite 
retaining it pyriform morphology. Blebbing was also evident (b). Representative 
examples of trophozoite morphology induced by PEOs are shown in panels B – E. 
All panels show a ‘grainy’ cytoplasm with nuclei being slightly enlarged and darkly 
stained with patchouli treated parasites being pyriform to rounded and swollen (B). 
Both myrrh (C) and elemi (E) treated trophozoites maintained a pyriform shape, but 
with blebbing. Large vacuole formation occurred in the cytoplasm (v) of myrtle 
treated trophozoites (D). Photographs were taken (copyright© SPDL) using a 
ColorView Soft Imaging System MTV-3 camera and analySIS® software. 
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Figure 2.4 In vitro viability of G. duodenalis trophozoites incubated with a 
titration of PEOs.  
Trophozoites were incubated for 24 h in the presence or absence of a final 
concentration of 0.02% (black bars), 0.01% (grey bars), 0.005% (white bars) PEO or 
67 µg ml-1 metronidazole and their viability assessed by TBMM.  
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Figure 2.5 In vitro viability of G. duodenalis trophozoites incubated with myrrh, 
myrtle or elemi oils.  
Trophozoites were incubated for 24 h in the presence or absence of myrrh (black 
bars), myrtle (grey bars), elemi (white bars) PEO or 67 µg ml-1 of metronidazole and 
their viability assessed by TBMM. The PEOs were titrated in doubling dilutions from 
0.02% - 0.00125% final concentrations.  
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Table 2.3 Inhibition of G. duodenalis trophozoite survival by different PEOs 
 INHIBITORY CONCENTRATION OF PEO 
PEO MICa MICb IC90a IC90b IC50a IC50b 
Metronidazole 67 μg ml-1 67 μg ml-1 21.8 μg ml-1 21.8 μg ml-1 5.6 μg ml-1 5.6 μg ml-1 
Amyris 0.02 200 0.009 90 0.004 40 
Buchu 0.02 200 0.01 100 0.006 60 
Lavender 0.02 200 0.011 110 0.007 70 
Patchouli 0.02 200 0.0097 97 0.006 60 
Sweet Fennel 0.02 200 0.013 130 0.006 60 
Geranium 0.01 100 0.007 70 0.003 30 
Marjoram 0.01 100 0.009 90 0.006 60 
Palmarosa 0.01 100 0.003 30 0.0009 9 
Thyme 0.01 100 0.0075 75 0.004 40 
Elemi 0.005 50 0.0048 48 0.003 30 
Myrtle 0.005 50 0.0049 49 0.003 30 
Myrrh 0.005 50 0.003 30 0.0015 15 
 
a Concentrations are given as a percentage v/v. 
b Concentrations are given as μg ml-1 where 0.0001% = 1 ppm = 1 μg ml-1. 
MIC = the minimum concentration required to inhibit the growth/culture of 100% 
trophozoites. 
IC90 and IC50 = the concentration required to inhibit the growth/culture of 90% or 
50% of trophozoites respectively. 
Viability was assessed using TBMM. 
 
Incubation of G. duodenalis trophozoites with PEO constituents 
The 3 PEOs having the lowest MIC were examined to determine their chemical 
composition with the assistance of F.D. Copeland and Sons. This company used gas 
chromatography coupled with mass spectroscopy to elucidate chemical compositions 
for the oils of myrrh, myrtle and elemi (Appendix 3). Myrrh had a complex 
composition with over 50 individual constituents being found. Unfortunately the 
constituents in greatest abundance (the furanic sesquiterpenes furanodiene [31.97%] 
and curezene [26.69%]) were unavailable for purchase from chemical manufacturers. 
This meant that no further investigations into the activity of these constituents could 
be performed.  
 
In the case of myrtle oil the major constituents were found to be the monoterpenes α-
pinene and eucalyptol (syn. 1,8-cineole) comprising 51.72% and 22.35% of the 
whole oil respectively. The main constituents of elemi oil composition were found to 
be the terpene, limonene (51.54%; syn. (+)-p-Mentha-1,8-diene; (+)-Carvene; (R)-4-
Isopropenyl-1-methyl-1-cyclohexene), α-phellandrene (16.23%) and elemol 
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(10.90%). Whilst both the main constituents of myrtle were available for purchase 
only limonene could be obtained for elemi oil. 
 
Oil constituents were used at concentrations equivalent to that found in the whole oil 
such that if the constituent comprised 51.72% of the oil then the constituent, when 
tested on its own, would be used at a concentration 51.72% of the whole oil 
concentrations, i.e. 0.0026%. 
 
When the constituents were initially used at the equivalent screening concentration of 
the oils at 0.02% both α-pinene and limonene reduced the viability of G. duodenalis 
trophozoites by 100% (Figure 2.6). The second constituent of myrtle oil was 1,8-
cineole and when tested at a concentration of 0.0045% (its equivalent concentration 
found in 0.02% of the whole oil) reduced trophozoite viability by only 17%. This 
would indicate that the active constituent responsible for the death of G. duodenalis 
trophozoites in vitro in myrtle oil was α-pinene and not eucalyptol. Maximum killing 
was still observed when both these constituents were used in combination suggesting 
that eucalyptol did not have any agonistic or antagonistic effects upon the action of 
α-pinene. Limonene was the only one constituent of elemi available for testing and 
when used at a final concentration of 0.01% killed 100% of G. duodenalis 
trophozoites. Limonene would appear to be the active constituent found in elemi oil. 
 
However, when the constituents were examined at the MIC levels found in their 
respective whole oils, i.e. 0.005%, all constituents failed to significantly reduce the 
viability of G. duodenalis trophozoites when compared with untreated controls 
(Figure 2.7).  
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Figure 2.6 In vitro viability of G. duodenalis trophozoites incubated with myrtle 
or elemi oils and their constituents at screening concentrations.  
Trophozoites were incubated for 24 h in the presence or absence of 0.02% myrtle, 
0.02% elemi PEO, 0.01% α-pinene, 0.0045% eucalyptol, a combination of α-pinene 
and eucalyptol, 0.01% limonene or 67 µg ml-1 of metronidazole and their viability 
assessed by TBMM.  
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Figure 2.7 In vitro viability of G. duodenalis trophozoites incubated with myrtle 
or elemi oils and their constituents at MIC concentrations.  
Trophozoites were incubated for 24 h in the presence or absence of 0.005% myrtle, 
0.005% elemi PEO, 0.0026% α-pinene, 0.0011% eucalyptol, a combination of α-
pinene and eucalyptol, 0.0026% limonene or 67 µg ml-1 of metronidazole and their 
viability assessed by TBMM.  
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Incubation of G. duodenalis trophozoites with PEOs and their constituents over a 2 h 
time course 
It was noted that some parasiticidal action occurred within 120 min of incubation 
when a visual inspection of the microtitre plates being incubated for 24 h was 
routinely performed to determine adherence and general viability of trophozoites 
before being left to continue incubation. Whilst this was anecdotal evidence of 
trophozoites starting to round up, losing motility and swelling, an experiment was 
designed to quantify this activity. The MICs of each PEO and selected constituents 
were used and the viability of trophozoites was assessed after 30, 60 and 120 min 
incubation.  
 
All PEOs with the exception of myrrh killed 100% of trophozoites within 60 min of 
incubation at their MICs (Figure 2.8). This was significantly different from 
metronidazole which failed to kill 100% of trophozoites when compared to the 
untreated controls at all three incubation times tested (Figure 2.8, P > 0.05). 
Metronidazole did, however, reduce trophozoite viability after 24 h (Figure 2.9). Oils 
of lavender (MIC = 0.02%), marjoram (MIC = 0.01%), palmarosa (MIC = 0.01%) 
and geranium (MIC = 0.01%) were able to kill 100% of trophozoites after only 30 
min (Figure 2.8). The difference in the activity between the oils may be due to 
differences in their constituents. 
 
There was no significant difference in the activities of α-pinene, eucalyptol (myrtle 
constituents) and limonene (elemi constituent) on trophozoite viability throughout 
the incubation times tested (30 min to 24 h). All failed to significantly change 
trophozoite viability from untreated control levels (Figure 2.9).  
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Figure 2.8 In vitro viability of G. duodenalis trophozoites incubated with PEOs 
over a 2 h time course.  
Trophozoites were incubated for up to 2 h in the presence or absence of PEO at a 
final concentration equivalent to the PEO pre-determined MIC. Viability of 
trophozoites was assessed after 30 min incubation (black bars), 60 min (grey bars), 
120 min (white bars) of PEO or 67 µg ml-1 metronidazole and their viability assessed 
by TBMM.  
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Figure 2.9 In vitro viability of G. duodenalis trophozoites incubated with PEOs 
and constituents over a 2 h time course. 
Trophozoites were incubated for up to 24 h in the presence or absence of myrtle, 
elemi or their main constituents at a final concentration equivalent to the oils pre-
determined MIC. Viability of trophozoites were assessed after 30 min incubation 
(black bars), 60 min (grey bars), 120 min (diagonal bars) or 24 h (white bars) PEO or 
67 µg ml-1 metronidazole and their viability assessed by TBMM.  
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Trophozoite protein profiling by SDS-PAGE analysis 
Lysate titration – SDS PAGE analysis 
In order to be able to visualise a protein profile from a parasite lysate, one requires a 
minimum amount of protein which can be stained and analysed. A titration of G. 
duodenalis trophozoite lysate concentrations for use in SDS-PAGE analysis was 
performed. Increasing the concentration of parasites increased the amount of protein 
available for staining in the SDS-PAGE gel. Concentrations of parasites ranged from 
2.7 x 105 ml-1 up to 5 x 107 ml-1. No protein profiles were visible with Colloidal blue 
G staining until at least 1 x 107 ml-1 trophozoites were used to prepare lysates and 
optimal visualisation occurred with 5 x 107 ml-1(data not shown). This concentration 
was then used in all SDS-PAGE analysis experiments. This was the equivalent of 
3.75 x 106 trophozoites lane-1. 
  
Heat and freeze killing of trophozoites 
 Viability assessment 
A positive control for killing trophozoites was required. Whilst metronidazole was 
used in previous experiments, controls that produced a protein profile similar to that 
of untreated trophozoites were sought. Two methods for the rapid killing of 
trophozoites were used, heat killing and freeze killing, in order to make comparisons 
with metronidazole and PEO effects on trophozoite protein profile. 
 
Live trophozoites were subjected to heat treatment (56°C for 10 min) or freeze 
treatment (liquid nitrogen, 2 min) and their viability assessed by TBMM. In both 
treatment regimens all trophozoites included Trypan blue indicating non-viability 
with a swollen morphology and were non-motile. Trophozoite plasma membrane 
permeability was increased as indicated by the uptake of Trypan blue, but no other 
disruption to the trophozoite plasma membrane was observed, with the parasites 
remaining intact (Figure 2.10). 
 
 SDS-PAGE analysis 
Once viability had been assessed, lysates were prepared from the trophozoites, 
fractionated by SDS-PAGE and stained with Colloidal blue G. Heat killing (HK) 
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trophozoites caused changes to the protein profile when compared to untreated 
trophozoite controls (Figure 2.11). Some proteins had greater expression with HK 
compared to untreated trophozoites as indicated by more intensely stained bands 
(Figure 2.11). In both HK and FK treatments a band corresponding to ~100 kDa was 
upregulated compared to the untreated control. A 37 kDa protein was absent when 
trophozoites were freeze killed but was present in untreated trophozoites and 
upregulated in heat killed trophozoites indicating that this protein is possibly a heat 
shock protein or closely related to that class of proteins due to its upregulation in heat 
treated trophozoites. Untreated trophozoites showed molecular masses ranging from 
~25 – 250 kDa. 
 
 
Figure 2.10  The effect of heat and freeze killing on G. duodenalis trophozoites. 
Trophozoites were subjected to heat treatment (HK; 56°C, 10 min) or freezing (FK; 
liquid nitrogen, 2 min) and their viability assessed by TBMM. Representative 
photographs are shown for each method. Untreated trophozoites had typical pyriform 
morphology and excluded Trypan blue stain (A). Both heat killed trophozoites (B) 
and freeze killed trophozoites (C) showed an uptake of Trypan blue and had rounded 
morphology. Photographs were taken (copyright© SPDL) using a ColorView Soft 
Imaging System MTV-3 camera and analySIS® software. 
 
Metronidazole titration – SDS PAGE analysis 
Incubation of trophozoites with increasing concentrations of metronidazole did not 
change the outcome of viability. The reference drug was just as effective in killing 
trophozoites at the final concentration of 20 µg with the high numbers of parasites 
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used in this protein analysis experiments in comparison to the previous viability 
studies (5 x 107 ml-1 compared to 2.7 x 105 ml-1). SDS-PAGE analysis shows no 
difference in the protein profile at each concentration of metronidazole used (Figure 
2.12). However, metronidazole appears to enhance the production of a ~100kDa 
protein when compared with untreated controls. This was also observed for heat and 
freeze killed trophozoites indicating that this protein is upregulated during death by a 
variety of means. 
 
      kDa       MW          G HK     FK 
 
Figure 2.11 The effect of heat and freeze killing on G. duodenalis trophozoite 
protein profile using SDS-PAGE analysis.  
Trophozoites were subjected to heat treatment (HK; 56°C, 10 min) or freezing (FK; 
liquid nitrogen, 2 min) and lysates were prepared. Lysates were compared with 
untreated trophozoites (G) and were loaded on a 12% acrylamide separating gel and 
4% acrylamide stacking gel and electrophoresed at 180V for 55 min. Protein bands 
are visualised using the Colloidal blue G staining system and run against a molecular 
weight marker (MW; Bio-Rad). 
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Figure 2.12 Titration of metronidazole for use in SDS-PAGE analysis.  
G. duodenalis trophozoites (5 x 107 ml-1) were incubated in the presence or absence 
of final concentrations 0, 20, 40, 80 or 160 µg of metronidazole in 96 well microtitre 
plates and compared with untreated trophozoites (G). Heat killed (HK) and freeze 
killed (FK) trophozoite lysates were prepared as other controls for trophozoite 
killing. All lysates prepared were loaded on a 12% acrylamide separating gel and 4% 
acrylamide stacking gel and electrophoresed at 180V for 55 min. Protein bands are 
visualised using the Colloidal blue G staining system and run against a molecular 
weight marker (MW; High and Low weight range polypeptide markers Bio-Rad). 
 
PEOs and their constituents’ effect on G. duodenalis cell biology  
Effect of myrtle oil on viability as assessed by TBMM and SDS PAGE 
analysis 
Incubation of 5 x 107 ml-1 trophozoites in the presence of myrtle oil at concentrations 
used in previous experiments (0.02, 0.01, 0.005 and 0.0025% final concentrations) 
elicited similar responses in that there was a concentration dependant reduction in 
trophozoite viability (Table 2.4). Of note is that using this higher concentration of 
trophozoites (5 x 107 ml-1 instead of 2.67 x 105 ml-1) than used in previous PEO 
experiments, the MIC was changed from 0.005% to 0.01% for the previous PEO 
experiments. In Table 2.4 it can be seen that there is a small, but significant (2.4 ± 
2.2%; P < 0.05) percentage of trophozoites still viable at the previously determined 
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MIC of 0.005%. This phenomenon was also observed with elemi oil treated 
trophozoites under the same conditions (Table 2.4). 
 
SDS-PAGE analysis of these myrtle treated trophozoites show a concentration 
dependant increase in the upregulation of proteins of the following molecular 
weights: 200, 150, 100, 50 and ~30 kDa (Figure 2.13). Killing of trophozoites with 
myrtle oil caused the specific upregulation of a 200 and a 150 kDa protein. All other 
killing treatments (heat, freezing and chemotherapeutic) did not affect these proteins 
and as the concentration of myrtle oil was reduced, so was the production of this 
protein as seen by a reduction in the intensity of the protein band staining. This was 
also evident with the 50 and the ~30 kDa protein. Treatment of trophozoites with 
myrtle oil did not just cause the upregulation of proteins but also caused their 
abrogation. Both the 37 kDa and a ~70 kDa protein were inhibited by high 
concentrations of myrtle oil (0.02 and 0.01%) and started to reappear at the lower 
concentrations used (0.005 and 0.0025%). This is in accordance with the Trypan blue 
data which suggested that there were some viable trophozoites present when treated 
with 0.005% and 0.0025% myrtle oil. The SDS-PAGE analysis details a 
reappearance of these proteins (37 and ~70 kDa) as the number of viable 
trophozoites increase with a decrease in myrtle oil concentration. Only myrtle oil 
abolishes the ~70 kDa protein, with this protein found at equal intensities in 
untreated trophozoites and in heat, freeze and metronidazole killed trophozoites. The 
37 kDa protein abolished by myrtle oil was also abolished by the actions of freeze 
killing and metronidazole treating the trophozoites. 
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Table 2.4 A comparison between the effect of myrtle and elemi oil on G. 
duodenalis trophozoite viability using different concentrations of parasites  
 
 Inhibition of trophozoites (%) 
Parasite Concentration  
(5 x 107 ml-1) 
Parasite Concentration  
(2.67 x 105 ml-1) 
PEO 
Concentration 
(%) Myrtle  
 
Elemi  Myrtle  Elemi  
0.02 100 ± 0 100 ± 0 100 ± 0 100 ± 0 
0.01 100 ± 0 100 ± 0 100 ± 0 100 ± 0 
0.005 97.6 ± 2.2 96.9 ± 3.4 100 ± 0 100 ± 0 
0.0025 69.4 ± 9.3 75.8 ± 7.2 31.3 ± 4.5 31.8 ± 4.5 
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Figure 2.13 The effect of myrtle oil on G. duodenalis trophozoite protein profile 
using SDS-PAGE analysis.  
G. duodenalis trophozoites (G; 5 x 107 ml-1) were incubated in the presence or 
absence of final concentrations of 20 µg metronidazole (Metro.) and 0.0025 – 0.02% 
myrtle oil in 96 well microtitre plates and compared with untreated trophozoites (G). 
Heat killed (HK) and freeze killed (FK) trophozoite lysates were prepared as other 
controls for trophozoite killing. All lysates prepared were loaded on a 12% 
acrylamide separating gel and 4% acrylamide stacking gel and electrophoresed at 
180V for 55 min. Protein bands are visualised using the Colloidal blue G staining 
system and run against a molecular weight marker (MW; Bio-Rad). 
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Effect of elemi oil on viability as assessed by TBMM and SDS PAGE analysis 
As observed with the myrtle oil treated trophozoites incubation of 5 x 107 ml-1 
trophozoites in the presence of elemi oil at concentrations used in previous 
experiments elicited similar responses in that there was a concentration dependant 
reduction in trophozoite viability (Table 2.4). As seen previously with myrtle oil, 
using a higher concentration of trophozoites (5 x 107 ml-1 instead of 2.67 x 105 ml-1) 
than used in previous PEO experiments changes elemi oils MIC from 0.005% to 
0.01%. In Table 2.4 it can be seen that there is a small but significant percentage (3.1 
± 3.4%; P < 0.05) of trophozoites still viable at the previously determined MIC of 
0.005%.  
 
SDS-PAGE analysis of these elemi treated trophozoites shows a concentration 
dependant increase in band intensities of proteins of the following molecular 
weights: 200, 150, 50 and ~30 kDa (Figure 2.14).  
 
Killing of trophozoites with elemi oil caused the specific upregulation of a 200 and a 
~30 kDa protein (Figure 2.14). All other killing treatments (heat, freezing and 
chemotherapeutic) did not affect these proteins and as the concentration of elemi oil 
was reduced, so was the production of this protein as seen by a reduction in the 
intensity of the protein band staining. This is in accordance with the Trypan blue data 
which suggested that there were some viable trophozoites present when incubated 
with 0.005% and 0.0025% myrtle oil. The SDS-PAGE analysis details an increase of 
these proteins as the percentage of viable trophozoites increase with a concurrent 
decrease in myrtle oil concentration. Treatment of trophozoites with elemi oil did not 
only cause the upregulation of proteins, it also caused their inhibition. The 37 kDa 
protein was inhibited with all concentrations of elemi oil. The 100 kDa protein was 
upregulated at all concentrations of elemi oil used. This was also shown in heat, 
freeze and metronidazole killed trophozoites. Untreated trophozoites expressed this 
protein less. 
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Figure 2.14 The effect of elemi oil on G. duodenalis trophozoite protein profile 
using SDS-PAGE analysis.   
G. duodenalis trophozoites (G; 5 x 107 ml-1) were incubated in the presence or 
absence of final concentrations of 20 µg metronidazole (Metro.) and 0.0025 – 0.02% 
elemi oil in 96 well microtitre plates and compared with untreated trophozoites (G). 
Heat killed (HK) and freeze killed (FK) trophozoite lysates were prepared as other 
controls for trophozoite killing. All lysates prepared were loaded on a 12% 
acrylamide separating gel and 4% acrylamide stacking gel and electrophoresed at 
180V for 55 mins. Protein bands are visualised using the Colloidal blue G staining 
system and run against a molecular weight marker (MW; Bio-Rad). 
 
 
Effect of oil constituents on viability as assessed by TBMM and SDS PAGE 
analysis 
As previous experiments determined that a concentration of 5 x 107 ml-1 trophozoites 
required a greater concentration of PEO to reach an MIC than with 2.7 x 105 ml-1 
trophozoites, each constituent examined were used at a concentration equivalent to 
0.02% of the whole oil.   
 
The main constituents of myrtle oil, α-pinene and eucalyptol (determined in 
Appendix 3), both failed to completely inhibit trophozoite viability as determined by 
Trypan blue inclusion/exclusion. Whilst both these constituents failed to completely 
inhibit G. duodenalis when used individually, in combination the inhibitory effect 
was increased and although this increase was slight, it was significant when 
compared to the inhibitory effect of α-pinene and eucalyptol alone (Figure 2.15; P < 
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0.05). This effect though, was less than additive and not synergistic. The main 
constituent of elemi, limonene, also failed to completely inhibit trophozoite viability. 
 
The most interesting result from SDS-PAGE analysis of these constituent treated 
trophozoites is that the inhibition of a 37 kDa protein seen in elemi and myrtle oil 
treated trophozoites was not observed when trophozoites were treated with their 
constituents, α-pinene, eucalyptol and limonene (Figures 2.16 and 2.17). This 
suggests that this protein is not inhibited by these constituents and that the effects of 
another constituent in the oil or a combination of all the constituents in the oil are 
responsible for this abrogation. In common with all treatments however, is the 
increase in expression of a 100 kDa protein suggesting that this is a protein that is 
possibly expressed during the death of trophozoites irrespective of the methods used 
to kill the trophozoites. 
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Figure 2.15 In vitro viability of G. duodenalis trophozoites incubated with the 
constituents of myrtle or elemi oil.  
Trophozoites were incubated for 24 h in the presence or absence of 0.01% α-pinene, 
0.0045% eucalyptol, a combination of α-pinene and eucalyptol, 0.01% limonene or 
67 µg ml-1 of metronidazole and their viability assessed. Heat killed (HK) and freeze 
killed (FK) trophozoites were prepared as other controls for trophozoite killing. A 
combination of α-pinene and eucalyptol was found to have greater inhibitory effects 
than α-pinene alone (*; P = 0.015). 
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Figure 2.16 The effect of plant oil constituents on G. duodenalis trophozoite 
protein profile using SDS-PAGE analysis.  
G. duodenalis trophozoites (G; 5 x 107 ml-1) were incubated in the presence or 
absence of final concentrations of 20 µg metronidazole (Metro.) and either 0.01% 
limonene (Lim.), 0.01% α-pinene (Pin.), 0.0025% eucalyptol (Euc.) or a 
combination of α-pinene and eucalyptol (P+E) in 96 well microtitre plates and 
compared with untreated trophozoites (G). Heat killed (HK) and freeze killed (FK) 
trophozoite lysates were prepared as other controls for trophozoite killing. All lysates 
prepared were loaded on a 12% acrylamide separating gel and 4% acrylamide 
stacking gel and electrophoresed at 180V for 55 mins. Protein bands are visualised 
using the Colloidal blue G staining system and run against a molecular weight 
marker (MW; Bio-Rad). 
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              MW     G         HK       FK    Metro   Lim.     Pin.      Euc.     P + E 
 
                                                                 Elemi 
                                                                             0.02      0.01     0.005     0.0025 
 
                                                                 Myrtle 
                                                                             0.02       0.01    0.005    0.0025 
 
 
Figure 2.17 The effect of plant oils and their constituents on a 37 kDa G. 
duodenalis trophozoite protein using SDS-PAGE analysis.  
G. duodenalis trophozoites (G; 5 x 107 ml-1) were incubated in the presence or 
absence of final concentrations of 20 µg metronidazole (Metro.) and either 0.01% 
limonene (Lim.), 0.01% α-pinene (Pin.), 0.0025% eucalyptol (Euc.) or a 
combination of α-pinene and eucalyptol (P+E) and 0.0025 – 0.02% elemi oil or 
myrtle in 96 well microtitre plates and compared with untreated trophozoites (G). 
Heat killed (HK) and freeze killed (FK) trophozoite lysates were prepared as other 
controls for trophozoite killing. All lysates prepared were loaded on a 12% 
acrylamide separating gel and 4% acrylamide stacking gel and electrophoresed at 
180V for 55 mins. Protein bands are visualised using the Colloidal blue G staining 
system and run against a molecular weight marker (MW; Bio-Rad). 
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Table 2.5 Quantity One software analysis of the intensity of a 37 kDa protein 
band 
 
A. Elemi oil. 
 
 Giardia 0.02 0.01 0.005 0.0025 
Band 
Intensity 
6.11 0.00 0.00 0.00 0.00 
 
B. Myrtle oil. 
 Giardia 0.02 0.01 0.005 0.0025 
Band 
Intensity 
12.78 0.00 0.00 8.89 16.78 
 
C. Limonene, α-pinene, eucalyptol, or a combination of α-pinene and eucalyptol. 
 
 Giardia Limonene α-pinene Eucalyptol P + E 
Band 
Intensity 
7.78 7.34 3.89 0.45 3.45 
 
 
Computer software image analysis was performed on selected SDS-PAGE gels 
shown in Figure 2.17. Analysis of the 37 kDa protein band using the Quantity One 
software package (Bio-Rad) highlighted the intensity of this band when G. 
duodenalis trophozoites were incubated with A) 0.0025 – 0.02% elemi oil, B) 0.0025 
– 0.02% myrtle oil and C) either 0.01% limonene, 0.01% α-pinene, 0.0025% 
eucalyptol  or a combination of α-pinene and eucalyptol. 
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2:5 DISCUSSION 
These experiments were designed to determine working concentrations of G. 
duodenalis trophozoites, diluents and reference drug for use in this project. Also 
determined were the effect of various PEOs and their main constituents on the 
viability and cell biology of Giardia trophozoites. Light microscopy was used 
identify morphological changes in these parasites and to determine trophozoite 
survival using Trypan blue inclusion / exclusion coupled with motility and 
morphology. The Trypan blue dye exclusion assay is the most commonly utilized test 
for cell viability (Eisenbrand et al. 2002; Freshney 1994; Patterson 1979; 
Pappenheimer 1917). The usefulness of this procedure is limited since the number of 
blue-staining cells increases following addition of the dye, requiring that cells be 
counted within 3 – 5 min (Hudson and Hay 1980). The proposed concentration of 
diluent to be used for the solublisation of PEOs was 75% diluent to 25% plant 
essential oils (PEOs) on a volume: volume ratio, to create a stock which would then 
be diluted further with medium. This stock concentrate would then give a volume of 
diluted PEO which could be pipetted with accuracy. A reference drug is commonly 
used, so that an unknown compound can be compared with a compound of known 
efficacy. In the case of these experiments, metronidazole, as the recognised drug of 
choice for giardiasis, was used.  
 
PEOs influence the cell biology of G. duodenalis trophozoites over time. PEOs 
caused the swelling, distortion, blebbing and increased killing of trophozoites in 
vitro. Incubation of G. duodenalis trophozoites with PEOs at a final concentration in 
the well of 0.02% significantly reduced their viability over the 24 h period studied. 
All PEOs were equally effective at this concentration, inhibiting the viability of 
trophozoites by 100% (Appendix 6). 
 
Recent advances in the understanding of the biochemistry and molecular biology of 
protozoa have permitted the study of molecules that directly participate in the 
parasites life cycle or their pathogenicity (North, Mottram and Coombs 1990). In this 
series of experiments, the mechanisms by which plant oils and their main 
constituents exerted an antigiardial effect were examined using SDS-PAGE analysis. 
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This study shows that the plant oils effects and to a limited extent, their main 
constituents can be modified at the molecular level. As well as causing 
morphological changes, PEOs can alter the protein profile of G. duodenalis 
trophozoites, by which the reduction of viability possibly occurs.  
 
Incubation of G. duodenalis trophozoites in DMSO alone at concentrations found 
when used as a diluent for PEOs caused a significant reduction in their viability 
(Table 2.2, P < 0.05). Damage caused by DMSO to trophozoites ranged from the 
retention of typical pyriform morphology but with Trypan blue uptake, to parasites 
being rounded and swollen, again with Trypan blue inclusion (Figure 2.1). This is at 
odds with previous findings for DMSO where concentrations of up to 10% are 
routinely used for cryopreservation with little or no effect (Phillips, Boreham and 
Shepard 1984) and concentrations of up to 1% having been used in vitro for drug 
dilutions having no effect on trophozoite morphology or viability (Müller et al. 2007; 
Céu Sousa 2001). As high error levels were recorded in the experiments performed 
and, due to variability of these results, it was decided that DMSO would not be used 
as a diluent for PEOs. 
 
Metronidazole was chosen as the reference drug and a positive control for inhibition 
of viability due to its current use in the treatment of giardiasis. This drug has known 
mechanisms of action, with its effect on G. duodenalis trophozoites being due to the 
generation of nitro radicals through reduction of the nitro ring by ferredoxin, which 
is in turn reduced by pyruvate:ferredoxin oxidoreductase (PFOR) (Samuelson 1999; 
Townson et al. 1994; Upcroft 1998; Upcroft et al. 1999). Reduced metronidazole 
serves as a terminal electron acceptor which binds covalently to DNA 
macromolecules (Müller 1983). This results in DNA damage in the form of a loss of 
helical structure, impaired template function and strand breakage, with subsequent 
trophozoite death (Gillis & Wiseman 1996; Townson et al. 1994). In addition to this 
effect, metronidazole inhibits trophozoite respiration (Farthing 1992; Paget et al. 
1989).  
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Using microscopic evaluation of parasite morphology and mobility, Jokipii and 
Jokipii first demonstrated that metronidazole and tinidazole were effective (Jokipii & 
Jokipii 1980). Subsequently, morphology (Meloni et al. 1990) growth inhibition 
(Crouch et al. 1990; Edlind 1989; Majewska et al. 1991), [3H] thymidine 
incorporation (Inge & Farthing 1987; McIntyre et al. 1986), serum killing (Hill, 
Burge and Pearson 1984), vital dye exclusion (Hill, Burge and Pearson 1984; Thiriat, 
Sidaner and Schwartzbrod 1998), inhibition of adherence (Baveja, Bhatia and 
Warhurst 1998; Farbey, Reynoldson and Thomson 1995; Meloni et al. 1990), 
metabolic (Céu Sousa & Poiares-da-Silva 1999) and colorimetric (Kang et al. 1998) 
assays have been employed to measure the in vitro response of the parasite to many 
therapeutic agents. However, as indicated by the variety of assays used, there is no 
standard for in vitro testing, making it difficult to compare results and apply in vitro 
findings to the clinical setting (reviewed by Gardner & Hill 2001). 
 
Treatment of trophozoites in experiments with different concentrations of 
metronidazole produces reduced trophozoite viability in a dose dependant manner 
(Figure 2.2). Although all trophozoites were killed after 24 h exposure to 67 µg ml-1 
metronidazole, concentrations of up to half that caused > 95% trophozoite death. The 
parasites used in this project were the kind donation of Dr. T. Paget and it was 
discovered that the MIC of metronidazole observed (67 µg ml-1) was 4 times greater 
than that observed in his own laboratory (T. Paget, Personal communications 2005). 
However, by investigating the 50% and 90% inhibition concentration levels it was 
demonstrated that metronidazole activity was present at low concentrations (IC90 = 
21.8 μg ml-1 and IC50 = 5.6 μg ml-1; Table 2.3). This brings the level of activity of 
metronidazole on the stock of G. duodenalis trophozoites used in the SPDL to 
activity levels found with Dr. Paget’s laboratory stocks. 
 
This variability of the effects of metronidazole on different clones and isolates of G. 
duodenalis has been shown previously and susceptibility was also shown to vary in 
culture with susceptible strains becoming slightly more resistant and increasing 
susceptibility in resistant strains (Argüello-García et al. 2004). Resistance to 
metronidazole has been induced in vitro (Boreham, Phillips and Shepard 1988) and 
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correlates with decreased activity of parasite pyruvate: ferredoxin oxidoreductase 
(PFOR), which is required for reductive activation of nitroimidazoles (Upcroft & 
Upcroft 1993). In the past, susceptibility assays have been monitored for a variety of 
end points and reported as 50% inhibitory concentrations (IC50) for Giardia ranging 
from 0.01 to 1 µg ml-1 (Upcroft & Upcroft 1993), 2.38 – 11.5 µM (Cruz et al. 2003), 
50% inhibitory dose (ID50) values of 0.2 and 1.5 µg ml-1 (Upcroft & Upcroft 1993), 
minimum lethal concentrations (MLCs) after 72 h of 50 to 100 µM for susceptible 
organisms (Upcroft et al. 1999).  
 
Trypan blue inclusion in metronidazole-treated trophozoites showed enlargement of 
both nuclei and strong staining of the edges of the nuclei (Figure 2.3 A). Also shown 
was evidence of blebbing and cytoplasmic granulation / condensation suggestive of 
apoptosis; an intriguing proposition as the cornerstone for apoptosis, the 
mitochondria, is absent in this protist (Chose et al. 2003). This formation of blebs or 
giant membrane protrusions has also been observed by Pérez-Arriaga et al. (2006) 
where the authors treated trophozoites with varying concentrations of curcumin, a 
naturally formed compound from the food spice, turmeric. In the experiments 
performed with myrrh, myrtle and elemi oils, giant protrusions were formed in many 
of the trophozoites (Figure 2.3 C, D and E). In all cases, condensation of the 
cytoplasm was evident, showing as granular staining with large vacuoles also formed 
in the cytoplasm of myrtle oil-treated trophozoites (Figure 2.3 D).  
 
The formation of giant membrane protrusions may or may not be a part of some kind 
of programmed cell death, it may also be due to changes to the structure of the cell 
membrane caused by the PEOs or their constituents. Changes in the osmoregulation 
of the cell could also be indicated by the swelling and rounding up of the 
trophozoites Figure 2.3 B, D and E) which was also observed by Pérez-Arriaga et al. 
(2006) in curcumin treated trophozoites and Campanati & Monteiro-Leal (2002) with 
metronidazole treated trophozoites. Interaction of the PEO with the cellular 
membrane is quite possible due to the lipophilic properties of PEOs and their ready 
diffusion across cell membranes (Boyom et al. 2003). Large vacuole formation in 
myrtle treated trophozoites (Figure 2.3 D) indicates that some kind of programmed 
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cell death may have been initiated, as this has also been observed in curcumin-treated 
trophozoites (Pérez-Arriaga et al. 2006). 
 
In order to elucidate MIC for each PEO used, a titration was carried from 0.02% to 
0.005% in the first instance and then down to 0.00125% for those oils whose MIC 
were determined to be < 0.005%. Sweet fennel, lavender, amyris, patchouli and 
buchu oil were determined to have n MIC of 0.02%, while marjoram, palmarosa, 
thyme and geranium all had a MIC of 0.01%. Only the oils of myrrh, myrtle and 
elemi were able to kill 100% of trophozoites in vitro at a concentration of 0.005% 
(Figure 2.4 and Table 2.3). However, at concentrations lower than this, the efficacy 
of these oils was lessened with 68% of trophozoites remaining viable for myrtle and 
elemi oils at a concentration of 0.0025% (Figure 2.5). The efficacy was improved 
with the treatment of myrrh with 18% of trophozoites remaining viable with 
0.0025% myrrh and 62% remaining viable below a myrrh concentration of 0.00125% 
(Figure 2.5). At this lower concentration of 0.00125% both myrtle and elemi oils had 
78% and 80% of viable trophozoites after 24 h incubation in vitro, respectively. This 
was significantly greater than with myrrh (Figure 2.5, P < 0.05). From this 
information it can be seen that myrrh oil has the greatest antigiardial effects causing 
a significant reduction in trophozoite viability at 0.0025%. Whilst this concentration 
was not the MIC, the reduction was such that possibly of longer incubation might 
cause a further lowering of the MIC of 0.005% at 24 h to perhaps 0.0025% at 48 or 
72 h. 
 
As with the metronidazole titration, the IC90 and IC50 levels for the oils tested were 
calculated. There was great variation between the IC90 and IC50 activities of the 
PEOs which agreed with their variable MIC activity, producing a range of values 
(IC90 = 0.003 – 0.013 % [30 – 130 μg ml-1], IC50 = 0.0009 – 0.007 % [9 – 70 μg ml-
1], Table 2.3) where 0.00001% = 1 ppm = 1 μg ml-1. Oils of myrrh, myrtle and elemi 
at their MIC of 0.005% (50 μg ml-1) were found to be more active than 
metronidazole at its determined MIC of 67 μg ml-1 indicating that PEOs may well be 
an effective alternative to conventional chemotherapeutics. However, there is a very 
sharp decline in PEO activity at lower than 100% inhibitory concentrations compared 
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with metronidazole, with the conventional drug being more effective at lower 
concentrations than the PEOs. This suggests that there is a narrower window of 
activity for PEOs. 
 
It is possible to identify the composition of oils, generally using methods such as Gas 
Chromatography (GC) coupled with Mass Spectroscopy (MS). This provides an 
insight into the potentially active constituent(s) that could be giardicidal in vitro. 
Investigations into the biological activities of essential oils of some medicinal plant 
species have revealed that some of them exhibited interesting activities, such as 
antibacterial (Lemos et al. 1990; Ferdous et al. 1992; Faouzia, Souad and Tantaoui-
Elaraki 1993; Demetzos et al. 1997; Fyfe, Armstrong and Stewart 1997; Smith-
Palmer, Stewart and Fyfe 1998 & 2002;  Hammer, Carson and Riley 1999; Burt 
2004), antifungal (Hammer, Carson and Riley 2003; Terzi et al. 2007) and 
antiplasmodial activity (Benoit-Vical et al. 1999 & 2001). In past studies, the whole 
oil has been investigated for any in vitro activity, with the composition of the oil 
being investigated afterwards, in order to determine any possible active constituent. 
Investigations into the active principles of essential oils having antibacterial or 
antifungal activity has been carried out (Hinou, Harvala and Hinou 1989; Oloke 
1992; Hammerschmidt et al. 1993; Zakarya, Fkih-Tetouani and Hajji 1993 and 
Carson & Riley 1995). 
Using GC-MS information supplied by F.D. Copeland & Sons (Appendix 3) the 
compositions of the oils myrrh, myrtle and elemi were determined and the main 
constituents (i.e. those found in the greatest quantities in the oil) were identified. In 
the case of myrtle oil, the major constituents were the monoterpenes α-pinene and 
eucalyptol (syn. 1,8-cineole) comprising 51.72% and 22.35% of the whole oil, 
respectively. Elemi oil contained mostly the terpene limonene (syn. (+)-p-Mentha-
1,8-diene; (+)-Carvene; (R)-4-Isopropenyl-1-methyl-1-cyclohexene) (51.54%), α-
phellandrene (16.23%) and elemol (10.90%). Myrrh oil comprised mainly of the 
furanic sesquiterpenes, furanodiene (31.97%) and curezene (26.69%). At the time of 
writing, only α-pinene, eucalyptol and limonene were readily available from 
chemical companies and, therefore, only experiments concerning myrtle and elemi 
oils could be carried out.  
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Using this information, investigations were carried out to determine which 
constituent was the active ingredient(s) of the whole oil, responsible for the 
antigiardial activity. The first experiments used the constituents at concentrations 
equivalent to those found in the whole oil at the screening concentration of 0.02%. 
When used at these concentrations the main constituent of myrtle oil, α-pinene, 
completely reduced the viability of trophozoites to zero. Its next most abundant 
constituent was eucalyptol which reduced the viability of trophozoites to 83% ± 5% 
and a combination of these 2 constituents completely inhibited trophozoite viability 
(Figure 2.6).  
 
The only constituent from elemi oil available for study was limonene and this 
constituent was responsible for the complete inhibition of trophozoite viability. 
These results indicate that α-pinene is the active constituent in myrtle oil and 
limonene is the active constituent in elemi oil. When the constituents were used at 
concentrations equivalent to the oils MIC (0.005%) a different efficacy emerged. The 
viability of trophozoites incubated with these constituents singly or in combination 
was unaffected when compared with untreated controls (Figure 2.7). This suggested 
that the compounds present in the greatest proportions are not necessarily responsible 
for their antigiardial activity. There may be a lower limit to the efficacy of these 
constituents where combinations of all constituents of the oils act in synergy to kill 
G. duodenalis trophozoites at this low MIC of 0.005%.  
 
This activity of constituents is somewhat similar to the findings of Cimanga et al. 
(2002) where no correlation between the amount of major constituents such as 
eucalyptol, α-pinene, p-cymene, cryptone or thymol and antibacterial activity was 
observed from 15 medicinal Congolese plants and their essential oils. Some of the 
constituents in that study, such as limonene, p-cymene and α-pinene, had been 
previously shown to exhibit low levels of antibacterial activity (Knobloch et al. 1989 
and Chalchat et al. 2000).  
 
Apart from antibacterial activity, limonene also has antifungal activity, inhibiting the 
growth of Fusarium verticillioides MRC 826 in vitro (Dambolena et al. 2008) and 
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has shown some antiparasitic actions as well, being able to inhibit the development 
in vitro of intraerythrocytic stages of P. falciparum (Moura et al. 2001; Rodrigues 
Goulart et al. 2004). Antifungal actions have been observed with eucalyptol 
(Hammer, Carson and Riley 2003; Terzi 2007) and antibacterial activity was also 
evident (Hammer, Carson and Riley 1999; Papadopoulos et al. 2006). 
 
The speed at which all the oils showed activity against G. duodenalis trophozoites 
was very rapid. Four of the 12 oils tested were able to completely reduce the viability 
of trophozoites to 0% in only 30 min of incubation in vitro (Figure 2.8). These oils 
were lavender (MIC = 0.02%), marjoram (MIC = 0.01%), palmarosa (MIC = 0.01%) 
and geranium (MIC = 0.01%). All other oils tested, with the exception of myrrh, 
were able to kill all trophozoites within 60 min of incubation. This is significantly 
faster than metronidazole which, after 120 min of incubation, still had no discernable 
effect on trophozoites (Figures 2.8 and 2.9). With metronidazole complete inhibition 
of trophozoites occurs somewhere between 2 h and 24 h of incubation.  
 
For adults, a standard treatment (up to 2 g metronidazole daily for between 3 and 7 
days) delivers a peak plasma concentration of 40 µg ml-1 within 3 h (McEvoy 1995). 
Ileal and colonic concentrations reach between 70 – 80% of the dose (Haughton et al. 
1979). Metronidazole has a half-life of approximately 8 h in humans, with 60 – 80% 
of the drug and its metabolites excreted in the urine and only 6 – 15% excreted in 
faeces. This means that a constant ‘top up’ of drug is required to kill trophozoites in 
vivo. This also means that there is a greater risk of any side effects occurring, 
reduced patient compliance with the treatment regimen and increased incidence of 
drug resistance in the parasite.  
 
A drug which can be fast acting and with a greater retention time within the target 
area (in the case of G. duodenalis the small intestine) would be of great benefit in 
reducing the quantity of drug to be taken whilst maintaining the same, if not 
increased, efficacy. Data on the bioavailability of plant oils or their constituents are, 
however, scarce. One class of constituent is the flavonoids. There have been over 
4000 different flavonoids described, categorized into flavonols, flavones, catechins, 
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flavanones, anthocyanidins and isoflavonoids. Little information is available, but the 
anthocyanins have been demonstrated to have low serum bioavailability in humans, 
but considerable longevity in the gastrointestinal tract and are known to reach the 
colon largely undegraded (up to 85% of the initial dose) either following their 
consumption (Kahle et al. 2006) or following in vitro simulation of human digestion 
(McDougall et al. 2005). This makes them ideal candidates for a potential drug with 
antigiardial action. 
 
However, the anthocyanidins are just one of a multitude of different constituents 
found in the PEOs tested and information on the bioavailability of terpene 
compounds (found within myrtle and elemi oils) is scanty. Further work would need 
to be carried out in this field before one could properly determine their suitability as 
a novel antigiardial drug. Nevertheless, the rapid action of the PEOs used in this 
study has shown a potential for novel drug design which could reduce the duration of 
treatment. 
 
Whilst the recognised drug for giardiasis, metronidazole, was used as a control for 
killing, different methods were also used in SDS-PAGE experiments to show any 
clear differences or similarities in protein profiles when compared to oil/constituent 
treated trophozoites. For this purpose both heat killing (56°C for 10 min) and freeze 
killing (liquid nitrogen, 2 min) were employed. Only one cycle of freeze thawing was 
used as several such cycles are generally required for the lysis of trophozoites. 
Following one cycle of rapid freezing and thawing or after heat killing, trophozoites 
were non-viable, being round and swollen and including Trypan blue.  
 
The use of higher concentrations of parasites did have an effect on PEO treatment. In 
both oils (myrtle and elemi) a higher MIC was observed with 5 x 107 ml-1 than with 
2.67 x 105 ml-1 trophozoites. Whilst the reduction of inhibition at the previously 
determined MIC of 0.005% for both oils was slight (2.4 ± 2.2% for myrtle and 3.1 ± 
3.4% for elemi), it was found to be significant (Table 2.4, P < 0.05). This may have 
ramifications in the possible use of these oils for the treatment of giardiasis. In the 
lumen of the small intestine, the concentration of trophozoites can be high and a 
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giardiasis patient can shed 1×108 viable cysts per gram of faecal material (Roxström-
Lindquist et al. 2006). 
 
Myrtle and elemi oil have been shown to produce morphological changes in Giardia 
including trophozoite swelling, rounding, blebbing and large vacuole formation. Also 
shown was the speed at which viability is reduced by these oils (60 min; Figure 2.8).  
The use of SDS-PAGE analysis can highlight any inhibition or upregulation of 
protein expression. The identification of these proteins may help in the understanding 
of how the PEOs or their constituents affect trophozoite viability.  
 
The apparent upregulation of a ~100 kDa protein compared to untreated trophozoites 
was shown in all trophozoite treatments in vitro. This would strongly suggest that 
this protein is linked to mortality of the cell, whether it is some kind of ‘programmed 
cell death’ protein or associated with another means of death remains to be seen. 
Molecules such as the cysteine proteases (caspases) have been shown to be a part of 
apoptosis in various eukaryotic cells and can be found as part of the mitochondria 
(Chose et al. 2003). However their presence in organisms which are devoid of 
mitochondria such as G. duodenalis and Trichomonas vaginalis remain unclear. To 
date, sequence analyses for homologues of mammalian apoptotic genes or proteins 
have not been reported in protozoa, especially Giardia (Nasirudeen 2005; Chose et 
al. 2003a; Chose et al. 2003b; McArthur et al. 2000). This is not to say that a 
caspase-like apoptosis reaction does not occur, or that caspases (or caspase-like 
proteins) are not present. Chose et al. (2002) has shown that with T. vaginalis, drugs 
which are caspase activators were able to induce an apoptosis-like action and that 
inhibitors of caspases prevented such apoptosis. In the same paper and in subsequent 
papers (Chose et al. 2003a; Chose et al. 2003b), this particular author also claims to 
have shown the same apoptotic-like morphological changes in Giardia using 
apoptosis inducing drugs, although these data have not been formally published. 
 
Both a 37 kDa and a ~70 kDa protein (present in untreated trophozoites) were 
abolished by high concentrations of myrtle oil (0.02 and 0.01%) and started to 
reappear when lower concentrations were used (0.005 and 0.0025%). The 37 kDa 
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protein was also abolished in elemi oil treated trophozoites in the manner described 
for myrtle and was also absent in freeze-killed and metronidazole-killed parasites, 
but not in heat-killed parasites.  
 
This 37 kDa protein ablated by the whole oils reappears when trophozoites were 
incubated with either α-pinene or limonene. Eucalyptol did not abolish this band 
completely. When investigating band intensities using the Quantity One software the 
intensity of the 37 kDa band present following limonene treatment is similar to that 
found in untreated controls and treatment with α-pinene reduces the band intensity by 
almost 50% (Table 2.5 C) with eucalyptol treatment causing the intensity of the band 
to be reduced to background levels. This result shows that whilst elemi oil can 
abolish the 37 kDa protein at low concentrations (0.0025%) this is not due to its main 
constituent, limonene. Similarly, eucalyptol and not α-pinene is responsible for the 
same action in myrtle oil. 
 
Many important parasite species such as E. histolytica, T. cruzi, Leishmania spp., T. 
vaginalis and Plasmodium spp. contain multiple proteases that play a role in their life 
cycle, morphogenesis and infectivity (McKerrow et al. 1993). Whilst both myrtle 
and elemi oil can cause morphological changes to G. duodenalis trophozoites in vitro 
without disruption of the cell, the speed at which those changes occurred suggested 
damage at the molecular level, possibly by inducing a form of programmed cell 
death.  
 
An understanding of what the proteins affected by the oils are and how they might be 
involved in the survival of the parasite may lead to a more defined mode of action for 
theses oils. Further analysis of the molecular weights of proteins mentioned here, 
especially the 37 kDa protein, is required. Without knowing the specific molecular 
weight and, preferably the amino acid sequence of the proteins highlighted in this 
study it is difficult to determine what role they have to play in the PEO induced death 
of Giardia trophozoites. The use of techniques such as Western blotting, 2-D 
electrophoresis and sequence analysis of the Giardia genome should allow the 
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correct identification of the proteins affected by the PEOs. Identifying these proteins 
would allow a better understanding of the mechanism of action of the PEOs tested. 
 
To the author’s knowledge this is the first time that such an extensive screening of 
PEOs has been carried out on the Giardia parasite. This study has shown that PEOs 
were effective in inhibiting trophozoite viability over a 24 h incubation period at a 
final concentration in the microtitre well of 0.02%. Furthermore, the parasite was 
found to be most sensitive to the oils of myrrh, myrtle and elemi with an MIC for 
these PEOs being 0.005%. Antigiardial activities of PEOs were found to be rapid 
with all but myrrh acting within 60 min of incubation. Further analysis of the PEOs 
suggests that the monoterpenes, α-pinene from myrtle oil and limonene from elemi 
oil were the active constituents responsible for the killing of G. duodenalis 
trophozoites in vitro found within these oils. 
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CHAPTER 3 
 
Cryptosporidium parvum 
 
Increased spontaneous excystation of Cryptosporidium parvum oocysts over time 
following pre-treatment with PEOs and their constituents. 
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3:1 ABSTRACT 
Interventions in the Cryptosporidium life cycle can, if they reduce the ability of the 
extracellular stages to infect enterocytes and thus reduce the number of intracellular 
stages, become potentially effective treatments for cryptosporidiosis. The term 
‘spontaneous’ excystation is used to define the process of excystation in vitro that 
occurs in the absence of known triggers, apart from temperature. This distinguishes it 
from the excystation that occurs following treatment with the maximised in vitro 
excystation protocol of Robertson, Campbell and Smith (1993b). In this study, 12 
PEOs were investigated for anticryptosporidial activity. When C. parvum oocysts 
were incubated for 24 h in the presence of 0.2% PEOs spontaneous excystation was 
increased, compared to untreated oocysts. Oils of sweet fennel, geranium and 
palmarosa caused significant increases in the spontaneous excystation rate when 
compared to untreated control oocysts (77.1 ± 12%, 90.9 ± 1.1%, 96.9 ± 1.7%, 
respectively; P < 0.01 for all oils). The effect of these oils main constituents, trans-
anethole, citronellol and geraniols were used to investigate the spontaneous 
excystation rate of C. parvum oocysts in vitro. These constituents had activity levels 
consistent with the effect of the whole oil (sweet fennel = 84.6 ± 5.7% vs. trans-
anethole = 87.9 ± 2.5%; geranium = 91.0 ± 1.2% vs. citronellol = 87.6 ± 2.7%; 
palmarosa = 96.8 ± 1.5% vs. geraniol = 97.8 ± 1.4%) during incubation at 37°C for 
24 h. Spontaneous excystation occurred in a time dependent manner for all PEOs and 
constituents tested. The most rapid increase in spontaneous excystation occurred with 
sweet fennel and trans-anethole after 4 h of incubation (sweet fennel = 0.4 ± 0.5% to 
57.1 ± 2.5%; trans-anethole = 0.4 ± 0.5% to 60.9 ± 1.1%, untreated controls = 18.7 ± 
2.3%). PEOs influence the in vitro excystation of C. parvum oocysts in a temperature 
and time dependent manner, but in the absence of known triggers such as bile salts, 
reducing agents and proteases. It was clear that the main constituents of the oils were 
the causative agents of spontaneous excystation induction and that this was also time 
dependent. Whilst aromatic ethers had a more rapid response, terpenes had a more 
sustained and ultimately greater effect on spontaneous excystation. Possible uses for 
these attributes are discussed.  
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3:2 INTRODUCTION 
The enteric parasite, Cryptosporidium parvum, causes self limiting diarrhoea in 
immunocompetent hosts and chronic, severe diarrhoea with potentially fatal 
consequences in immunocompromised hosts (Hunter & Nichols 2002). Of the 19 
species and over 40 genotypes of the protozoan parasite Cryptosporidium, 8 species 
and 5 genotypes are known to infect humans and of these, 2 species (C. hominis and 
C. parvum) are responsible for the majority of human disease (Smith 2008; Smith et 
al. 2007; Feltus et al. 2006; Leoni et al. 2006; Nichols, Campbell and Smith 2006; 
Caccio et al. 2005; Ryan et al. 2004; Xiao et al. 2004). C. parvum is the species most 
studied with respect to infectivity in vivo, viability in vitro and as it can be cultured 
in vitro, is also used mostly for drug discovery investigations. 
 
In the immunocompetent host, Cryptosporidium infection leads to self limiting 
diarrhoea after 2 – 3 weeks. This can be uncomfortable for the infected individual 
and can have financial implications if they cannot work. In the developed world this 
can be perceived to be an inconvenience. However, in developing countries this may 
affect an entire household if the main income earner is unable to work. 
 
When this parasite infects an immunocompromised host the diarrhoea may not be 
self limiting and can become chronic with potentially fatal consequences (Hunter & 
Nichols 2002). This may also be true for otherwise healthy young children or the 
very old.  
 
Of over 200 drugs tested, only nitazoxanide has been demonstrated to have efficacy 
for cryptosporidiosis with immunocompetent patients. It inhibits C. parvum growth 
in vitro and has been licenced in the USA by the Food and Drug Administration 
(FDA) since June 2004 for use in all persons ≥ 1 year of age (Rossignol 2006; Bailey 
& Erramousepe 2004; Smith & Corcoran 2004; Amadi et al. 2002; Theodos et al. 
1998).  
 
Oocysts of Cryptosporidium occur in the aquatic environment throughout the world 
and it is through the drinking of contaminated water and then person to person 
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transmission that most infections are acquired. The greatest such outbreak occurred 
in Milwaukee, USA in which over 400,000 individuals were estimated to have been 
infected (MacKenzie et al. 1994a and 1994b). Faecal contamination from infected 
animals is the source of oocysts (Hansen & Ongerth 1991; LeChevallier, Norton and 
Lee 1991). Oocysts are remarkably robust being able to persist in water for several 
months depending on the temperature of the water (Robertson, Campbell and Smith 
1992; Chauret et al. 1995; Olson et al. 1999) and are extremely resistant to the 
disinfectants commonly used in drinking-water treatment such as chlorine and ozone 
(Korich et al. 1990; Finch et al. 1993). Characteristics of this organism such as 
environmental robustness and low numbers required for infectivity (Dupont et al. 
1995; Okhuysen et al. 1999) make it one of the most critical pathogens in the 
production of safe drinking-water from surface water. 
 
In vitro and in vivo investigations into C. parvum excystation have highlighted some 
of the host- and parasite-derived triggers required to initiate infection. These include 
temperature (37oC), pH fluctuations, bile salts, reducing agents, proteases and time 
(Widmer et al. 2007; Smith, Nichols and Grimason 2005; Kato et al. 2001; 
Robertson, Campbell and Smith 1993b; Fayer & Leek 1984).  
 
The maximised in vitro excystation method of Robertson, Campbell and Smith 
(1993b), use these host derived triggers to mimic transit through the acidic stomach 
to the alkaline small intestine (Smith, Nichols and Grimason 2005; Kato et al. 2001; 
Robertson, Campbell and Smith 1993b; Fayer & Leek 1984). This is a recognised 
rapid and simple means of determining the ability of sporozoites to undertake the 
first step of the infection process. Temperature (37oC) and time (up to 24 h) are 
major triggers for maximised in vitro excystation (Robertson, Campbell and Smith 
1993b; Smith, Nichols and Grimason 2005). 
 
Exposure to acid (pH ~2) followed by incubation in bile salts, reducing agents and 
proteases, mimic transit through the acidic stomach to the alkaline small intestine and 
enhance excystation in vitro. The fact that oocysts can excyst in vivo and cause 
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disease in extraintestinal locations indicates that some of these host-derived triggers 
are not essential (Smith, Nichols and Grimason 2005).  
 
C. parvum oocysts are known to excyst within the small intestine of the mammalian 
host and their sporozoites multiply in the epithelial enterocytes. To this end, the 
parasite has adapted to passage through the acidic environment of the stomach 
without excysting before reaching the site of infection. Studies by Widmer et al. 
(2007) investigated this phenomenon and demonstrated that C. parvum oocysts are 
unaffected by incubation for 1 h in HCl at 37°C and that temperature alone cannot 
cause the excystation of the oocysts. However, passage through the stomach can take 
up to 4 h and the effect of acid for this length of time on C. parvum oocysts was not 
determined, nor was the effect that temperature had upon C. parvum excystation after 
acidification. 
  
Excystation of C. parvum oocysts in the stomach, which is too acidic for sporozoite 
survival (optimal pH 6.2, Woodmansee et al. 1987), causes sporozoite lysis, reduces 
enterocyte invasion and the subsequent propagation of infection. Similarly, 
stimulating oocyst excystation in the intestinal tract of the infected host before they 
are excreted reduces the number of infectious oocysts in the environment and limits 
the potential for propagation of infection. 
 
Interventions in the Cryptosporidium life cycle that reduce the ability of extracellular 
stages to infect enterocytes, by reducing the number of intracellular stages, can 
become potentially effective treatments for cryptosporidiosis. As sporozoites are the 
first extracellular stages generated in the infected host, interventions that influence 
the timing of their release from intact oocysts, including excystation in abnormal 
sites or ablation of excystation can be considered potentially therapeutic. By 
modifying the processes by which oocysts excyst we may be able to influence the 
propagation of infection. The isolate of C. parvum and how it has been purified may 
also influence the in vitro investigations of excystation in this parasite.  
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The antimicrobial properties of herbs and spices have been recognised for thousands 
of years and recently there has been renewed interested in such products, especially 
PEOs (Smith-Palmer, Stewart and Fyfe 1998; Kumar & Berwal 1998). Only 2 plant 
extracts have been tested against Cryptosporidium with any success. A mild (22.4%) 
reduction in C. baileyi oocyst output in infected chickens was observed when 
chicken were given garlic extract. Its effect was comparable to 2 commercially 
available derivatives of an anticoccidial drug (triazinone) (Sreter, Szell and Varga 
1999). When an extract of pine bark was given to C. parvum infected 
immunosuppressed C57BL/6N mice, oocyst shedding was reduced significantly, 
although the pine bark extract failed to decrease parasite colonisation of intestinal 
tissue (Kim & Healey 2001).  
 
One possible target for any novel drug is to affect the excystation of 
Cryptosporidium oocysts. Whilst some of the host and parasite-derived triggers for 
excystation are known (Smith, Nichols and Grimason 2005; Kato et al. 2001; 
Robertson, Campbell and Smith 1993b; Fayer & Leek 1984), their precise 
involvement in the process is still being investigated. Interventions to the excystation 
process, whether it is enhancing or inhibitory, may provide clues as to the 
excystation process itself, or may lead to potential therapeutics. 
 
In this study, the effect of pre-incubating intact C. parvum oocysts with acidified 
Hanks Balanced Salt Solution (HBSS; pH 2.75) for 1 – 4 h prior to incubation in 
non-acidified HBSS (~ pH 7) up to 24 h were assessed to determine whether acid 
influenced C. parvum excystation in vitro. As the maximised in vitro excystation 
method can determine the ability of sporozoites to undertake the first step of the 
infection process, the effect of incubating 12 different PEOs over 24 h with intact C. 
parvum oocysts was investigated to determine whether they influenced oocyst 
excystation dynamics in vitro. Of the 12 oils tested sweet fennel, geranium and 
palmarosa were found to have the greatest effect in increasing spontaneous 
excystation, without having any inhibitory effect on the normal excystation 
processes. These 3 oils were further investigated to determine their active 
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constituents and speed of activity. Some conclusions as to their possible uses are 
drawn. 
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3:3 MATERIALS AND METHODS 
3:3.1 Oocyst preparations 
Source of oocysts 
C. parvum oocysts were purchased from Bunch Grass Farm (BGF), Idaho (IOWA 
isolate, Lots 06-30 and 28-27), USA and the Moredun Research Institute (MRI), 
Penicuik (MD isolate, Lot C1/07/01), UK. Isolates were stored in either phosphate 
buffered saline (PBS) for IOWA or Hanks balanced salt solution (HBSS) for MD 
isolate, containing 100µg of streptomycin ml-1 and 100U penicillin ml-1 at 5ºC until 
used. The IOWA isolate was passaged in neonatal calves and isolated by ether 
extraction using a modification of methods (discontinuous sucrose and caesium 
gradient centrifugation) described by Riggs and Perryman (1987). The MD isolate 
was passaged in neonatal lambs and isolated by acidification of faeces as described 
by Hill et al. (1990). Both isolates are C. parvum as determined by polymerase chain 
reaction, restriction fragment length polymorphism and DNA sequencing analyses at 
2 18S rRNA loci (Xiao et al. 1999 & 2001; Nichols, Campbell and Smith 2003 & 
2006) and the Cryptosporidium oocyst wall protein (COWP) locus (Homan et al. 
1999) (data not shown).  
 
 Maximised in vitro excystation 
Oocysts from the stock suspension were excysted in vitro at weekly intervals 
according to Robertson, Campbell and Smith (1993b) to determine the consistency of 
excystation throughout the study. Briefly, 100µl of stock suspension of C. parvum 
oocysts (2 x107 ml-1) were incubated in 900 µl acidified HBSS (Gibco, UK; pH 2.75, 
60 min, 37ºC), then centrifuged (12,500 x g for 30 sec), the supernatant aspirated to 
100 µl and the pellet resuspended in 1 ml HBSS. This was repeated twice and the 
washed pellet resuspended in 50 µl of 0.44% w/v sodium hydrocarbonate (BDH), 
200 µl of 1% w/v bovine bile (Sigma-Aldrich, UK) in Hanks minimal essential 
medium (HMEM; Gibco, UK). Samples were incubated at 37ºC for 30 min and 4 h, 
with 10 µl aliquots viewed under Nomarski differential interference contrast (DIC) 
microscopy (Olympus BH2 microscope, x40 objective) at these time points. The 
percentage excystation (as an estimate of viability) was calculated according to 
Robertson, Campbell and Smith (1993b), whereby the proportion of totally excysted 
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(empty), partially excysted and intact oocysts were enumerated, in triplicate. 
Between 100 and 200 oocysts were counted for each enumeration and the percentage 
excystation was calculated as follows: 
 No. of empty oocysts + No. of partially excysted oocysts x 100 
                   Total no. of oocysts counted  
 
The sporozoite ratio was also assessed at the same time and the total number of 
excysted sporozoites was enumerated and calculated as follows: 
 
                         No. of free sporozoites                                  x 100 
 No. of empty oocysts + No. of partially excysted oocysts 
 
A modified excystation protocol, that excluded the acidification step from the assay 
and which investigated the role that oocyst purification protocols have on 
excystation, was also employed and the above calculations performed. In all cases 
the number of empty oocysts present in the stock suspension was always subtracted 
from the number of empty oocysts enumerated post-excystation. 
 
3:3.2 Experimental treatments of oocysts 
PEO and constituent preparation 
All PEOs were diluted in absolute ethanol to provide 25% v/v stock solutions (25% 
PEO, 75% absolute ethanol), which were used in these experiments. Complete 
information about each PEO used is given in Appendix 1. Briefly the oils used are as 
follows: sweet fennel, lavender, amyris, marjoram, palmarosa, patchouli, myrrh, 
myrtle, elemi, thyme, buchu and geranium. The most effective oils were determined 
to be sweet fennel (Foeniculum vulgare var. dulce BATT. & TRAB.), palmarosa 
(Cymbopogon martinii (ROXB.) J.F. WATSON) and geranium (Pelargonium 
graveolens). These oils were investigated with GC-MS to determine their 
composition and which constituents were in the highest concentrations. This 
procedure was carried out by F.D. Copeland & Sons with the composition of all the 
PEOs given in Appendix 3. Constituents which made the greater part of the PEO 
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were assessed at their equivalent concentration within the PEO, such that a 
constituent which comprises 75% of a PEO would be used at a concentration equal to 
75% of the final concentration of the whole PEO, i.e. 75% of 0.2% = 0.15%. The 
major constituent of palmarosa oil is the monoterpene alcohol, geraniol (syn. 3,7-
dimethyl-2,6-octadien-l-ol), comprising 80.02% of the whole oil. Sweet fennel oil is 
composed mainly of the aromatic ether, trans-anethole (syn. trans-1-methoxy-4-
(prop-1-enyl) benzene) (68.33%). The major constituent of geranium oil was the 
monoterpene, citronellol (syn. 3,7-dimethyloct-6-en-1-ol) (39%). These constituents 
were used in experiments as previously described for PEOs. 
 
The effect of temperature and time on spontaneous excystation in untreated 
oocysts  
Stock, untreated oocysts were exposed to elevated temperature and time (37ºC, up to 
24h), as both temperature elevation and time are known excystation triggers. A 
further temperature control consisted of stock, untreated oocysts incubated at 5ºC for 
24 h. This process of excystation in the absence of all recognised triggers, apart from 
temperature was named ‘spontaneous’ excystation as opposed to excystation which 
requires known triggers including pH change, bile etc. (Robertson, Campbell and 
Smith 1993b; Smith, Nichols and Grimason 2005). 
 
A 100 µl aliquot of C. parvum oocyst stock suspension (stock at 2 x 107 oocysts ml-1) 
was incubated in 900 µl HBSS (final oocyst concentration = 2 x 106 ml-1) for 4, 8, 12 
or 24 h at 37ºC, prior to excystation using the maximised in vitro excystation 
protocol, at each of these time points. 
 
The effect of 1 or 4 h acidification on the spontaneous excystation of C. 
parvum oocysts 
100 µl of C. parvum oocyst stock suspension (stock at 2 x 107 oocysts ml-1) was 
incubated in 900 µl acidified HBSS (pH 2.75) for either 1 or 4 h at 37ºC then washed 
as described previously. Subsequently, either i) the percentage excystation was 
determined under DIC microscopy or ii) oocysts were resuspended in 1 ml HBSS 
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and incubated for a further 1, 4 or 24 h at 37ºC to determine the effects of the 1 or 4 h 
acidification on oocyst spontaneous excystation.  
 
Incubation of oocysts with PEOs 
The following controls were used: a) 100µl of C. parvum oocyst stock suspension 
(stock at 2 x 107 oocysts ml-1) mixed with 900 µl HBSS and incubated for 24h at 
37ºC and b) an ethanol control, to determine whether ethanol affects in vitro 
excystation, consisting of 8 µl of a 75% v/v solution of absolute ethanol in distilled 
water, to produce a final concentration of 0.6%.  
Eight µl of PEO diluted in ethanol (25% v/v stock) was added to a 1.5 ml 
microcentrifuge tube followed by 892 µl of HBSS and vortexing for 20 sec, followed 
by the addition of 100µl of a 2 x 107 ml-1 stock suspension of C. parvum oocysts 
(final concentration of 2 x 106 ml-1 oocysts suspended in 0.2% of PEO), vortexing 
and incubation for 24 h at 37ºC.  
Determining whether PEO treatment influences maximised in vitro 
excystation when standard excystation triggers are used. 
Following treatment with PEOs, each oocyst suspension was subjected to the 
maximised excystation protocol of Robertson, Campbell and Smith (1993b) as 
described previously, to determine whether PEO treatment had any effect on in vitro 
excystation when standard triggers were used. The rate of excystation of the 
remaining unexcysted oocysts from PEO treatment was determined. 
 
Incubation of oocysts with PEO constituents 
Having prepared the constituent stock in the manner described for PEOs, the volume 
of the stock added to a 1.5 ml microcentrifuge tube was adjusted to give the 
following final concentrations: a) geraniol 0.16%, b) trans-anethole 0.14% and c) 
citronellol 0.1%. This was followed by vortexing and addition of C. parvum oocysts 
as previously described for PEOs. 
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Incubation of C. parvum oocysts with PEOs and PEO constituents over a 24 
h time course 
A time course experiment was employed to determine how quickly the PEOs and 
their constituents caused spontaneous excystation. The PEOs and constituents were 
used at the same concentrations as in the 24 h experiments. The oocysts were 
incubated in the presence or absence of the PEO or PEO constituents for 4, 8, 12 and 
24 h at 37ºC. 
 
Following incubation, each sample was washed three times in HBSS and 10 µl 
samples were viewed under DIC and the percentage excystation was calculated as 
previously described. The number of empty oocysts present in the stock suspension 
was always subtracted from the number enumerated post-PEO treatment.  
 
3:3.3 Oocyst analysis 
 Enumeration of oocyst excystation / spontaneous excystation 
Following incubation in all experiments, each sample was centrifuged (12,500 x g 
for 30 sec), the supernatant aspirated and the pellet resuspended in 100 µl HBSS. Ten 
µl samples were then viewed under DIC and the percentage excystation was 
calculated as described in the maximized excystation protocol. The number of empty 
oocysts present in the stock suspension was always subtracted from the number 
enumerated post-PEO treatment.  
 
 Statistical analysis 
All results are means of 2 trials, with triplicate counts of 100 – 200 oocysts 
undertaken per trial. The means and standard deviation of these enumerations were 
used in formulating graphs and tables, with a Student’s 2-tailed, unpaired, t-test 
being used to determine significance, with a P value of less than or equal to 0.05 
being regarded as significant. Data and statistical analysis was performed using 
Microsoft Excel® software. 
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3:4 RESULTS 
3:4.1 Acidification experiments 
Effect of time and temperature on the excystation of untreated C. parvum 
oocysts 
Incubation at 37ºC generated a significant increase in spontaneous excystation (P < 
0.05) that was time dependent when untreated oocysts were incubated in HBSS for 4 
h (Table 3.1; IOWA = 6.0 ± 1.6%; MD = 8.3 ± 3.7%) or 24 h at 37°C (Table 3.1; 
IOWA = 24 ± 2.9%; MD = 20.9 ± 4.3%). 
 
Table 3.1 Effect of time and temperature on the spontaneous excystation rate of 
C. parvum oocysts 
 
 
Treatment 
 
Isolate 
% 
Excystation 
(0 h 37°C) 
% 
Excystation 
(1 h 37°C) 
% 
Excystation 
(4 h 37°C) 
% 
Excystation 
(24 h 37°C) 
IOWA 2.9 ± 1.4 2.0 ± 0.9 4.3 ± 1.3 24.6 ± 2.6 HBSS 
(1 h) MD 4.3 ± 2.8 7.7 ± 2.6 9.1 ± 1.5 22.3 ± 2.8 
IOWA 0.5 ± 1.1 4.5 ± 2.0 24.4 ± 4.9 87.5 ± 3.0 Acidified 
HBSS (1 h) MD 0.5 ± 0.4 3.9 ± 2.1 8.0 ± 3.2 15.1 ± 2.3 
IOWA 6.0 ± 1.6 7.3 ± 3.3 9.2 ± 3.1 22.8 ± 3.8 HBSS 
(4 h) MD 8.3 ± 3.7 9.8 ± 1.3 14.8 ± 2.5 20.9 ± 4.3 
IOWA 3.9 ± 2.6 4.8 ± 2.2 16.4 ± 2.8 75.1 ± 4.4 Acidified 
HBSS (4 h) MD 0.5 ± 0.8 3.9 ± 1.4 6.2 ± 0.9 12.5 ± 2.0 
 
Oocysts were incubated in the presence or absence of acidified HBSS (pH 2.75) for 
either 1 or 4 h at 37°C and then further incubated at 0, 1, 4 or 24 h at 37°C in HBSS. 
The rate of spontaneous excystation was then calculated.  
 
Effect of purification methods on in vitro excystation 
The methods used to purify the isolates had no significant effect on oocyst 
excystation rate when the maximised excystation protocol (Robertson, Campbell and 
Smith 1993b) was employed (Table 3.2, P > 0.05). For both isolates, excystation was 
greater than 94% after 4 h incubation (IOWA = 97.9 ± 1.9%; MD = 94.7 ± 1.7%) and 
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the indicator of infectivity, the sporozoite ratio, when assessed after 30 min was 
found to be very high (IOWA = 4.0 ± 0.1; MD = 3.3 ± 0.8, Table 3.2). A sporozoite 
ratio of 4 is the theoretical maximum. No sporozoites were detected after 4 h 
incubation for either isolate. 
 
However, when the acidification step of the maximised excystation protocol was 
omitted (modified protocol) and the oocysts exposed to bile salts and sodium 
hydrocarbonate for 30 min, there was a significant increase in excystation with the 
MD, compared to the IOWA isolate (65.1 ± 3.4% vs. 2.4 ± 0.4%, Table 3.2, P < 
0.05). The sporozoite ratio for both isolates were found to be similar to each other 
and both were lower than that observed in the maximised protocol,  but this was not 
found to be significant (Modified: IOWA = 2.0 ± 1.9; MD = 2.5 ± 0.6 vs. 
Maximised: IOWA = 4.0 ± 0.1; MD = 3.3 ± 0.8, Table 3.2, P ≥ 0.05). 
 
At 4 h, MD isolate excystation by the modified protocol was similar to that obtained 
with the maximised excystation protocol (97.4 ± 1.4% vs. 94.7 ± 1.7%, Table 3.2). 
Excystation of the IOWA isolate was 39.8 ± 2.1%, significantly lower than in the 
maximised protocol (97.9 ± 1.9%; Table 3.2, P < 0.01). 
 
Of note is the observation of sporozoites after 4 h in the modified excystation 
protocol. Motile sporozoites were determined in both isolates after 4 h incubation 
(IOWA = 3.3 ± 0.3; MD = 2.1 ± 1.4, Table 3.2) suggesting that excystation was an 
ongoing process in the modified protocol, whereas in the maximised protocol no 
sporozoites were observed at 4 h. 
 
Effect of acidification on spontaneous excystation of C. parvum oocysts 
Exposing IOWA isolate oocysts to an acidic environment (HBSS, pH 2.75) for 4 h 
significantly increased spontaneous excystation compared to a 1 h exposure (1 h = 
0.5 ± 1.1% vs. 4 h = 3.9 ± 2.6%, P < 0.01). There was no significant difference in 
spontaneous excystation between the 1h and 4h incubation periods observed with the 
MD isolate (1 h = 0.5 ± 0.4% vs. 4 h = 0.5 ± 0.8%, Table 3.1). 
 
 119
When compared with MD, the IOWA isolate showed a significant increase in 
spontaneous excystation after 4 h acidification (IOWA = 3.9 ± 2.6% vs. MD = 0.5± 
0.8%, P < 0.05, Table 3.1).  In both isolates, treatment of oocysts with HBSS at 37°C 
for 1 or 4 h consistently induced significantly greater levels of spontaneous 
excystation than their acidified counterparts (Table 3.1, P < 0.05). 
 
Incubation of oocysts in an acid environment for 1 or 4 h followed by further 
incubation at 37°C for up to 24 h in HBSS produced a significant increase in the rate 
of spontaneous excystation compared to control (HBSS treated) oocysts, but only for 
the IOWA isolate (Table 3.1). The MD isolate was found to have a significantly 
lower rate of spontaneous excystation than its control.  
 
A time dependent increase in spontaneous excystation was observed when both 
isolates were exposed to HBSS for 1 or 4 h at 37°C and then further incubated for 0, 
1, 4 or 24 h. This phenomenon was also observed for both isolates after initial 
incubation in acidified HBSS for 1 or 4 h. The IOWA isolate, however, produced the 
greatest increase in spontaneous excystation over time after acidification. After 1 h of 
acidification this isolate exhibited a low spontaneous excystation rate (0.5 ± 1.1%, 
Table 3.1) that increased over time with further incubation in HBSS (1 h = 4.5 ± 
2.0%; 4 h = 24.4 ± 4.9; 24 h 87.5 ± 3.0, Table 3.1). A 4 h acidification had less of an 
impact on spontaneous excystation in the IOWA isolate, with 4 h and 24 h further 
incubation in HBSS causing significantly less excystation than 1 h acidification (1 h 
acidified HBSS + 24 h un-acidified HBSS = 87.5 ± 3.0%; 4 h acidified HBSS + 24 h 
un-acidified HBSS = 75.1 ± 4.4%; 1 h acidified HBSS + 4 h un-acidified HBSS = 
24.4 ± 4.9%; 4 h acidified HBSS + 4 h un-acidified HBSS = 16.4 ± 2.8%, Table 3.1). 
This is in spite of the 4 h acidified oocysts being treated for overall longer incubation 
periods than the 1 h groups. 
 
There was no significant difference in the spontaneous excystation rates observed in 
the MD isolate, when they were incubated for 1 h or 4 h in acidified HBSS or when 
they were further incubated in HBSS for 1, 4 or 24 h. These results were consistently 
lower for the same isolate treated with HBSS throughout the experiment (Table 3.1, 
 120
P < 0.05). They were also significantly lower than IOWA isolate oocysts treated with 
acid for 1 h or 4 h and when these were further incubated in HBSS for up to 24 h 
(Table 3.1, P < 0.05). 
 
Table 3.2 Effect of purification methods and isolate type on the excystation of C. 
parvum oocysts 
 
 30 min Bile Sp. ratio 4 h Bile Sp. ratio 
IOWA 86.7 ± 1.5% 4.0 ± 0.1 97.9 ± 1.9% nd Maximised 
Excystation 
Protocol MD 81.5 ± 6.1% 3.3 ± 0.8 94.7 ± 1.7% nd 
IOWA 2.4 ± 0.4% 2.0 ± 1.9 39.8 ± 2.1% 3.3 ± 0.3 Modified 
Excystation 
Protocol MD 65.1 ± 3.4% 2.5 ± 0.6 97.4 ± 1.4% 2.1 ± 1.4 
 
nd - none detected Sp. - Sporozoites 
 
Oocysts were treated with a full, maximised excystation protocol including a 1 h 
acidification step (Robertson, Campbell and Smith 1993b) or excluding a 1 h 
acidification step (modified excystation protocol).  
 
3:4.2 PEO treatment experiments 
Control oocysts 
To ensure that the oocyst suspension used throughout the study retained a consistent 
level of excystation, an aliquot was exposed to the maximised excystation protocol 
weekly and the excystation rate calculated. Over the 2 month study period, the mean 
percentage excystation of the stock suspensions was 96.4 ± 1.8%. The ethanol (0.6% 
final concentration) control neither increased nor decreased the spontaneous 
excystation rate of oocysts significantly (P > 0.05) over a 24 h incubation period at 
37°C when compared to the untreated oocyst control (22.9 ± 3.8% compared with 
23.6 ± 5.3%), indicating that any effect on spontaneous excystation was attributable 
to the PEOs. 
 
Effect of time and temperature on spontaneous excystation in C. parvum 
oocysts 
To determine how temperature influenced the spontaneous excystation of C. parvum 
oocysts, samples were incubated at 5ºC and 37ºC for 24 h. Incubation at 37ºC 
generated a significant increase in spontaneous excystation (16.0 ± 5.2%) compared 
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with incubation at 5ºC (-0.5 ± 1.4%, P < 0.01). Spontaneous excystation at 37ºC was 
time dependant, with a rapid increase occurring from 0 – 4 h incubation reaching a 
maximum of 16.0 ± 5.2% within 12 h (Table 3.3).  
 
Table 3.3 Effect of time and temperature on C. parvum oocyst spontaneous 
excystation 
 
Time (h) Spontaneous excystation 
rate at 37ºC (%) 
0 0.7 ± 0.8 
4 14.4 ± 6.1 
8 11.1 ± 3.9 
12 16.0 ± 5.2 
24 15.5 ± 4.5 
 
Untreated oocysts were incubated for up to 24 h at 37°C in HBSS and the 
spontaneous excystation rate calculated at different time points. There was no 
significant difference between the oocyst spontaneous excystation rates after 4 h of 
incubation (P < 0.05).  
 
Effect of PEOs on the spontaneous excystation of C. parvum oocysts 
When C. parvum oocysts were incubated for 24 h in the presence of 0.2% PEOs, an 
increase in spontaneous excystation was observed, compared to untreated oocysts 
(Figure 3.1). Incubation in palmarosa oil produced the greatest level of spontaneous 
excystation (96.9 ± 1.7% of oocysts), comparable to that observed with stock oocysts 
exposed to the maximised excystation protocol (average over 2 months = 96.4 ± 
1.8%). Oils of sweet fennel, thyme and geranium also caused a significant increase in 
the spontaneous excystation rate when compared to untreated control oocysts (77.1 ± 
12%, 51.1 ± 9.6%, 90.9 ± 1.1%, respectively; P < 0.01 for all oils).  
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Figure 3.1 Effect of different PEOs on spontaneous excystation in C. parvum 
oocysts.  
Oocysts were incubated for 24 h at 37ºC in the presence or absence of plant essential 
oils used at a final concentration of 0.2% v/v.  
 
Determining whether PEO treatment influences maximised in vitro 
excystation when standard excystation triggers are used. 
None of the PEOs tested influenced the outcome of the maximised excystation 
protocol following PEO pre-treatment (Appendix 7, Figure 1). This would indicate 
that oil treatment induces spontaneous excystation through a mechanism which does 
not affect the normal excystation mechanisms. 
 
Incubation of oocysts with PEOs / constituents 
PEOs found to cause high levels of spontaneous excystation of C. parvum oocysts in 
vitro were re-examined to determine if the action of the PEOs was due to their main 
constituents. In all PEOs, their main constituents caused spontaneous excystation of 
C. parvum oocysts to levels almost identical to that found with the PEO, with no 
significant difference being found between the effects of the whole oil and its major 
constituent (P > 0.05).  After 24 h incubation, 0.16% geraniol caused 97.8 ± 1.4% 
spontaneous excystation with 0.2% palmarosa oil causing 96.8 ± 1.5%. This 
difference between the 2 excystation rates was insignificant as geraniol is the active 
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constituent in palmarosa oil which is responsible for the in vitro excystation of C. 
parvum oocysts.  
 
Similarly, both the main constituents of sweet fennel oil (trans-anethole) and 
geranium oil (citronellol) caused spontaneous excystation of C. parvum oocysts at 
levels similar to that of their respective PEOs. After 24 h incubation, 0.14% trans-
anethole caused 87.9 ± 2.5% spontaneous excystation with 0.2% sweet fennel oil 
causing 84.6 ± 5.7%. Furthermore, 0.1% citronellol caused 87.6 ± 2.7% spontaneous 
excystation with 0.2% geranium oil causing 91.0 ± 1.2%. These constituents can be 
regarded as the main active constituents in their respective oils responsible for the in 
vitro excystation of C. parvum oocysts.  
 
Incubation of C. parvum oocysts with PEOs and their constituents over a 24 
h time course 
In order to determine the speed at which palmarosa, sweet fennel, geranium oil and 
their constituents induced the spontaneous excystation of C. parvum oocysts, 
samples of PEO treated oocysts were enumerated after 4, 8 12 and 24 h of 
incubation.  
 
After 4 h incubation the spontaneous excystation rate of untreated control oocysts 
reached levels of 11.3 ± 3.8 to 18.7 ± 4.4% after which the rate of spontaneous 
excystation reached a plateau (Figures 3.2, 3.3 and 3.4). Both palmarosa and 
geranium demonstrated a time dependent increase in C. parvum oocyst spontaneous 
excystation when 0.2% of oil was incubated with the parasites (Figures 3.2 and 3.3). 
Both constituents demonstrated the same time dependant effect and had the same 
levels of activity as their respective PEOs (Figures 3.2 and 3.3, P > 0.05). Oils of 
geranium, palmarosa and their constituents did not cause a significant increase in 
spontaneous excystation within 4 h incubation when compared with untreated control 
oocysts (Figures 3.2 and 3.3, P > 0.05), but did demonstrate significant increases 
between 4 and 24 h incubation (Figures 3.2 and 3.3, P < 0.05). 
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The PEO and its main constituent which induced the most rapid increase in 
spontaneous excystation rate were sweet fennel and trans-anethole. In the initial 4 h 
of incubation the excystation rate increased from 0.4 ± 0.5% to 57.1 ± 2.5% for 
sweet fennel and from 0.4 ± 0.5% to 60.9 ± 1.1% for trans-anethole (Figure 3.4). The 
percentage spontaneous excystation remained at a plateau until 12 h and 24 h 
incubation, where it increased to 84.6 ± 5.7% for sweet fennel and 87.9 ± 2.5% for 
trans-anethole, a significant increase when compared to the initial 4 h incubation (P 
< 0.05). 
 
In all cases the oil constituent performed similarly to the PEO over the time course 
studied, providing further evidence that they are the active constituents of the oils. 
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Figure 3.2 Effect of palmarosa oil and geraniol on the in vitro spontaneous 
excystation rate of C. parvum oocysts over time. 
Oocysts were incubated for 4, 8, 12 or 24 h at 37ºC in the presence or absence of 
0.2% v/v palmarosa oil ( ), its main constituent, geraniol ( ) at 0.16% v/v, or 
untreated oocysts ( ) and the rate of spontaneous excystation calculated at these 
time points. 
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Figure 3.3 Effect of geranium oil and citronellol on the in vitro spontaneous 
excystation rate of C. parvum oocysts over time. 
Oocysts were incubated for 4, 8, 12 or 24 h at 37ºC in the presence or absence of 
0.2% v/v geranium oil ( ), its main constituent, citronellol ( ) at 0.1% v/v, or 
untreated oocysts ( ) and the rate of spontaneous excystation calculated at these 
time points. 
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Figure 3.4 Effect of sweet fennel oil and trans-anethole on the in vitro 
spontaneous excystation rate of C. parvum oocysts over time. 
Oocysts were incubated for 4, 8, 12 or 24 h at 37ºC in the presence or absence of 
0.2% v/v sweet fennel oil ( ), its main constituent, trans-anethole ( ) at 0.14% v/v, 
or untreated oocysts ( ) and the rate of spontaneous excystation calculated at these 
time points. 
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Table 3.4 Hazard Safety Data for the most effective plant oils. 
 
 Fennel Anethole Palmarosa Geraniol Geranium Citronellol 
Rat Oral 
LD50 
3120 mg 
kg-1 
2090 mg 
kg-1 
>5000 mg 
kg-1 
3600 mg 
kg-1 
>5000 mg 
kg-1 
3450 mg 
kg-1 
Mouse 
Oral LD50 
nd 3050 mg 
kg-1 
nd nd nd nd 
Guinea Pig 
Oral LD50 
No Data 2167 mg 
kg-1 
nd nd nd nd 
Skin 
Rabbit 
LD50 
>5000 
mg kg-1 
nd >5000 mg 
kg-1 
>5000 
mg kg-1 
2500 mg 
kg-1 
2650 mg 
kg-1 
I.M. 
Mouse 
LD50 
nd nd nd 4000 mg 
kg-1 
nd 4000 mg 
kg-1 
S.C. 
Mouse 
LD50 
nd nd nd 1090 mg 
kg-1 
nd 880 mg kg-
1 
I.P. Mouse 
LD50 
nd 650 mg 
kg-1 
nd LD100 
1760  mg 
kg-1 
nd nd 
I.P. Rat 
LD50 
nd 900 mg 
kg-1 
nd nd nd nd 
I.V. 
Rabbit 
LD50 
nd nd nd 50 mg 
kg-1 
nd nd 
Skin 
Irritation 
Man 
nd nd nd 16mg, 
24H, 
Severe 
nd 16mg, 
48H, 
Moderate 
Skin 
Irritation 
Rabbit 
500mg, 
24H, 
Moderate 
nd 500mg, 
24H, 
Moderate 
100mg, 
24H, 
Severe 
500mg, 
24H, 
Moderate 
100mg, 
24H, 
Severe 
Skin 
Irritation 
Guinea Pig 
nd nd nd 100mg, 
24H, 
Severe 
nd 100mg, 
24H, 
Severe 
Ecotoxicity 
Fish 
LC50/LC100 
nd nd nd nd nd nd 
Ecotoxicity 
Crustaceae 
EC50 
nd nd nd nd nd nd 
 
 
nd = No Data available 
 
All oils are used at 0.2% (< 2 mg ml-1) in C. parvum experiments. In Aromatherapy 
oils are commonly used at concentrations of 1 – 30%. A 1000 mg kg-1 dose is the 
equivalent dose of 65g in an average 65kg adult, where 1ml of oil is roughly the 
equivalent of 1g. Basic safety guidelines suggest limits of between 0.5 ml (~0.5 g) 
and 2.5 ml day-1 (~2.5 g) orally (Tisserand & Balacs, 1995).  
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3:5 DISCUSSION 
Interventions in the Cryptosporidium life cycle that reduce the ability of extracellular 
stages to infect enterocytes will reduce the number of intracellular stages and can 
become potentially effective treatments for cryptosporidiosis. Sporozoites are the 
first extracellular stages produced in the life cycle and interventions that influence 
their release from intact, ingested oocysts, such as premature excystation in a hostile 
environment or ablation of excystation can be considered as potentially therapeutic. 
For example, exposure of C. parvum sporozoites to pH 6.2 or lower causes them to 
lyse in vitro (Woodmansee et al. 1987). Therefore, increasing excystation in the 
acidic environment of the stomach can lyse sporozoites, preventing them from 
invading the mucosa and preventing the propagation of infection. 
 
Conventional excystation stimuli include exposure to acid (pH ~2) followed by 
incubation in bile salts, reducing agents and proteases, which mimics oocyst transit 
through the acidic stomach to the alkaline small intestine (Smith, Nichols and 
Grimason 2005). However, oocysts can excyst in vivo and cause disease in extra 
intestinal locations, indicating that some host-derived triggers are not essential 
(Travis et al. 1990; French et al. 1995; Dunand et al. 1997; Smith, Nichols and 
Grimason 2005). Lower oocyst excystation rates at 4ºC support the hypothesis that 
increasing the temperature to 37ºC activates excystation, even in the absence of other 
host stimuli (Fayer & Leek 1984; Reduker & Speer 1985). 
 
In this study, it was found that acidification has a major influence on the rate of 
spontaneous excystation, over time. Two C. parvum isolates from 2 different sources 
utilising different purification methods were used to demonstrate this observation. 
Increasing the temperature to 37ºC also increased C. parvum oocyst excystation in 
vitro over a 24 h period. The maximum spontaneous excystation levels due to 
temperature were 15.5 ± 4.5%, which occurred after 24 h incubation, supporting 
previous findings (Fayer & Leek 1984; Reduker & Speer 1985). The term 
‘spontaneous’ excystation is used here to define the process of excystation in vitro 
that occurs in the absence of known triggers, apart from temperature so that it can be 
distinguished from excystation that occurs following maximised in vitro excystation 
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(Robertson, Campbell and Smith 1993b). Of great interest is the finding that PEOs 
influence the in vitro excystation of C. parvum oocysts in a temperature and time 
dependent manner, but in the absence of known triggers such as bile salts, reducing 
agents and proteases. Of the oils tested, palmarosa, geranium and sweet fennel oil 
were found to be the most effective at inducing spontaneous excystation of C. 
parvum oocysts in vitro. In these experiments both the speed at which spontaneous 
excystation could be induced and the constituent of the oil responsible for this effect 
were determined. 
 
When 2 different isolates of C. parvum were incubated for up to 28 h in HBSS at 
37°C there was a significant increase in spontaneous excystation but with no 
significant difference between the isolates. This indicates that under these particular 
conditions, the oocyst isolate did not influence spontaneous excystation. Both 
isolates showed a time dependent increase in spontaneous excystation supporting 
previous findings (Fayer & Leek 1984; Reduker & Speer 1985). This would also 
suggest that the oocyst purification methods employed by both suppliers (a modified 
ether extraction with discontinuous sucrose and caesium gradient for BGF – IOWA 
isolate; acid flocculation for MRI – MD isolate) had no effect either. Further 
evidence for this is provided by the similar excystation rates of both isolates when 
oocysts were exposed to the maximised excystation protocol of Robertson, Campbell 
and Smith (1993b) (IOWA = 97.9 ± 1.9% vs. MD = 94.7 ± 1.7%). 
 
However, treatment of oocysts in acidified HBSS followed by incubation in acid free 
HBSS at 37ºC for up to 24 h affects the rate of spontaneous excystation. Comparison 
of the isolates showed that there was a significantly greater increase in spontaneous 
excystation observed for the IOWA isolate compared with the MD after acidification 
and then incubation for 24 h in HBSS. Incubation of oocysts in the presence of 
acidified HBSS for 1 or 4 h showed a slight, but significant increase in the rate of 
spontaneous excystation for the IOWA isolate with the 4 h acidification but not for 
the MD isolate (Table 3.1, P < 0.05). The latter isolate failed to show any difference 
in spontaneous excystation between the 2 incubation periods. 
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When these acid treated oocysts were then exposed to HBSS for 24 h, the IOWA 
isolate had a spontaneous excystation rate of 87.5 ± 2.5% and the MD isolate 
spontaneous excystation rate of 15.1 ± 2.3%. Not only was this rate significantly 
lower than the IOWA isolate, it was also significantly lower than HBSS treated 
controls for the MD isolate over the same incubation period (acidified MD = 15.1 ± 
2.3% vs. control MD = 24.6 ± 2.6%, Table 3.1, P < 0.01). This reduction in 
spontaneous excystation observed for the MD isolate may have been influenced by 
the increased exposure of these oocysts to low pH. Prior to experimental exposure, 
the MD isolate is exposed to acid (0.01% v/v concentrated HCl) during the MRI 
purification procedures whereas the IOWA isolate is exposed to acid only during the 
experiments. 
 
This acid sensitivity of oocysts was further investigated by employing the maximised 
excystation protocol of Robertson, Campbell and Smith (1993b) and a modification 
of this protocol where the acidification step was omitted, i.e. exposing the oocysts to 
other known triggers of excystation such as temperature and bile salts. Experiments 
showed that the MD isolate exposed to the modified protocol achieved excystation 
rates similar to that demonstrated with the maximised protocol (maximised = 94.7 ± 
1.7% vs. modified = 97.4 ± 1.4%, Table 3.2). However, this was not observed with 
the IOWA isolate. With IOWA, acidification was a required step in the excystation 
protocol and its omission caused a significant reduction to the excystation rate 
(maximised = 97.9 ± 1.9% vs. modified = 39.8 ± 2.1%, P < 0.01). Comparison of 
both isolates treated with the maximised protocol showed no significant differences 
for excystation rates after 30 min and 4 h and no significant difference between their 
sporozoite ratios measured after 30 min. 
 
The MD isolate, as previously mentioned, had already been exposed to acid in its 
purification and when exposed to the modified excystation protocol the oocysts 
began excysting at an accelerated rate compared to the IOWA isolate (MD 30 min = 
65.1 ± 3.4% vs. IOWA 30 min = 2.4 ± 0.4%, Table 3.2, P < 0.01). When a 
maximised protocol was used, the IOWA and MD isolates showed similar 
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excystation rates at 30 min and were significantly higher than that observed for the 
modified protocol (MD = 81.5 ± 6.1%; IOWA = 86.7 ± 1.5%, Table 3.2, P < 0.05). 
 
Acidification appears to be a requirement for maximising C. parvum oocyst 
excystation. However, the isolate and its method of purification bear an important 
role in excystation. Purification of oocysts using an acidic method appears to 
desensitise the oocysts to spontaneous excystation following subsequent acid 
exposure. Oocysts which have been purified without the use of acid are sensitive to 
the action of acid, which will enhance their spontaneous excystation and also their 
excystation induced by the maximised protocol. The absence of acid inhibits 
excystation induced by the modified protocol. 
 
Oocysts of the IOWA isolate were used in PEO treatment experiments to investigate 
their activity on oocysts not previously primed for excystation by acidification. 
Oocysts incubated in the presence or absence of sweet fennel or palmarosa oil at 5ºC 
do not excyst spontaneously (Appendix 7, Figure 2). Therefore, temperature is a 
major factor in this phenomenon. Of the 12 PEOs tested, 4 significantly affected the 
spontaneous excystation of C. parvum oocysts (P < 0.01, Figure 3.1). Those PEOs 
causing spontaneous excystation at 37ºC, significantly above untreated control 
levels, included palmarosa, sweet fennel, thyme and geranium oils (96.9 ± 1.7%, 
77.1 ± 12%, 51.1 ± 9.6%, 90.9 ± 1.2%, respectively). This is particularly the case 
with palmarosa oil, which generated excystation rates similar to that found with 
oocysts exposed to the maximised in vitro excystation method of Robertson, 
Campbell and Smith (1993b) (96.9 ± 1.7% compared with 96.4 ± 1.8%). To the 
author’s knowledge, this is the first time that the effect of PEOs on spontaneous 
excystation of C. parvum has been reported. 
 
Incubating oocysts at 37ºC in the presence of PEOs increased spontaneous 
excystation significantly compared to control values (e.g. from ~19% to ~96% for 
palmarosa oil, P < 0.01). Therefore, the triggers for excystation must be different. 
The act of spontaneous excystation in the absence of all recognised triggers except 
temperature, would suggest that the PEOs might be acting in 1 of 2 ways i) that the 
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PEOs augment the effect of temperature on oocyst excystation by increasing oocyst 
wall permeability or ii) the reverse hypothesis, that an increase in temperature causes 
an activation of spontaneous excystation initiated by PEOs, especially with oils of 
palmarosa, geranium, sweet fennel and thyme, respectively. 
 
Oocysts which did not spontaneously excyst with the application of PEOs were 
found to do so in the presence of the classical triggers of the maximised excystation 
in vitro protocol, suggesting that pre-incubation with PEOs doesn’t inhibit the 
actions of in vitro excystation triggers.  
 
A potential use of PEOs may be as a means of limiting the propagation of infection 
of C. parvum in neonatal livestock, perhaps by including the PEO in their feed, 
providing the PEO can survive passage through the gut to the site of infection. PEOs 
can be safely kept for periods up to 2 years with no changes to its composition or its 
constituents by oxidation providing they are stored in the dark, in airtight containers 
and at 2 – 5°C.  Oxidation can occur much more quickly if PEOs are not kept in 
these conditions and the decomposition products may be toxic.  
 
Oils of thyme, sweet fennel, palmarosa and geranium are all readily available from a 
variety of sources and are currently used in the food and scent industries. Hazard 
safety data for these oils is limited (Table 3.4). However, due to their extensive use 
in various applications they are ‘generally regarded as safe’ (GRAS) by the United 
States’ FDA. 
 
Initially, the composition of palmarosa, geranium and sweet fennel oil were 
determined by GC-MS means with the assistance of F.D. Copeland & Sons. From 
this it could be determined that the monoterpene alcohol, geraniol, comprised 80% of 
palmarosa oil, the aromatic ether, trans-anethole comprised 68% of sweet fennel oil 
and that the monoterpene, citronellol comprised 39% of geranium oil. Incubation of 
these constituents on their own with oocysts at concentrations equivalent to that 
found in the PEO were able to elicit the spontaneous excystation of C. parvum 
oocysts in vitro at levels commensurate with their respective PEOs (sweet fennel = 
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84.6 ± 5.7% vs. trans-anethole = 87.9 ± 2.5%; geranium = 91.0 ± 1.2% vs. citronellol 
= 87.6 ± 2.7%; palmarosa = 96.8 ± 1.5% vs. geraniol = 97.8 ± 1.4%). These results 
would indicate that the constituents investigated were responsible for the actions of 
the PEO. 
 
The almost complete excystation of oocysts caused by geraniol and palmarosa oil at 
levels comparable with untreated controls undergoing the maximised excystation 
protocol may have beneficial applications. Whilst it takes 24 h of exposure to elicit 
almost 100% spontaneous excystation, there may be potential for the use of PEOs, or 
their constituents, in the treatment of farmyard faecal slurry so that the risk of viable 
oocysts being present in any water contaminated by such material can be reduced. By 
inducing excystation of oocysts outwith the body, the released sporozoites are 
exposed to conditions that are hazardous to their survival. The purpose of the oocyst 
wall is to provide a safe and protected environment for the sporozoites to exist until 
they have reached conditions which are optimal for their survival and invasion of 
enterocytes. 
 
Both palmarosa and its main constituent, geraniol, appear to be the most effective 
method of causing excystation over a 24h period. This constituent also has the 
advantage of being tested extensively for hazard data and is known to be bio-
degradable in the soil (United States’ Environmental Protection Agency (EPA 
2004)). Geraniol is also the metabolite of geranyl-acetate. It is metabolises in the 
intestines of mammals when it is consumed. Where geraniol is required, it may be 
possible to administer geranyl-acetate and this takes advantage of the mammal 
metabolic processes to produce geraniol in situ. Geranyl-acetate is also commonly 
used in foods as flavouring and has also been given GRAS status by the FDA. 
 
The speed at which spontaneous excystation occurred was also examined. A time 
dependant increase in spontaneous excystation was observed for each PEO and their 
constituents. Both palmarosa / geraniol and geranium / citronellol were able to exert 
their maximal effect 12 – 24 h after incubation, but their 4 h action was limited. 
Sweet fennel and trans-anethole, however, exerted between 57.1 – 60.9% 
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spontaneous excystation within 4 h. While this level of excystation is lower than the 
overall rate after 24 h for these compounds (84.6 and 87.5% respectively), it is 
significantly higher than that obtained with palmarosa / geraniol and geranium / 
citronellol over the same 4 h (palmarosa / geraniol = 5.2 – 6.8%; geranium / 
citronellol = 5.9 – 6.8%). It is also significantly higher than untreated oocysts after 4 
h incubation at 37°C (Figure 3.4, P < 0.05). Considering that passage through 
stomach can take up to 4 h, this is an intriguing result. Potentially, there may be 
applications for sweet fennel oil or trans-anethole as a means of excysting C. parvum 
oocysts prior to entry into the small intestine.  
 
The maximised in vitro excystation method of Robertson, Campbell and Smith 
(1993b), is completed within 5 h (pre-acidification of oocysts for 1 h, followed by 
incubation in bile salts for 4 h). While the spontaneous excystation rate induced by 
sweet fennel oil or trans-anethole is significantly lower than the maximised 
excystation rate at the same time point, it is still an interesting result. This oil and its 
constituent are working in a manner independent of acid and bile to induce an initial 
high rate of excystation. This may be due to the PEO and constituent causing the 
oocyst wall to become more permeable, as would normally happen during 
acidification or perhaps augmenting temperature induced permeability. 
 
It is well recognised that if excystation of C. parvum oocysts occurs in the stomach, 
which is too acidic for sporozoite survival (optimal pH 6.2, Woodmansee et al. 
1987), sporozoites lyse, which reduces both enterocyte invasion and the subsequent 
propagation of infection. By utilising the speed at which trans-anethole and sweet 
fennel oil are able to cause spontaneous excystation, it may be possible to induce this 
action at a site which is unfavourable to the sporozoite survival, e.g. the stomach. 
 
Further, the slower acting geranium, palmarosa, citronellol and geraniol may also 
have chemotherapeutic uses for cryptosporidiosis. By inducing the release of 
sporozoites prior to the release of oocysts in faeces, we can limit the propagation of 
infection, not just in humans as an immediate treatment, but also prophylactically in 
cattle and other livestock. This is a major source of infection for humans (Caccio et 
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al. 2005). Providing that the pharmacokinetics of these constituents are found to be 
favourable for a sustained exposure in the gut, they may become prime novel drug 
candidates. Considering that infected humans may shed oocysts for at least 2 weeks 
in 82% of infected people, 3 weeks in 42% and 4 weeks in 21% (Baxby, Hart and 
Blundell 1985), the slower action of geranium and palmarosa oils may be used to 
induce excystation of oocysts prior to or just after excretion, again limiting the 
propagation of infection. 
 
Some hazard information is currently available for the compounds citronellol, 
geraniol and trans-anethole as well as the essential oils geranium, palmarosa and 
sweet fennel. All 3 constituents and PEOs are currently used in food as flavourings 
with the FDA considering them all to be GRAS for food use (FDA Food additive 
status list 2006). This may allow their potential use internally as chemotherapeutic 
compounds. Safety information regarding these constituents and PEOs is given in 
Table 3.4. 
 
The World Health Organisation (WHO) states that citronellol most likely 
metabolises to harmless substances and that the majority of the compound is 
eliminated in the urine. This is based on data on a corresponding substance, geraniol. 
It is also an indication that these 2 compounds may share common pharmacokinetics. 
Indeed, geraniol, a naturally occurring straight chain terpene alcohol, is structurally 
related to citronellol and differs only by the presence of an additional double bond 
(Cantwell et al. 1978). Geraniol is produced by many flowering plants, including 
geraniums and citrus fruits, in the scent glands of honey bees and is found in over 
250 essential oils. It is used commercially for its fragrance, being used in the 
manufacture of detergents, soaps, creams, lotions, cosmetics and aromatherapy 
products (Höschle & Jendrossek 2005). This chemical is also used as a synthetic 
flavouring agent in beverages, ice cream and sweets and is granted GRAS status 
under section 409 of the Federal Food, Drug and Cosmetic Act (FFDCA 2004). Both 
geraniol and citronellol do not present any known health risks to humans (Höschle & 
Jendrossek 2005). 
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Trans-anethole is used as a flavouring substance in foods at approximate levels 
ranging from 2.5 ppm in gravies to 1500 ppm in chewing gum (Newberne et al. 
1999).  This roughly equates to concentrations from 0.00025% (2.5 µg g-1) to 0.15% 
(1500 µg g-1).  In mice, rats and humans, orally administered trans-anethole and 
other alkoxypropenylbenzene derivatives are rapidly absorbed from the gastro-
intestinal tract and they are completely metabolized mainly in the liver to yield polar 
acidic metabolites, which are conjugated and eliminated primarily in urine (Fritsch, 
De Saint Blanquat and Derache 1975; Le Bourhis 1968 and 1970; Solheim & 
Scheline 1973 and 1976).  
 
Other than food or fragrance uses, both geraniol and citronellol are being currently 
investigated for potential chemotherapeutic use. Research has demonstrated that 
geraniol is an effective insect repellent when tested against the mosquitoes Aedes 
albopictus (associated with the transmission of dengue, eastern equine encephalitis 
and dog heartworm and potentially with St. Louis and LaCrosse encephalitis 
viruses), Culex nigripalpus (a possible vector of West Nile virus) and Ochlerotatus 
triseriatus (vector for LaCrosse encephalitis viruses) (Barnard & Xue 2004). 
Citronellol is already utilised in many insect repellents. Both geraniol and palmarosa 
oil have antimicrobial properties (Prashar et al. 2003; Duarte et al. 2007), both 
geranium oil and citronellol have antifungal properties (Shin & Lim 2004) and trans-
anethole and sweet fennel are antimicrobial acting on a range of bacteria, yeasts and 
fungi (De et al. 2002; Fyfe, Armstrong and Stewart 1997). 
 
It is clear that these three PEOs and their constituents have a role to play in the 
excystation of C. parvum oocysts in vitro. The only other triggers required for 
spontaneous excysation to occur in the presence of these constituents appears to be 
an increase in temperature and time. The mechanism by which sweet fennel, 
palmarosa, geranium, trans-anethole, geraniol and citronellol are able to induce this 
form of spontaneous excystation is still unclear. It is generally agreed that in vivo 
requirements for excystation are an increase in temperature, acidification prior to 
exposure of bile salts, reducing agents and proteases found in the small intestine, 
although what role each has to play is still being investigated (Smith, Nichols and 
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Grimason 2005). It is known that both an increase in temperature and acidification 
will increase the permeability of  the oocyst wall. The tranduction of signals through 
an oocyst wall made increasingly permeable by elevated temperature have been 
shown to elicit responses in the sporozoites which can initiate excystation (Forney et 
al. 1996a and 1996b; Okhuysen et al. 1996; Smith & Ronald 2002).  
 
The increased permeability by temperature has previously been shown to allow the 
ingress of small molecules such as the nuclear fluorogenic dye 4′6-diamidino-2-
phenyl indole (DAPI) in a time dependent manner. This molecule has a formula 
weight (FW) of 457.48 and with increased temperature and time, it may migrate 
though the oocyst wall, although a further requirement in vitro is acidification. This 
permits a more rapid entry of the dye through an increased permeability of the wall 
(Campbell, Robertson and Smith 1992). The FWs of the terpenes and aromatic ether 
investigated are less than half that of DAPI (geraniol FW 154.25; trans-anethole FW 
148.2; citronellol FW 156.27), which would indicate that they may be able to pass 
through a less permeable wall, or at least one which would preclude the passage of 
DAPI. The lipophilic properties of PEOs and the presence of lipids in the oocyst wall 
(Smith & Ronald 2002) may help augment this permeability. This might be through 
being an alternative to acidifcation for increasing permeability and allowing the 
easier entry of constituents of the oil into the oocyst. This may potentially affect the 
sporozoites and initiate excystation. What is not known is if this possible increase in 
wall permeability enhanced by PEOs is selective (i.e. allowing controlled 
excystation) or non-selective, where ‘pores’ are formed, rapidly changing the 
permeability of the oocyst and exposing the sporozoites to the PEOs which may 
damage them, thus preventing their invasion of enterocytes. 
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CHAPTER 4 
 
Trypanosoma cruzi 
 
The activity of various PEOs and their constituents, on Trypanosoma cruzi 
epimastigote viability in vitro. 
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4:1 ABSTRACT 
The trypanocidal action of the PEOs sweet fennel, lavender, amyris, marjoram, 
palmarosa, patchouli, myrrh, myrtle, elemi, thyme, buchu, geranium and some of 
their constituents (α-pinene and eucalyptol) was investigated on T. cruzi 
epimastigotes in vitro. The MIC of the oils and constituents against T. cruzi was 
determined by cell counting in a Neubauer chamber. Treatment with oils and their 
constituents demonstrated that they reduce parasite viability, with myrtle and elemi 
essential oil being the most active (MICs for both oils = 0.00125% [12.5 μg ml-1]).  
Comparison of IC50 values with that cited in the literature for benznidazole 
demonstrated that both myrtle and elemi oils had activity that was within the range of 
benznidazole (myrtle IC50 = 2 μg ml-1; elemi IC50 = 3 μg ml-1; benznidazole IC50 = 
0.73 – 4.4 μg ml-1). All of the PEOs investigated were able to reduce parasite 
viability within 2 h when used at their MICs. The results presented here demonstrate 
those plant oil/s which could have a role to play in the treatment of Chagas’ disease.  
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4:2 INTRODUCTION 
The disease caused by T. cruzi, Chagas’ disease, is named after its discoverer, Carlos 
Chagas and occurs in the Americas, ranging from the Southern United States of 
America, through Mexico and into mainly rural areas of Central South America and 
as far South as Argentina (CDC Chagas’ disease fact sheet, accessed 28th August 
2008). The increased distribution of Chagas’ disease in rural areas compared with 
urban and suburban population centres can be accounted for by the types of 
dwellings used by the human population. As the Reduviid bugs’ natural habitat is in 
shrubs and bushes, the thatched roofs in rural dwellings make a good substitute for 
its natural habitat with the added bonus of easy access to blood meals.  With the loss 
of natural habitat and the use of more ‘modern’ building materials of concrete, bricks 
and slate roofs in urban / suburban areas, there are fewer habitats in which the 
Reduviid bug may survive, thus reducing the interaction of Reduviid bugs with 
humans and so reducing the distribution of Chagas’ disease in these areas. 
 
Chagas’ disease is of major medical importance throughout Latin America due to its 
public health and economic impact. Approximately 16 – 18 million people are 
infected, with up to 120 million at risk of infection (25% of the population of Latin 
America). It is estimated that 25 – 30% of those infected suffer chronic irreversible 
damage to the heart and digestive tract leading to approximately 50,000 fatalities 
being reported every year (WHO Technical Report Series 2002). More than 10 
million people carry the protozoan parasite T. cruzi, which multiplies inside cells, 
particularly those of the heart and smooth muscle (Miles 1997). Infection in humans 
leads to varied clinical presentations with mild symptoms. Patent parasitaemia lasting 
40 – 60 days can occur, with the disease often not being recognized at this stage. In 
the chronic phase of infection, up to 30% of infected people may develop severe 
abnormalities on the electrocardiogram and present with chagasic cardiomyopathy 
(WHO 2002). 
  
Chagas' disease is especially dangerous at the present time as there are no 
satisfactory prophylactic or curative agents available for the chronic stage of the 
infection. Once the disease is contracted by a patient, the individual remains infected 
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until death. Although there are drugs (nifurtimox and benznidazole) available for 
treatment of the acute stage of infection,  symptoms are rarely recognised in time for 
chemotherapeutic intervention to take place. 
 
The acute phase of infection can be characterised by an intense and localised 
inflammatory response at the site of inoculation, forming a small red nodule/lesion 
(chagoma). Where infection occurs through the conjunctiva of the eye, inflammatory 
responses cause oedema of the conjunctiva and eyelid with a swelling of the 
preauricular lymph node. These ocular symptoms collectively constitute the classical 
sign of acute infection known as Romaña’s sign. The acute phase is often 
asymptomatic and whilst there are effective drug treatments (nifurtimox and 
benznidazole) for this stage, it is often difficult to diagnose. Patient compliance with 
treatment regimens is often poor, as the treatment is lengthy.  
 
Resistance to these drugs are now being reported (Buckner et al. 1998) and both 
drugs require a high degree of patient compliance for optimum results. Nifurtimox is 
given at a dose of 5 mg/kg/day orally, slowly increased to 15 mg/kg/day (divided 
over 3 doses) for 2 to 4 months during the acute cycle of infection. However, this 
drug is now no longer being produced and whilst there are still stocks available, the 
cost to the patient can be prohibitive ($48 US per treatment regimen, the equivalent 
of one month’s pay for a Bolivian miner; Weir 2006). Benznidazole is generally 
given at 5 – 10 mg/kg/day orally in 2 daily doses for 1 – 2 months. Common side 
effects for both drugs include neurotoxicity, anorexia, nausea and leukopoenia. 
Nifurtimox exhibits these the most frequently whilst benznidazole shows a greater 
degree of skin manifestations such as rashes in as much as 30% of patients (Castro, 
de Mecca and Bartel 2006). Benznidazole is no longer produced by the original 
manufacturer (Roche) and is now produced by the Brazilian Government who were 
given the commercial rights and equipment to manufacture this drug. Problems with 
the supply of the primary constituent of this drug have led to delays in its 
distribution, often up to 4 months (Weir 2006). 
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It is clear that alternative therapuetics must be sought and one particular source of 
novel drugs may be from the plant world. Plants and their extracts have been used for 
many centuries as treatments for ailments, from headaches to parasite infections. 
However, it is only in the past 20 – 30 years that scientists have seriously begun to 
determine whether plant-derived traditional remedies are effective and if so, their 
mode of action (Anthony, Fyfe and Smith 2005). In the last 17 years, 199 papers 
have been published concerning the antitrypanosomal activities of plants and their 
identified constituents, many of which have come through the investigation of 
traditional native remedies (PubMed query accessed 10th January 2008). Recently 
Vieira et al. (2008) published an investigation into 215 plants from Northeastern 
Brasil for their activity against T. cruzi epimastigotes in vitro. Of these plants only 4 
were found to have significant trypanocidal efficacy with a combination of 8 
different constituents from these plants being found to be active. Flavenoids from 
plants have been investigated with some success (Sülsen et al. 2007), as have 
polyacetylenes (Senn et al. 2007) and terpenic compounds (Mikus et al. 2000; Hoet 
et al. 2006; Santoro et al. 2007a).  
 
Axenic culture of T. cruzi epimastigotes/metacyclic trypomastigotes has been 
possible for many years (Contreras et al. 1985). Axenic culture is commonly used for 
the screening of compounds for novel antitrypanosomal effects as well as studies on 
the biology of Trypanosoma parasites (Bringaud, Rivière & Coustou 2006; Schinella 
et al. 2002). Epimastigotes/metacyclic trypomastigotes of T. cruzi are deposited on 
the skin in the faeces and urine from the Reduviid bug as it takes a blood meal from 
its host (Chapter 1, pp 43 – 44; Figure 1.9). When the bite wound is scratched, 
epimastigotes enter the bloodstream of the host and rapidly invade host cells 
whereupon they differentiate into replicative amastigotes. The prevention of infective 
epimastigotes/metacyclic trypomastigotes entering the host cells is an advantageous 
step in limiting the propagation of infection. As the epimastigotes can be readily 
axenically cultured and are found on the skin, PEOs may be of use in this initial 
treatment of infection by ridding the skin of infective epimastigotes. The complete 
life cycle of T. cruzi is given in Chapter 1. 
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The method most commonly used to screen drugs for the treatment of Chagas' 
disease (microscopic counting of viable trypanosomes), can be very accurate but it is 
time-consuming, labour-intensive and dependent on the observer. Another method 
which may alleviate some of these problems is the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. This is comparatively quick and accurate, 
but requires careful attention to experimental design and interpretation of the results 
(Muelas-Serrano, Nogal-Ruiz and Gómez-Barrio 2000). A problem with this assay is 
that the reduction of the tetrazolium salt to a formazan product requires further 
solublisation in the medium before recording absorbance readings. This further 
complicates the assay, as it requires several procedures and manipulations of the test 
organism before complete analysis is carried out. This can lead to error in the final 
analysis. A less complicated method has been developed by the company Promega, 
where a novel tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) has been 
developed in a modification of the MTT assay. The MTS assay is simple, requiring 
the addition of a set dilution of reagent to the well of a 96 well microtitre plate 
containing a volume of cells or parasites. The biochemical reduction of the 
tetrazolium salt occurs with live organisms and the formazan product formed is 
soluble in tissue culture medium. The quantity of formazan product measured by 
absorbance at 492nm is directly proportional to the number of living cells in culture 
(Promega Technical Bulletin; http://www.promega.com/tbs/tb245/tb245.html 
accessed 8th January 2008).  
 
There is an intense search for new trypanocidal drugs, with plant extracts and PEOs 
appearing to be promising alternatives to classical chemotherapeutics. Thus the 
purpose of this series of experiments is several fold: (i) to establish the working 
concentrations of T. cruzi epimastigotes in a 96 well microtitre assay system, (ii) to 
determine whether the diluent (ethanol) can be safely used without affecting 
epimastigote viability (iii) to examine the use of a biochemical, colourmetric assay 
(MTS assay) or morphological analysis with the addition of vital dye (Trypan blue, 
motility and morphological assay [TBMM]) to accurately determine viability, so that 
statements could be made as to the efficacy of any tested plant essential oils, (iv) to 
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analyse the activity of 12 different PEOs on the viability of T. cruzi epimastigotes in 
vitro and (v) to determine their active constituents and potentially their mode of 
action. 
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4:3 MATERIALS AND METHODS 
4:3.1 T. cruzi in vitro culture 
Source and maintenance of T. cruzi epimastigotes 
Epimastigotes of T. cruzi (Silvio X10 isolate) were maintained axenically in sealed 
flat sided 110 mm x 16 mm culture tubes (Nunc, Denmark) at 25ºC, in Optimem 
medium (Gibco-BRL, Paisley, UK) supplemented with 10% (v/v) heat-inactivated 
foetal bovine serum (complete medium) (Gibco-BRL) and filled to ~50% capacity. 
Sub-culturing was performed routinely at 7 day intervals by harvesting from the 
culture tubes and then pipetting 1 ml of the suspended epimastigotes into ~6 ml of 
fresh complete medium.  
 
T. cruzi enumeration for experiments 
Epimastigote enumeration was performed using an improved Neubauer 
haemocytometer, with epimastigote viability determined by Trypan blue inclusion / 
exclusion where dead cells (stained) were determined microscopically. A lack of 
motility and changes to the morphology served as corroborating parameters of cell 
death (TBMM). Briefly, epimastigotes were harvested from the culture tubes by 
centrifuging the culture tubes (500 x g, 5 min). The supernatant was aspirated to 
waste and the pellet resuspended in 1 ml complete medium. A 20 µl aliquot of this 
suspension was added to 80 µl of complete medium in a 1.5 ml microcentrifuge tube 
to dilute the numbers of epimastigotes for easier counting. A 20 µl aliquot of this 
suspension was then added to 20 µl 0.4% w/v Trypan blue solution (Gibco-BRL) and 
mixed thoroughly. After mixing, 10 µl were dispensed into both chambers of an 
improved Neubauer haemocytometer, allowed to settle (30 – 60 sec) and then 
enumerated. Epimastigote enumeration was determined under bright field 
microscopy in the manner previously described in Chapter 2 for G. duodenalis 
trophozoites.  
 
Comparison of incubation at 25°C and 37°C in the MTS assay and the 
optimisation of T. cruzi epimastigote concentrations 
Epimastigotes at concentrations from 5 x 103 – 1 x 107 epimastigotes ml-1 were 
incubated over 24 h at 25°C using 100 µl well-1 in 2 x 96 well microtitre plates. 
Following incubation, 20 µl of MTS reagent was added to each well containing 100 
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µl of parasites. One 96 well plate was then further incubated at 25°C with the other at 
37°C in the dark. After 1.5, 3, 4 and 6 h for 25°C and 1, 2, 3, 4 h for 37°C 
incubation, the absorbance at 492nm for each well was performed. From these results 
a time of 4 h at 25°C or 3 h at 37°C was demonstrated to be optimal for viability 
assessment using MTS with a concentration of 1 x 107 epimastigotes ml-1. 
 
4:3.2 Experimental treatments of epimastigotes 
Viability in ethanol  
It had been previously demonstrated that ethanol could be used as a diluent without 
affecting G. duodenalis viability (Chapter 2). To determine whether this diluent 
could have any affect on T. cruzi epimastigotes, a final concentration equivalent to 
that obtained with a diluted PEO was assessed. A volume of 16 µl 75% v/v EtOH 
stock was diluted in 1 ml of complete medium, with vortexing for 20 sec and 50 µl of 
this being immediately added to 50µl of 2 x 107 epimastigotes ml-1. Incubation 
occurred in sealed 96 well microtitre plates at 25°C for 24 h following which parasite 
viability was assessed by microscopy and Trypan blue inclusion/exclusion as well as 
the MTS assay.  
 
PEO preparation 
All PEOs were diluted in absolute ethanol to provide 25% v/v stock solutions (25% 
PEO, 75% absolute ethanol), which were used in these experiments. The full list of 
PEOs investigated is given in Appendix 1.  
 
 Incubation of T. cruzi epimastigotes with PEOs 
After 5 days of culture, epimastigotes were harvested. Experiments were performed 
in sterile, 96 well microtitre plates covered with plate sealer film and lids (Costar, 
Corning). Final concentrations of 0.02 % of PEOs were initially used. A final 
concentration of 0.02% in the microtitre well was achieved by diluting 16 µl of PEO 
(25% v/v stock) in 1 ml of complete medium and vortexing for 20 sec with 100 µl of 
this being immediately added to 100µl of 1 x 107 epimastigotes ml-1.Where 100% 
killing of epimastigotes was observed, the active PEOs were titrated using doubling 
dilutions starting at 0.02% to determine their MICs. The microtitre plates were sealed 
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and incubated for 24 h at 25ºC, after which the epimastigotes were enumerated. After 
2 h of incubation the parasites were examined microscopically in their wells and also 
again at 24 h prior to enumeration of viability. 
 
Controls consisted of 1 x 107 epimastigotes ml-1 in 200 µl complete medium in the 
absence of PEOs. Unfortunately, the reference drugs for the treatment of American 
trypanosomiasis were unavailable and a drug control was not able to be used. A 
control with epimastigotes exposed to 56°C for 10 min was used as a visual 
comparison. All samples were prepared in triplicate and each experiment in 
duplicate. 
 
 Incubation of T. cruzi epimastigotes with PEOs and PEO constituents over a 
2 h time course 
During the 2 h observation period it was noted that there was evidence of 
antiparasitical activity. A 2 h time course experiment was then employed to 
determine how quickly PEOs exhibited antitrypanosomal activity. T. cruzi 
epimastigotes were incubated in sealed microtitre plates for 2 h in the presence or 
absence of PEOs at their MIC (Table 4.1). 
 
Table 4.1 Minimal inhibitory concentration of PEOs used in experiments. 
MIC (%) PEO 
0.01 Buchu 
0.01 Thyme 
0.005 Lavender 
0.005 Palmarosa 
0.0025 Amyris 
0.0025 Geranium 
0.0025 Marjoram 
0.0025 Myrrh 
0.0025 Patchouli 
0.0025 Sweet Fennel 
0.00125 Elemi 
0.00125 Myrtle 
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 Incubation of T. cruzi epimastigotes with PEO constituents 
Continuing from the PEO titration experiments, one particular PEO exhibited the 
greatest antitrypanosomal properties, as assessed by MIC when compared with the 
other 11 PEOs. Oil of myrtle was examined for its composition using GC-MS as 
previously described in Chapter 2 with the composition of the PEO given in 
Appendix 3.  The major constituents of myrtle oil were the monoterpenes, α-pinene 
and eucalyptol (syn. 1,8-cineole) comprising 51.72% and 22.25% of the PEO 
respectively. These constituents were prepared in the same manner as their PEOs and 
used in experiments. 
 
The constituents α-pinene and eucalyptol were incubated for 24 h with the parasites 
initially at the equivalent myrtle oil concentration of 0.02% (i.e. α-pinene = 0.01% 
and eucalyptol = 0.0044%). A titration of doubling dilutions was performed so that 
final concentrations of α-pinene were 0.01, 0.005, 0.0025 and 0.00125% and 
eucalyptol at 0.0044, 0.0022, 0.0011 and 0.00055%. These constituents were also 
incubated in combination, in the presence of epimastigotes at the above 
concentrations so that 0.01% α-pinene was added with 0.0044% eucalyptol, 0.005% 
α-pinene with 0.0022% eucalyptol and so on. 
 
4:3.3 Epimastigote culture analysis 
T. cruzi cell count assay 
Epimastigote enumeration was performed using an improved Neubauer 
haemocytometer and epimastigote viability determined by TBMM. Epimastigotes 
were harvested from wells, the contents of triplicate wells were combined into 1.5 ml 
microcentrifuge tubes and centrifuged (10 sec, bench top centrifuge 5410, Eppendorf 
GmbH, Germany). The supernatant was aspirated to waste and the pellet resuspended 
in 100 µl complete medium and 100 µl 0.4% w/v Trypan blue solution (Gibco, UK) 
and mixed thoroughly. After mixing, 10 µl were dispensed into both chambers of an 
improved Neubauer haemocytometer, allowed to settle (30 – 60 sec) then assessed as 
previously described in Chapter 2.  
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Epimastigote viability was also determined in experiments using the CellTiter 96® 
AQueous One Solution Cell Proliferation Assay (Promega, USA; MTS Assay) which 
uses the novel tetrazolium compound, MTS and the electron coupling reagent, 
phenazine ethosulphate (PES). The procedures followed were as previously 
described in section 4:3.1 of this chapter.  
 
The recommended medium to use for the MTS assay is RPMI 1640 although any 
medium which does not absorb light at 492nm may be used. As the parasites were 
cultured in Optimem, this was used in the assay. In all experiments, wells containing 
Optimem were used as ‘blanks’ to assess its absorption of light at 492nm and were 
subtracted from all absorption readings. At the determined incubation time and 
temperature of 4h and 25°C for use in experiments (Section 4:3.1) Optimem has a 
mean absorbance of 0.342 ± standard deviation x3 of 0.044. This would mean that 
for epimastigotes to be determined as being viable by formazan reduction, the lowest 
uncorrected absorbance would have to be greater than the highest positive standard 
deviation for Optimem, i.e. > 0.386. 
 
 Statistical analysis 
In this series of experiments epimastigotes of T. cruzi from each microtitre well from 
2 experiments were enumerated, providing a total of 6 enumerations for each PEO 
concentration tested. The means and standard deviation of these enumerations were 
used in formulating graphs and tables, with a Student’s 2-tailed, unpaired, t-test used 
to determine significance with a P value of less than or equal to 0.05 being regarded 
as significant. The construction of dose–response curves and calculation of IC50 and 
IC90 values was performed using XLfit 4® software with other data and statistical 
analysis performed using Microsoft Excel® software. 
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4:4 RESULTS 
Comparison of incubation at 25°C and 37°C in the MTS assay and the optimisation 
of T. cruzi epimastigote concentrations 
In order to determine the optimal concentration of T. cruzi epimastigotes for use in 
vitro for viability assays, an experiment was designed to assess the ability of the 
novel tetrazolium salt, MTS, to be reduced by different concentration of parasites at 
different incubation temperatures. Whilst the incubation temperature for MTS 
reduction identified by the manufacturer is 37°C, T. cruzi epimastigotes are 
maintained in vitro at 25°C. A comparison was made between the incubation of MTS 
at 37°C and 25°C to determine if this final incubation step of 37°C in the presence of 
MTS would affect the viability of T. cruzi epimastigotes over the time required to 
reduce formazan by producing a colour change which was measurable at 492nm. In 
this series of experiments it could be seen that increasing the concentration of 
parasites in the well from 5 x 103 ml-1 to 1 x 107 ml-1 led to an increase in MTS 
reduction at both incubation temperatures of 37°C (Figure 4.1) and 25°C (Figure 4.2) 
following incubation of parasites alone at 25°C for 24 h.  
 
The corrected maximum absorbance for parasites incubated with MTS at 37°C 
ranged from 0.354 ± 0.023 after 1 h to 0.821 ± 0.06 after 4 h with a concentration of 
1x10-7 ml-1 epimastigotes (Figure 4.1). This did not significantly vary from when the 
parasites were incubated with MTS at 25°C from 1.5 h to 6 h (0.342 ± 0.012 to 0.729 
± 0.045; Figure 4.2) except when comparing both the 3 h and 4 h incubation points. 
In each case, incubation at 37°C significantly increased absorbance and therefore 
MTS reduction when compared with incubation at 25°C (3 h incubation = 37°C 
0.709 ± 0.046 vs. 25°C 0.513 ± 0.01, P < 0.01; 4 h incubation = 37°C 0.821 ± 0.06 
vs. 25°C 0.672 ± 0.047, P < 0.05). From this it could be determined that a more rapid 
response could be obtained by incubating the epimastigotes in the presence of MTS 
at 37°C rather than for the corresponding time at 25°C, with no loss of viability as 
seen by the continued metabolic reduction of MTS. To obtain an absorbance equal to 
4 h incubation at 37°C one had to incubate the parasites with MTS for 6 h at 25°C.  
 
It was observed that the lower limit of detection for the absorbance of reduced MTS 
at 37°C corresponded to 1 x 105 ml-1 viable epimastigotes (Figure 4.1) but a longer 
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incubation period for MTS at 25°C and more viable epimastigotes (5 x 10-5 ml-1, 
Figure 4.2) were required before detection. A concentration of 1 x 107 ml-1 
epimastigotes represented the upper detection limits for both incubation temperatures 
whereby differences in viability could be observed (such as decreases and increases 
in parasite numbers) and detected readily at both 3 h 37°C and 6 h 25°C incubation. 
This concentration was used for all future in vitro viability experiments. 
 
Although a 3 h incubation of MTS at 37°C showed no significant difference between 
the 4 h incubation (Figure 4.1, P = 0.063) and could be used in viability experiments, 
it was decided that as epimastigotes undergo physical changes at 37°C in the human 
host, 37°C would not be used as an MTS incubation temperature. Instead, 25°C was 
used with the lengthier incubation of 4 h in the MTS assay as this incubation 
temperature and time showed no significant difference between the absorbance’s 
detected for 1 x 107 ml-1 epimastigotes at 37°C with 3 h MTS incubation (25°C, 4 h = 
0.672 ± 0.047; 37°C 3 h = 0.709 ± 0.047, P = 0.378). 
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Figure 4.1 Assessment of epimastigote viability and optimal concentration using 
MTS at 37°C. 
Different concentrations of T. cruzi epimastigotes were incubated in 96 well 
microtitre plates in complete medium for 24 h at 25°C. On completion of incubation 
20µl of MTS were added to each well of the plate and then incubated in the dark for 
( ) 1, ( ) 2, ( ) 3, or ( ) 4 h at 37°C.  
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Figure 4.2 Assessment of epimastigote viability and optimal concentration using 
MTS at 25°C. 
Different concentrations of T. cruzi epimastigotes were incubated in 96 well 
microtitre plates in complete medium for 24 h at 25°C. On completion of incubation 
20µl of MTS were added to each well of the plate and then incubated in the dark for 
( ) 1.5, ( ) 3, ( ) 4, or ( ) 6 h at 25°C.  
 
 
 
T. cruzi epimastigote morphological alterations (TBMM assay) 
Epimastigotes of T. cruzi were incubated in complete Optimem for 24 h at 25°C and 
light microscopy images were taken. Reference drugs were unavailable for 
comparison testing and so an alternative method was employed to show epimastigote 
death under Trypan blue staining. The method selected was heat killing at 56°C for 
10 min. Viable epimastigotes were motile, possessing a single long whip-like 
flagellum and a slender oval cell body which excluded Trypan blue (Figure 4.3 A). 
Heat killing of epimastigotes led to internalisation of the flagellum, rounding up and 
swelling of the cell body, accompanied by uptake of Trypan blue (Figure 4.3 B). 
Some epimastigotes remained oval shaped and elongated, with the flagellum 
retaining its full length, but were non-motile and appeared in a comma shaped 
configuration (Figure 4.3 B). 
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Effects of ethanol on T. cruzi viability 
Incubation of 1 x 107 ml-1 T. cruzi epimastigotes in the presence of ethanol at 0.06%, 
did not significantly reduce their viability over a 24 h period. This was demonstrated 
using two methods; the MTS assay and TBMM assay. Ethanol treated and untreated 
epimastigotes both caused the reduction of formazan in the MTS assay to similar 
levels as indicated by the absorbance at 492nm (ethanol = 0.827 ± 0.06 vs. untreated 
= 0.821 ± 0.03; P > 0.05).  This similarity was also demonstrated in the TBMM 
assay where no significant difference in their viability between ethanol treatment and 
untreated epimastigotes could be determined (ethanol = 98.02 ± 1.4% vs. untreated = 
98.04 ± 1.5%; P > 0.05). 
 
 
 
Figure 4.3 Viable and non-viable epimastigotes of Trypanosoma cruzi as assessed 
by TBMM. 
Epimastigotes of T. cruzi were incubated in complete Optimem at 25°C for 24 h and 
then aliquots were either mixed directly with an equal volume of Trypan blue (A) or 
treated with 56°C for 10 min prior to mixing with Trypan blue (B) and then viewed 
under a light microscope (total mag. X1250). Images are from representative 
samples. Photographs were taken (copyright© SPDL) using a ColorView Soft 
Imaging System MTV-3 camera and analySIS® software. 
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Incubation of T. cruzi epimastigotes with PEOs 
Screening of PEOs 
A range of 12 PEOs were incubated with T. cruzi epimastigotes for 24 h at 25°C. 
When screened at a final concentration of 0.02% in each well, each PEO killed 100% 
of epimastigotes as assessed by Trypan blue inclusion / exclusion (Figure 4.4 A). 
When the MTS assay was used to investigate viability, all PEOs with the exception 
of myrrh, caused little or no reduction of formazan by the epimastigotes, indicating 
that they were non-viable (Figure 4.4 B). The formazan reductive activity observed 
with myrrh treated trophozoites was slight, but significantly different from other 
PEO treated parasites (P < 0.05). Representative examples of PEO influence on 
morphology are given in Figure 4.5. Both untreated and ethanol treated epimastigotes 
show typical spindle shaped cell bodies with a single long flagellum (Figure 4.5 A & 
B). All the oils caused the epimastigotes to round up and include Trypan blue dye, 
indicating non-viability. The parasite cell body, apart from rounding up, also 
significantly contracted in length and area size, with the exception of myrrh (Table 
4.2, P < 0.05). In many cases a shortened flagellum free of the undulating membrane 
was present (Figure 4.5 D – G, I, K, M & N). An absence of a flagellum occurred 
with oils of sweet fennel, patchouli, myrtle and thyme (Figure 4.5 C, H, J & L 
respectively). The greatest change in morphology occurred with oils of myrtle and 
thyme, with these oils reducing epimastigotes to a non-motile, unflagellated and 
poorly defined morphology (Figure 4.5 J & L, respectively) over 24 h incubation. 
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Table 4.2 Effect of PEO treatment on T. cruzi epimastigote size. 
 Epimastigote Cell Body Measurement 
PEO Length (µm) Breadth (µm) Area (µm2) 
Control 8.94 ± 1.77 3.36 ± 0.34 20.52 ± 4.77 
Amyris 4.44 ± 0.95 3.42 ± 0.82 10.82 ± 3.90 
Buchu 5.05 ± 0.73 3.75 ± 0.61 13.84 ± 2.91 
Elemi 4.71 ± 0.69 3.49 ± 0.65 10.16 ± 2.35 
Geranium 4.18 ± 0.62 3.15 ± 0.58 10.42 ± 2.42 
Lavender 4.24 ± 0.95 3.42 ± 0.82 10.82 ± 3.90 
Marjoram 4.66 ± 0.61 3.59 ± 0.86 12.72 ± 2.49 
Myrrh 5.65 ± 1.04 4.18 ± 0.72 17.57 ± 6.10 
Myrtle 4.42 ± 0.75 3.25 ± 0.40 10.68 ± 2.46 
Palmarosa 4.48 ± 0.90 3.53 ± 0.76 11.44 ± 4.63 
Patchouli 4.35 ± 0.42 3.31 ± 0.42 10.44 ± 3.44 
Sweet Fennel 4.55 ± 0.73 3.81 ± 0.76 13.25 ± 4.12 
Thyme 4.94 ± 0.51 3.75 ± 0.85 15.63 ± 3.78 
 
Parasites were incubated at 25°C in 96 well microtitre plates in the presence or 
absence of different PEOs at a final concentration 0.02% in the well. Epimastigote 
viability was assessed by TBMM under light microscopy using a total magnification 
of x1250. Images of epimastigotes were taken using a ColorView Soft Imaging 
System MTV-3 camera and analysed using analySIS® software. Measurements from 
10 epimastigotes were taken for each PEO. 
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Figure 4.4 Incubation of T. cruzi epimastigotes in vitro with various PEOs. 
Parasites were incubated at 25°C in 96 well microtitre plates in the presence or 
absence of different PEOs at a final concentration 0.02% in the well or ethanol at a 
final concentration of 0.06%. A) Parasite viability was assessed by TBMM under 
light microscopy or B) MTS solution (20 µl per well) added directly to the wells 
following PEO exposure and incubated for 4h at 25°C in the dark before the 
absorbance at 492nm was measured. Geranium oil was not available when this assay 
was performed (nd). 
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Figure 4.5 Incubation of T. cruzi epimastigotes in vitro with various PEOs 
showing their effect on morphology. 
Parasites were incubated at 25°C in 96 well microtitre plates in the presence or 
absence of different PEOs at a final concentration 0.02% in the well or ethanol at a 
final concentration of 0.06%. A) epimastigotes alone, B) ethanol treated, C) sweet 
fennel, D) lavender, E) amyris, F) marjoram, G) palmarosa, H) patchouli, I) myrrh, 
J) myrtle, K) elemi, L) thyme, M) buchu and N) geranium. Parasite viability was 
assessed by Trypan blue inclusion/exclusion under light microscopy. Representative 
photographs of epimastigotes using a total magnification of x1250 under Nomarski 
DIC. Photographs were taken (copyright© SPDL) using a ColorView Soft Imaging 
System MTV-3 camera and analySIS® software. 
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 Titration of PEOs 
As all the PEOs at a final concentration of 0.02% caused 100% killing of 
epimastigotes, a PEO titration was determined. Doubling dilutions of all PEOs were 
incubated with epimastigotes for 24 h at 25°C, beginning with the concentration used 
for screening (0.02%).  
 
The epimastigotes were sensitive to all of the PEOs at concentrations below 0.02% 
with the lowest MIC being recorded for myrtle and elemi (0.00125%; Figure 4.6 and 
Table 4.3). All other oils had MICs of 0.01% (thyme and buchu), 0.005% (lavender, 
amyris, marjoram, palmarosa and patchouli) and 0.0025% (sweet fennel, myrrh and 
geranium; Figure 4.6 and Table 4.3).  
 
Lowering the concentration of myrtle and elemi oil below the MIC to 0.000625% 
reduced antitrypanosomal effects (from 100% epimastigote killing to 97 – 97.7%), 
but this was not found to be significant (P > 0.05). The same level of effect (97.6 ± 
1.9%; Figure 4.6) was maintained with myrtle at a concentration of 0.000313%, but 
not with elemi (40.6 ± 32.9%; Figure 4.6). However, once myrtle oil was diluted to 
0.000156% there was no significant difference in epimastigote viability between the 
untreated control and the 0.000156% myrtle oil treated epimastigotes  (control = 6.5 
± 6.5% vs. 0.000156% myrtle = 8.6 ± 5.0%, P > 0.05).  
 
Whilst reference drugs were unavailable for use in these experiments, other 
investigators have been able to source benznidazole and IC50 values of 7.4 – 50 µg 
ml-1 have been quoted with T. cruzi epimastigotes in vitro (del Olmo et al. 2001; 
Sepúlveda-Boza & Cassels 1996).  In order to compare the PEOs with benznidazole 
the percentage concentrations had to be converted into µg ml-1 as described in 
Chapter 2. 
 
All PEOs tested were more effective than benznidazole in killing epimastigotes(IC50 
= 2 – 39 μg ml-1 [0.0002 – 0.0039%], Table 4.3). Both myrtle and elemi exhibited the 
lowest IC50 results, being 2 and 3 μg ml-1 respectively (Table 4.3). These figures are 
lower than that of benznidazole as cited in the literature (del Olmo et al. 2001; 
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Sepúlveda-Boza & Cassels 1996) and suggest that both these oils are highly 
antitrypanosomal. 
 
When treated with 0.02% of myrtle or elemi oil, changes in parasite morphology 
included: rounding up of the cell body and an absence of a flagellum (Figure 4.7 A & 
B far left panel). As the concentration of PEO decreased the morphology of the 
treated epimastigotes changed from being rounded, lacking a visible flagellum and 
stained with Trypan blue to becoming typically spindle shaped with a highly motile 
flagellum being observed with a concentration of 0.000156% oil (Figure 4.7 A & B 
viewed left to right). These changes in morphology observed for the 2 oils 
demonstrate the rapid switch between killing and survival of the epimastigotes at 
concentrations just below the MIC shown in figure 4.6. 
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Table 4.3 Inhibition of T. cruzi epimastigote survival by different PEOs 
 
 INHIBITORY CONCENTRATION  
PEO MICa MICb IC90a IC90b IC50a IC50b 
Buchu 0.01 100 0.0045 45 0.0037 37 
Thyme 0.01 100 0.0047 47 0.0039 39 
Amyris 0.005 50 0.0022 22 0.0016 16 
Lavender 0.005 50 0.002 20 0.0015 15 
Marjoram 0.005 50 0.0014 14 0.0009 9 
Palmarosa 0.005 50 0.0044 44 0.0033 33 
Patchouli 0.005 50 0.0007 7 0.0005 5 
Geranium 0.0025 25 0.0021 21 0.0017 17 
Myrrh 0.0025 25 0.0014 14 0.0008 8 
Sweet Fennel 0.0025 25 0.002 20 0.0017 17 
Elemi 0.00125 12.5 0.0005 5 0.0003 3 
Myrtle 0.00125 12.5 0.0003 3 0.0002 2 
 
a Concentrations are expressed as a percentage v/v. 
b Concentrations are expressed as μg ml-1 where 0.001% = 10 ppm = 10 µg ml-1. 
MIC = the minimum concentration required to inhibit the growth / survival of 100% 
epimastigotes. 
IC90 and IC50 = the concentration required to inhibit 90% or 50% of epimastigotes 
respectively. 
Inhibition was assessed using TBMM. 
 
 
 
 
Figure 4.7 Titrations of myrtle and elemi PEOs investigated with T. cruzi 
epimastigotes in vitro demonstrating morphological alterations.  
Parasites were incubated in the presence or absence of doubling dilutions of A) 
myrtle oil or B) elemi oil. Final concentrations used in each well started at 0.02% 
(first panel on the left hand side) with doubling dilutions (0.01%, 0.005%, 0.0025%, 
0.00125%, 0.000625%, 0.000313% and 0.000156%) progressing from left to right 
(HIGH to LOW). Parasite viability was assessed using TBMM. Representative 
photographs of epimastigotes using a total magnification of x1250. Photographs were 
taken (copyright© SPDL) using a ColorView Soft Imaging System MTV-3 camera 
and analySIS® software. 
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Incubation of T. cruzi epimastigotes with PEO constituents 
Considering that myrtle oil was the only oil able to sustain 97.6 ± 1.9% epimastigote 
killing down to a concentration of 0.000313% over 24 h, the activity of this PEO was 
further investigated. As previously shown in Chapter 2 and Appendix 3, myrtle oil 
consists of several constituents, with its main constituents being α-pinene (51.72%) 
and eucalyptol (22.35%). Given this information, a titration of each constituent either 
singly or in combination was carried out to determine if they were responsible for the 
observed epimastigote killing. The constituents were used at concentrations 
equivalent to that to be found in the whole oil such that the starting concentration of 
α-pinene was 0.01% (equivalent of 0.02% whole oil) and eucalyptol was 0.0044%. 
 
When used at 0.01%, α-pinene alone reduced epimastigote viability by 100% (Figure 
4.8). A concentration dependent decrease in α-pinene efficacy was also 
demonstrated. At 0.0025%, α-pinene did not reduce the viability of epimastigotes. 
This concentration of α-pinene was the equivalent of 0.005% myrtle oil, which has 
previously been demonstrated to kill 100% of epimastigotes in the same incubation 
time (Figures 4.6 and 4.9). The secondary constituent of myrtle oil, eucalyptol, had 
no significant effect on epimastigote viability (Figure 4.8, P > 0.05). 
 
A concentration dependent increase in antitrypanosomal activity was demonstrated 
when these 2 constituents were used in combination. There was no significant 
reduction in epimastigote viability until a myrtle oil equivalent concentration of 
0.005% was reached. At this concentration the effect of 0.0025% α-pinene + 
0.0011% eucalyptol was more than additive and most likely to be synergistic (Figure 
4.8). If the activity was additive, then epimastigote mortality would be 4.3 ± 3.9%. 
However, when used in combination, these 2 constituents caused 24.6 ± 15.2% death 
of epimastigotes, significantly greater than their additive activities (P < 0.05) and a 
5.7 fold increase on the additive value. The activity of α-pinene and eucalyptol 
combined was always greater than that of α-pinene alone, but was only significantly 
higher at a myrtle equivalent concentration of 0.005%. 
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Figure 4.8 Titration of the 2 major constituents of myrtle oil investigated with T. 
cruzi epimastigotes in vitro.  
Parasites were incubated in the presence or absence of doubling dilutions of α-pinene 
and eucalyptol on their own or in combination. The starting concentration used was 
the equivalent concentration to be found in 0.02% of whole oil. α-pinene [ ] would 
therefore start at a concentration of 0.01% and  eucalyptol [ ] at 0.0044%. These 2 
constituents were also used in combination [ ] at 0.01% for α-pinene and 0.0044% 
for eucalyptol. Parasite viability was assessed by using TBMM.  
 
 
Incubation of T. cruzi epimastigotes with PEOs over a 2 h time course 
Whilst PEO treated epimastigotes were being incubated at either their screening 
concentrations or MICs, routine observations after 2 h at 25°C indicated that 
morphological changes were occurring with the treated epimastigotes. In order to 
quantify this observation, a 2 h time course was performed at PEO MIC levels with 
epimastigotes in vitro. Of the 12 PEOs investigated, 9 reduced epimastigote viability 
by 100% after 2 h incubation (Figure 4.9). Oils of lavender, marjoram and myrtle did 
reduce epimastigote viability, but to a lesser degree than described for the other 9 
PEOs (99.3 ± 0.8%, 99.8 ± 0.4% and 99.0 ± 1.1% respectively). This reduction in the 
activity of the oils was slight but was not significant (P > 0.05) for lavender and 
marjoram oils and for myrtle oil (P = 0.0502). These results would indicate that 
PEOs killing of epimastigotes can occur within 2 h. 
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Figure 4.9 Incubation of T. cruzi epimastigotes in vitro with various PEOs at 
their MICs for 2 h. 
Parasites were incubated at 25°C for 2 h in 96 well microtitre plates in the presence 
or absence of different PEOs at their MICs. These MICs are as follows: sweet fennel 
(0.0025%), lavender (0.0025%), amyris (0.0025%), marjoram (0.0025%), palmarosa 
(0.05%), patchouli (0.0025%), myrrh (0.0025%), myrtle (0.00125%), elemi 
(0.00125%), thyme (0.01%), buchu (0.01%) and geranium (0.0025%). Parasite 
viability was assessed using TBMM.  
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4:5 DISCUSSION 
This series of experiments was designed to (i) determine working concentrations of 
T. cruzi epimastigotes and diluents for use in this project and (ii) to identify whether 
PEOs could influence T. cruzi epimastigote viability in vitro over time.  
 
Light microscopy was used to identify morphological changes in the epimastigotes, 
such as absence of a flagellum and rounding up of the cell body. As identified in 
Chapter 2, this is the most commonly utilized test for cell viability (Eisenbrand et al. 
2002; Freshney 1994; Patterson 1979; Pappenheimer 1917).  
 
A colourmetric biochemical assay was also used to assess viability. The MTS cell 
proliferation assay is used to identify the cytotoxic potential of a sample. This assay 
measures (by absorbance) the formation of a soluble formazan product which is 
directly proportional to the number of live cells in the investigated sample. The 
influence of incubation time on absorbance values generated with the MTS assay has 
been previously reported (Cory et al. 1991; Buttke, McCubrey & Owen 1993), where 
a linear relationship between incubation time and absorbance for short incubation 
times of up to 5 h was demonstrated. An advantage of MTS over the original MTT 
assay is that the formazan crystals of MTS are soluble in culture medium and don't 
require solublisation. Formazan crystals of MTT are insoluble in culture medium and 
require the addition of SDS or DMSO for solublisation whereas the MTS does not 
need a solublisation step. This difference of an additional step for solublisation may 
be small, but it can increase the length of time for an assay to be completed, its 
individual cost and accuracy due to increased manipulation of samples. Since MTS 
has been assessed by others to be faster than, simpler than and just as accurate as 
MTT (Berg et al. 1994; Cory et al. 1991), this method was employed for the 
assessment of T. cruzi epimastigote viability in conjunction with Trypan blue 
inclusion/exclusion, motility and morphology. 
 
To date much of the antimicrobial and antiparasitical work involving plants has 
revolved around crude extracts (methanolic, ethanolic or water), with very little work 
regarding PEOs being investigated. In the last 17 years, 199 papers have been 
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published concerning the trypanocidal effects of plants and their extracts (PubMed 
search performed 10th January 2008) but, of these papers, only 5 concerned essential 
oils. 
 
TTO, lemon balm, thyme, peppermint, basil, Strychnos spinosa, yarrow, clove, 
lemongrass and oregano oils have all been investigated for their in vitro trypanocidal 
properties (Chapter 1, Table 1.1; Mikus et al. 2000; Hoet et al. 2006; Santoro et al. 
2007a, 2007b and 2007c). In the experiments of Mikus et al. (2000) lemon balm, 
peppermint, thyme and TTO demonstrated greater toxicity to T. brucei 
trypomastigotes than to human HL-60 cells in vitro. Strychnos spinosa oil has shown 
activity against T. brucei trypomastigotes that was not selective for the parasite 
alone, being toxic to J774 macrophages, but 2 of its constituents, E-nerolidol and 
linalool, were more effective against the parasite than the PEO (Strychnos spinosa 
IC50 = 13.5 µg ml-1; E-nerolidol IC50 = 1.7µg ml-1; E-nerolidol IC50 =2.5 µg ml-1; 
Hoet et al. 2006). These 2 constituents were also found to have a more selective 
activity to the parasite than to the J774 macrophage (SI = 35.7 and > 40 
respectively). Growth inhibition of T. cruzi epimastigotes and trypomastigotes by 
thyme and its constituent thymol has been demonstrated with cytoplasmic swelling 
occurring (Santoro et al. 2007a). In addition the oils of basil, clove, lemon grass, 
oregano and yarrow have also been tested against T. cruzi epimastigotes and 
trypomastigotes and exhibit a range of IC50 from 77 – 145.5 µg ml-1 for 
epimastigotes and 15.5 – 467.5 µg ml-1 for trypomastigotes (Santoro et al. 2007a, 
2007b and 2007c). Here, 12 PEOs were investigated. This increased the total number 
of PEOs evaluated for trypanocidal action in the literature from 10 to 22.  
 
A concentration of epimastigotes was determined for use using the MTS assay. The 
requirements are that there must be sufficient to be detectable by the assay at both 
low and high viability levels. A concentration of 1 x 107 ml-1 epimastigotes added to 
the wells of a 96 well microtitre plate was found to elicit an absorbance level 
(~0.800) which could be readily observed after 24 h incubation, allowing increases 
and decreases in cell numbers to be determined. Also determined was a time and 
temperature dependant increase in absorbance. Increasing the incubation temperature 
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from 25°C to 37°C following addition of MTS allowed for more rapid formazan 
reduction to take place. Incubation at 37°C for the time of assay development (up to 
4 h) had no adverse effects on the epimastigote viability, as assessed by formazan 
reduction, where after 3 h of incubation at 37°C, a level of absorbance was found 
which could be used in experiments. Whilst epimastigote viability was not affected at 
37°C, there is the potential for the transformation of epimastigotes to trypomastigotes 
at this higher temperature. For this reason, an incubation of up to 6 h at 25°C was 
used.  
 
In order to accurately assess the activity or effectiveness of a test sample a reference 
compound is used to compare activities / effects. Both benznidazole (syn. Rochagan® 
and Radanil®) and nifurtimox (syn. Lampit®) are the recognised drugs of choice for 
American trypanosomiasis, with benznidazole regarded as the first choice. However, 
it is difficult to obtain. Production of benznidazole is intermittent, as the production 
and licence of the drug has been transferred from Roche to the government of Brazil. 
Availability is limited due to problems of sourcing the main ingredients for drug 
production. Difficulties in the acquisition of nifurtimox is due to its production being 
suspended by Bayer in 1997 and then restarted on a limited scale for the treatment of 
African trypanosomiasis in 2000 on a ‘demand’ basis, i.e. if there is enough demand 
the company will continue its production (Jannin & Villa 2007). At the time of this 
project, neither drug was unavailable for purchase. 
 
PEOs required to be diluted in a non-aqueous diluent and since, in previous 
experiments using G. duodenalis trophozoites, ethanol had demonstrated no adverse 
effect on trophozoite viability (Chapter 2), this diluent was tested with T. cruzi 
epimastigotes. Ethanol when used at a concentration of 0.06% demonstrated no 
effect on epimastigote viability and so was chosen as the diluent for PEOs in 
experiments. 
 
When used at a final concentration of 0.02%, all PEOs investigated reduced 
epimastigote viability by 100%, causing the rounding up of epimastigotes in vitro 
when compared to untreated epimastigotes. The epimastigote killing was confirmed 
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using the MTS assay, where a lack of colour change in the assay indicates the 
prevention of biochemical reduction of MTS to formazan. This can indicate that the 
function of the single mitochondria present in this organism was inhibited. 
 
Unfortunately, at this point in the project, the parasite stocks became problematic to 
culture in sufficient quantity for all experiments. The MTS assay experiments were 
performed in the latter half of the project after the Trypan blue data had been 
collected and, therefore, much of the TBMM data obtained could not be corroborated 
with the MTS assay. 
 
The greatest observed effect of PEOs was on the morphology of epimastigotes. The 
rounding up of the epimastigotes (Figure 4.5) suggest that the cellular membrane 
remains intact and that perhaps the oils affect the cytoskeleton rather than damaging 
the cell membrane, or perhaps change the osmoregularity of the cell, as this would 
tend to cause swelling of the cell body seen in the G. duodenalis experiments 
(Chapter 2). Also seen was the reduction in area of the epimastigote cell body by up 
to 50% (Table 4.2). Further experiments using SEM or TEM would help in the 
morphological analysis of PEO treated epimastigotes and give insights into the 
mechanism of action of PEOs by defining any morphological alterations. Such 
analysis has been carried out by Santoro et al. (2007a), where trypanosomes treated 
with oregano and thyme oil, demonstrated rounding of the cell body with little 
alteration at the plasma membrane using SEM. TEM studies, however, showed 
cytoplasmic swelling with occasional morphological alteration in the plasma and 
flagellar membrane such as blebbing.  
 
The PEOs investigated had IC50s ranging from 2 – 39 μg ml-1 ([0.0002 – 0.0039%], 
Table 4.3). As reference drugs were unavailable for use in these experiments, other 
investigators found that benznidazole IC50 levels were in the range 2.82 – 16.9 μM 
(0.73 – 4.4 μg ml-1) (Batista et al. 2008; Jimenez-Ortiz et al. 2005; Villarreal et al. 
2004; del Olmo et al. 2001), with concentrations up to ~50 µg ml-1 being quoted with 
T. cruzi epimastigotes in vitro (Sepúlveda-Boza & Cassels 1996). Both myrtle and 
elemi oils exhibited the lowest IC50 data, being 2 and 3 μg ml-1 respectively (Table 
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4.3). These figures are within the quoted range for benzidazole and suggest that these 
PEOs are as potent as the reference drugs. These 2 oils may have further potential as 
a source of novel antitrypanosomal drugs. 
 
There is evidence in the literature to show that the constituents of essential oils exert 
trypanocidal actions. The terpene, terpinen-4-ol, from TTO oil has a high selectivity 
of 1000 (i.e. being 1000 times more selective against the parasite than human HL-60 
cells), which is within the range of commercially available drugs such as Suramin 
(Mikus et al. 2000). Further, terpenic compounds from Strychnos spinosa (E-
nerolidol and linalool) have demonstrated antitrypanosomal activity, inhibiting the 
growth of the bloodstream form of T. brucei in vitro (Hoet et al. 2006). In the 
experiments of Hoet et al. (2006) and Mikus et al. (2000), the terpenic compounds 
were found to have a greater affect than that of the whole oil.  
 
Since myrtle oil was the most effective oil to be tested in this project, an 
investigation into its major constituents was carried out. It was determined that the 
monoterpenes, α-pinene and eucalyptol comprised 51.72% and 22.25% of myrtle oil 
respectively. At concentrations found in 0.02% of the whole oil, α-pinene (0.01%) 
was able to reduce to 0% the number of viable epimastigotes as assessed by TBMM, 
whereas eucalyptol (0.0044%) failed to have any apparent effect on viability (Figure 
4.8). This result indicated that α-pinene was the active constituent in myrtle oil. 
When this constituent was titrated, a concentration dependent increase in viability 
was demonstrated, so at 0.0025% (myrtle oil equivalent concentration of 0.005%) 
there was 100% viability (Figure 4.8). When 0.0011% eucalyptol was used in 
conjunction with a corresponding concentration of α-pinene (0.0025%) to be found 
in 0.005% myrtle oil, an increase in epimastigote killing was demonstrated when 
compared to either eucalyptol or α-pinene alone (eucalyptol 0.0011% = 1.1 ± 0.72%; 
α-pinene 0.0025% = 3.2 ± 3.2%; α-pinene + eucalyptol = 24.6 ± 15.2%; Figure 4.8). 
This was not an additive action, but synergistic.  
 
This demonstrates that while a constituent may be more concentrated than another in 
a PEO, it does not necessarily mean that it is responsible for the efficacy of the PEO. 
 169
With myrtle, 2 constituents working in combination provided greater 
antitrypanosomal activity. However, the remaining constituents of myrtle are found 
in low concentrations, which if used in these experiments would prove very difficult 
to accurately measure. One example of this would be linalool which has previously 
been demonstrated to inhibit trypanosome growth (Hoet et al. 2006) and is found in a 
small quantity (3.67%; Appendix 3) in myrtle oil. Such a concentration of constituent 
would prove very difficult to achieve in the well of a 96 well microtitre plate. 
 
Observation of the experimental microtitre plate wells, using a light microscope, 2 h 
after the addition of PEOs to the parasites suggested the commencement of 
epimastigote killing, with epimastigotes in culture beginning to lose motility, starting 
to condense and become spherical. An experiment was designed and followed to 
quantify this observation. After 2 h of incubation, viable epimastigotes were 
enumerated. When incubated with PEOs at their pre-determined MICs, epimastigotes 
treated with 9 of the 12 PEOs were found reduce viability to 0% (Figure 4.9). Oils of 
lavender, marjoram and myrtle did not kill all the epimastigotes, but rather 99.3 ± 
0.8%, 99.8 ± 0.4% and 99.0 ± 1.1% respectively. The reduction in the activity of the 
oils was slight, found to be insignificant (P > 0.05) for both lavender and marjoram 
oils and only just insignificant for myrtle oil (P = 0.0502).  
 
The rapid action of the PEOs investigated could have some bearing on the potential 
application of any of the PEOs as novel antitrypanosomal drugs. The faster acting a 
PEO can be, the greater the chance it has of limiting infection. As the most common 
route of infection for T. cruzi is through entry of epimastigotes / metacyclic 
trypomastigotes at the mucosal membrane near the eye, nose or mouth, a possible use 
of PEOs are topical application to the surrounding area of a Reduviid bug bite. The 
epimastigotes / metacyclic trypomastigotes are excreted in the urine and faeces of the 
bug as it takes a blood meal from its chosen host. The bite wound is accompanied by 
pruritus (itch), shows similar symptoms of histamine-induced inflammation within 
the wound, causing reddening of the skin, plasma extravasation, the development of 
a weal (tissue oedema) and a flare (wider spread erythema). The action of scratching 
the irritated bite allows the epimastigotes / metacyclic trypomastigotes in the urine 
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and faeces to enter through the skin into the wound. Topical application of oils 
directly to the bite and its surrounding area may help clear the skin of potentially 
infective T. cruzi epimastigotes / metacyclic trypomastigotes and thus reduce the risk 
of infection. Current drugs used to treat Chagas’ disease are only effective during the 
acute phase of infection. The acute phase is usually asymptomatic making effective 
early treatment difficult. Therefore, the prevention of entry to viable epimastigotes / 
metacyclic trypomastigotes may help in the overall treatment and management of T. 
cruzi infection. Most acute cases resolve over a period of 2 to 3 months into an 
asymptomatic chronic stage which at the moment is untreatable, with only the 
management of the clinical manifestations of the disease being possible.  
 
A secondary benefit of some essential oils is that they may actually reduce the 
irritation accompanied with the bite, helping to alleviate the pruritus and thus 
reducing the compulsion to scratch the affected area. Lavender oil has been used as 
an alternative medicine for the treatment of insect bites and burns as it is able to 
reduce pruritus (Tisserand & Balacs 1995). This, however, has no scientific 
corroboration. Although, TTO has been used traditionally for the relief of discomfort 
caused by the symptoms of insect bites and has been scientifically tested. This oil has 
been demonstrated to reduce histamine induced inflammation in human volunteers 
(Koh et al. 2002) and also reduces histamine induced oedema in murine ears (Brand 
et al. 2002). As histamine is released to cause the swelling, redness and itchiness 
associated with insect bites, it is possible that the ability of the oil and its major 
constituent terpinen-4-ol, to reduce histamine induced inflammation may be of 
benefit in controlling the discomfort of insect bites. 
 
Historically, many plant oils and extracts, such as TTO, myrrh and clove, have been 
used as topical antiseptics, or have been reported to have antimicrobial properties 
(Hoffman 1987; Lawless 1995). It is important to investigate scientifically those 
plants which have been used in traditional medicines as potential sources of novel 
antimicrobial compounds (Mitscher et al. 1987). Topical application of essential oils 
should not be problematic as many are currently used in that manner today in the 
practice of aromatherapy. When used on the skin for aromatherapy, oils are usually 
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mixed with inert carrier oils such as almond oil and can be found in concentrations 
varying from 1 – 30% (Tisserand & Balacs 1995). This is obviously far greater than 
the concentrations that have been used in the project experiments.  
 
It is clear that there is potential for further investigation in the antitrypanosomal 
properties of these oils, especially myrtle oil with its low MIC of 0.00125% (12.5 μg 
ml-1), IC90 of 0.0003% (3 μg ml-1) and IC50 of 0.0002% (2 μg ml-1) which is within 
the range of benzidazole (IC50 = 2.82 – 16.9 μM [0.73 – 4.4 μg ml-1]). The very 
properties of PEOs that lend them for use in aromatherapy can be of benefit for any 
future applications as novel treatments for Reduviid bug bites by having a dual 
purpose. That is i) relieving the discomfort of the bite itself and thus preventing entry 
of the parasite into the wound by scratching and ii) killing the epimastigotes on the 
skin before they have a chance to infect the host. 
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 CHAPTER 5 
 
The effect of blueberry extracts on Giardia duodenalis viability and spontaneous 
excystation of Cryptosporidium parvum oocysts, in vitro. 
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5:1 ABSTRACT 
The protozoan parasites G. duodenalis and C. parvum are common causes of 
diarrhoea, worldwide. Effective drug treatment is available for G. duodenalis, but 
with anecdotal evidence of resistance or reduced compliance. There is no effective 
specific chemotherapeutic intervention for Cryptosporidium. Recently, there has 
been renewed interest in the antimicrobial properties of berries and their phenolic 
compounds but little work has been done on their antiparasitic actions. The effect of 
various preparations of blueberry (Vaccinium myrtillus) extract on G. duodenalis 
trophozoites and C. parvum oocysts were investigated. Pressed blueberry extract, a 
polyphenolic-rich blueberry extract and a commercially produced blueberry drink 
(Bouvrage) all demonstrated antigiardial activity. The polyphenol-rich blueberry 
extract reduced trophozoite viability in a dose dependent manner. At 167 µg ml-1, 
this extract performed as well as all dilutions of pressed blueberry extract and the 
Bouvrage beverage (9.6 ± 2.8% live trophozoites remaining after 24 h incubation). 
The lowest dilution of blueberry extract tested (12.5% v/v) contained >167 µg ml-1 of 
polyphenolic compounds suggesting that polyphenols are responsible for the reduced 
survival of G. duodenalis trophozoites. The pressed blueberry extract, Bouvrage 
beverage and the polyphenolic-rich blueberry extract increased the spontaneous 
excystation of C. parvum oocysts at 37ºC, compared to controls, but only at a 
dilution of 50% Bouvrage beverage, equivalent to 213 µg ml-1 gallic acid equivalents 
in the polyphenolic-rich blueberry extract. Above this level, spontaneous excystation 
is decreased. The conclusion is that water soluble extracts of blueberries can kill G. 
duodenalis trophozoites and modify the morphology of G. duodenalis and C. 
parvum. 
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5:2 INTRODUCTION 
The protozoan parasites, Giardia duodenalis (syn. G. lamblia, G. intestinalis) and C. 
parvum are common causes of diarrhoea, worldwide. Effective drug treatment is 
available for G. duodenalis, but with anecdotal evidence of resistance. Oral 
metronidazole is the drug of choice, but side effects such as nausea, headaches and 
an unpalatable strong metallic taste reduce patient compliance. Trophozoites from 
infective cysts infect the duodenum, attaching onto enterocytes through 
hydrodynamic forces and microtubule contraction of their ventral ‘sucking’ disc 
(Kulda & Nohyhová 1995; Holberton 1974; Céu Sousa et al. 2001) and by lectins 
localised on the trophozoite plasma membrane (Céu Sousa et al. 2001; Farthing, 
Pereira and Keusch 1986; Lev et al. 1986; Ward et al. 1987), which are specific for 
D-glucosyl and D-mannose residues (Faubert 2000; Farthing, Pereira and Keusch 
1986). In poorer countries where giardiasis is endemic, chemotherapy may be 
minimally effective due to continual re-infection from the environment (Harris et al. 
2000).  
 
Chemotherapy for cryptosporidiosis is limited, with nitazoxanide being the only drug 
to be recommended for use with immunocompetent patient’s ≥ 1 years of age (US 
FDA 2004). Of the 19 valid Cryptosporidium species and 40 genotypes, 8 species 
and 5 genotypes are known to infect humans, with C. parvum and C. hominis 
accounting for the majority of human infections (Smith 2008; Smith et al. 2007; 
Feltus et al. 2006; Leoni et al. 2006; Nichols, Campbell and Smith 2006; Caccio et 
al. 2005; Ryan et al. 2004; Xiao et al. 2004). Of the Cryptosporidium species, C. 
parvum is the most readily available commercially and has been the most commonly 
used species in scientific investigations. 
 
Ingested, infectious C. parvum oocysts are exposed to body temperature, the acid 
environment of the stomach followed by the alkaline environment of the proximal 
small intestine and trypsin and bile salts. These major host triggers cause the 
sporozoites within intact infectious oocysts to excyst and initiate the infection of 
enterocytes (Smith, Nichols and Grimason 2005). A small percentage (<20% 
depending on oocyst age and isolate) of sporozoites will excyst when incubated at 
 175
37ºC over a 24 h period, in the absence of any of the other major host triggers 
(Smith, Nichols and Grimason 2005). Excystation at elevated (37ºC) temperature in 
the absence of other major host triggers has been named ‘spontaneous excystation’. 
Interventions in the Cryptosporidium life cycle that reduce the ability of sporozoites 
to infect enterocytes can become potentially effective treatments for 
cryptosporidiosis. As sporozoites are the first infective, extracellular stages generated 
in the host, interventions that influence the timing of their release from intact 
oocysts, including excystation in abnormal sites, can be considered potentially 
therapeutic. Possible therapeutic benefits of spontaneous excystation include i) 
release of C. parvum (but not C. muris) sporozoites in the acidic environment of the 
stomach leading to their premature lysis and ii) increased excystation in the intestine, 
leading to a reduction in the excretion of infectious oocysts. 
 
Plants and plant products have been used as traditional remedies for various ailments 
in numerous countries, with little or no side effects (Jones 1996). Blueberries 
(Vaccinium myrtillus, syn. Blaeberries, Whortleberries, Bilberries) have been used to 
treat ‘fluxes’ (florid diarrhoea) historically in the UK. This is demonstrated in the 
following passage: “…sell us whortle berries, or the vaccinia nigra of Virgil,… …the 
astringency lies all in the black skin and not in the pulse. Our soldiers eat them for 
the bloody flux, while encamped at Fort-Angus (Fort Augustus – Ed.)…our men 
were getting flux from loch [Ness] water…” – Anon Physician, 3rd September 1746 
(Anon. 1825). The true causes of such fluxes are poorly understood, but could be due 
to various enteropathogens (Haydock 2002; Cox 2002) including Giardia and 
Cryptosporidium.  
 
Other evidence for the treatment of fluxes using blueberries comes from the study of 
archaeological material at microscopic level. An archaeobotanical / archaeomedical 
project investigating the contents of a sealed hospital drain dating from the early 14th 
century AD (Soutra) in Scotland, UK discovered Giardia cysts in human coprolites 
in the presence of blueberries. Also identified were Ascaris and Trichuris ova in the 
presence of common tormentil (Potentilla erecta) and wild strawberry (Fragaria 
vesca) (Personal Communications, Dr. Brian Moffat, Director of the Soutra Hospital 
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Archaeoethnopharmacological Research Project [SHARP], Edinburgh, 2006). The 
Augustinian canons at that hospital and other sites used these plants as remedies for 
helminthic infections and blueberries, in particular, for diarrhoea (Webber & Watson 
1998). 
 
The antimicrobial properties of plant products have been recognised for numerous 
years and recently there has been renewed interest in berries and their phenolic 
compounds such as anthocyanins and ellagitannins (Nohynek et al. 2006; 
Puupponen-Pimiä et al. 2005a & 2005b). Polyphenol-rich berry extracts inhibit the 
growth of enteropathogenic bacteria such as Salmonella, Escherichia, 
Staphylococcus, Helicobacter, Bacillus, Clostridium and Campylobacter species and 
blueberry polyphenolics are bacteriostatic for three Staphylococcus aureus strains 
(Puupponen-Pimiä et al. 2005b). The predominant polyphenolic compounds found in 
blueberries are the flavonoids, especially the anthocyanins (i.e. anthocyanidin 
glycosides), which are responsible for the deep red or blue colouring of many berries 
(Häkkinen et al. 1999). 
 
Inactivation and short-term immobilisation of viable bacteria or protozoan parasites 
by berry extracts might be exploited to inhibit their adhesion to and their colonisation 
of, human enterocytes. Proanthocyanidins found in cranberry juice (Vaccinium 
macrocarpon and in other Vaccinium species such as blueberry) have potent bacterial 
anti-adhesion activity (Puupponen-Pimiä et al. 2005b; Howell 2002).  
 
Plant products also possess anti-protozoan effects, but little is known. Garlic extract 
inhibits G. duodenalis trophozoite growth in vitro, primarily due to the 
transformation product (diallyl trisulphide) of its major constituent (allicin) (Lun et 
al. 1994). Treatment of humans with garlic extract can reduce clinical signs and 
symptoms more rapidly than metronidazole, the drug of choice (Soffar & Mokhtar 
1991). Whole garlic extract co-cultured with trophozoites causes internalisation of 
flagella and ventral disc fragmentation (Harris et al. 2000; Anthony, Fyfe and Smith 
2005). Thyme oil can also be as effective as metronidazole in killing G. duodenalis 
cysts (Sahebani, Farsangi and Movahed 2004). Only 2 plant extracts have been tested 
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against Cryptosporidium with any success. Garlic extract caused a mild (22.4%) 
reduction in oocyst output in C. baileyi infected chickens and its effect was 
comparable to 2 commercially available derivatives of an anticoccidial drug 
(triazinone) (Sreter, Szell and Varga 1999). An extract of pine bark significantly 
reduced oocyst shedding in C. parvum infected, immunosuppressed C57BL/6N mice. 
However, it failed to decrease parasite colonisation of the intestine (Kim & Healey 
2001). 
 
There are no published scientific data available on the anti-protozoan effects of 
berries and their polyphenolic compounds, despite their proven anti-bacterial effects. 
Here, we investigate a pressed extract of blueberries, a commercial drink made from 
the extract and a polyphenolic-rich extract for their ability to influence i) Giardia 
duodenalis trophozoite viability over time, in vitro and ii) the percentage 
spontaneous excystation of C. parvum oocysts.  
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5:3 MATERIALS AND METHODS 
5:3.1 Source of parasites 
Source of G. duodenalis trophozoites 
Trophozoites of the BVM strain of G. duodenalis were maintained axenically in flat 
sided 110 mm x 16 mm culture tubes at 37ºC, in a modified TYI-S-33 medium 
(Keister 1983) supplemented with 10% (v/v) heat-inactivated foetal bovine serum. 
Sub-culturing was performed routinely at 72 - 96 h intervals as described in Chapter 
2. 
 
Source of oocysts 
Purified C. parvum oocysts, passaged in calves, were purchased from Bunch Grass 
Farm (BGF; Lots 06-4 and 06-30), Idaho, USA and were stored in sterile distilled 
water containing 100µg of Streptomycin ml-1 and 100U Penicillin ml-1 at 5ºC until 
used. Oocysts were <3 months old when used. 
 
5:3.2 Experimental treatments of parasites 
Pressed blueberry extract and beverage preparation  
The extract from pressed Finnish Blueberries (FB) is used to produce the commercial 
beverage (Bouvrage Blaeberry; BB). BB contains 25% FB. Both were kindly 
supplied by Ella Drinks Ltd., Scotland, UK. For the G. duodenalis experiments, FB 
and BB were diluted in TYI-S-33 and adjusted to pH 7 with 0.1M NaOH, then 
passed through a sterile 0.22 µm filter (Sartorius, Germany). For the 
Cryptosporidium experiments, FB and BB were diluted in Hanks’ balanced salt 
solution (HBSS; Gibco, UK) and adjusted to pH 7 with 0.1M NaOH. 
 
Preparation and analysis of polyphenol and anthocyanin contents of 
blueberry polyphenolic-rich extract  
Polyphenolic-rich extracts of Scottish-grown blueberries (PRBE) (Vaccinium 
myrtillus, variety Berkley) were purified by solid phase extraction using the method 
of Ross, McDougall and Stewart (2007). The polyphenolic and anthocyanin contents 
of PRBE, FB and BB were determined using a modified Folin-Ciocalteu method and 
by differential colorimetric methods (Ross, McDougall and Stewart 2007). The 
 179
polyphenol content of PRBE was 920 ± 15 µg gallic acid equivalents (GAE) ml-1 and 
the anthocyanin content was measured at 780 µg cyanidin-3-glucoside equivalents 
(CGE) ml-1. Aliquots of the polyphenolic-rich extract, containing 200 µg phenol 
content as GAE, were dried using a speed-vac centrifugal evaporator. This was 
carried out by staff at the Scottish Crop Research Institute (SCRI, Invergowrie, UK). 
Dried aliquots were reconstituted in TYI-S-33 at a concentration of 2 mg ml-1 then 
passed through a sterile 0.22 µm filter (Sartorius) for the G. duodenalis experiments 
or in HBSS to make 200 µg ml-1 stock solutions for the C. parvum experiments. 
 
 Incubation of G. duodenalis trophozoites with FB, BB and PRBE 
After 72 h of culture, trophozoites were harvested by chilling culture vessels in iced 
water for 20 min. Experiments were preformed in sterile, 96 well microtitre plates 
covered with plate sealer film and lids. To 100 µl of trophozoite culture (~2.7 x 104 
trophozoites) was added 200µl of FB diluted in TYI-S-33, to give a final 
concentration of 50%, 25% or 12.5% v/v in 300 µl. Similarly, 200 µl of BB, diluted 
in TYI-S-33, to give a final concentration of 50% v/v in 300 µl was added to 100 µl 
of trophozoite culture (~2.7 x 104 trophozoites). The microtitre plates were sealed 
and incubated for 24 h at 37ºC, after which the trophozoites were enumerated. Final 
concentrations of 167, 133, 67 and 33 µg ml-1 of PRBE (diluted from a 2 mg ml-1 
stock into a final volume of 100µl of 2.7 x 105 trophozoites ml-1 and 200 µl TYI-S-
33) were used.  
 
The positive control consisted of 2.7 x 104 trophozoites in 300 µl TYI-S-33 
containing 67 µg ml-1 metronidazole (determined by titration as described in Chapter 
2) and the negative controls consisted of 2.7 x 104 trophozoites in 300 µl TYI-S-33 in 
the absence of blueberries or metronidazole. All samples were prepared in triplicate.  
 
 Incubation of C. parvum oocysts with FB, BB and PRBE 
To each 1.5 ml microcentrifuge tube, 100 µl of a 2 x 107 ml-1 stock suspension of C. 
parvum oocysts were added to give a final concentration of 2 x 106 ml-1 oocysts 
suspended in either FB (50% v/v), BB (50% v/v) or PRBE (213 µg and 860 µg ml-1 
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GAE, equivalent to 50% BB and 50% FB, respectively) diluted in HBSS. Samples 
were vortexing then incubated for 24 h at 37ºC. 
 
5:3.3 Parasite enumeration and analysis 
G. duodenalis cell count assay 
Trophozoite enumeration was performed using an improved Neubauer 
haemocytometer and trophozoite viability determined by Trypan blue inclusion / 
exclusion, motility and morphology (TBMM) as previously described in Chapter 2 
 
 Oocyst analysis 
Following incubation, each sample was washed in HBSS, centrifuged (12,500 x g for 
30 sec), the supernatant aspirated to waste and the pellet resuspended in HBSS. This 
was repeated three times and the percentage excystation (as an estimate of 
spontaneous excystation) was performed as previously described in Chapter 3. The 
control consisted of 100 µl of C. parvum oocyst stock suspension mixed with 900 µl 
HBSS and incubated for 24 h at 37ºC in the absence of blueberry extract. 
 
 Statistical analysis 
Results are the means of triplicate counts performed on 2 separate experiments. A 
Student’s 2-tailed, unpaired, t-test was used to determine significance with a P value 
of less than or equal to 0.05 being regarded as significant. Data and statistical 
analysis was performed using Microsoft Excel® software. 
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5:4 RESULTS 
Polyphenolic content of FP, BB and PRBE 
The polyphenolic content of FP, BB and PRBE are presented in Table 5.1. All FB 
and BB samples contained greater than the GAE content of the most effective 
concentration (167 µg ml-1) of PRBE in the G. duodenalis trophozoite viability 
experiments. 
 
Table 5.1 Composition of FB and BB. 
 
Key. 
BB = Bouvrage beverage 
FB = pressed Finnish blueberries  
 
The polyphenol and anthocyanin contents of the polyphenol-rich blueberry extract 
(PRBE), the pressed Finnish blueberries (FB) and Bouvrage beverage (BB) were 
expressed as a gallic acid equivalents (GAE) and cyanidin glucoside equivalents 
(CGE) respectively. 
 
Survival of G. duodenalis trophozoites in FB, BB and PRBE 
Viable (motile and sessile) trophozoites excluded Trypan blue. Motile trophozoites 
exhibited forward movement during which they rotated around their longitudinal axis 
displaying both a tumbling movement resembling that of a falling leaf and an up and 
down movement known as ‘skipping’. Sessile (viable) trophozoites excluded Trypan 
blue and retained their typical pyriform shape and internal morphology (Figure 5.1 
A, panels A1 - A3). Dead trophozoites included Trypan blue and often their typical 
pyriform shape became either slightly misshapen or rounded and swollen (Figure 5.1 
A, panels A4 - A9). Also found was evidence of blebbing of the trophozoite surface 
membrane (Figures 5.1 A, panels A4 and A7) and flagellar truncation (Figure 5.1 A, 
panel A7).  
 BB 
(100%) 
BB 
(50%) 
FB 
(100%) 
FB 
(50%) 
FB 
(25%) 
FB 
(12.5%) 
Polyphenol 
Content 
(µg GAE ml-1) 
426 ± 12 213 1720 ± 13 860 430 215 
Anthocyanin 
content 
(µg CGE ml-1) 
254 ± 9 127 1239 ± 19 619 309 155 
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Incubation of trophozoites in the presence of FB significantly reduced their viability 
over the 24 h period studied (P ≤ 0.01) compared to untreated trophozoites (Figure 
5.2). BB had the greatest effect on trophozoite survival with only 6.5 ± 1.8% 
trophozoites remaining viable after 24 h. As the concentration of FB used in BB is 
25%, then 50% v/v BB is equivalent to 12.5% v/v FB. All concentrations of FB 
significantly reduced trophozoite viability (50% = 8.4 ± 2.9%; 25% = 10.5 ± 3.7%; 
12.5% = 10.8 ± 3.8%) but not in a dose dependent manner. Interestingly, 50% BB 
was significantly more effective (P = 0.037) than 25% and 12.5% v/v FB. 
 
Trophozoite survival was also inhibited by PRBE, but in a dose dependent manner 
(Figure 5.3). At a dose of 167 µg ml-1, PRBE was as effective as any dilution of FB 
tested (167 µg ml-1= 9.6 ± 2.8%; 50% v/v FB = 8.4 ± 2.9%; 25% = 10.5 ± 3.7%; 
12.5% = 10.8 ± 3.8%; no significant difference between treatments).  
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Figure 5.1 A Viable and dead G. duodenalis trophozoites exposed to extracts of 
blueberry.  
Figure 5.1 B C. parvum spontaneous excystation 
Pictures were taken using a ColorView Soft Imaging System MTV-3 camera and 
analySIS® software. Trophozoites were incubated for 24 h in the presence or absence of 
FB, BB or PRBE and viable trophozoites were viewed under bright field microscopy (x1250 
total magnification). Viable G. duodenalis trophozoites are shown in division (panel A1); in 
ventral view, showing typical pyriform appearance and ventral sucking disc (sd) (panel A2); 
in dorsal view, exhibiting flagella (fl) and the 2 characteristic nuclei (nu) (panel A3). Dead 
trophozoites included Trypan blue and often retained their pyriform shape. Some were 
slightly misshapen (panels A4 -7) or swollen (panels A8 and A9). In some trophozoites, 
blebbing (bl) was evident (panels A4 and A7) and flagella appeared truncated (tr) (panel 
A7). All treatments caused changes in trophozoite morphology and panels A4 – 9 show 
typical examples of these changes.  
 
Viable C. parvum oocysts as seen under Nomarski DIC optics (x1250 total magnification) 
(panels B1 - 3). Three sporozoites (sp) can be seen in panel B1. The unexcysted oocysts in 
panels B2 and B3 show internalised sporozoites (sp). Sporozoites exit through the suture 
(su) in the oocyst wall (panels B4, B5 and B6). Panels B4 and B5 show partially excysted 
oocysts. Panels B7, B8 and B9 show empty oocysts retaining the residual body (rb) and 
suture (su). 
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Figure 5.2 Effect of blueberry juice on G. duodenalis trophozoite survival in vitro. 
Trophozoites were incubated for 24 h in the presence or absence of pressed blueberry 
juice (FB) or the commercially available Bouvrage Blaeberry (BB). Metronidazole 
(67 µg ml-1) was used as positive control. Both FB and BB significantly reduced the 
survival of G. duodenalis trophozoites when compared to untreated trophozoites (P ≤ 
0.01). 
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Figure 5.3 Effect of blueberry juice phenolics extract on G. duodenalis trophozoite 
survival in vitro. 
Trophozoites were incubated for 24 h in the presence or absence of phenolic extract 
of blueberries (PRBE). Metronidazole (67 µg ml-1) was used as positive control. All 
concentrations of PRBE significantly reduced the survival of G. duodenalis 
trophozoites when compared to untreated trophozoites (P ≤ 0.01) but there was no 
significant difference between the treatments.  
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Effect of FB, BB and PRBE on the spontaneous excystation of C. parvum oocysts 
Typical images of totally excysted (empty), partially excysted and intact oocysts are 
shown in Figure 5.1 B (panels B1 – B9). Spontaneous excystation, whereby 
sporozoites within intact oocysts excyst without the classical triggers of acidification 
and bile, requiring only an increase in temperature and time, was increased in the 
presence of FB or BB, compared to controls. When C. parvum oocysts were 
incubated for 24 h in the presence of 50% v/v FB or BB, a significant increase (P ≤ 
0.01) in spontaneous excystation was observed, compared to untreated oocysts 
(Figure 5.4). Incubation in 50% v/v BB produced the greatest level of spontaneous 
excystation compared to untreated oocysts (40.5 ± 2.4% vs. 20 ± 4.3%, P ≤ 0.01) 
which was significantly greater (P ≤ 0.01) than the effect exerted by 50% v/v FB 
(40.5 ± 2.4% vs. 31.3 ± 1.1%).  
 
PRBE at 213 µg and 860 µg ml-1 (Figure 5.5) significantly increased spontaneous 
excystation compared to untreated oocysts (213 µg ml-1 = 23.8 ± 3.2%; 860 µg ml-1 = 
18.0 ± 2.4% vs. 10.7 ± 1.9%). As before, incubation in 213 µg ml-1 PRBE (50% v/v 
BB equivalent) produced the greatest level in spontaneous excystation compared to 
untreated oocysts (23.8 ± 3.2% vs. 10.7 ± 1.9%, P ≤ 0.01) which was significantly 
greater (P ≤ 0.05) than the effect exerted by 860 µg ml-1 PRBE (50% v/v FB 
equivalent) (23.8 ± 3.2% vs. 18.0 ± 2.4%). 
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Figure 5.4 Effect of FB and BB on the spontaneous excystation of C. parvum oocysts. 
Oocysts were incubated for 24 h in the presence or absence of pressed blueberry 
juice (FB) or commercially available Bouvrage Blaeberry (BB) both at 50% 
concentration (v/v). The results are the means of three counts ± SEs. Both FB and 
BB significantly increased C. parvum oocyst spontaneous excystation when 
compared to untreated oocysts (P ≤ 0.01) with BB performing significantly better 
than FB (P ≤ 0.01). 
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Figure 5.5 Effect of PRBE on the spontaneous excystation of C. parvum oocysts. 
Oocysts were incubated for 24 h in the presence or absence of a polyphenolic rich 
blueberry extract (PRBE). The results are the means of three counts ± SEs. Both 
concentrations of PRBE significantly increased C. parvum oocyst spontaneous 
excystation compared to untreated oocysts (P ≤ 0.01) with 213 µg ml-1 performing 
significantly better than 860 µg ml-1 (P ≤ 0.05). 
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5:5 DISCUSSION 
Here it is shown that extracts of blueberries influence the cell biology of G. 
duodenalis and C. parvum over time. Light microscopy was used to identify 
morphological changes in these parasites. Incubation of G. duodenalis trophozoites 
in extracts of blueberries caused their distortion, swelling, blebbing, flagellar 
truncation and increased killing, while these extracts increased the rate of 
spontaneous excystation of C. parvum oocysts. As the extracted juice of blueberries 
is acidic, the pH of FB, BB and the diluents used (TYI-S-33 and HBSS) were 
adjusted to pH 7 before addition to the parasites to ensure that any effect observed 
was not due to an acidic environment. Incubation of G. duodenalis trophozoites with 
FB significantly reduced their viability over the 24 h period studied. The commercial 
beverage (BB) was most effective in killing G. duodenalis trophozoites, with only 
6.5 ± 1.8% of trophozoites remaining viable after 24 h. Incubation in 50% v/v FB 
produced similar results (8.4 ± 2.9% trophozoite viability).  
 
There was no significant increase in trophozoite killing between 50%, 25% or 12.5% 
v/v FB and maximal inhibition occurred at the lowest concentration used. 
Interestingly, 50% BB (which contains the equivalent of 12.5% v/v FB) was 
significantly more effective (P = 0.037) than 25% and 12.5% v/v FB in killing 
trophozoites. This is probably because other constituents in BB (such as 5% raw cane 
sugar) potentiate the effect of FB. PRBE reduced trophozoite viability in a dose 
dependent manner. At 167 µg ml-1, PRBE was as effective as all dilutions of FB and 
BB tested. 
 
Given that 167 µg ml-1 of polyphenols killed 90.4 ± 2.8% of G. duodenalis 
trophozoites and that the lowest dilution of FB (12.5% v/v) contained at least 215 µg 
of polyphenolic compounds (Table 5.1), the lack of a FB dose-response can be 
explained by them containing polyphenols at a concentration in excess of the 
minimum required to kill ~90% of trophozoites. As PRBE was prepared by solid 
phase extraction, it lacks organic acids and sugars found in the pressed blueberry 
extract. This suggests that the polyphenols are responsible for killing trophozoites. 
Considering that anthocyanins contribute > 70 % of the polyphenol content of FB 
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and > 80 % of the polyphenol content of PRBE, these compounds are strong 
candidates to be the active ingredients. 
 
Metronidazole is the drug of choice for giardiasis and, for adults, a standard 
treatment (up to 2 g daily for between 3 and 7 days) delivers a peak plasma 
concentration of 40 µg ml-1 within 3 h (McEvoy 1995). Ileal and colonic 
concentrations reach between 70 – 80% of the dose (Houghton et al. 1979). In vitro, 
the IC90 for metronidazole was calculated as 21.8 µg ml-1 (Chapter 2, Table 2.3), 
with an MIC of 67 µg ml-1. The anthocyanin content (µg CGE ml-1) of BB and PRBE 
that killed ~90% of trophozoites were similar (50% BB = 127µg ml-1, PRBE = 142 
µg ml-1; Figures 5.3 and 5.4), equating, in terms of trophozoite death, to 21.8 µg ml-1 
metronidazole. As no significant increase in trophozoite killing was observed 
between 50%, 25% or 12.5% v/v FB (Figure 5.2) and if we adopt the lowest 
concentration responsible for killing ~90% of trophozoites (12.5% FB = 155µg ml-1 
CGE) rather than the highest (50% FB = 619µg ml-1 CGE), then the anthocyanin 
levels responsible for killing ~90% of trophozoites are similar (50% BB = 127µg ml-
1, 12.5% FB = 155µg ml-1, PRBE = 142 µg ml-1). Unlike metronidazole which has a 
half-life of approximately 8 h in humans, with 60 – 80% of the drug and its 
metabolites excreted in the urine and only 6 – 15% excreted in faeces, anthocyanins 
are retained in the gut longer with almost 85% being excreted in faeces. This should 
increase the exposure of G. duodenalis trophozoites, either attached onto enterocytes 
or in the lumen, to anthocyanins ingested in aqueous extracts of blueberries. The 
manufacturer of Bouvrage uses the pressed juice of 80 g of Finnish blueberries in 
250 ml of their beverage, therefore the in vitro effects that we describe can be found 
in 40 g of blueberries. 
 
Both FB and BB caused spontaneous excystation of C. parvum oocysts at 37ºC, 
significantly above untreated control levels (31.3 ± 1.1% for 50% v/v FB and 40.5 ± 
2.4% for BB vs. 20 ± 4.3% for control oocysts) over the 24 h time period. In 
addition, both concentrations of PRBE tested (213 and 860 µg ml-1) also caused 
significant increase in spontaneous excystation compared to control oocysts. 50% BB 
and 213 µg ml-1 PRBE have the same GAE content and caused the highest levels of 
 189
spontaneous excystation observed (Figures 5.5 and 5.6). Similarly, 50% FB and 860 
µg ml-1 PRBE have the same GAE content, but the level of spontaneous excystation 
observed with these was lower than that observed with 50% BB and 213 µg ml-1 
PRBE (Figures 5.5 and 5.6). In our experiments, this is suggestive that there is a 
level of polyphenolics which maximise spontaneous excystation in C. parvum 
oocysts (50% BB and 213 µg ml-1 PRBE) above which (50% FB and 860 µg ml-1 
PRBE) spontaneous excystation is decreased. Experiments to investigate this 
phenomenon further should be performed as should others to generate dose response 
data for this phenomenon.  
 
As FB, BB and PRBE increase spontaneous excystation significantly, they could be 
considered for use as oral supplements to reduce the excretion of infectious oocysts 
in human and non-human cases of C. parvum cryptosporidiosis.  
 
Blueberries are rich in polyphenolic compounds such as the flavonoids, of which the 
anthocyanins (anthocyanidin glycosides) are the predominant group. Anthocyanins 
can make up >80 % of the total polyphenolic content of blueberry and can reach 
concentrations of 2 – 5 g kg-1 fresh weight, in this fruit (Puupponen-Pimiä et al. 
2005b). Anthocyanins have antibacterial properties with bacteriostatic effects due to 
their anti-adhesion properties in Escherichia coli (Puupponen-Pimiä et al. 2005b). 
Anthocyanins from cranberry (Vaccinium macrocarpon) juice possess anti-adhesion 
properties as demonstrated by inhibition of E. coli adherence to uroepithelium and 
multiplication in vitro (Ofek et al. 1991; Foo et al 2000; Reid et al. 2001). Whole 
cranberry juice inhibited adhesion of E. coli by type 1 fimbriae (mannose specific) in 
the yeast aggregation assay, to Chinese hamster ovary cells and murine adrenal cells 
in vitro. Cranberry juice also inhibited adhesion and agglutination of P fimbriated E. 
coli, a α-Gal(1→4)β-Gal specific lectin (Zafriri et al. 1989). 
 
Blueberry anthocyanins may also reduce G. duodenalis trophozoite and C. parvum 
sporozoite attachment to enterocytes in a similar lectin-specific manner. Selective 
colonisation of enterocytes of the proximal small intestine may be mediated by 
lectins localised on the trophozoite plasma membrane (Céu Sousa et al. 2001; 
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Farthing, Pereira and Keusch 1986; Lev et al. 1986; Ward et al. 1987), which are 
specific for D-glucosyl and D-mannose residues (Faubert 2000; Farthing, Pereira and 
Keusch 1986). A role for C. parvum sporozoite D-galactose/N-acetyl-D-
galactosamine (Gal/GalNAc) surface lectin in adherence to intestinal mucin has been 
suggested (Smith, Nichols and Grimason 2005). Adherence to a substrate is a key 
event for intestinal pathogens, as it enables an organism to maintain its station 
against the flow of food. For Entamoeba histolytica trophozoite adherence, 
attachment to colonic mucus is a key event, facilitated through interaction between 
trophozoite-derived Gal/GalNAc surface lectin and host glycoconjugates (Huston 
2004).  
 
Interference with lectin mediated host-parasite attachment, reducing the ability of 
protozoan enteropathogens to attach onto enterocytes and increasing the likelihood of 
them being flushed through the gut, could be a further mode of action of FB, BB and 
PRBE. Blueberry anthocyanins consist of five anthocyanidin aglycones linked to 
glucosyl, galactosyl and arabinosyl sugar (Macheix, Fleuriet and Billot 1990) and 
further work should focus on the specific constituents which interfere with the life 
cycle phenomena (trophozoite viability, lectin mediated enterocyte attachment) 
described here.  
 
Blueberries may be potentially useful for treating giardiasis. Anthocyanins are the 
major polyphenol constituent of blueberries and appear to be prime candidates for 
the anti-giardial effects we report. Although anthocyanins have low serum 
bioavailability in humans, they have considerable longevity in the gastrointestinal 
tract and are known to reach the colon largely undegraded (up to 85% of the initial 
dose) either following their consumption (Kahle et al. 2006) or following in vitro 
simulation of human digestion (McDougall et al. 2005).  
 
This study has shown that water soluble extracts of blueberries can kill G. duodenalis 
trophozoites in vitro and that this phenomenon is most likely due to polyphenolic 
compounds. Furthermore, water soluble extracts of blueberries increase the 
spontaneous excystation of C. parvum oocysts, but the data indicate that when a 
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certain concentration is exceeded (>213 µg ml-1GAE), spontaneous excystation 
decreases. It is suggested that there are 2 possible modes of action for the effects of 
water soluble extracts of blueberries on enteropathogenic protozoa, namely, i) 
modification of parasite morphology and life cycle and ii) reduction / inhibition of 
lectin-mediated attachment to enterocytes. Thus, the historical use of blueberries as 
an antidiarrhoeal treatment may have further basis in fact. 
 
This chapter was based upon data successfully published in the Journal of Methods 
in Phytochemistry and Natural Products (reproduced with permission): 
Anthony, J.P., Fyfe, L., Stewart, D., McDougall, G. and Smith, H. (2007). The effect 
of blueberry extracts on Giardia duodenalis viability and spontaneous excystation of 
Cryptosporidium parvum oocysts in vitro. Journal of Methods in Phytochemistry and 
Natural Products. Vol 42. Issue 4, pp. 399-348. 
Blueberry PRBE extract was prepared by Drs. G. McDougall and D. Stewart of the 
SCRI. Anthocyanin and polyphenol content analysis was also carried out at that 
establishment.  
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CHAPTER 6 
 
The effect of polyphenol-rich fruit extracts on Giardia duodenalis viability. 
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6:1 ABSTRACT 
Current conventional treatment for G. duodenalis infection of humans appears to be 
effective, albeit with anecdotal evidence of drug resistance occurring and reduced 
patient compliances due to side effects. Alternatives to metronidazole are being 
sought and various polyphenol-rich fruit extracts (PRFEs) covering 11 fruits and 5 
different families were investigated for antigiardial activity. Extracts from 
strawberry, blackberry, cloudberry and artic bramble from the Family Rosaceae were 
able to reduce trophozoite viability by 100%. Of these 4 PRFEs, cloudberry was 
found to have the greatest antigiardial activity being able to reduce viability at 
concentrations comparable to the reference drug metronidazole (67 µg ml-1). This 
activity was not thought to be due to the biodegradation of ellagitannins (found in 
high quantities within the Rosaceae family) to ellagic acid. The use of cloudberries 
as a treatment for giardiasis warrants further examination. 
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6:2 INTRODUCTION 
It has been estimated that ~280 million people are at risk from giardiasis worldwide 
(Lane & Lloyd 2002; Olson, Ceri and Morck 2000). This flagellated protozoan can 
infect a wide range of mammals with 25 – 100 cysts causing infection in humans 
(Rendtorff 1954; Smith et al. 2007). It is one of the most common waterborne causes 
of parasite infection world wide (Karanis, Kourenti and Smith 2007). After ingestion 
the cyst is triggered to excyst following exposure to gastric acids and the alkalinity of 
the small intestine, the trophozoite excysts from the cyst. The trophozoites colonize 
the proximal surface of the small intestine and rapidly reproduce by binary fission. 
Most infections (60%) are asymptomatic with cysts being passed in the faeces of the 
host to continue the infectious cycle (Ortega & Adam 1997). In other cases, 
symptomatic infections will present 1 – 2 weeks after cyst ingestion. During the 
acute phase of symptomatic infection there is a sudden onset of explosive, watery, 
foul smelling diarrhoea, associated with abdominal distension and an increase in foul 
flatulence that may last for up to 6 weeks. However, in the immunocompromised and 
in some immunocompetent hosts, the acute symptoms may last for several months, 
causing weight loss, malabsorption and steatorrhoea. 
 
Conventional chemotherapy for G. duodenalis infection involves the use of the 5-
nitroimidazoles, metronidazole and tinidazole. Drug resistance has been shown in the 
laboratory and there is anecdotal evidence of drug resistance in vivo (Upcroft & 
Upcroft 1993). Oral metronidazole, however, is still the drug of choice, but side 
effects such as nausea, headaches and an unpalatable strong metallic taste reduce 
patient compliance.  
 
The plant world can be a source for novel chemotherapeutics with 25% of 
prescription drugs currently derived from plants (Editorial 1994). Polyphenols from 
plants have previously been examined for their antiparasitical activity and their 
antimicrobial with some success (Anthony et al. 2007; Kolodziej, Radtke and 
Kiderlen 2007; Kolodziej & Kiderlen 2006; Mendonca-Filho et al. 2004; Radtke et 
al. 2003; Kolodziej et al. 2001a & 2001b; Puupponen-Pimiä et al. 2005b; Sotohy, 
Müller and Ismail 1995).  
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Flavonoids and phenolic acids form the building blocks for polymeric tannins, which 
can be classified into hydrolysable and condensed tannins. Hydrolysable tannins are 
glucose esters of gallic and ellagic acids with condensed tannins having a flavonoid 
core as a basic structure.   Fruits, especially of the Family Rosaceae, 
Genus Rubus, are rich in hydrolysable tannins called ellagitannins (Puupponen-Pimiä 
et al. 2005a). These ellagitannins have demonstrated wide ranging antibacterial 
effects against both gram-negative and gram-postive organisms (Rauha et al. 2000) 
with gallic acids causing the permeabilisation of the Salmonella outer membrane, but 
not anthocyanins (Nohynek et al. 2006). Other mechanisms of action include the 
interference of bacterial adhesion through the interference of lectin binding and 
mannose specific adhesion of E. coli bacteria by anthocyanins (Foo et al. 2000; Reid 
et al. 2001; Ofek et al. 1991; Zafriri et al. 1989). 
 
As attachment to enterocytes is a key event in giardiasis, allowing the trophozoites to 
maintain position within the small intestine, any interference with attachment could 
lead to premature transit to the colon and their death. Attachment by Giardia is 
mediated through hydrodynamic forces of the ventral disc and lectin binding to D-
glucosyl and D-mannose residues (Céu Sousa et al. 2001; Faubert 2000; Farthing, 
Pereira and Keusch 1986; Lev et al. 1986; Ward et al. 1987).  
 
As the results of Chapter 5 demonstrated that the polyphenol-rich extract of a fruit 
(blueberry) has antigiardial activity, possibly through anthocyanin activity, other fruit 
extracts were examined for giardiacidal properties. PRFEs of 11 fruits from 5 
different Families, gifted by the SCRI were investigated for their ability to influence 
G. duodenalis trophozoite viability over time, in vitro. 
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6:3 MATERIALS AND METHODS 
6:3.1 Parasite culture  
Source of G. duodenalis trophozoites 
Trophozoites of the BVM strain of G. duodenalis were maintained axenically in flat 
sided 110 mm x 16 mm culture tubes at 37ºC, in a modified TYI-S-33 medium 
(Appendix 4) supplemented with 10% (v/v) heat-inactivated foetal bovine serum. 
Sub-culturing was performed routinely at 72 – 96 h intervals as described in Chapter 
2. 
 
Preparation and analysis of polyphenol contents of PRFEs  
PRFEs of 11 different soft fruits (Table 6.1) were purified by solid phase extraction 
using the method of Ross, McDougall and Stewart (2007) at SCRI. The polyphenolic 
and anthocyanin contents of PRFEs were determined as described in Chapter 5. 
Dried aliquots were reconstituted in 1 ml TYI-S-33 at a concentration of 2 mg ml-1 
then passed through a sterile 0.22 µm filter (Sartorius). 
 
Table 6.1 Soft fruits used to create polyphenol-rich extracts. 
FAMILY BOTANICAL NAME VULGAR NAME 
Elaeagnaceae Hippophae rhamnoides Sea Buckthorn 
Ericaceae Vaccinium myrtillus 
Vaccinium vitis-idaea L. 
Blueberry/Bilberry 
Lignonberry/Cowberry 
Grossulariaceae Ribes nigrum Blackcurrant 
Punicaceae Punica granatum L. Pomegranate 
Rosaceae Fragaria vesca 
Rubus arcticus 
Rubus chamaemorus 
Rubus fruticosus  
Rubus idaeus 
Sorbus aucuparia 
Strawberry 
Artic Bramble 
Cloudberry 
Blackberry  
Raspberry  
Rowan 
 
 
 Preparation of ellagic acid 
Following the titration selected of PRFEs, a metabolite of ellagitannin which is 
known to exist in high quantities in the Rosaceae Family of plants, was investigated 
for its antigiardial activity. This compound (ellagic acid) was found to be highly 
insoluble in water and required to be diluted in absolute ethanol and water (50% v/v) 
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before any dilutions in TYI-S-33 could be made at a stock concentration of 2 mg ml-
1. This was further diluted in TYI-S-33 medium to a concentration of 1 mg ml-1 to 
reduce the volume of ethanol in the microtitre plate wells in the presence of Giardia 
trophozoites. The highest final concentration of ethanol in the well corresponding to 
133.4 µg ml-1 ellagic acid was calculated to be 13%. Because of this, an ethanol 
control was included. Dilutions of ellagic acid started at 133.4 µg ml-1, which 
corresponded to one dilution above the MIC of cloudberry extract and titrated to 33 
µg ml-1. Ethanol concentrations corresponding to that found in ellagic acid solution 
(13, 6.5 and 3.25%) were also incubated with Giardia trophozoites. 
 
6:3.2 Experimental treatments of parasites  
 Incubation of G. duodenalis trophozoites with PRFE 
After 72 h of culture, trophozoites were harvested by chilling culture vessels in iced 
water for 20 min. Experiments were preformed in sterile, 96 well microtitre plates 
covered with plate sealer film and lids. Final concentrations of 333.5 µg ml-1 of 
PRFE (diluted from a 2 mg ml-1 stock into a final volume of 150 µl of 2.7 x 105 
trophozoites ml-1 and 150 µl TYI-S-33) were initially used. Where 100% killing of 
trophozoites was observed, the PRFEs responsible were further titrated to 
concentrations of 266.8, 133.4 and 67 µg ml-1. The microtitre plates were sealed and 
incubated for 24 h at 37ºC, after which the trophozoites were enumerated. 
 
The positive control consisted of 2.7 x 104 trophozoites in 300 µl TYI-S-33 
containing 67 µg ml-1 metronidazole (see below) and the negative controls consisted 
of 2.7 x 104 trophozoites in 300 µl TYI-S-33 in the absence of PRFE or 
metronidazole. All samples were prepared in triplicate. 
 
 Incubation of G. duodenalis trophozoites with metronidazole 
The minimum concentration of metronidazole that killed 100% of trophozoites in 
vitro was previously determined to be 67 µg ml-1 (20 µg per well; Chapter 2). This 
concentration was used in all positive controls. 
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6:3.3 Parasite culture / experimental analysis  
G. duodenalis cell count assay 
Trophozoite enumeration was performed using an improved Neubauer 
haemocytometer and trophozoite viability determined by Trypan blue inclusion / 
exclusion with motility and morphology (TBMM) as described in Chapter 2. 
 
 Statistical analysis 
In this series of experiments, Giardia trophozoites from each microtitre well from 2 
experiments were counted providing a total of 6 enumerations for each PRFE 
concentration tested. The means and standard deviations of these enumerations were 
used in formulating graphs and tables, with a Student’s 2-tailed, unpaired, t-test used 
to determine significance with a P value of less than or equal to 0.05 being regarded 
as significant. Data and statistical analysis was performed using Microsoft Excel® 
software. 
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6:4 RESULTS 
Incubation of G. duodenalis trophozoites with PRFEs 
Screening of PRFEs 
All 11 PRFEs significantly reduced the viability of G. duodenalis trophozoites at a 
concentration of 167 µg ml-1 (Figure 6.1, P > 0.05).  Only 4 of the 11 investigated 
were able to reduce trophozoite viability by 100%. These were strawberry, 
blackberry, cloudberry and artic bramble. Interestingly these 4 fruits are all from the 
same scientific Family (Rosaceae), however, while both rowan and raspberry are 
from the same family, these failed to completely reduce trophozoite viability. 
Raspberry extract killed 11.9 ± 4.7% of the trophozoites while rowan extract was 
considerably more effective, inducing a 83.3 ± 14.3% reduction in trophozoite 
viability. However, rowan PRFE activity was not significantly different from that of 
pomegranate and blueberry (86.2 ± 10.9 and 90.4 ± 2.8% respectively; P < 0.01) and 
was significantly lower than the activities of strawberry, blackberry, cloudberry and 
artic bramble. 
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Figure 6.1 Effect of PRFEs on G. duodenalis trophozoite survival in vitro. 
Trophozoites were incubated for 24 h in the presence or absence of PRFE. 
Metronidazole (67 µg ml-1) was used as positive control. All berry extracts 
significantly reduced the survival of G. duodenalis trophozoites when compared to 
untreated trophozoites (P ≤ 0.05).  
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Titrations of the most active PRFEs 
As extracts of strawberry, blackberry, cloudberry and artic bramble were able to kill 
100% of Giardia trophozoites at 167 µg ml-1, titrations of these extracts were 
performed down to the lowest concentration of 33 µg ml-1. A dose dependent 
reduction in the survival of trophozoites was observed for each extract (Figure 6.2). 
A polyphenol-rich extract of strawberry demonstrated an MIC of 167 µg ml-1 with 
concentrations below this failing to completely reduce trophozoite viability. Both 
artic bramble and blackberry extracts had an MIC of 133 µg ml-1 with cloudberry 
demonstrating an MIC of 67 µg ml-1. At a concentration of 33 µg ml-1, cloudberry 
showed an ablation of its antigiardial activity, being equal in effect as the untreated 
controls (Giardia trophozoites alone = 11.3 ± 8.6% vs. cloudberry 33 µg ml-1 = 12.6 
± 6.0%, Figure 6.2, P > 0.05). 
 
Incubation of trophozoites with ellagic acid  
The Family Rosaceae of plants is known to have high levels of ellagitannins and as 
ellagic acid is known to be a metabolite of ellagitannin, this compound was 
investigated.  When used at a concentration demonstrated by PRFEs to kill 100% of 
trophozoites (133 µg ml-1), ellagic acid appeared to cause a reduction in trophozoite 
viability (75.2 ± 4.0%), with further dilutions showing a dose dependent decrease in 
antigiardial activity (Figure 6.3 A). However, the high concentrations of ethanol 
calculated to be present in the ellagic acid dilutions demonstrate that ethanol is 
responsible for the reduction of viability and not ellagic acid (Figure 6.3 B). 
Interestingly, the addition of ellagic acid helps to increase trophozoite survival, 
which was reduced by ethanol (Figure 6.3). Ethanol, at a concentration of 13%, 
killed 100% of trophozoites and ellagic acid, at 133 µg ml-1 in the presence of 13% 
ethanol, killed 75.2 ± 4.0% trophozoites, significantly reducing the ethanol induced 
antigiardial effects (P < 0.01).  
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Figure 6.2 Effect of 4 berry phenolic extracts on G. duodenalis trophozoite 
survival in vitro. 
Trophozoites were incubated for 24 h in the presence or absence of 4 different 
PRFEs at different concentrations (33, 67, 133 and 167 µg ml-1). Untreated 
trophozoites ( ) and metronidazole 67 µg ml-1 treated trophozoites ( ) were used as 
controls. Strawberry ( ), blackberry ( ), cloudberry ( ) and artic bramble ( ) 
caused a dose dependent reduction in trophozoite viability.  
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Figure 6.3 Effect of ellagic acid and ethanol on G. duodenalis trophozoite 
survival in vitro. 
Trophozoites were incubated for 24 h in the presence or absence of ellagic acid (A) 
or ethanol (B) at different concentrations (133.4, 67 and 33 µg ml-1 for ellagic acid 
and 13, 6.5 and 3.25% for ethanol). Metronidazole (67 µg ml-1) was used as positive 
control. Ethanol was used at concentrations corresponding to that found in the ellagic 
acid dilutions. 
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6:5 DISCUSSION 
It was demonstrated that PRFEs influence the viability of G. duodenalis over a 24 h 
incubation. Four water soluble PRFEs demonstrated high activity against 
trophozoites of G. duodenalis in vitro when compared with the remaining PRFEs. 
These PRFEs were strawberry, blackberry, cloudberry and artic bramble and 
represent 4 out of 6 members of the Family Rosaceae that were tested. All 4 PRFEs 
were able to reduce trophozoite viability by 100% at a concentration of 167 µg ml-1 
and showed a dose dependent reduction of viability. Cloudberry extract was the most 
active of all the PRFEs, reducing significantly trophozoite viability at a concentration 
of 67 µg ml-1 (P > 0.05).  
 
As PRFEs were prepared by solid phase extraction, they lack organic acids and 
sugars found in the pressed fruit extracts. This would mean that the remaining 
phenolic compounds, such as flavonoids, lignans, stilbenes and polymeric tannins 
(condensed and hydrolysable), are responsible for any giardiacidal effects. The 
antiparasitical activity of plant phenols has been demonstrated by others. 
Experiments by Kolodziej et al. (2001) provided evidence for antileishmanial 
activity of proanthocyanidins, condensed tannins which have a flavonoid core as 
their basic structure. The activities of these phenols were not directly against the 
parasite, as L. donovani promastigotes in vitro survived incubation with these 
compounds. The intracellular survival of amastigotes, however, was significantly 
inhibited, with activities reported to be lower than that of the drug, Pentostam®. This 
indicated that the proanthocyanidins were responsible for the activation of 
intracellular killing mechanisms of infected macrophages. 
 
The antimicrobial properties of the purified phenolic compounds present in many 
plant foods have been well documented (Chung, Wei and Johnson 1998). However, 
the complex mixture of phenolics to be found in berry extracts have not been 
extensively examined until recently.  Puupponen-Pimiä et al. (2005a) demonstrated 
that phenolic berry extracts have wide ranging antimicrobial effects by inhibiting 
their growth, with a phenolic extract of cloudberry possessing the strongest 
antimicrobial activity, followed by raspberry and strawberry. Rauha et al. (2000) also 
studied antimicrobial effects of some berry extracts against food poisoning bacteria 
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(Aspergillus niger, Bacillus subtilis, Candida albicans, Escherichia coli, 
Micrococcus luteus, Pseudomonas aeruginosa, Saccharomyces cerevisiae, 
Staphylococcus aureus and Staphylococcus epidermidis). They found that the widest 
bactericidal activity was also expressed by berries belonging to the 
genus Rubus (cloudberry and raspberry) which are rich in the hydrolysable tannins 
known as ellagitannins, formed from the glucose esters of gallic and ellagic acid.  
 
Nohynek et al. (2006) demonstrated that the outer membrane (OM) of Salmonella 
typhimurium and S. infantis was disintegrated by phenolic extracts of cloudberries 
and raspberries. It was believed that this activity occurred through the chelation of 
divalent cations from the OM as the addition of MgCl2 inhibited the destruction of 
the OM by these berry phenolics. Further examination discovered that this 
permeabilisation or disintegration of the OM was not due to the ellagitannin and 
anthocyanin fractions of raspberry and cloudberry phenolic extracts (Nohynek et al. 
2006). Also the growth inhibition of Salmonella was only partly caused by the berry 
phenolics and ellagitannins, with most of the inhibition seeming to originate from 
other compounds, such as organic acids (Puupponen-Pimiä et al. 2005a). This would 
indicate that the ellagitannins from these berries in phenolic extracts are not 
responsible for their antimicrobial effect on Salmonella spp. 
 
Whilst the ellagitannins have been shown not to be responsible for the antimicrobial 
effects for the disintegration of Gram-negative bacteria OM, they cannot be 
disregarded for antigiardial effects demonstrated with the ellagitannin rich 
cloudberry, artic bramble and strawberry PRFEs without some in vitro investigation. 
To this end, purified ellagitannins were sought for use in this project. However, 
whilst ellagitannins were unavailable, the biodegradation product (ellagic acid) was 
donated by Dr. McDougall (SCRI) for use in experiments. The breakdown of 
ellagitannin to ellagic acid by intestinal microflora may cause this phenolic acid to be 
present in high quantities at sites where G. duodenalis trophozoites also occupy. 
Experiments, however, demonstrated that Giardia trophozoites were unaffected by 
ellagic acid (Figure 6.3). From this it can be suggested that any antigiardial effect of 
the PRFEs from strawberry, blackberry, cloudberry and arctic bramble may have in 
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vitro, is not due to the degradation products of ellagitannins, i.e. ellagic acid. As the 
PRFEs are devoid of organic acids and that ellagic acid was found not to affect 
trophozoite viability, the potential remaining classes of phenolic compounds in 
PRFEs with antigiardial properties could be the flavonoids, lignans, stilbenes or 
condensed tannins (Puupponen-Pimiä et al. 2005a).  
 
Previous experiments have suggested the possibility that anthocyanins may be 
responsible for the antigiardial effects of PRFEs (Anthony et al. 2007; Chapter 5). 
This was suggested due to the blueberry PRFE, the whole pressed juice and a 
commercial drink made from the same juice all containing large amounts of 
anthocyanins. This was calculated to be 70 – 80% of its polyphenol content being 
made of anthocyanins. In the current experiments however, the PRFEs which were 
most antigiardial were from a family known to be particularly high in their 
ellagitannin content. Also, strawberry and cloudberry phenolics have been shown to 
cause the immobilisation and death of S. aureus and S. typhimurium (Nohynek et al. 
2006). This may have implications in the treatment of diarrhoeal infections where the 
prevention of adhesion of pathogenic bacteria and possibly protozoan parasites such 
as G. duodenalis to intestinal epithelial cells would be of benefit to the host.  
 
However, it is becoming clear that different classes of polyphenol compounds differ 
greatly in their bioavailability (Manach et al. 2005). Constituents such as 
anthocyanins, which are abundant in berries (Deighton et al. 2000), have low 
bioavailability and / or poor stability in vivo (McDougall et al. 2005). A large 
proportion of the ingested polyphenol dose from berries will not be taken up into the 
circulation and will pass through the upper gastrointestinal tract (GIT) to the large 
intestine where they may be biotransformed, or broken down by the indigenous 
microflora (Aura et al. 2005; Gonthier et al. 2003). This however, may be of benefit 
in the treatment of giardiasis. Unlike metronidazole, anthocyanins are retained in the 
gut longer, with almost 85% being excreted in faeces. This should increase the 
exposure of G. duodenalis trophozoites, either attached onto enterocytes or in the 
lumen, to polyphenols ingested in aqueous extracts of cloudberries. 
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However, the antimicrobial activity of phenolic compounds can also depend on the 
pH of the matrix in which the organism grows. This can vary with different bacterial 
species and different phenolic compounds. For example, certain phenolic 
compounds, such as the phenolic acids (the cinnamic and benzoic acids), are unstable 
at high pH but are stable at low pH, being bactericidal at low pH (< pH 5) and 
bacteriostatic at higher pH (> pH 6) (Friedman and Jürgens 2000; Puupponen-Pimiä 
et al. 2005a; Wen et al. 2003).  Thus, when evaluating the antimicrobial efficacy of 
phenolic compounds either in food as a preservative, or in the human body as 
chemotherapy, pH is a very important parameter to be considered, especially as a 
potential use of cloudberry in the treatment of giardiasis could be the oral 
administration of either the whole fruit, or pressed juice of the fruit. There is some 
precedence for this, where experiments by Ryan, Wilkinson and Cavanagh (2001) 
demonstrated that E. coli growth was inhibited in vitro by a dilution of raspberry 
juice or cordial, providing some scientific evidence for the common practice of using 
raspberry cordial as an antidiarrhoeal therapy in livestock and humans in Australia. 
 
This study has shown that PRFEs of various soft fruits can kill G. duodenalis 
trophozoites in vitro and that this phenomenon is most likely to be due to 
polyphenolic compounds. Furthermore, PRFEs of cloudberry, artic bramble, 
blackberry and strawberry, at concentrations of 167 µg ml-1, completely reduced 
trophozoite viability. As cloudberry PRFE has activity which is comparable to 
metronidazole this may indicate the possible use of cloudberries as an antidiarrhoeal 
treatment induced by giardiasis warrants further examination. 
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CHAPTER 7 
 
The examination of latrine and cess pit sediments from 2 different localities in 
Britain and eras of history for protozoan parasites, with a special emphasis on 
Cryptosporidium spp. 
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7:1 ABSTRACT 
Sites of scientific interest from both the Viking and medieval era were examined for 
the presence of protozoan parasites. Samples from a sealed 14th century AD hospital 
drain (Soutra Aisle, UK) and from latrine sediments (16 – 22 Coppergate, York, UK) 
were examined using light and epifluorescent microscopy and nested 18S 
polymerase chain reaction coupled with restriction fragment length polymorphism 
(PCR-RFLP) techniques. Both samples were found to contain ova of the helminths 
Trichuris spp. and Ascaris spp. Also found were Cryptosporidium spp. oocysts, 
which were visualised using fluorescein isothiocyante conjugated monoclonal 
antibody (FITCmAb) for Cryptosporidium spp. indicating the presence and 
robustness of the oocyst epitopes which the antibodies are directed against. The 2 
step nested 18S PCR-RFLP techniques employed discovered the presence of 
Cryptosporidium spp. DNA in the Soutra samples but not in the York samples, but 
analysis could not determine the species of the Cryptosporidium found. The presence 
of the Cryptosporidium DNA of the same amplicon size in imported topsoil samples 
from above the archaeological layer, indicate a possible existence of 
Cryptosporidium in the top soil which had leached down into the archaeological 
layer. Further analysis using other nested 18S PCR-RFLP techniques would be 
required to ultimately identify the Cryptosporidium species found in all DNA 
positive samples. If these techniques determine that the Cryptosporidium DNA 
present in the imported topsoil samples is different from the archaeological samples, 
then this will be the first reported finding of Cryptosporidium in an European 
archaeological site. 
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7:2 INTRODUCTION 
The examination of paleo-faecal remains for parasites is becoming routine in 
archaeological excavations (Araujo & Ferreira 2000). The significance of examining 
such material is to try to gain an insight into the diseases of the past, diet and 
possibly the treatment of diseases. Such endeavours have so far been carried out in 
archaeological sites in North and South America (Horne 1985; Kliks 1990; Ferreira 
et al. 1991; Ferreira, Araujo and Duarte 1993; Schmidt Duszynski and Martin 1992; 
Araujo & Ferreira 2000; Faulkner et al. 2000), Europe (Taylor 1955; Grzywinski 
1959; Pike 1968; Herrmann 1988; Jones 1985; Greig 1981; Bouchet 1995; Araujo & 
Ferreira 2000; Bouchet et al. 2002) and Egypt (Ruffer 1910).  
 
Parasite ova from nematodes, cestodes and trematodes are the most commonly found 
evidence of parasites throughout the world and have been found from a number of 
different sources including waterlogged deposits, concreted faecal deposits and arid 
deposits. One such examination has recently discovered trematode and nematode ova 
in the coprolites of terrestrial vertebrates from the Early Cretaceous Bernissart 
Iguanodon shaft in Belgium (Poinar & Boucot 2006).  
 
The detection of protozoan parasites in archaeological material, whether it is 
coprolites, latrine sediments or a mixture of faecal material and soil, is not frequent 
in palaeoparasitology (the study of parasites in archaeological material) (Goncalves, 
Araujo and Ferreira 2003). Unlike the ova of helminths, protozoan cysts, such as 
Giardia spp., appear to degrade and quickly decay in the conditions found in 
archaeological sites (such as high or low moisture levels, cool or hot temperatures). 
Direct microscopic examination of these parasites is difficult. However, it is possible 
to detect these parasites using other means. Giardia spp. cysts and Cryptosporidium 
spp. oocysts have been identified in human coprolites from ancient Peruvian 
mummies approximately 4,300 to 1,100 BP (Before Present, i.e. the present year and 
not BC [Before Christ]) using fluorescence microscopy (Ortega & Bonavia 2003). 
More recently, intact intestinal protozoan cysts have been found in Early Cretaceous 
coprolites (Poinar & Boucot 2006). 
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Of particular interest is a sealed hospital drain / cess pit dating from the early AD 
(Anno Domini) 14th century (Soutra) in Scotland, UK. At this site and other hospital 
sites, Augustinian canons used common tormentil (Potentilla erecta) and wild 
strawberry (Fragaria vesca) plants as remedies for helminthic infections and 
blueberries, in particular, for the treatment of diarrhoea (Webber & Watson 1998). 
Currently an archaeobotanical / archaeomedical project (Soutra Hospital 
Archaeoethnopharmacological Research Project; SHARP) investigating this site is 
continuing to investigate the medieval use of plants as medicines by the Augustinian 
canons. This is possible due to the retention of organic material with little decay 
because of the waterlogged clay soil in which the material is entombed.  
 
This current study was undertaken to attempt to find and identify any intestinal 
protozoan parasites in hospital drain / cess pit samples from Soutra and also to 
confirm and identify any other parasites to be found in latrine sediments from a 
Viking settlement latrine excavated from 16 – 22 Coppergate, York dating from AD 
800 – 1000 and to attempt to associate plants with any parasites found. Light and 
fluorescence microscopy was used for the primary identification of any parasites 
found and a highly sensitive PCR method was also employed for the identification of 
Cryptosporidium spp. oocysts. 
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7:3 MATERIALS AND METHODS 
7:3.1 Source of archaeological samples  
Soutra cess pit samples 
Samples of a medieval cess pit (Soutra Aisle, ~17 miles South East of Edinburgh, 
UK, Ordinance Survey reference: NT 452 584 GB, Figure 7.1) dating from the 14th 
century AD were obtained from a depth of approximately 1.5 m (Figures 7.2 A and 
7.2 B). These samples are of special interest as they are from waste material from a 
medieval hospital which, in previous archaeological studies, has well preserved 
organic material, allowing the identification of plants used in medicinal preparations 
(Dr. Brian Moffat, Personal Communications 2006). 
 
Figure 7.1 Location of Soutra Aisle. 
 
The location of Soutra Aisle within the UK is marked on the map © Crown Copyright 
2007 www.ordnancesurvey.co.uk/getamap Image produced from Ordnance Survey's 
Get-a-map service. Image reproduced with permission of Ordnance Survey and 
Ordnance Survey of Northern Ireland. Scale 1:625,000. 
 
 
In total, 8 samples of soil were taken from the site with 6 samples from a pristine, 
untouched layer of the cess pit (sample identifications S1 – S6) and 2 samples from 
the soil above the archaeological layer (sample identifications S7 & S8). This soil 
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had been added to the site after previous excavations where the archaeological layer 
of waterlogged clay was initially exposed and then subsequently protected with this 
‘top soil’ of loam and building rubble mixture obtained from different areas of the 
UK (Dr. Brian Moffat, Personal Communications 2006). A waterproof and protective 
layer of plastic sheeting and gravel was then laid on top. This preparation, by the 
archaeologists, protected the archaeological layer from extraneous contaminants 
whilst enabling relatively simple access to this layer for future investigations. Soil 
samples were obtained by inserting the open end of a sterile 60 ml specimen 
container (Sterilin, UK) into the excavated archaeological layer creating a ‘plug’ of 
soil in the container. This process was carried out by the archaeologist in charge of 
the excavation (Dr. Brian Moffat, Director of SHARP) so that the appropriate 
archaeological layer would be exposed and examined. All samples were labelled and 
sealed in ‘zip lock’ bags and then stored at 4°C until used. 
 
York latrine samples 
Two samples from latrine sediment dating from the Viking era (~AD 800 – 1000) 
from the city of York, UK (16 – 22 Coppergate, York, UK, Ordinance Survey 
reference: SE 604 517 GB, Figure 7.3) were provided by the York Archaeological 
Trust from the 1976 – 1981 excavation of this area (Sample identities 76.81.7 and 
99.94.6). The initial sample analysis and formol ether concentration were carried out 
at the Scottish Parasite Diagnostic Laboratories (SPDL; Stobhill Hospital) by Prof. 
Huw Smith, with further analysis by Mr. Grant Spence (Senior Biomedical Scientist) 
then 0.5% trisodium phosphate rehydration / concentration and analysis carried out 
by myself at the Methicillin Resistant Staphylococcus aureus (MRSA) Reference 
Laboratories, a separate lab on the same hospital site. 
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Figure 7.2 Excavation of Soutra Aisle. 
        
 
 
 
 
 
 
 
 
 
 
 
Photograph of the area excavated and marked in yellow (A). The diagrammatic 
representation of the excavation area (B). An area of ~1 m square (Yellow square) 
was marked off and excavated to a depth of 1.5 m. Samples were removed in a 
horizontal line from a 0.3 m exposed area of the archaeological layer (S1 – S6) and 
from 0.3 m under the surface of the imported protective ‘Top Soil’ layer (S7 and S8) 
by Dr. Brian Moffat in 60 ml sterile sample containers.  
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Figure 7.3 Location of York. 
 
The location of York within the UK is marked on the map © Crown Copyright 2007 
www.ordnancesurvey.co.uk/getamap Image produced from Ordnance Survey's Get-
a-map service.  Image reproduced with permission of Ordnance Survey and 
Ordnance Survey of Northern Ireland. Scale: 1:625,000. 
 
Figure 7.4 Location of 16 – 22 Coppergate in York. 
 
The area of the Coppergate excavation carried out between 1976 and 1981 is circled 
in red. This site revealed the buried remains of Viking age York, now recreated in the 
Jorvik Viking Centre. Image reproduced with permission of Ordnance Survey and 
Ordnance Survey of Northern Ireland and the British Geological Survey. Scale: 
1:1250. 
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7:3.2 Sample preparations  
Formol ether concentration of samples 
A further modification of the simplified Ritchie’s formol-ether method for the 
concentration of cysts, ova and larvae in faeces (Ridley and Hawgood 1956) used by 
Allen and Ridley (1970) was used to concentrate the samples for microscopic 
examination. This method achieves an increase in the concentration of parasite cysts 
and ova by 15 to 50 fold over the simplified Ritchie’s formol-ether method. Whilst 
this increase in concentration is dependent upon the parasite sought (i.e. helminth 
ova) this further modification by Allen and Ridley (1970) provides a good 
concentrate of protozoan cysts and helminth ova which are diagnostically 
satisfactory (Allen and Ridley 1970).  
 
A sample of approximately 0.5 – 1.0 g (pea sized) was added using an applicator 
stick to a 15 ml conical tube containing 7 ml of 10% formalin (10% of a 40% 
solution of formaldehyde in water). The sample was then thoroughly comminuted 
with the applicator stick. The resulting suspension was then filtered through a 355 
µm aperture size 38 mm diameter sieve [355 µm aperture size, 38 mm diameter is 
equivalent to 36 mesh British Standard (BS 410-86) or 40 mesh American Standard 
(ASTM E11-81)] into a beaker and the filtrate poured back into the tube allowing the 
efficient separation of parasites from larger particles. Debris trapped on the sieve was 
discarded and both the sieve and the beaker washed thoroughly in running tap water 
between each sample. 
 
A 3 ml aliquot of diethyl ether (or ethyl acetate) was added to the formolinised 
solution, the neck of the tube sealed with a rubber bung and shaken vigorously for 30 
sec then centrifuged at 750 x g for 60 sec.  
 
In a normal faecal concentrate there would be a fatty plug present in the sample after 
centrifugation and this would be discarded along with the fluid both above and below 
it by inversion, leaving only a few drops behind to resuspend the pellet in. With the 
historical samples, no fatty plug was observed and the supernatant could be readily 
decanted. 
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The resuspended pellet could then be either examined microscopically, or 1 ml of 
distilled water could be added, the container sealed and the suspension kept for 
further examination at a later date without risk of drying out. 
 
 Trisodium phosphate rehydration and resuspension of samples 
The following procedures were carried out in a laboratory that had no prior contact 
or history of working with protozoan parasites, in a building unattached to the SPDL 
(MRSA reference laboratory). A sample of approximately 0.5 – 1.0 g (pea sized) was 
added using an applicator stick to a 50 ml centrifuge tube containing 10 ml of 0.5% 
trisodium phosphate (prepared from a 5% w/v stock solution in distilled water). 
Where York samples were investigated, 0.1 g was added to the tubes. The applicator 
stick was used to ‘grind up’ the York and Soutra samples to aid softening. Each tube 
was then sealed and left at 5°C for 8 weeks to soften and vortexed weekly to 
resuspend the sample. After softening the samples were centrifuged at 1100 x g for 
15 min. The supernatant was removed and stored in a fresh 50 ml centrifuge tube and 
the pellet resuspended in 2.5 ml of fresh 0.5% trisodium phosphate. 
 
 Immunomagnetic separation (IMS) of samples 
A 500 µl volume of resuspended pellet from a volume 2.5 ml of either a formol-ether 
concentrate or 0.5% trisodium phosphate concentrate was added to 9500 µl of 
distilled water in Dynal L10 tubes to give a final volume of 10 ml. 
 
For each 10 ml sample, the protocol for the commercially available IMS kit was 
followed. Briefly, the following quantities of buffers (Dynal IMS kit, Invitrogen Ltd, 
Paisley UK) were added to the tubes: 1 ml of 10 x SLTM- Buffer A and 1 ml of 10 x 
SLTM- Buffer B. Anti-Cryptosporidium Dynabeads are resuspended by vortexing, 
then 100 µl of resuspended beads were added to the Dynal L10 tubes, containing the 
sample concentrate and SLTM buffers. The tubes were then attached to a rotating 
mixer, rotated at 15 – 25 rpm for 1 h at room temperature (RT). 
  
The tubes were removed from the rotator and placed in a magnetic particle 
concentrator (Dynal MPC-6), with the flat side of the tubes facing towards the 
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magnet. The tubes were rocked through approximately 90°, tilting the cap-end and 
the base-end of the tube up and down in turn per second for 2 min, with the flat side 
of the tube facing downwards. Oocysts in the sample will be bound to the 
paramagnetic beads through antigen binding at the oocyst surface, with the oocyst-
bead complexes magnetically attracted to the back of the tube, appearing as a black 
line. In order to retain the oocyst–bead complex, the tubes were carefully decanted to 
remove the supernatant whilst still in the magnetic particle concentrator, with the 
supernatant being decanted into suitable containers in case of magnetic failure and 
the complex being accidentally decanted.   
 
The tubes were then removed from the Dynal MPC-6 and the beads-oocyst complex 
resuspended in 1ml of 1 x SLTM - Buffer A by adding 900 µl of 1 x SL TM - Buffer A 
into the tubes, mixed gently and then transferring all of the liquid from the Dynal 
L10 tubes to a labelled 1.5 ml microcentrifuge ‘snap cap’ tube. The remaining 
material was resuspended by shaking the glass L10 tube three times and by the 
addition of 100 µl of 1 x SL TM - Buffer A to the tube and then transferred to the 
microcentrifuge tube. 
 
The microcentrifuge tubes were placed in a magnetic particle concentrator (Dynal 
MPC-S), with the magnetic strip placed in the vertical position. The tubes were 
rocked through approximately 180° for 1 min with one rocking movement per sec. At 
the end of this step, the bead-oocyst complexes should form a clear ‘dot’ on the back 
of the tubes. Supernatants were aspirated from the tubes using a pipette and thin 
yellow pipette tips (P200 yellow pipette tips [Cat. No. 739290, Greiner Bio-One 
Laboratories), taking care not to disturb the bead-oocyst complexes attached to the 
wall of the tubes adjacent to the magnet. After the removal of the supernatant, the 
oocysts were dissociated from the beads firstly by removing the magnetic strip from 
the Dynal MPC-S and then 50 µl of 0.1 M hydrochloric acid (HCl) was carefully 
added to the microcentrifuge tube which was capped then vortexed for 5 – 10 sec. 
The tubes were returned to the Dynal MPC-S and allowed to stand in a vertical 
position for 5 min at RT then vortexed for 5 - 10 sec. 
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Once all the sample had been allowed to settle at the base of the tube the magnetic 
strip was re-inserted into the Dynal MPC-S and the apparatus allowed to stand 
undisturbed for a minimum of 10 sec in a tilted position so that the magnetic beads 
could attach to the Dynal MPC-S magnet. 
 
To a labelled, single welled slide, 5 µl of 1.0 N sodium hydroxide (NaOH) was 
added to the well and the entire sample from the tube was transferred to the slide, 
taking care not to disturb the beads at the back wall of the tube. This sample was then 
mixed with the NaOH on the slide. 
 
The sample was allowed to air dry at RT and the prepared sample slides stored at RT 
in a dry box, or in a refrigerator at 4 – 8°C until stained with a commercial 
fluorescein isothiocyante conjugated monoclonal antibody for Giardia cysts and 
Cryptosporidium oocysts (G-C FITCmAb; Giardia/Crypto-Cel Immunofluorescence 
[IF] Test, TCS Biosciences) and DAPI. 
 
Alternatively, the beads-oocyst complexes were not dissociated after the removal of 
supernatant. A 50 µl volume of lysis buffer was added in the place of HCl and the 
sample was used for direct DNA extraction. 
 
 Fluorescence staining of samples 
Sample turbidity was such that it was necessary to dilute the initial sample 
concentrate for fluorescence staining. A 100 µl aliquot of a trisodium phosphate 
prepared sample concentrate was added to a 1.5 ml microcentrifuge tube containing 
1.4 ml of distilled water to create a 1:15 dilution for each sample. A 50 µl aliquot of 
this diluted trisodium phosphate prepared sample, or formol ether prepared sample, 
was added to the well of a labelled single well slide and allowed to air dry. The 
slide/s were then fixed in methanol for 1 min and allowed to air dry. To each slide, 
50 µl of G-C FITCmAb were added to the methanol fixed sample and then incubated 
at 37°C in a humidity chamber for 60 – 90 min.  
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Using the methods of Smith et al. (2002), a Büchner type aspirator was used to 
aspirate the excess G-C FITCmAb from the slide by carefully tilting the slide and 
placing the aspirator tip close to, but not touching, the fluid in a well. To the well, 50 
µl of PBS was added and incubated at RT for 1 min before aspirating. This was 
repeated once more and 50 µl DAPI of a 1:5000 dilution (in PBS) from a working 
stock of 2 mg ml-1 was added and incubated at RT for 2 min. This was then aspirated 
from the well in the manner previously described for the removal of excess G-C 
FITC mAb. A single drop of deionised water was added to the well with a plastic 
pastette and left on the well for 1 min at RT, then aspirated. 
 
Once the slide air dried at RT, 10 µl of mounting medium was applied to the well 
and a 22 mm x 22 mm coverslip was gently lowered onto the well and allowed to 
settle before being sealed using clear nail varnish. Two slides for each concentration 
method per sample were analysed. 
 
DNA extraction from oocyst positive slides or from IMS bead-oocyst 
complexes 
A small volume of liquid nitrogen was transferred, from the designated storage area, 
in a small laboratory thermos to the DNA extraction laboratory. After microscopic 
examination, the slides were prepared for DNA extraction using the method of 
Nichols, Campbell and Smith (2006). 
 
Briefly, the slides were placed on absorbent tissue and the nail varnish sealing the 
coverslips was removed by swabbing the perimeter of the coverslip with a cotton 
swab impregnated with nail varnish remover to soften the sealing nail varnish. The 
softened nail varnish was then scraped away from the coverslip-slide interface onto 
the absorbent tissue by using the opposite end of the swab. A clean scalpel blade was 
used to lever a corner of the coverslip from the slide surface and then the coverslip 
was gently lifted off the slide. The opposite end of the coverslip was gently held to 
avoid sideways movement of the coverslip or slide. Once lifted, the coverslip was 
inverted and placed onto the absorbent tissue. The Teflon-coated area of the slide 
surrounding the well was dried with a small piece of folded absorbent tissue and then 
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10 µl of lysis buffer (LB; 50 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 0.5% 
sodium dodecyl sulfate) was pipetted onto the well of the slide. The entire surface of 
the well was scraped with a sterile 1 µl bacteriological inoculation loop (Nunc, UK) 
and, once scraped, the loop was placed on a support so that it did not rest on a 
potentially contaminated surface.  
 
Residual LB was recovered by tilting the slide to an angle of ~45° from the 
horizontal and aspirating the fluid which collected at the bottom of the well by 
placing the tip of a P20 Gilson pipette fitted with a filter-tipped pipette tip close to 
the fluid. The scraped sample in LB was pipetted into an appropriately labelled 0.5 
ml screw-cap microcentrifuge tube. A further 10 µl volume of fresh LB was 
deposited onto the sample well using a clean pipette tip and the sample was scraped 
using the same inoculation loop. As before, the loop was placed on a support so that 
it did not rest on a potentially contaminated surface. All liquid was removed from the 
well as previously described and the slide rotated through 180° with the slide-
scraping steps repeated, twice again. The final volume of the sample amounted to 
~40 µl. The loop was carefully snapped, by pressing it against the inner wall and the 
rim of the microcentrifuge tube and left inside the tube, which was capped. Swabs, 
gloves and absorbent tissues were disposed of immediately after each sample was 
removed from a slide.  
 
IMS bead-oocyst complexes which were not dissociated with HCl were suspended in 
50 µl of LB and DNA extraction was performed as described by Nichols & Smith 
(2004) and Nichols, Campbell and Smith (2003).  
 
Briefly, tubes containing the scraped suspensions and the end of the bacteriological 
loop or IMS Bead-complexes in 1.5 ml microcentrifuge tube tubes were immersed in 
liquid nitrogen for 1 min and thawed in a 65°C water bath for 1 min. This freeze-
thawing cycle was repeated 15 times and every five cycles, tube contents were mixed 
by gentle rocking. Each sample was centrifuged at 14,000 x g for 10 sec to ensure 
that all the sample lysate was deposited at the base of the tube. Lysates were 
transferred into a clean tube containing 2 µl of proteinase K (5 mg ml-1) and 
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incubated at 55°C for 3 h in a water bath. Following incubation, capped tubes were 
centrifuged at 14,000 x g for 10 sec to ensure that all the sample lysate was deposited 
at the base of the tube. Samples were incubated at 90°C for 20 min in a water bath to 
denature proteinase K, chilled on ice for ~1 min and then centrifuged at 14,000 x g 
for 5 min at RT. All supernatant (~30 ml) was transferred to a clean, labelled tube 
and stored at -20°C until used. 
 
Sample preparation for gel electrophoresis 
Either 3 or 15µl of gel loading buffer (bromophenol blue in 1 x Tris-acetate-EDTA 
buffer (Appendix 7) and 50% glycerol) were added to clean 0.5ml microcentrifuge 
tubes and 10 or 50µl of PCR product, respectively, were mixed with the gel loading 
buffer. The sample was loaded in the gel wells with a micropipette immediately 
before the electrophoresis run. DNA molecular weight markers, (100bp DNA ladder, 
Invitrogen, UK), was diluted to give a final concentration of 0.5µg per 10 µl in TE 
buffer (10mM Tris-HCl, 1mM EDTA, pH 8.0) and bromophenol blue loading buffer 
and stored at 4°C. Ten µl of the prepared DNA ladder dilution were run alongside the 
samples as DNA size references. 
 
7:3.3 Sample analysis 
 Microscopic examination of sample concentrates – light microscopy 
Initial examination of the sample concentrates occurred under light microscopy 
conditions (Olympus BH-2 epifluorescence microscope equipped with Nomarski 
DIC optics) where a 10 – 25 µl aliquot of either a formol ether or trisodium 
phosphate prepared concentrate was placed on a clear glass slide and a 22 mm x 22 
mm cover slip placed on top. This was then sealed with clear nail varnish to prevent 
the sample from drying out. Scanning of this ‘wet’ mount commenced in the upper 
left hand corner of the cover slip under the x20 objective lens, working across the 
slide from left to right, 1 field width at a time, until the upper right-hand edge of the 
sample was reached. The microscope stage was then moved so that the field was 
moved down 1 field height and then continued to scan across the slide from right to 
left, field by field, until the right-hand edge of the sample was reached. This 
continued until the slide had been completely scanned for parasite ova. During this 
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period of observation, the fine focus was adjusted continuously so that the depth of 
the sample was also scanned and any parasites discovered were identified, counted 
and photographed (ColorView Soft Imaging System MTV-3 camera and analySIS® 
software, GmbH, Germany), with any identification being carried out under the x40 
objective lens and confirmed by another member of the laboratory. 
 
Microscopic examination of sample concentrates – Fluorescence stained 
samples 
Epifluorescence microscopy using ultra-violet (UV) excitation (excitation 355nm, 
emission 450 nm) was used to determine the presence of the DAPI stained sporozoite 
or trophozoite nuclei. A blue filter block (excitation 490 nm; emission 510 nm) was 
used to visualise G-C FITCmAb emissions. Nomarski DIC optics was used to 
determine the presence of internal morphology. Under fluorescent conditions, G-C 
FITCmAb stained Cryptosporidium spp. oocysts appear as apple green circular discs 
4 – 6 µm in diameter and Giardia spp. cysts appearing as apple green ovals ~8 x 12 
µm in size. Any object located under the x40 oil immersion objective showing the 
above fluorescence was further examined using the x100 oil immersion objective. 
The fluorescent image was related to the bright field image and its size measured 
with the eye-piece graticule. DAPI intercalates with the nuclei of the sporozoites 
within viable or non-viable Cryptosporidium oocysts and the trophozoites of Giardia 
cysts and fluoresces as a bright sky blue colour. The demonstration of up to four 
DAPI stained nuclei in an object of a comparable size to an oocyst was counted as a 
possible oocyst of Cryptosporidium. All objects that appeared to correspond to either 
Cryptosporidium oocysts or Giardia cysts were assessed for their size, shape and the 
presence of internal organelles by DIC with the x40 and x100 (oil) objective lenses. 
All fluorescent stained slides were of the single well type and were scanned in the 
manner previously described for light microscopy. Two slides for each concentration 
method per sample were analysed. 
 
 Polymerase chain reaction (PCR) of samples 
Two 2-step nested 18S rRNA gene PCRs for species identification were used and 2 
genetic loci were selected. These are published nested PCR methods using the 18S 
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rRNA Cryptosporidium gene to determine Cryptosporidium species and genotypes 
(Diagnostic = Nichols & Smith 2004; Nichols, Campbell and Smith 2003 & 2006; 
Xiao = Xiao et al. 1999 & 2001).  
 
All PCR megamix reactions were prepared in a laminar flow cabinet presterilised by 
UV light in an area designated as the pre-PCR lab, DNA extraction was prepared in a 
separate lab within the same building (designated as the DNA extraction lab) and 
DNA lysates were added to the PCR reaction volumes in the extraction lab and PCR 
1 products were added to the PCR 2 reaction mixtures in a third lab (designated as 
the PCR lab) to reduce cross contamination. All these procedures were performed in 
the MRSA reference laboratory. 
 
For the 2 nested 18S PCR reactions total volumes of either 50 µl or 100 µl were 
used, containing premixed reagents at final concentrations of 200 nM of the forward 
and reverse primers (MWG BioTech, Milton Keynes, UK), DNAse and RNAse free 
water (Sigma-Aldrich Company Ltd, Dorset, UK), 200 µM of each of the four 
deoxynucleoside triphosphates (dNTPs; Invitrogen Ltd, Paisley, UK), bovine serum 
albumin (BSA) at 4 mg ml-1 (Sigma-Aldrich), 20% Tween 20 (BDH), MgCl2 (2.5 
mM) and Taq polymerase (0.5U) in 1 x PCR buffer IV, (ABgene, Epsom, UK) 
(Nichols & Smith 2004; Nichols, Campbell & Smith 2003 and 2006; Xiao et al. 1999 
and 2001) and the PCR megamix dispensed into 0.5 ml thin walled tubes. Both 18S 
reactions incorporated polyvinylpyrrolidone (PVP) in the PCR megamix to reduce 
potential PCR inhibition (Nichols, Campbell and Smith 2006). A stock solution of 10 
mg ml-1 of PVP in 50 mM Tris-HCL (pH 8.0), used at a final concentration of 2 mg 
ml-1 of PVP was incorporated directly into the PCR mixture.  
 
Varying volumes of DNA lysate or first PCR product were used according to the 
PCR assay being carried out. Both DNA lysate and the first PCR product are used at 
a volume at which each PCR assay will work optimally (i.e. a maximum of 5 μl of 
DNA lysate and 3 μl of PCR 1 product). DNA lysate in the first PCR should not 
exceed one tenth of the total reaction volume, as this ratio has been optimised for the 
immediate inactivation of SDS, present in the DNA lysate, by Tween 20 
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(Goldenberger et al. 1995; Nichols & Smith 2004). Also possible PCR reaction 
inhibitors present in the DNA lysates prepared from the Soutra and York samples 
need to be eliminated. In order to do this, lesser volumes of lysate are used in the 
reaction and the ‘shortfall’ in volume made up with DNAse and RNAse free water so 
that the inhibitors become diluted. For the first amplification (PCR 1) 5 or 3 µl of 
DNA lysate was added to the reaction mixture to achieve a total volume 50 µl. For 
the second amplification (PCR 2) 3 µl of PCR 1 product are used with the reaction 
mixture to achieve a total volume of 100 µl. 
 
Controls were used at each stage of the PCR with C. parvum (IOWA isolate) oocyst 
lysate diluted at one sporozoite per µl, 104 oocysts ml-1, used as a positive 
Cryptosporidium DNA control. In the pre-PCR lab a negative control consisting of 
DNAse and RNAse free water was prepared and added to a PCR reaction. Two other 
negative controls were prepared consisting of LB and added to reaction volumes in 
the DNA extraction lab. Set protocols were followed for the preparation and addition 
of samples to the reaction volumes. The first negative (DNAse and RNAse free 
water) was prepared in the pre-PCR lab and then the second negative (LB) was 
prepared followed by all the test samples, the third negative control (LB) and finally 
the positive control. 
 
All PCR amplifications were performed in a GeneAmp PCR Thermal Cycler (model 
9700, Applied Biosystems, Perkin-Elmer, UK). The PCR product was visualized by 
gel electrophoresis on either 2% or 1.4% agarose gels (Appendix 7) and stained with 
ethidium bromide on a UV transilluminator (UVT-20 M/V; UV emission at 302 nm; 
Herolab). Gels were photographed using the Gel Doc 2000 system (Bio-Rad, United 
Kingdom) equipped with the Quantity-One software for gel documentation and 
quantitation of PCRs. 
 
Oligonucleotide primers 
Oligonucleotides were purchased from MWG BioTech (UK) and reconstituted to 
100µM according to manufacturer’s instructions. Primers were added to the PCR at 
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concentration recommended in published methods. The sequences of primers used 
for each PCR assays are as follows:  
 
18S.a reaction (Diagnostic) the following primers were used: 
PCR1 forward primer was WR494F (5'-TGA GTK AAG TAT AAA CCC CTT 
TAC-3') and its reverse primer being XiaoR1 (5'-CCC ATT TCC TTC GAA ACA 
GGA-3'). This would produce a PCR product of ~655 bp. In the PCR2 reaction the 
forward primer used was CPB-DIAG.F (5'-AAG CTC GTA GTT GGA TTT CTG-
3') and its reverse CPB-DIAG.R (5'-TAA GGT GCT GAA GGA GTA AGG-3') 
giving a product of ~435 bp. 
 
18S.b reaction (Xiao) the following primers were used: 
PCR1 forward primer was XiaoF1 (5'-TTC TAG AGC TAA TAC ATG CG-3’) and 
its reverse primer being XiaoR1 (5'-CCC ATT TCC TTC GAA ACA GGA-3’). This 
would produce a PCR product of ~1,325 bp. In the PCR2 reaction the forward primer 
used was XiaoF2 (5'-GGA AGG GTT GTA TTT ATT AGA TAA AG-3’) and its 
reverse XaioR2 (5'-AAG GAG TAA GGA ACA ACC TCC A-3’) giving a product 
of ~826 bp. 
 
For each pair of primers, the respective thermocycler programmes used are shown in 
Appendix 8.  
 
Enzymatic digestion of positive secondary PCR products and RFLP analysis 
The positive secondary PCR products of the nested-18S.a assay were digested with 
specific restriction enzymes and the fragments separated by electrophoresis in 2% 
agarose gels. 
 
The 18S.a positive PCR2 amplicon were initially digested, simultaneously, with the 
restriction enzymes AseI (New England Biolabs, UK) and DraI (Invitrogen Ltd). 
These restriction enzymes allow the profile of Cryptosporidium species to be 
determined and are shown in Appendix 8; Table 1. 
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The buffers used with each enzyme were provided by the suppliers and used 
according to their instructions. Restriction digests were performed in 50 µl total 
reaction volume of which 20 µl consisted of the positive PCR product and 2 µl (20U) 
of each restriction enzyme. The tubes were incubated at 37°C for 2 h and the 
digested products separated in 2% agarose gels stained with ethidium bromide.  
 
Gel electrophoresis  
The electrophoresis apparatus consisted of submerging gel tanks, a selection of 
combs (Anachem Ltd, UK) and a power supply (Electrophoresis power Supply 
500/400, Pharmacia, UK). The gel was first submerged in 1 x TAE buffer, then 
samples were loaded into the wells and run at 80V for 1 h (1.4% gels) or up to 3 h 
(2% gels). The 3 h gel runs were required to obtain good separation of small DNA 
fragments.  
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7:4 RESULTS 
Microscopic examination of sample concentrates – light microscopy 
Sample concentrates from both methods (formal-ether and trisodium phosphate) 
were examined microscopically for helminth ova and protozoan cysts and oocysts. 
The presence of Trichuris spp. ova were found for both York samples with up to 6 
ova being found in each slide for York sample 99.94.6. However, in York sample 
76.81.7 only one Trichuris spp. ovum was found in all the analyses. A single 
Trichuris ovum was found in the Soutra samples (S4). The same York sample that 
contained Trichuris ova (99.94.6), also showed the presence of a single infertile 
Ascaris ovum after analysing 2 slides. These findings were consistent between both 
sample preparation methods of formol-ether concentration and 0.5% trisodium 
phosphate rehydration.  
 
 
Figure 7.5 Parasites discovered in Soutra and York.  
Brightfield microscopy of an infertile Ascaris ovum (A) and a Trichuris ovum (B). 
Parasites are viewed under a total magnification of x250 for Ascaris and x500 for 
Trichuris. Representative photographs of each parasite from 2 replicate slide analysis 
for both formol-ether concentration and 0.5% trisodium phosphate rehydration 
methods are shown. The parasites were viewed under brightfield conditions with an 
Olympus BH-2 microscope fitted with Nomarski DIC optics. Photographs were 
taken (copyright© SPDL) using a ColorView Soft Imaging System MTV-3 camera 
and analySIS® software. 
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Microscopic examination of sample concentrates – Fluorescence stained samples 
G-C FITCmAb was used to visualise Cryptosporidium oocysts and Giardia cysts in 
both formol-ether concentrates and 0.5% trisodium phosphate concentrates. Initially, 
formol-ether concentrates were examined and oocysts of Cryptosporidium identified 
by FITC staining and the inclusion of the nuclear fluorogenic dye, DAPI. 
Identification was confirmed by another member of SPDL staff (Mr G. Spence). 
Sample 76.81.7 from York was found to contain 4 oocysts on the slides showing the 
characteristic size (5 µm x 5 µm) and shape (spherical) of oocysts which also stained 
bright apple green with G-C FITCmAb. Present in the oocyst were 4 DAPI stained 
nuclei indicated by 4 sky blue ‘dots’ (Figure 7.6 C – F). A third method of 
microscopic identification is usually undertaken by viewing viewed under Nomarski 
DIC microscopy (Olympus BH2 microscope, x40 and x100 objectives) however, 
DIC views were unobtainable due to debris obscuring the sample. Soutra samples 
were also found to contain oocysts of Cryptosporidium.  
 
From 2 Soutra samples prepared by 0.5% trisodium phosphate 
rehydration/concentration (S2 and S3), a total of 3 G-C FITCmAb stained, roughly 
spherical bodies of the correct size for Cryptosporidium were found (Figure 7.7). 
They could not be positively identified as Cryptosporidium oocysts when viewed 
under UV-DAPI filters, as these brightly FITC stained objects did not show the 
presence of sporozoite nuclei. This was partly due to the high ‘background’ staining 
of DAPI most likely due to the presence of bacteria in the sample and partly due to 
debris obscuring the field of view (Figure 7.7). 
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Figure 7.6 Fluorescence staining of formol-ether sample concentrates from 
York and Soutra.  
G-C FITCmAb staining of Cryptosporidium spp. oocysts (B, D & F) and DAPI (A, 
C & E) showing 4 distinct nuclei characteristic of Cryptosporidium oocysts. Soutra 
(A & B) and York (C – F). The parasites were viewed under epifluorescence 
microscopy using UV excitation (excitation 355nm, emission 450 nm) with an 
Olympus BH-2 microscope fitted with Nomarski DIC optics at a total magnification 
of x1250. Pictures were taken (copyright© SPDL) using a ColorView Soft Imaging 
System MTV-3 camera and analySIS® software. 
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Figure 7.7 Fluorescence staining of 0.5% trisodium phosphate sample 
concentrates from Soutra.  
G-C FITCmAb staining of Cryptosporidium spp. oocysts A) and DAPI B) showing 
staining of an oocyst like body, having the correct size for Cryptosporidium spp. 
oocysts (5 µm x 5 µm). DAPI staining of sporozoites was not visible and 
confirmation that the object was a Cryptosporidium spp. oocyst could not be made. 
The oocyst like body is shown under epifluorescence microscopy using UV 
excitation (excitation 355nm, emission 450 nm) with an Olympus BH-2 microscope 
fitted with Nomarski DIC optics at a total magnification of x1250. Pictures were 
taken (copyright© SPDL) using a ColorView Soft Imaging System MTV-3 camera 
and analySIS® software. 
 
PCR analysis of samples 
As intact Cryptosporidium oocysts containing sporozoites, as visualised by DAPI 
incorporation, were found in the formol-ether preparations, DNA lysates were 
prepared from the positives slides. Both 18S.a and 18S.b methods were employed to 
identify Cryptosporidium DNA and if possible, differentiate the species. Analysis of 
the G-C FITCmAb and DAPI positive slides from formol-ether concentrates showed 
non-specific amplication of PCR products (Figure 7.8). By using slurries from 0.5% 
trisodium phosphate prepared concentrates it was hoped that this non-specific 
amplification or inhibitory / interference effect would be avoided. Preparation of 
these slurries, DNA lysate, as well as the PCR reactions were all carried out in a 
laboratory which had never handled Cryptosporidium DNA or oocysts. 
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These slurries were subjected to IMS and lysates were prepared directly from oocyst-
bead complexes. They were then analysed for the presence of Cryptosporidium DNA 
using the 18S.a method of Nichols, Campbell and Smith (2003) with either 5 μl or 3 
μl of lysate. This latter concentration of lysate was used to minimise the 
concentration of any inhibitory products from the sample. All the Soutra samples 
were very weakly positive for Cryptosporidium DNA (Figure 7.9) and further 
analysis to confirm this was carried out. Since the positive sample amplicons were of 
the same size, a second gel using selected DNA which had been prepared from 5 μl 
lysates was run on 2% agarose to obtain better separation of small DNA fragments. 
This would help to confirm that the Soutra sample amplicons which were weakly 
positive for Cryptosporidium spp. DNA were of an equivalent size to that of the C. 
parvum DNA positive control.  Soutra samples S4 and S8 were chosen for this gel as 
well as both York samples together with a control negative and a control positive. 
Both the Soutra samples remained very weakly positive and were found to be ~450 
bp in size. This is of comparable size with the C. parvum DNA positive control, 
suggesting that the samples are positive for Cryptosporidium DNA (Figure 7.10). 
However, further analysis would be required to confirm this and so enzymatic 
digestions of the samples were performed. 
 
Enzymatic digestion of positive secondary PCR products and RFLP analysis 
The positive secondary PCR products of the nested-18S.a assay were digested with 
specific restriction enzymes and the fragments separated by electrophoresis in 2% 
agarose gels. Enzymatic cleavage was used to confirm that the investigated samples 
were positive for Cryptosporidium DNA and also to determine which species they 
might be. 
 
RFLP analysis of the amplicons, by simultaneous digestion with the enzymes AseI 
and DraI, demonstrated amplicons of a size compatible with Cryptosporidium 
species. However, the fragmented PCR product amplicon lengths are slightly 
different from C. parvum (as shown with the control DNA sample) and further 
analysis would be required to make a further identification of the species, possibly 
using sequencing technologies (Figure 7.11). 
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Figure 7.8 PCR analysis of Cryptosporidium oocyst positive slides.  
Five oocyst positive samples from Soutra (panels A and B, lanes 3 – 7) and 2 from York 
(panels A and B, lanes 8 – 9) were analysed for the presence of Cryptosporidium DNA using 
A) 18S.a method of Nichols, Campbell and Smith (2003) and B) 18S.b method of Xiao et al. 
(1999, 2000a). Cryptosporidium DNA negative (panels A and B, lanes 1 & 2) and 
Cryptosporidium DNA positive controls (panels A and B, lanes 10 & 11) were also used. 
Unfortunately, parasite DNA was not amplified in this experiment. Samples were run on a 
1.4% agarose gel at 80V for 1 h stained with ethidium bromide. 
 
 
Figure 7.9 PCR analysis for Cryptosporidium DNA in 0.5% trisodium phosphate 
rehydrated/concentrated samples.  
DNA lysates were prepared from all the sample concentrates from 0.5% trisodium phosphate 
rehydration/concentration. They were then analysed for the presence of Cryptosporidium 
DNA using the 18S.a method of Nichols, Campbell and Smith (2003) with either A) 5 μl of 
lysate or B) 3 μl of lysate. Cryptosporidium DNA negative (lanes 1, 2 and 13) and 
Cryptosporidium DNA positive controls (lanes 14 & 15) were used. Lanes 3 – 10 
represent all the samples obtained from Soutra (S1 – S8) and lanes 11 and 12 
represent both York samples (99.94.6 and 76.81.7, respectively). All the Soutra 
samples were very weakly positive for parasite DNA and further analysis to confirm 
this was then carried out. Samples were run on a 1.4% agarose gel at 80V for 1 h 
stained with ethidium bromide. 
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Figure 7.10 PCR analysis for Cryptosporidium DNA from selected 0.5% 
trisodium phosphate rehydrated/concentrated samples.  
Samples which were thought to be positive for Cryptosporidium DNA using the 18S.a 
method of Nichols, Campbell and Smith (2003) were run on a second gel to enhance 
separation of small DNA fragments and confirm their size compared with a known C. 
parvum DNA positive control (lane 6). Two samples from Soutra (S4 and S8; lanes 2 and 3 
respectively) and both York samples (99.94.6 and 76.81.7; lanes 4 and 5, respectively) 
were prepared from all the sample concentrates from 0.5% trisodium phosphate 
rehydration/concentration. Cryptosporidium DNA negative (lane 1) was also used. All the 
Soutra samples were very weakly positive for parasite DNA and were of a size which 
compared to the positive control. Samples were run on a 2% agarose gel at 80V for 2 h 
stained with ethidium bromide. 
 
 
Figure 7.11 A 2% agarose gel electrophoresis analysis of amplicons after 
simultaneous digestion with restriction enzymes DraI and AseI. 
Samples which were thought to be positive for Cryptosporidium DNA using the 18S.a 
method of Nichols, Campbell and Smith (2003) were digested with the enzymes AseI and 
DraI. All 8 samples from Soutra (lanes 1 – 8) were digested along with a C. parvum positive 
DNA control (lane 9). Samples were run on a 2% agarose gel at 80V for 2 h stained with 
ethidium bromide. 
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7:5 DISCUSSION 
Palaeoarchaeological analyses are performed to provide some clues as to the dietary 
behaviours, nutrients, health conditions and the natures of occupation to supplement 
other archaeological evidence of historical habitation. Desiccated, or mineralized, 
coprolites and soils, recovered from archaeological sites, are routinely analysed for 
parasites. Parasites and/or ova have been found in archaeological materials, usually 
from the periods associated with humans (Araujo & Ferreira 2000).  
 
The positive identification of parasites in humans from faeces is a routine operation 
in many laboratories around the world. The methods by which they occur are 
generally through the use of microscopy (fluorescence and bright field) and 
sometimes by the use of molecular techniques. However, samples from antiquity 
provide different and often complicated challenges for the scientist, where sample 
type can often be calcified and dehydrated and requiring weeks to months of 
rehydration before the sample can be examined. In clinical samples one can have an 
idea of what particular parasites to look for, as the sample will often be clearly 
defined and is accompanied with clinical notes telling the patient history. In ancient 
samples, the patient is long dead, leaving behind, at times, only scanty evidence of 
existence. The challenge for the scientist is to be able to not just identify organisms 
but simply to find them in samples. 
 
In this study the latrine sediments of a Viking settlement in York (UK) and soil 
samples from a 14th century AD hospital cess pit were examined microscopically and 
molecularly for the presence of intragastric parasites, with a special emphasis for on 
the protozoan parasites Cryptosporidium and Giardia. Both sample types were found 
to contain ova from Trichuris and one sample from York also contained an ovum 
from Ascaris. All samples were positive for Cryptosporidium spp. oocysts by 
fluorescent microscopy methods. PCR-RFLP analysis of Cryptosporidium positive 
slides indicate that Cryptosporidium spp. was found in the Soutra hospital drain. 
 
In western countries, it has been reported that Ascaris sp. and Trichuris sp. are the 
most commonly encountered ova of parasites from historical sources (Taylor 1955; 
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Pike 1967 & 1968; Jones 1982; Aspock, Auer and Picher 1996). They have been 
reported from as early as the Neolithic, up to the Roman and Saxon eras, in England, 
Germany, Australia, Holland, Poland, Denmark and Israel. Previous findings from 
York and Soutra also discovered these ova (Dr. Brian Moffat, Personal 
Communications 2006; Anon. 1999; Kenward & Hall 1995) and the results provided 
in this thesis are able to confirm these previous findings. 
 
The possible presence of intact oocysts in both the York and Soutra samples prepared 
from formol-ether concentration was at first an exciting prospect, as the only other 
report of Cryptosporidium oocysts being found in antiquity was from the coprolites 
isolated from Peruvian mummies (Ortega & Bonavia 2003). The identification of 
Cryptosporidium spp. oocysts was possible using G-C FITCmAb directed against 
known epitopes. This suggests that not only are the glycoprotein epitopes found on 
the oocyst wall extremely robust, being able to survive at least 4,300 years BP 
(Ortega and Bonavia 2003), but that they are also highly conserved through this 
period of time, with little or no change to their structure.  
 
DNA analysis of historical samples is now, in the past 10 years, being used to 
determine the diagnosis and confirmation of infectious diseases (Araújo et al. 1998). 
An example of this has been the successful diagnosis of trypanosomiasis in South 
American mummies. Initially, the infection was proposed in mummies through the 
microscopic examination of amastigote pseudocysts in mummified tissues 
(Rothhammer 1985; Rothhammer et al. 1985; Fornaciari et al. 1992). The diagnosis 
of this disease in South American mummies was then successfully confirmed using 
PCR techniques (Guhl et al. 1997 & 1999; Ferreira et al. 2000). 
 
In order to determine the presence and identification of Cryptosporidium spp. DNA 
in the archaeological samples, two 2-step nested 18S rRNA gene PCRs (Diagnostic 
and Xiao) for species identification were used. These are published nested PCR 
methods using the 18S rRNA Cryptosporidium gene to determine Cryptosporidium 
species and genotypes (Diagnostic = Nichols & Smith 2004; Nichols, Campbell and 
Smith 2003 & 2006; Xiao = Xiao et al. 1999 & 2001). Unfortunately no 
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Cryptosporidium DNA was amplified using this method from the formol-ether 
concentrates. It was thought that perhaps the presence of formol-ether in the samples 
was at a concentration sufficient to inhibit the PCR reaction. All these examinations 
were originally prepared and analysed at the SPDL.   
 
Whilst the above slides were prepared in the SPDL using standard bench aseptic 
techniques, this facility does handle various types of Cryptosporidium samples (in 
water and faeces) on a regular basis and so the equipment used and the prepared 
formol-ether concentrates could not be absolutely guaranteed to be free of 
Cryptosporidium oocysts. In order to ensure that the parasites observed were not 
some contamination of the sample by oocysts in the atmosphere or on the equipment, 
a secondary lab was used to freshly prepare concentrates (MRSA reference 
laboratory). This facility was in the same hospital grounds as the SPDL, had no 
history of working with Cryptosporidium and was in another building almost half a 
mile from the SPDL. Also, due to the inhibition of the PCR reaction by formol-ether 
concentration, samples were prepared in a solution of 0.5% trisodium phosphate to 
rehydrate followed by centrifugation of the samples to concentrate them. It is not 
known whether this solution would have any adverse affect on the PCR reaction, but 
it has been routinely used in the rehydration of samples for the identification of 
parasites microscopically since the 1940’s (Van Cleave & Ross 1947; Pike 1968). 
 
Where the presence of oocysts was suspected under fluorescence microscopy in 
Soutra samples reconstituted in 0.5% trisodium phosphate and examined, the nested 
2 step 18S rRNA assay (a highly sensitive assay being able to amplify and identify as 
few as 5 oocysts on a single slide) and RFLP analysis of the samples was carried out 
to confirm or deny the presence of Cryptosporidium DNA. Using the diagnostic 
primers (PCR 1 = WR494F [forward] + XiaoR1 [reverse]; PCR2 = CPB-DIAG 
[forward and reverse]) and method of Nichols and Smith (2004) and Nichols, 
Campbell and Smith (2003), amplicons of a length comparable to Cryptospordium 
DNA was demonstrated, suggesting its presence, albeit very weakly in all the 
samples from Soutra, but not York. Further analysis to identify the species of 
Cryptosporidium provided by the CPB-DIAG primers was performed by RFLP using 
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the digestion enzymes DraI and AseI. In this analysis, the presence of 
Cryptosporidium DNA was further confirmed but the species / genotype could not be 
determined. These amplicons elicited the same size of digest fragments, indicating 
that the species of Cryptosporidium found was of the same type in all the Soutra 
samples. These initial results would indicate the first reporting of Cryptosporidium in 
archaeological findings in Europe. 
 
The identification of the Cryptosporidium species found in the Soutra samples could 
have implications as to the health of individuals from 14th C AD at that site, as of the 
19 valid species (Chapter 1; Table 1.4), 8 are known to infect humans and of those 8, 
C. parvum and C. hominis predominate infections (Smith 2008; Smith et al. 2007; 
Feltus et al. 2006; Leoni et al. 2006; Nichols, Campbell and Smith 2006; Caccio et 
al. 2005; Ryan et al. 2004; Xiao et al. 2004). The identification of Cryptosporidium 
species in the Soutra samples could provide hints as to the source of 
Cryptosporidium, i.e. C. meleagridis is known to infect turkeys (Slavin 1955), 
whereas C. baileyi infects chickens  (Current, Upton and Haynes 1986) and C. 
parvum infects man and other mammals (Ng et al. 2008; Zintl et al. 2008; Feltus et 
al. 2006; Xiao et al. 2004; reviewed by O'Donoghue 1995; Current et al. 1983; 
Tzipori et al. 1981; Nime et al. 1976).  
 
The correct identification of the origin of the specimens can pose special problems in 
the validity of data. When faecal material is not obtained from a mummified body, it 
can be difficult to ascertain its origin. Parasites found in faecal material or even in 
the intestines of preserved human remains have to be approached with a degree of 
caution when interpretating the recorded parasitism. For example, the parasite ova or 
cysts may be present in the human digestive tract through the consumption of the 
parasites’ definitive host. The ingestion of contaminated meat or offal was thought to 
be the reason behind the finding of Eimeria mira, a protozoan parasite of the Red 
Squirrel, in the intestines of the Bog Man of Grauballe dated between 1540 and 1740 
years BP (Hill 1990). 
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In this study the Cryptospordium amplicons observed in the Soutra samples were 
found to be of similar size and would indicate a common source. This is potentially a 
worry for the correct identification of this parasite at the site. Two of the stated 
positive samples were taken from topsoil used to infill the site at the time of the 
original excavation and was sourced from another area in Britain (Dr. Brian Moffat, 
Personal Communications 2006). There is the possibility that the parasites, or their 
DNA, was present in the imported soil and has ‘leached’ with the action of water 
downwards to the archaeological layer. This would account for the presence of 
uniform fragment lengths in the PCR-RFLP analysis. However, further PCR-RFLP 
analysis is required to positively identify the species of Cryptosporidium found. With 
this technology and the with the aid of sequencing the DNA found, it may be 
possible to prove or disprove this hypothesis, that there are Cryptosporidium oocysts 
/ DNA present in the samples and that they are of a different species from those 
found in the imported top soil. The use of larger sample volumes in the original 
softening and concentration stage may help increase the quantity of oocysts to be 
found and subsequently, the quantity of DNA to be amplified allowing the 
sequencing of the DNA amplicons. If these techniques determine that the 
Cryptosporidium DNA present in the imported topsoil samples is different from the 
archaeological samples, this will be the first reported finding of Cryptosporidium in a 
European archaeological site. 
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CONCLUSIONS 
 
This series of experiments were designed to determine if PEOs and PRFEs had any 
effect on the viability of 3 protozoan parasites, covering 2 Phyla and 3 Families. The 
organisms tested were the enteric pathogens C. parvum, G. duodenalis and the 
intracellular protozoan T. cruzi. These parasites are responsible for debilitating 
diseases in millions of people worldwide (an estimated 280 million for Giardia and 
16 – 18 million for T. cruzi and over 500, 000 humans thought to have been infected 
with Cryptosporidium during 1983 – 2003 in waterborne outbreaks). Whilst 
chemotherapeutic methods of treatment may be available, there are various factors 
involved in drug management (such as increasing parasite resistance, side effects of 
drugs and their cost) that require new sources of therapeutic compounds to be made 
available.  
 
With Cryptosporidium, only one drug, nitazoxanide, has been used to any great 
effect and is currently licenced for use with immunocompetent patients ≥ 1 years of 
age in the USA (Rossignol 2006; Smith & Corcoran 2004). All other attempts at 
chemotherapy have had mixed results both in vitro and in vivo, but none of over 200 
drugs tested were effective or specific enough in its action for chemotherapeutic use. 
Whilst this parasite causes self limiting diarrhoea in immunocompetent hosts, 
potentially fatal consequences can occur when it infects the very young, the old or 
immunocompromised.  
 
T. cruzi does currently have effective chemotherapy, however, the 2 drugs of choice, 
benznidazole and nifurtimox, are either expensive, difficult to obtain (Weir 2006), 
have poor patient compliance due to lengthy treatments, have side effects and 
parasite resistance to the drug (Buckner et al. 1998). Also, the greatest difficulty in 
treatment is that both drugs are effective in treating the acute phase of infection, 
which can be difficult to diagnose, but not the chronic. It is during the chronic phase 
of infection that most complications and fatalities occur. The most frequently used 
treatment is the management of the clinical manifestations of the disease, such as 
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pacemakers being fitted for heart arrhythmias, chronic heart failure, transplantation 
and surgery for megacolon.  
 
Of the 3 parasites, Giardia is the least complicated to treat by chemotherapy. In the 
majority of cases, a short treatment regimen of tinidazole (Fasigyn®) (2 g once in 
adults) or metronidazole (Flagyl®) (250 mg three times daily 7 days for adults) are 
80% to 95% effective, respectively (Petri 2005). However, it is the common side 
effects of these drugs which are problematic. They have been variously described as 
nausea, headaches, diarrhoea, abdominal cramps, a strong metallic taste, dizziness, 
dark discoloured urine and a disulphiram-like reaction when taken with alcohol 
(nausea and vomiting). These problems can be such that patients will often endure 
the parasite, rather than attempt to cope with the side effects of chemotherapy.  
 
The aims of the project were: i) to determine if any of the tested PEOs and PRFEs 
had antigiardial, antitrypanosomal, or anticryptosporidial effects in vitro; ii) to 
determine the minimum concentration of PEOs and PRFEs required to inhibit the 
growth of G. duodenalis trophozoites and T. cruzi epimastigotes and to affect the 
excystation of C. parvum oocysts; iii) to determine the mode of action of the PEOs 
and PRFEs and compare the inhibitory properties of the PEOs and PRFEs with 
metronidazole; iv) to determine potential active constituents from the composition of 
effective PEOs and their mechanism of action through microscopic and biochemical 
means so that their potential as novel drugs could be evaluated; v) to determine the 
validity of the historical / traditional use of bilberries for the treatment diarrhoea and 
vi) to determine the presence or absence of protozoan parasites in a medieval hospital 
drain and a Viking latrine. 
 
It was demonstrated that PEOs influence the morphology of G. duodenalis 
trophozoites and T. cruzi epimastigotes over time. Also, PEOs can induce the 
spontaneous excystation of C. parvum oocysts in vitro in the absence of recognised 
in vitro excystation triggers, with the exception of time and elevated temperature. 
Bright field microscopy was used to identify morphological changes in the parasites. 
PEOs incubated at a final concentration of 0.02% for 24 h caused the swelling, 
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distortion, blebbing and increased killing of trophozoites in vitro and the contraction, 
rounding and flagellar internalization of epimastigotes (Chapter 2; Figure 2.3 and 
Chapter 4; Figure 4.5 and Table 4.2). All PEOs were equally effective at 0.02% in 
reducing parasite viability by 100%.  In the Cryptosporidium experiments, the 
concentration required to induce spontaneous excystation in the presence of PEOs 
was 0.2%, 10 times greater than that for Giardia trophozoites and Trypanosoma 
epimastigotes. This is possibly due to Cryptosporidium’s robust oocyst wall which is 
known to be resistant to environmental pressures (Nichols, Paton and Smith 2004; 
Robertson, Campbell and Smith 1992) and resistant to disinfection (Angus et al. 
1982; Blewett 1989; Campbell et al. 1982; Korich et al. 1990; Li et al. 2004; 
Pavlasek 1984; Peeters et al. 1989). 
 
The changes to the morphology of both Giardia and Trypanosoma parasites indicate 
an action of PEOs by interaction with the cell / plasma membrane. The formation of 
giant membrane protrusions may or may not be a part of some kind of programmed 
cell death, but may also be due to changes to the structure of the cell / plasma 
membrane caused by the PEOs or their constituents. Changes in the osmoregulation 
of the cell could also be indicated by the swelling and rounding up of Giardia 
trophozoites (Chapter 2; Figure 2.3 B, D and E), which has also been observed by 
Pérez-Arriaga et al. (2006) with curcumin treated trophozoites and by Campanati & 
Monteiro-Leal (2002) with metronidazole treated Giardia trophozoites. Interaction of 
PEO with the cell / plasma membrane is quite possible due to the lipophilic 
properties of PEOs and their ready diffusion across cell / plasma membranes (Boyom 
et al. 2003). Large intracytoplasmic vacuole formation in myrtle treated trophozoites 
(Chapter 2; Figure 2.3 D) indicate that some kind of programmed cell death may 
have been initiated as this has also been observed in curcumin treated trophozoites 
(Pérez-Arriaga et al. 2006).  
 
The inhibition of T. cruzi epimastigote growth by ajoene from garlic has been shown 
to cause changes in the phospholipid composition of the parasites cell membrane, 
leading to the previously most abundant phospholipids, phosphatidylcholine (PC), to 
become the least abundant, with its immediate precursor (phosphatidylethanolamine) 
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becoming the most abundant. This suggests that ajoene exerts its effects by inhibiting 
the final stage of PC biosynthesis and thus, alter the phospholipid composition of the 
cell. This could also be observed ultrastructurally with a concentration dependent 
alteration in intracellular membranous structures such as mitochondrial swelling and 
the aggregation or fusing of membrane vesicles (Urbina et al. 1993). Studies such as 
this may help further elucidate the morphological action of PEOs tested in this thesis.  
 
Protein analyses of myrtle (Myrtus communis L.) and elemi (Canarium luzonicum L.) 
oils demonstrate that they can inhibit the expression of a 37 kDa protein and the 
upregulation of other proteins in Giardia trophozoites. Whilst these particular 
proteins remain unidentified, it clearly shows that these oils can not only affect the 
morphology of the cell but also its biology.  
 
Nuclear enlargement in PEO treated Giardia trophozoites was also observed, 
indicating a possible intracytoplasmic action similar to that found in metronidazole 
treatment (Chapter 2; Figure 2.3 A). Also demonstrated was blebbing and 
cytoplasmic granulation, suggestive of apoptosis, an intriguing proposition as the 
cornerstone for apoptosis, the mitochondrion, is absent in this protist (Chose et al. 
2003). 
 
Unlike the vegetative forms of parasites, oocysts of C. parvum were more resistant to 
the effects of the majority of the PEOs tested. However, sweet fennel (Foeniculum 
vulgare var. dulce BATT. & TRAB.), geranium (Pelargonium graveolens) and 
palmarosa (Cymbopogon martinii (ROXB.) J.F. WATSON) were found to have the 
greatest effects in inducing spontaneous excystation, with palmarosa being 
determined to have the greatest activity. This PEO was able to induce excystation of 
oocysts at levels comparable to that of the maximised in vitro excystation protocol 
(Chapter 3; Figure 3.1). 
 
The antitrypanosomal and antigiardial actions of PEOs were found to be 
concentration dependent. When incubated in different concentrations of PEOs, 2 
were found to have the lowest MICs and were effective against both Giardia 
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trophozoites and Trypanosoma epimastigotes. These oils were myrtle and elemi. 
Increasing the concentration of Giardia trophozoites also required a slight increase in 
the concentration required for 100% killing. This may have connotations for the 
treatment of giardiasis where up to 1 x108 cysts can be excreted per gram of faeces 
(Roxström-Lindquist et al. 2006) indicating a high burden of Giardia trophozoites 
present in the small intestine. The maximum concentration of trophozoites used in 
this thesis was 5 x 107 ml-1 which is likely to be lower than that found in an active 
infection. This would then indicate a greater concentration of oil would be required 
to exert the same antigiardial activity in vivo than with the in vitro concentrations. 
 
Titration of the PEOs identified the MICs required for the complete killing of 
parasites. Studies demonstrated that the oils myrtle and elemi had the greatest 
antigiardial and antitrypanosomal effects with MICs of 0.005% (50 μg ml-1) in G. 
duodenalis trophozoites and at least 0.00125% (12.5 μg ml-1) in T. cruzi 
epimastigotes, with the added effect of killing > 97% at lower concentrations of 
0.000313% (3.13 μg ml-1) for myrtle and 0.000625% (6.25 μg ml-1) for elemi with T. 
cruzi epimastigotes. For Giardia trophozoites, these oils did have greater activity 
than metronidazole when examining the MIC data (myrtle and elemi MIC = 0.005% 
[50 μg ml-1]; metronidazole MIC = 67 μg ml-1) but not when the 90% and 50% 
inhibitory concentrations were investigated. The activity with T. cruzi epimastigotes, 
however, revealed these oils exhibited an IC50 in the range given for benznidazole 
(myrtle IC50 = 0.0002% [2 μg ml-1]; elemi IC50 = 0.0003% [3 μg ml-1]; benznidazole 
IC50 0.73 – 4.4 μg ml-1) identifying these oils as a possible source of novel 
chemotherapy for American trypanosomiasis. This low concentration can also have 
potential implications for therapeutic use, where myrtle oil has been shown to cause 
no detectable skin sensitization when diluted, with both myrtle and elemi capable of 
being used on the skin with low risks of allergic reactions (Tisserand & Balacs 
1995). This would indicate that it is possible to use these PEOs safely to kill 
epimastigotes on the skin surrounding the bite wound of the Reduviid bug, thus 
preventing the entry of viable epimastigotes into the body. 
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Studies by Mikus et al. (2000) and Hoet et al. (2006) have demonstrated that the 
individual constituents of PEOs may exert trypanocidal actions. The terpenic 
constituents’ terpinen-4-ol, E-nerolidol and linalool were all effective at inhibiting T. 
brucei growth in vitro and were highly selective for the parasite and not mammalian 
cells. The constituent terpinen-4-ol was also found to be as selective as the drug 
Suramin® (Mikus et al. 2000). 
 
In those experiments, the terpenic compounds were found to have a greater affect 
than that of the whole oil. All the active PEOs in this thesis contain terpenes, but 
unlike the above examples, they were found to have actions comparable to and 
sometimes less than that of the whole oil. As synthesis of these compounds are 
possible and with them having actions in most cases comparable to the whole oil, it 
may be that the compounds could be manufactured for therapeutic use instead of the 
large scale production of PEOs. An example of such large scale production with low 
yield is the production of myrtle oil. In the PEO industry, myrtle oil production can 
show yields of 0.25 – 0.55% or, in other words, every 100 g of plant material 
distilled will yield only 0.25 – 0.55 g of PEO. This would obviously require a great 
deal of plant material to produce large quantities of this oil. This is precisely the 
problem encountered with production of the antimalarial drug, artemisinin. There is 
an estimated 150 million treatments available from the current world wide stocks of 
Artemisia annua. However, there is an estimated 300 – 500 million cases of malaria 
and the time taken to increase the production from plant material to drug is 
approximately 12 – 18 months (WHO 2007). Also, the yield of the active constituent 
is naturally low in the plant (< 1%) which has lead to the formation of a project to 
increase the yield of artemisinin from the plant to reduce the costs of production (the 
Centre for Novel Agricultural Products Artemisia research project, Dept. of Biology, 
University of York, UK). 
 
The speed at which the PEOs tested demonstrated effects on T. cruzi epimastigotes, 
could have some bearing on the potential application of any of the PEOs as novel 
antitrypanosomal drugs. A rapid antitrypanosomal effect may be useful in limiting 
the risk of infection. With American trypanosomiasis, the bite of an infected 
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Reduviid bug is a means of entry for T. cruzi epimastigotes / metacyclic 
trypomastigotes. Access is via the bite wound, with epimastigotes / metacyclic 
trypomastigotes present in the urine and faeces of the insect contaminating the 
wound when the host scratches the irritated area. All the PEOs investigated in this 
project showed antitrypanosomal activity after 2 h of incubation in vitro. As the 
epimastigotes were killed within 2 h, a topical application of PEO directly to the bite 
and its surrounding area may help clear the skin of potentially infective T. cruzi 
epimastigotes / metacyclic trypomastigotes, thus reducing the risk of infection.  
 
A secondary benefit of some PEOs is that they may actually reduce the irritation 
accompanied with the bite, helping to alleviate the pruritus which will reduce the 
compulsion to scratch the affected area. Evidence to support this theory is the action 
of TTO to reduce histamine induced inflammation and oedema in humans and mice 
(Brand et al. 2002; Koh et al. 2002). As histamine is released to cause the swelling, 
redness and itchiness associated with insect bites it is thought that the ability of the 
oil and its major constituent terpinen-4-ol, to reduce histamine induced inflammation 
can be of benefit in controlling the discomfort of insect bites. Also, PEOs can be 
applied topically, being used safely in aromatherapy at concentrations between 1 and 
30% in inert carrier oils such as almond oil (Tisserand & Balacs 1995). 
 
Considering that the current chemotherapy of Chagas’ disease is effective only 
during the acute phase of infection which can be difficult to detect, the prevention of 
entry to viable epimastigotes / metacyclic trypomastigotes may help in the overall 
treatment and management of T. cruzi infection. Alternatively, plant oils may also be 
used as insect repellents. By reducing contact with infected Reduviid bugs, one can 
limit the chances of infection. Myrtle oil, along with many other PEOs, contains 
citronellol which is in use today in many ‘natural’ insect repellents. 
 
Myrtle, elemi, α-pinene and limonene could all be used internally for giardiasis 
providing they can be delivered to the intestine without being metabolised en route, 
or being adsorbed elsewhere. A drug which can be fast acting and with a greater 
retention time within the target area (in the case of G. duodenalis, the small intestine) 
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would be of great benefit in the reduction of the quantity of drug taken with 
increased efficacy. Data on the bioavailability of plant oils or their constituents are, 
however, scarce.  
 
An alternative to the use of PEOs are the phenolic compounds found in berries. 
Polyphenol-rich extracts of berries were found to reduce G. duodenalis trophozoite 
viability. Of particular interest were 4 extracts from the same Family (Rosaceae). 
These were cloudberry (Rubus chamaemorus), artic bramble (Rubus arcticus), 
strawberry (Fragaria vesca) and blackberry (Rubus fruticosus). All 4 at 
concentrations of 167 µg ml-1 killed 100% of trophozoites within 24 h (Chapter 6; 
Figure 6.1). However, cloudberry showed the greatest antigiardial action being able 
to kill 96 ± 4.4% of trophozoites at 67 µg ml-1, a concentration comparable to that of 
metronidazole (Chapter 6; Figure 6.2). Whilst cloudberry is known to contain high 
levels of ellagitannins, experiments with its degradation product, ellagic acid, 
demonstrated no antigiardial activity (Chapter 6; Figure 6.3). 
 
As the PRFEs investigated are devoid of organic acids and the ellagic acid was found 
not to affect trophozoite viability, the potential remaining classes of phenolic 
compounds in PRFEs with antigiardial properties could be the flavonoids, lignans, 
stilbenes or condensed tannins (Puupponen-Pimiä et al. 2005a).  
 
One such class of constituent, the flavonoids, have over 4000 different flavonoids 
described, categorized into flavonols, flavones, catechins, flavanones, anthocyanidins 
and isoflavonoids. Blueberries may be potentially useful for treating giardiasis. 
Anthocyanins are the major polyphenol constituent of blueberries and appear to be 
prime candidates for the anti-giardial effects reported in this thesis. Although 
anthocyanins have low serum bioavailability in humans, they have considerable 
longevity in the gastrointestinal tract and are known to reach the colon largely 
undegraded (up to 85% of the initial dose) either following their consumption (Kahle 
et al. 2006) or following in vitro simulation of human digestion (McDougall et al. 
2005). This makes them ideal candidates for a potential drug with intragastric action 
and also perhaps as a drug for the treatment of cryptosporidiosis. A possible use for 
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anticryptosporidial activity may be when the sporozoites have invaded enterocytes 
and during the replicative cycle where the release of the actively motile merozoites 
from type I schizonts can infect neighbouring cells. By interfering with either their 
motility or viability the infection could be limited. Investigations into the anti-
sporozoite or merozoite capabilities of berry phenols or plant oils could be carried 
out in vitro. For antigiardial effects to occur, only a small quantity of blueberries 
were required (40 g) and with the antigiardial effect of cloudberry being found to be 
comparable to that of metronidazole, they could be used as food supplements in the 
case of giardiasis for its treatment rather than the current drug therapy with its side 
effects. 
 
However, the anthocyanins are just one of the multitude of different compounds 
found within plants and for the PEOs tested in this thesis, information on the 
bioavailability of terpene compounds (the active class of compounds found in 
palmarosa, geranium, myrtle and elemi oils) is scanty. Further work would need to 
be carried out in this field before one could properly determine their suitability as 
novel antigiardial drugs. Nevertheless, the rapid action of the PEOs in this study has 
shown a potential for novel drug design which could reduce the duration of 
treatment. 
 
Potentially, there may be applications for sweet fennel oil or trans-anethole as a 
means of excysting C. parvum oocysts prior to entry in the small intestine with their 
57% spontaneous excystation rate over 4 h. It is well known that sporozoites of 
Cryptosporidium are unable to survive extremes of pH and that excystation of C. 
parvum oocysts in the stomach, which is too acidic for sporozoite survival (optimal 
pH 6.2, Woodmansee et al. 1987) causing sporozoite lysis, thus reducing enterocyte 
invasion and the subsequent propagation of infection. By utilising the speed at which 
trans-anethole and sweet fennel oil are able to cause spontaneous excystation it may 
be possible induce this action at a site which is unfavourable to the sporozoite 
survival, e.g. the stomach. 
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Further, the slower acting geranium, palmarosa, citronellol and geraniol may also 
have chemotherapeutic uses for cryptosporidiosis. By inducing the release of 
sporozoites prior to the release of oocysts in faeces we can limit the propagation of 
infection, not just in humans as an immediate treatment but also prophylactically in 
cattle and other livestock, a major source of infection for humans (Caccio et al. 
2005). Providing that the pharmacokinetics of these compounds are found to be 
favourable for a sustained exposure in the gut they become prime novel drug 
candidates. With oocyst secretion lasting up to 4 weeks in humans (Baxby, Hart & 
Blundell 1985), this slow action (up to 24 h for peak activity) may help limit the 
propagation of infection through the induction of excystation just prior to release or 
by weakening the oocyst wall so that it becomes environmentally sensitive. 
 
With the demonstrated action of palmarosa, geranium and their terpenic constituents, 
geraniol and citronellol (a breakdown product of geraniol in bacterial metabolism), 
there are possible uses in livestock. By limiting the amount of infected oocysts being 
passed in faeces it is possible to reduce the risk of potential human infection caused 
by the faecal contamination of potable water. Using these compounds in animal feed 
may be one means of control but the treatment of farmyard faecal slurry may also be 
of benefit especially as geraniol is known to safely and rapidly biodegrade in the soil. 
 
Some hazard information is currently available for the compounds citronellol, 
geraniol and trans-anethole as well as geranium, palmarosa and sweet fennel PEOs. 
All 3 constituents and PEOs are currently used in food as flavourings. Indeed, the US 
FDA considers them all as GRAS for food use (FDA Food additive status list 2006; 
FFDCA 2004).  The WHO have assessed that citronellol most likely metabolises to 
harmless substances based on data on a corresponding substance (geraniol) and that 
the majority of the compound is eliminated in the urine. Both citronellol and geraniol 
are used as synthetic flavourings being GRAS (FDA Food additive status list 2006; 
FFDCA 2004). This may allow their potential use internally as chemotherapeutic 
compounds. 
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Historically, many PEOs and extracts, such as TTO, myrrh and clove, have been 
used as topical antiseptics, or have been reported to have antimicrobial properties 
(Hoffman 1987; Lawless 1995). Also the use of fruit as medicine in the treatment of 
diarrhoea has been shown historically (Dr. Brian Moffat, Personal Communications 
2006; Webber and Watson 1998; Anon 1825). It is important to investigate 
scientifically those plants which have been used in traditional medicines as potential 
sources of novel antimicrobial compounds (Mitscher et al. 1987). Samples of soil 
from a medieval hospital drain demonstrated the possible presence of 
Cryptosporidium spp. oocysts, or at least their DNA (Chapter 7). If their presence 
could be confirmed and if further analysis of the samples could find plant material 
associated with this protozoan, it may be possible to identify remedies in use at that 
hospital for the treatment of cryptosporidiosis, or its symptoms. That is, of course, id 
the Cryptosporidium species can be identified and is 1 of the 8 species which are 
known to infect humans. 
 
The historical use of blueberries for the treatment of diarrhoea was demonstrated 
with the juice and polyphenol rich extract of this fruit being able to inhibit Giardia 
trophozoite viability at concentrations to be found in the equivalent of 40 g of 
blueberries. Also demonstrated were the exceptional properties of one family of 
fruits (Rosaceae) which had strong antigiardial activity, with cloudberry PRFE in 
particular being comparable to metronidazole. 
 
This is the first time that such an extensive screening of PEOs and PRFEs has been 
carried out on G. duodenalis trophozoites, T. cruzi epimastigotes and C. parvum 
oocysts. This study has shown that PEOs were effective in inhibiting G. duodenalis 
trophozoite and T. cruzi epimastigote viability over a 24 h incubation period at final 
concentrations in the microtitre well of 0.02%. Furthermore, the trophozoites of 
Giardia and epimastigotes of Trypanosoma were found to be more sensitive to oils 
of myrtle and elemi, with a MIC for these PEOs of 0.005% (50 μg ml-1) for Giardia 
and 0.00125% (12.5 μg ml-1) for Trypanosoma. Antigiardial actions of PEOs were 
found to be rapid, with all but myrrh acting within 60 min of incubation. Further 
analysis of the PEOs suggests that the monoterpenes α-pinene, from myrtle oil and 
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limonene, from elemi, were the active constituents found within the oil responsible 
for the killing of G. duodenalis trophozoites and Trypanosoma epimastigotes in vitro. 
The effect of spontaneous excystation of Cryptosporidium oocysts in the absence of 
all recognised triggers except temperature caused by palmarosa, geranium, sweet 
fennel oil and the terpenes geraniol and citronellol, would argue that they might be 
acting in 1 of 2 ways; i) that the PEOs augment the effect of temperature on oocyst 
excystation by increasing oocyst wall permeability through pore formation or 
integration with oocyst wall or ii) the reverse hypothesis, that an increase in 
temperature causes an activation of spontaneous excystation initiated by the PEOs. 
 
All these data indicate that there is potential use for plant oils, plant extracts and their 
constituents as novel drugs for the treatment of protozoan parasitic infections. Their 
uses could vary from the intragastric treatment of infection to the topical application 
of oils / constituents to prevent parasite entry into the blood stream and tissues. Apart 
from direct treatment of human infection, limiting the propagation of parasites in 
livestock may also be possible. 
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APPENDICES 
Appendix 1: Plant essential oils used.
 
Family: Apiaceae, Foeniculum vulgare var. dulce BATT. & TRAB. (Sweet Fennel). Fennel 
is an erect growing perennial herb native to southern Europe and the Mediterranean area. 
Reaching a height of 1.5 metres (5 feet), the plant has yellow flowers on a compound umbel. 
Approximately 60 percent of the essential oil is located in the fruit/seeds, with the rest in the 
rays of the umber and other green plant parts. Illustration: Köhler’s Medicinal Plants, 1887. 
Photograph: Wikipedia, Carsten Niehaus, 2005. 
 
 
 
Family: Burseraceae, Canarium luzonicum L. (Elemi). It is a tropical tree from the 
Philippines that can grow up to 30 metres (98 feet) high. The tree exudes a pale yellow resin 
when the tree sprouts leaves. The aromatic oil is steam distilled from this resin. Illustration: 
Köhler’s Medicinal Plants, 1887. 
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Family: Burseraceae, Commiphora myrrha (NEES) ENGL. (Myrrh). The myrrh plant is a 
pubescent perennial, up to 90 cm (3 feet) in height, with thin, soft, pinnate leaves which 
grow in the Middle East and eastern Africa. The dark yellow or reddish brown resin is 
exuded naturally or from incisions made in the bark with the aromatic oil being distilled 
from this exudate. Illustration: Köhler’s Medicinal Plants, 1887.  Photograph: Anon. 
 
 
 
 
 
Family: Geraniaceae, Pelargonium graveolens (Geranium/Rose Geranium). The woody, 
perennial herb is native to South Africa and is produced in Egypt, France, the People's 
Republic of China, Algeria, South Africa, Morocco and Spain. Reaching a height of 1 metre 
(~ 3 feet), the plant has pubescent, fragrant, green, deeply lobed leaves and rose-colored 
flowers. The essential oil accumulates in small glands found in the foliage and flowers. 
Illustration: Flore des serres et des jardins de l’Europe by Charles Lemaire et al. Gent, 
Louis van Houtte, 1850, volume 6, plate 607. Photograph: Wikipedia, Eric Hunt, 2005. 
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Family: Lamiaceae, Lavandula angustifolia MILLER (Lavender). Lavender is the name for 
any of several aromatic shrubs, including English lavender, Lavandula angustifolia Mill. 
subsp. angustifolia and French lavender, Lavandula dentata L. English lavender is native to 
southern Europe and the Mediterranean area. Cultivated extensively for perfume and 
ornamental purposes in several European countries, the plant reaches a height of about 1 
metre (~ 3 feet), has linear, lanceolate leaves covered with a velvety pubescence and 
develops blue or purple flowers. Lavender oil is obtained by the immediate steam distillation 
or solvent extraction of flowers harvested at full bloom. Illustration: Köhler’s Medicinal 
Plants, 1887. Photograph:  J-P Anthony, Botanic Gardens, Glasgow, 2004 (copyright© 
SPDL and QMU). 
 
 
 
 
Family: Lamiaceae, Origanum majorana L. (Marjoram). Marjoram is a tender perennial 
herb native to North Africa and southwest Asia and naturalized in southern Europe. The 
plant reaches a height of 50 cm (1.5 feet) and has small, grey-green, ovate leaves, pink or 
purple flowers and erect, glabrous to tomentose stems. Harvesting is generally accomplished 
at full bloom and can be done 2 or three times per year with the oil obtained by the steam 
distillation of plant material. Photograph: Wikipedia, Mark Pellegrini, 2005. 
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Family: Lamiaceae, Pogostemon cablin (BLANCO) Benth. (Patchouli).The patchouli plant 
is a bushy herb reaching 75 – 90 cm (2 – 3 feet) in height with soft, opposite, egg-shaped 
leaves and square stems. It is a tropical member of the mint family, native to southeast Asia 
and is cultivated in the East and West Indies. Leaves are harvested several times a year, dried 
and exported for distillation of the oil, although the highest quality oil is usually produced 
from fresh leaves, distilled close to the plantation. Photograph: J-P Anthony, Botanic 
Gardens, Glasgow, 2004 (copyright© SPDL and QMU). 
 
 
 
 
 
Family: Lamiaceae, Thymus vulgaris L. (Thyme). Thyme is the general name for the many 
herbs of the Thymus species, all of which are small perennial plants native to Europe and 
Asia. Common or garden thyme, Thymus vulgaris L., is considered the principal type and is 
utilized commercially for flowering and ornamental purposes. This low-growing woody 
shrub has grey-green leaves and white, pink, or purple flowers. Harvesting is generally 
accomplished at full bloom with the oil obtained by the steam distillation of plant material. 
Illustration: Köhler’s Medicinal Plants, 1887. Photograph: J-P Anthony, Botanic Gardens, 
Glasgow, 2004 (copyright© SPDL and QMU). 
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Family: Myrtaceae, Myrtus communis L. (Myrtle). The Myrtle is an evergreen shrub or 
small tree, growing to 5 metres (15 feet) tall, native to southern Europe and north Africa. The 
leaves are entire, 3-5 cm long, with a pleasantly fragrant essential oil. The star-like flowers 
have five petals and sepals and an amazingly large number of stamens. Petals are usually 
white, with globose blue-black berries containing several seeds. Steam distillation of the 
leaves and twigs produce the essential oil. Illustration: Prof. Dr. Otto Wilhelm Thomé Flora 
von Deutschland, Österreich und der Schweiz 1885, Gera, Germany. Photograph: Wikipedia, 
Iorsh, Mount Carmel, Israel, 2004.  
 
 
Family: Poaceae, Cymbopogon martinii (ROXB.) J.F. WATSON (Palmarosa). It is a wild 
growing, herbaceous perennial green and straw-coloured grass, native to India and Pakistan, 
with long slender stems, terminal flowering tops and fragrant grassy leaves reaching 1.5 
metres (3 feet) in height. It is harvested before the flowers appear and the highest yield is 
obtained when the grass is fully dried. 
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Family: Rutaceae, Amyris balsamifera L. (Amyris or Balsam Torchwood). A native of the 
Caribbean and Gulf of Mexico this perennial small bushy tree with oval, opposite leaves and 
star-like, pink – red flowers with 4 petals. The essential oil is produced from the steam 
distillation of the wood. Illustration: Köhler’s Medicinal Plants, 1887. Photograph: Anon. 
 
 
 
Family: Rutaceae, Agathosma (prev. Barosma) betulina (P.J. BERGIUS) BART. & 
WENDL. (Buchu). A low, white or pink-flowered shrubs native to South Africa chiefly 
found in the south-west region of Cape Colony. The leaves are of a pale green colour, 1/2 to 
3/4 inch long, 1/2 inch or less wide, leathery and glossy, with a blunt, strongly-curved tip 
and finely-toothed margin, with round oil glands scattered through the leaf. The leaves have 
a strongly aromatic taste and a peppermint-like odour and are steam distilled for their oil. 
Illustration: Köhler’s Medicinal Plants, 1887. Photograph: Anon. 
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Appendix 2: Soft fruits used. 
 
Family: Elaegnaceae, Hippophae rhamnoides (Sea Buckthorn). There are three species, 
native over a wide area across Europe and Asia. They reach 0.5 – 6 m tall, rarely up to 18 m 
in central Asia and typically occur in dry, sandy areas. The Hippophae rhamnoides is by far 
the most widespread, with a range extending from the Atlantic coasts of Europe right across 
to northwestern China. Sea-buckthorn branches are dense and stiff and very thorny. The 
leaves are a distinct pale silvery-green, lanceolate, 3 – 8 cm long and less than 7 mm broad. 
It is dioecious, with separate male and female plants. The male produces brownish flowers 
which produce wind-distributed pollen. The female plants produce orange berries 6 – 9 mm 
in diameter, soft and juicy and rich in vitamin C, some varieties are also rich in vitamin A, 
vitamin E and oils. Illustration: Johann Georg Sturm, Deutschlands Flora in Abbildungen. 
1796. (Painter: Jacob Sturm). Photograph: Wikipedia, Sander van der Molen, 2006. 
 
 
 
Family: Ericaceae, Vaccinium myrtillus (Bilberry). Bilberry is a name given to several 
species of low-growing shrubs in the genus Vaccinium (family Ericaceae) that bear tasty 
fruits. The species most often referred to is Vaccinium myrtillus L., also known as blaeberry, 
whortleberry, whinberry (or winberry), myrtle blueberry, fraughan and probably other names 
regionally. Bilberries are found in damp, acidic soils throughout the temperate and subarctic 
regions of the world.  Illustration: Prof. Dr. Otto Wilhelm Thomé Flora von Deutschland, 
Österreich und der Schweiz 1885, Gera, Germany. Photograph: Wikipedia, Marek Silarski, 
2005. 
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Family: Ericaceae, Vaccinium vitis-idaea L. (Lignonberry/Cowberry). This is a small 
evergreen shrub in the flowering plant family Ericaceae that bears edible fruit. It is seldom 
cultivated, but the fruits are commonly collected in the wild. The native habitat is the 
circumboreal forests of northern Eurasia and North America, extending from temperate into 
subarctic climates. Cowberry shrubs of both varieties are typically 10 – 40 cm in height and 
have a compact habit. The species resembles the related and similar cranberry (Vaccinium 
oxycoccus, V. microcarpum and V. macrocarpon), differing mainly in having white (not 
pink) flowers, with the petals partially enclosing the stamens and stigma (the petals are 
reflexed backwards in cranberries) and rounder, less pear-shaped berries. Other related plants 
in the genus Vaccinium include blueberries, bilberries and huckleberries.  Illustration: C. A. 
M. Lindman, Bilder ur Nordens Flora, Projekt Runeberg: published 1917–1926. Photograph: 
Wikipedia, Jonas Bergsten 2005. 
 
 
 
 
Family: Grossulariaceae, Ribes nigrum (Blackcurrant). A native of central and northern 
Europe and northern Asia, it is a small shrub growing 1 – 2 metres (3 – 6 feet) in height. The 
leaves are alternate, simple, 4 – 9 cm long and broad and palmately lobed with five lobes, 
with a serrated margin. The flowers are 4 – 6 mm diameter, with five reddish-green to 
brownish petals; they are produced in racemes 5 – 10 cm long. The fruit is an edible berry 1 
cm diameter, very dark purple in colour, almost black, with a glossy skin and a persistent 
calyx at the apex and containing several seeds. Illustration:  Groningen, J.B. Wolters, 
Nederlandsche flora en pomona beschreven en uitgegeven door het bestuur der 
Pomologische Vereeniging te Boskoop, by K.J.W. Ottolander, A. Koster & C. de Vos 
(editors) 1876-1879. Chromolithograph by A.J. Wendel. Photograph: Wikipedia, Jerzy 
Opiola, 2006. 
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Family: Punicaceae, Punica granatum L., (Pomegranate). This is a fruit-bearing deciduous 
shrub or small tree growing to 5 – 8 metres (16 – 27 feet) tall. The pomegranate is native 
from Iran to the Himalayas in northern India and has been cultivated and naturalized over the 
whole Mediterranean region including Armenia since ancient times. It is widely cultivated 
throughout Iran, India, the drier parts of southeast Asia, Malaya, the East Indies and tropical 
Africa. The leaves are opposite or sub-opposite, glossy, narrow oblong, entire, 3 – 7 cm long 
and 2 cm broad. The flowers are bright red, 3 cm in diameter, with five petals (often more on 
cultivated plants). The fruit is between an orange and a grapefruit in size, 7 – 12 cm in 
diameter with a rounded hexagonal shape and has thick reddish skin and around 600 seeds. 
The edible parts are the seeds and the red seed pulp surrounding them; indeed, the fruit of the 
pomegranate is a berry. Illustration: Prof. Dr. Otto Wilhelm Thomé Flora von Deutschland, 
Österreich und der Schweiz 1885, Gera, Germany. Photograph: Wikipedia, Luis Fernandez 
Garcia, 2003. 
 
 
 
 
Family: Rosaceae, Rubus arcticus (Artic Bramble). The arctic bramble can grow up to 30 
cms (12 inches) tall. It is spineless and the leaves have three fingers. The plant flourishes in 
June – July with rose-red flowers which are alone, 2 by 2 or three by three. The flowers are 
either male or female, with both sexes eventually present in the same plant. The fruits are 
dark brown/red, very aromatic and maturation begins in August. It is distrubuted in the 
northern hemisphere mostly in Scandinavian countries, Canada and the more temperate 
regions of Asia.. Illustration: C. A. M. Lindman, Bilder ur Nordens Flora, Projekt Runeberg: 
published 1917–1926. Photograph: Kore Wild Fruit Nursery, 2005. 
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Family: Rosaceae, Rubus fruticosus (Blackberry). Growing to 3 metres (10 feet) and 
producing a soft-bodied fruit, this plant is common throughout the temperate regions 
including North America and Europe. It has palmate or pinnate compound leaves of three to 
five leaflets with flowers of white or pink appearing from May to August, ripening to a black 
or dark purple fruit, the blackberry or “bramble”. In proper botanical language, it is not a 
berry at all, but instead an aggregate fruit of numerous drupelets. Illustration: Nederlandsche 
flora en pomona beschreven en uitgegeven door het bestuur der Pomologische Vereeniging 
te Boskoop, by K.J.W. Ottolander, A. Koster & C. de Vos (editors). Groningen, J.B. 
Wolters, [1875-] 1876-1879. Chromolithograph by A.J. Wendel. Photograph: Wikipedia, G. 
King, 2002. 
 
 
 
Family: Rosaceae, Rubus chamaemorus (Cloudberry). This is a slow-growing alpine or sub-
arctic species of Rubus, producing amber-colored edible fruit. The cloudberry grows to 10 – 
25 cm high. The leaves alternate between having 5 and 7 soft, handlike lobes on straight, 
branchless stalks. After pollination, the white (sometimes reddish-tipped) flowers form 
raspberry-sized berries. Encapsulating between 5 and 25 drupelets, each fruit is initially pale 
red, ripening into an amber colour in early autumn. Cloudberries occur naturally throughout 
the Northern Hemisphere mainly in mountainous areas. In Europe and Asia, they grow in the 
Nordic countries, the moorlands of Britain and Ireland, the Baltic states and across northern 
Russia east to the Pacific Ocean. Small populations are also found further south, as a 
botanical vestige of the Ice Ages; it is found in Germany's Weser and Elbe valleys, where it 
is under legal protection. In North America, cloudberries grow wild across most of Canada 
and Alaska and in the lower 48 states of the United States in northern Minnesota, New 
Hampshire, Maine and a small population on Long Island, New York. Illustration: C. A. M. 
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Lindman, Bilder ur Nordens Flora, Projekt Runeberg: published 1917–1926. Photograph: 
Wikipedia, Veli Holopainen, 2004. 
 
 
 
Family: Rosaceae, Rubus idaeus (Raspberry). This is a commonly cultivated edible soft 
fruit for commercial purposes and is frequently found throughout the United Kingdom and 
Europe. This shrub grows to around 1.5m high with the leaves being pinnate with 3 -7 ovate 
leaflets. Their flowers are about 1 cm across and are white and the fruits are an aggregate of 
numerous drupelets. Illustration: Köhler’s Medicinal Plants, 1887. Photograph: Wikipedia, 
Juhanson, 2004. 
 
 
 
Family: Rosaceae, Fragaria vesca (Woodland/Wild Strawberry). This vastly edible soft 
fruit is common to the Northern Hemisphere (temperate Asia, Europe and North America) 
where it has been cultivated for its fruit for many years. A larger fruit variety is now 
cultivated which is a hybrid (Fragaria x ananassa – Garden Strawberry). This herbaceous 
perennial plant spreads by seed, short rhizomes and leafless stolons. The toothed leaves are 
thin and basal with a petiole generally 3 – 12 cm. They appear in leaflets of 3 and are 
sparsely hairy above. The flowers have 5 white petals with numerous pistils and 20 – 35 
stamens. The five bractlets are often bilobed. The red fleshy fruit is covered with achenes. 
Illustration: Prof. Dr. Otto Wilhelm Thomé Flora von Deutschland, Österreich und der 
Schweiz 1885, Gera, Germany. Photograph: Wikipedia, Philip Jagenstedt, 2005. 
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Family: Rosaceae, Sorbus aucuparia (Rowan). They are native throughout the cool 
temperate regions of the northern hemisphere, with the highest species diversity in the 
mountains of western China and the Himalaya, where numerous apomictic microspecies 
occur. Rowans are mostly small deciduous trees 10 – 20 metres (30 – 67 feet) tall, though a 
few are shrubs. The best known species is the 'Rowan Clark' Sorbus aucuparia, a small tree 
typically 4 – 12 metres (13 – 40 feet) tall growing in a variety of habitats throughout 
northern Europe and in mountains in southern Europe and southwest Asia. Its berries are a 
favourite food for many birds and are a traditional wild-collected food in Britain and 
Scandinavia.The leaves are arranged alternately and are pinnate, with (8)-11– 35 leaflets. 
The flowers are borne in dense corymbs; each flower is creamy white and 5 – 10 mm across 
with five petals. The fruit is a small pome 4-8 mm diameter, bright orange or red in most 
species, but pink, yellow or white in some Asian species.  Illustration: Prof. Dr. Otto 
Wilhelm Thomé Flora von Deutschland, Österreich und der Schweiz 1885, Gera, Germany. 
Photograph: Wikipedia, Krzysztof P. Jasiutowicz, 2005. 
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Appendix 3. Gas chromatography-Mass spectroscopy of plant oils used. 
Elemi:  
1 – α-Pinene (0.52%) 
3 – β-Pinene (0.23%) 
5 – Sabinene (5.34%) 
7 – Hyrcrene (0.44%) 
8 – α-Phelanohene (16.23%) 
9 – α-Teyinene (0.31%) 
10 – Limonene (51.54%) 
11 – β-Phelandrene (2.39%) 
13 – C. β-Ocimene (0.34%) 
15 – γ-Teyinene (0.2%) 
16 – T. β-Ocimene (0.25%) 
18 – Para-Cymene (1.41%) 
19 – Terpinolene (0.92%) 
74 – α-Terpinene (1.64%) 
99 – Methyl Eugenol (0.32%) 
A – Elemol (10.9%) 
B – Elemicine (4.37%) 
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Myrtle: 
1 – α-Pinene (51.72%) 
A – Unknown (0.39%) 
3 – β-Pinene (0.54%) 
6 – Δ,3-Carene (0.66%) 
9 – α-Teyinene (0.46%) 
10 – Limonene (8.34%) 
12 – 1,8-Cineole (22.25%) 
15 – γ-Teyinene (0.29%) 
16 – Unknown (0.233%) 
18 – Para-Cymene (1.83%) 
19 – Teyinolene (0.89%) 
48 – Linalool (3.67%) 
51 – Actelinalyle (0.6%) 
56 – β-Caryophyllene (0.7%) 
59 – Teyinene (0.31%) 
MC – Methyl chavicol (0.13%) 
72 – Unknown (0.41%) 
74 – γ-Teyineol (1.91%) 
85 – Acte Geranyle (1.96%) 
92 – Geraniol (0.3 / 0.1%) 
99 – Unknown (0.41%) 
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Myrrh: 
1 – D-Elemene (0.71%) 
4 – Unknown (0.07%) 
9 – Unknown (0.23%) 
10 – β-Elemene (3.63%) 
13 – Elemene (1.14%) 
18 – D-Germacrene (0.98%) 
23 – Unknown (0.8%) 
26 – β-Germacrene (2.18%) 
28 – Curezene (26.39%) 
32 – Unknown (1.5%) 
37 – Furano (Endem – 1,3 diene) (31.97%) 
38 – Unknown (7.49%) 
44 – Unknown (6.75%) 
 319
 
 320
 
 321
 
 322
 
 323
 
 324
Sweet Fennel: 
1 – Fenchone 
2 – trans-anethole 
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Geranium: 
1 – Citronellol 
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Palmarosa: 
1 – Geraniol 
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Appendix 4. Keister modification of TYI-S-33 medium 
 
K2HPO4  2 g (BDH Ltd., UK) 
KH2PO4  1.2 g (BDH) 
Casein Digest peptone  40 g (BD-Difco, USA) 
Yeast Extract  20 g (BD-Difco) 
Glucose  20 g (BDH) 
NaCl  4 g (BDH) 
Cysteine HCl Monohydrate  4 g (Gibco-BRL) 
L Ascorbic acid  400 mg (Sigma-Aldrich) 
Ferric Ammonium Citrate  45.6 mg (Sigma-Aldrich) 
Dehydrated Bovine Bile  2 g (Sigma-Aldrich) 
 
Dissolve above in 1 L distilled water and adjust pH to 7.0 with 1M Sodium 
hydroxide (NaOH). Adjust the final volume to 1800 ml with distilled water and then 
filter with a Whatman No. 1 filter paper or equivalent. Dispense into sterile 100 ml 
bottles after further filtering with a peristaltic pump and a 0.45 μm membrane filter 
(Sartorius, Germany) and store at -20oC. 
 
When culturing parasites thaw the required volume of basic medium and add 10% 
heat inactivated bovine (or equine) serum and 200 μl / 100 ml Gentamicin sulphate 
(10 mg ml-1 stock; Gibco-BRL) and filter with a 0.2 μm membrane filter (Sartorius). 
 
Sterile complete medium can be stored at 4oC for 2 weeks.  This is often dispensed 
into 16 x 110 mm flat sided culture tubes, which are canted at a 5° angle from the 
horizontal, filled to 90 – 95% of its capacity. 
 
 
 
 
 
 331
Appendix 5. SDS-Polyacrylamide gel electrophoresis 
 
Preparation of reagents 
 
1. Acrylamide/Bis (30% T, 2.67% C) (Solution A) 
29.2 g acrylamide (Sigma-Aldrich, UK) 
0.8 g N'N'-bis-methylene-acrylamide (Sigma-Aldrich) 
Make to 100 ml with deionised water. Filter and store at 4 °C in the dark (30 
days maximum.) 
 
2. 10% (w/v) Sodium dodecylsulphate (SDS) 
Dissolve 1 g SDS (Sigma-Aldrich) in 90 ml water with gentle stirring and 
bring to 10 ml with deionised water. Store at room temperature. 
 
3. 1.5 M Tris-HCl, pH 8.8 buffer solution (Solution B) 
18.15 g Tris base (Sigma-Aldrich) 
80 ml deionised water 
Adjust to pH 8.8 with 6 N HCl and bring the total volume to 100 ml with 
deionised water and store at 4 °C.  
 
4. 0.5 M Tris-HCl, pH 6.8 buffer solution (Solution C) 
6 g Tris base (Sigma-Aldrich) 
60 ml deionised water 
Adjust to pH 6.8 with 6 N HCl and bring the total volume to 100 ml with 
deionised water and store at 4 °C.  
 
5. Sample Buffer 
3.55 ml deionised water 
1.25 ml 0.5 M Tris-HCl, pH 6.8 (Solution C) 
2.5 ml Glycerol (BDH) 
2.0 ml 10% (w/v) SDS 
0.2 ml 0.5% (w/v) Bromophenol blue (BDH) 
0.5 ml 2-Mercaptoethanol (BDH) 
10 ml total volume. 
Store at room temperature. 
 
6. 10x Electrode (Running) Buffer, pH 8.3 (makes 1 L) 
30.3 g Tris base  
144.0 g Glycine (Sigma-Aldrich) 
10.0 g SDS 
Dissolve and bring total volume up to 1,000 ml with deionised water. Do not 
adjust pH with acid or base. Store at 4 °C. If precipitation occurs, warm to 
room temperature before use. Mix thoroughly before use. 
 
7. 10% Ammonium persulphate (APS) (made fresh daily) 
100 mg APS (Sigma-Aldrich) 
Dissolved in 1 ml of deionised water. 
 
 332
8. Fixative solution 
25 ml 100 % Methanol (BDH) 
7 ml Glacial Acetic Acid (BDH) 
75 ml deionised water 
Prepare a 25 % (v/v) Methanol solution by combining the above volumes of 
methanol and water and then remove 7 ml of this. Replace the removed 
volume with 7 ml glacial acetic acid. This fixative solution can be re-used 
several times. Store at room temperature. 
 
9. Colloidal blue G staining solution 
40 ml 1x Colloidal blue G solution (Sigma-Aldrich) 
10 ml 100 % Methanol 
Prepare a 1x working solution of colloidal blue G as per the manufacturer’s 
instructions and store at 4°C. Ensure that the solution is thoroughly mixed 
before removing a 40 ml aliquot and to this add 10 ml 100% methanol. Mix 
well before pouring onto gel and prepare this solution immediately before 
use. 
 
10. Acetic Acid Destain 
25 ml 100 % Methanol (BDH) 
10 ml Glacial Acetic Acid (BDH) 
75 ml deionised water 
Prepare a 25 % (v/v) Methanol solution by combining the above volumes of 
methanol and water and then remove 10 ml of this. Replace the removed 
volume with 10 ml glacial acetic acid. Store at room temperature. 
 
11. Methanol Destain 
25 ml 100 % Methanol (BDH) 
75 ml deionised water 
Prepare a 25 % (v/v) Methanol solution by combining the above volumes of 
methanol and water. Store at room temperature. 
 
 
Casting of Polyacrylamide gels (Bio-Rad Mini-Protean 3 system) 
 
1. Place the Casting Frame upright with the pressure cams in the open position 
and facing forward on a flat surface. 
 
2. Place a Short Plate on top of the Spacer plate. 
 
3. Orient the Spacer Plate so that the labelling is "up". Slide the 2 glass plates 
into the Casting Frame, keeping the Short Plate facing the front of the frame 
(side with pressure cams). 
 
4. Ensure both plates are flush on a level surface and labelling on the Spacer 
Plate is oriented correctly. Leaking may occur if the plates are misaligned or 
oriented incorrectly. 
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5. When the glass plates are in place, engage the pressure cams to secure the 
glass cassette sandwich in the Casting Frame. Check that both plates are flush 
at the bottom. 
 
6. Engage the spring loaded lever and place the gel cassette assembly on the 
grey casting stand gasket. Insure the horizontal ribs on the back of the 
Casting Frame are flush against the face of the Casting Stand and the glass 
plates are perpendicular to the level surface. The lever pushes the Spacer 
Plate down against the grey rubber gasket. Mark out level of separating gel 
required (~ 5mm lower than the base level of the comb). 
 
7. Prepare the separating gel (12% Acrylamide gel). The volumes given below 
is enough to prepare 2 0.75 mm thick gels:   
3.4 ml Deionised water 
     4.0 ml Solution A  
2.5 ml Solution B  
0.1 ml 10% SDS 
 
8. Degas under vacuum for minimum of 15 min in a conical flask with side arm 
to remove oxygen which inhibits the polymerisation of acrylamide. 
 
9. Immediately prior to pouring the gel, add the catalyst: 
     50 µl 10% APS  
10 µl   N,N,N’, N’-Tetramethylethylenediamine 
(TEMED; Sigma-Aldrich) 
 
10. Carefully pour the separating gel in between the glass plates and apply a thin 
layer of isopropanol on top of each gel before it sets to remove air bubbles. 
The gel should be left for 30 min to allow it to fully polymerise. 
 
11. During this time, prepare the stacking gel (4% acrylamide): 
6.1 ml Deionised water 
     1.5 ml Solution A  
2.5 ml Solution B  
0.1 ml 10% SDS 
 
12. Degas under vacuum for minimum of 15 min in a conical flask with side arm. 
 
13. Remove the isopropanol by diluting and rinsing it with deionised water. Blot 
off the remaining water, using dry filter paper. 
 
14. Immediately prior to pouring the stacking gel, add the catalyst: 
     50 µl 10% APS  
5 µl TEMED 
 
15. Gently pour the stacking gel on top of the polymerised separating gel and 
insert the appropriate well comb, place in polythene bag and place in 37ºC 
incubator for up to 150 min. 
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16. Ensure that the stacking gel has polymerised. Remove the comb gently and 
pour the 1x running buffer onto solidified stacking gel. Store at 4ºC in a zip 
lock bag until required. 
 
 
Staining of SDS-PAGE gels 
 
1. Once the electrophoresis run is complete, disassemble the clamping frame 
and gel cassette sandwich. Carefully separate the 2 plates of the gel cassette. 
 
2. Run the sharp edge of the Gel Releaser along each spacer to separate the gel 
from the spacer. Remove the gel by floating it off the glass plate by inverting 
the gel and plate under the fixative solution and gently moving the plate in 
the buffer until the gel separates from the plate. 
 
3. Rinse the Mini-Protean 3 cell electrode assembly, Clamping Frame and Mini 
Tank with distilled, deionised water after use. 
 
4. Keep the gel in the fixative solution for at least 1 h then gently pour off the 
solution, replacing it with freshly prepared Colloidal blue G staining solution 
for up to 2 h. The gel may be placed in fixative solution overnight if required 
without any adverse effects, just as staining the gel overnight will only lead to 
a longer destaining period being required. 
 
5. Pour off the Colloidal blue G staining solution and replace with acetic acid 
destaining solution for 30 – 60 sec and then pour off. 
 
6. Replace with 2 washes of methanol destain solution and leave in the final 
wash over night. The gel can be then photographed and stored in 25% APS 
solution. 
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Appendix 6: Incubation of G. duodenalis trophozoites with PEOs. 
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G. duodenalis trophozoites were incubated for 24 h at 37°C in the presence or 
absence of PEOs at 0.02% or 67 µg ml-1 metronidazole and their viability assessed 
by TBMM. 
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Appendix 7. Determination of the effects of PEO treatment on C. parvum 
oocysts at 5°C and on the maximised in vitro excystation protocol. 
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Figure 1. Determining whether PEO treatment influences maximised in vitro 
excystation when standard excystation triggers are used. 
Oocysts were incubated for 24 h at 37ºC in the presence or absence of PEOs used at 
a final concentration of 0.2%. Following PEO treatment, the remaining unexcysted 
oocysts underwent the maximised in vitro excystation protocol of Robertson, 
Campbell and Smith (1993).   
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Figure 2. Determining whether PEO treatment influences spontaneous 
excystation rate at 5°C. 
Oocysts were incubated for 24 h at 5ºC in the presence or absence of PEOs used at a 
final concentration of 0.2%. 
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Appendix 8. Agarose gel electrophoresis and PCR thermocycler programmes 
 
50 x concentrated Tris-acetate-EDTA (TAE) buffer 
242 g of TRIZMA base (Sigma-Aldrich Company Ltd, Dorset UK) was weighted 
and dissolved in 500ml of distilled water in a 1L beaker, to which 57.1ml of glacial 
acetic acid and 100ml of 0.5M EDTA, pH 8.0 (Sigma-Aldrich Company Ltd, Dorset 
UK) were also added. The solution was mixed on a magnetic stirrer with a magnetic 
stirring rod and made up to a final volume of 1L with distilled water. The expected 
pH is 7.5 – 8.0 and was confirmed using a pH meter (Mettler-Delta 340). 
 
Gel loading buffer 
Bromophenol blue loading buffer (bromophenol blue in 1 x TAE and 50% glycerol) 
was prepared by weighing 50 mg of the dye indicator bromophenol blue in a 15ml 
plastic universal and dissolving the powder in 9.6ml of distilled water. Ten ml of 
glycerol was added to this solution and 0.4ml of 50 x TAE were also added, mixed 
well and stored at room temperature. 
 
Agarose gels 
Agarose gels of 1.4% or 2% strength were prepared by weighing 1.2g or 2g, 
respectively of agarose and adding the powder to a 250ml screw top bottle containing 
50ml of 1 x TAE buffer, the agarose powder remaining in the weighing boat was 
then rinsed with a small volume of 1 x TAE buffer and added to the bottle. The final 
volume was completed to either 80 or 100ml with 1 x TAE buffer. The agarose was 
melted thoroughly by heating in a microwave oven for 2 min. The solution was left 
to cool and 5µl of a 10mg ml-1 ethidium bromide (Sigma-Aldrich) stock solution was 
added to give a final concentration of 0.5µg ml-1. After mixing by swirling the 
agarose was poured into a gel mould fitted with the appropriate comb for moulding 
the agarose gel wells. The gel was left to solidify at room temperature, transferred to 
the gel tank and submerged in 1 x TAE buffer.  
 
The thermocycler programmes used for each PCR assay 
For each pair of primers, the following cycling programme conditions (initial 
denaturation, annealing, elongation, final extension and total number of cycles) used 
is shown below. All PCR amplifications are performed in a GeneAmp® PCR 
Thermal Cycler, model 9700 (Applied Biosystems, Perkin-Elmer, UK). 
 
18S.a. 
PCR1:  
1 cycle of 95°C for 5 min. 
35 cycles of 94°C for 30 sec followed by 60°C for 30 sec followed by 72°Cfor 3 min. 
1 cycle of 72°C for 10 min followed by 4°C. 
 
PCR2: 
1 cycle of 94°C for 1 min. 
35 cycles of 94°C for 30 sec followed by 60°C for 30 sec followed by 72°Cfor 45 
secs. 
1 cycle of 72°C for 10 mins followed by 4°C. 
 
 338
18S.b. 
PCR1:  
1 cycle of 94°C for 3 min. 
35 cycles of 94°C for 45 sec followed by 55°C for 45 sec followed by 72°Cfor 3 min. 
1 cycle of 72°C for 10 min followed by 4°C. 
 
PCR2: 
1 cycle of 94°C for 1 min. 
35 cycles of 94°C for 45 sec followed by 55°C for 45 sec followed by 72°Cfor 3 min. 
1 cycle of 72°C for 7 mins followed by 4°C. 
 
Table 1. Predicted restriction analysis pattern of the amplicon defined by 
primers CPB-DIAG R/F according to available GenBank sequences of the 18S 
rRNA gene. 
Cryptosporidium species 
amplicon length (bp) 
AseI DraI GenBank Accession 
No. 
C. parvum 1 (438) 222, 104, 112 None L16997 
C. parvum 2 (435) 219, 104, 112 None L16996, AF161856 
C. muris (432) 320, 112 None AF093498, 
AF093497 
C. andersoni (431) 319, 112 None AF093496, L19069 
C. felis (455) 239, 104, 112 405, 50 AF087577 
C. baileyi (428) 212, 104, 112 344, 84 L19068, AF093495 
C. meleagridis (434) 171, 104, 112, 47 None AF112574 
C. serpentis (430) 318, 112 None AF093502 
C. wrairi 219, 104, 112 None AF115378 
Cryptosporidium pig 219, 104, 112 None AF108861 
Cryptosporidium desert 
monitor (432) 
216, 108, 112 None AF112573 
Cryptosporidium mouse (439) 175, 104, 112, 48 None AF108863 
Cryptosporidium ferret (438) 174, 103, 113, 48 None AF112572 
Cryptosporidium dog (429) 213, 014, 112 None AF112576 
Cryptosporidium koala (436) 220, 104, 112 None AF108860 
Cryptosporidium kangaroo 
(436) 
220, 104, 112 None AF112570 
Cryptosporidium monkey 
(436) 
220, 104, 112 None AF112569 
Cryptosporidium bear (432) 216, 104, 112 None AF247535 
Cryptosporidium spp. KLJ-7 
(425)  
313, 112  AY324641 
Cryptosporidium cervine (434) 171, 104, 112, 47 None AF442484 
Cryptosporidium QQ7 storm 
W 
226, 112, 104 None AF262333 
Table adapted from Nichols, Campbell and Smith (2003).
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